STOCK TITAN

Braze signs $47.50-a-share merger deal with Salesforce

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
PREM14A

Rhea-AI Filing Summary

Braze, Inc. (BRZE) entered into a merger agreement for acquisition by Salesforce on October 19, 2026. Under the proposed transaction, Salesforce subsidiary Banff Acquisition Sub Inc. will merge into Braze, which will survive as a wholly owned Salesforce subsidiary. At the effective time, Braze Class A holders are entitled to $47.50 in cash per share, without interest, subject to the agreement’s terms and conditions.

The Braze board unanimously approved the agreement and recommends that stockholders vote for it. Closing is expected in Braze’s fiscal year beginning February 1, 2027, subject to stockholder approval and required regulatory clearances; Braze and Salesforce filed HSR notifications on November 12, 2026. Support stockholders agreed to vote 5,999,825 shares, approximately 5.3% of voting power, in favor. If specified regulatory conditions trigger the reverse termination fee, Salesforce would pay Braze $300,000,000; Braze may owe Salesforce $191,390,000 in specified circumstances.

Filing Explained

If the merger closes, unvested RSUs and PSUs continue as Salesforce awards, unlike common shares exchanged for cash.

This preliminary proxy asks Braze stockholders to approve the agreed Salesforce merger; the merger remains pending, with shareholder approval and regulatory clearances required before closing. Approval requires holders of a majority of the voting power of outstanding Class A shares, and abstentions or failures to vote have the same effect as votes against; eligible holders would receive $47.50 cash per share and cease to own Braze stock, while Braze would become a wholly owned Salesforce subsidiary.

At closing, options with an exercise price below $47.50 are canceled for cash based on covered net shares, while options at or above that amount are canceled without payment. Vested RSUs are canceled for cash; unvested RSUs and PSUs convert into Salesforce RSUs, retaining service-based vesting but not PSU performance conditions.

A holder who does not vote in favor may seek court appraisal instead of the merger payment only if the merger closes, the holder continuously owns the shares through the effective time, and statutory procedures are followed; the court-determined value may be higher than, equal to, or lower than $47.50 per share.

Merger consideration $47.50 per share Cash, without interest, for each Braze Class A share at the effective time, subject to the agreement’s terms and conditions.
Shares covered by voting support agreements 5,999,825 shares Support stockholders’ aggregate beneficial ownership as of October 19, 2026; they agreed to vote in favor of the merger.
Voting power covered by support agreements Approximately 5.3% Support stockholders’ aggregate voting power as of October 19, 2026.
Regulatory reverse termination fee $300,000,000 in cash Payable by Salesforce to Braze under specified regulatory termination conditions.
Braze termination fee $191,390,000 in cash Payable by Braze to Salesforce in specified circumstances.
Expected closing period Braze fiscal year beginning February 1, 2027 Expected timing, subject to stockholder approval, regulatory clearances and other conditions.
Merger Consideration financial
"receive the applicable Merger Consideration upon the surrender of such shares"
Merger consideration is the total payment a company or buyer offers to shareholders of a target company in exchange for combining the two businesses, and can include cash, shares in the surviving company, debt assumption, or a mix of these. Investors care because the form and amount affect the deal’s value, tax consequences, immediate cash received versus future ownership, and the risk and upside of holding new shares — similar to choosing between cash now or stock that could grow later.
Regulatory Reverse Termination Fee financial
"referred to as the “Regulatory Reverse Termination Fee”"
A regulatory reverse termination fee is a pre-agreed payment that one party in a merger or acquisition must pay the other if the deal collapses specifically because regulators block or restrict the transaction. For investors it serves as a form of insurance and compensation — like a deposit returned with interest when a home sale falls through — signaling how much each side believes regulatory risk could harm value and helping set expectations for potential losses or payouts.
appraisal rights regulatory
"will have the right to seek appraisal of the fair value of its shares"
A legal right that lets shareholders who dislike the price or terms of a buyout, merger or other major corporate change ask for an independent determination of the fair value of their shares instead of accepting the deal price. Think of it like asking a neutral referee to set the payout if you believe the offered price is too low. For investors, appraisal rights can provide a way to recover a higher cash value but can be slow, costly and create uncertainty around deal outcomes.
Burdensome Condition regulatory
"without the imposition of a Burdensome Condition"
Adjusted RSU technical
"converted into a restricted stock unit award with respect to a number of shares"
HSR Act regulatory
"filed a notification of the proposed merger under the HSR Act"
The HSR Act (Hart‑Scott‑Rodino Antitrust Improvements Act) requires companies in the United States to notify federal regulators and observe a waiting period before completing certain large mergers or acquisitions so authorities can check for anti-competitive effects. For investors it matters because the review can delay or block deals, force changes such as selling assets, and alter the expected value or timing of a transaction—like needing a permit before finalizing a major home renovation.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much will Salesforce pay per share for BRZE?

Braze Class A holders are entitled to receive $47.50 in cash per share, without interest, at the merger’s effective time, subject to the agreement’s terms and conditions.

When could Salesforce’s acquisition of BRZE close?

The merger is expected to close in Braze’s fiscal year beginning February 1, 2027, subject to stockholder approval, required regulatory clearances and the other closing conditions.

What vote is required to approve BRZE’s merger with Salesforce?

Approval requires holders of at least a majority of the outstanding Class A voting power to vote in favor of the merger agreement. The agreement also requires specified regulatory clearances, including expiration or termination of the applicable HSR Act waiting period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

TABLE OF CONTENTS

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant  ☐
Check the appropriate box:
☒
Preliminary Proxy Statement
 ☐
Confidential, for Use of the Commission Only (as permitted by Rule 14a 6(e)(2))
 ☐
Definitive Proxy Statement
 ☐
Definitive Additional Materials
 ☐
Soliciting Material under § 240.14a 12
BRAZE, INC.
(Name of Registrant as Specified In Its Charter)
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
 ☐
No fee required.
☒
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
 ☐
Fee paid previously with preliminary materials.

TABLE OF CONTENTS

PRELIMINARY PROXY STATEMENT – SUBJECT TO COMPLETION
DATED NOVEMBER 20, 2026

 
MERGER PROPOSED—YOUR VOTE IS VERY IMPORTANT
Dear Braze, Inc. Stockholder:
On October 19, 2026, Braze, Inc. (referred to as “Braze”), Salesforce, Inc. (referred to as “Salesforce”) and Banff Acquisition Sub Inc., a wholly owned subsidiary of Salesforce (referred to as “Banff Acquisition Sub”), entered into an Agreement and Plan of Merger that provides for the acquisition of Braze by Salesforce (such agreement, as it may be amended, supplemented or modified from time to time, referred to as the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, Banff Acquisition Sub will merge with and into Braze (referred to as the “Merger”), with Braze surviving the Merger as a wholly owned subsidiary of Salesforce. The Braze board of directors (referred to as the “Braze Board of Directors”) has unanimously approved the Merger Agreement and the Merger.
Upon the terms and subject to the conditions of the Merger Agreement, at the effective time of the Merger, you will be entitled to receive, for each share of Class A Common Stock of Braze, par value $0.0001 per share (referred to as the “Class A Common Stock”), that you own, $47.50 in cash, without interest.
The Braze Board of Directors has unanimously (i) determined that the terms of the Merger Agreement and the transactions contemplated thereby (referred to as the “Transactions”), including the Merger, are fair to, and in the best interests of, Braze and Braze stockholders, (ii) determined that it is fair to and in the best interests of Braze and Braze stockholders, and declared it advisable, to enter into the Merger Agreement, (iii) approved the execution and delivery by Braze of the Merger Agreement and by the stockholders party to the voting and support agreement entered into in connection with the Transactions (referred to as the “Voting and Support Agreement”) of the Voting and Support Agreement, the performance by Braze of its covenants and agreements contained in the Merger Agreement and the consummation of the Merger and the other Transactions, in each case, upon the terms and subject to the conditions contained in the Merger Agreement and (iv) resolved to recommend that Braze stockholders approve and adopt the Merger Agreement and the Transactions, including the Merger.
At the special meeting of Braze stockholders described in the accompanying proxy statement (referred to as the “Special Meeting”), you will be asked to approve a proposal to adopt the Merger Agreement (referred to as the “Merger Agreement Proposal”) and to vote on other Merger-related matters. The Braze Board of Directors unanimously recommends that Braze stockholders vote “FOR” the Merger Agreement Proposal and “FOR” each of the other proposals described in the accompanying proxy statement.
Your vote is very important regardless of the number of shares of Class A Common Stock that you own. Salesforce and Braze cannot complete the Merger without the approval of the Merger Agreement Proposal by Braze stockholders holding at least a majority of the voting power of the shares of Class A Common Stock outstanding at the close of business on   ,   , the record date for the Special Meeting. The failure of any Braze stockholder to vote will have the same effect as a vote against the Merger Agreement Proposal. Whether or not you plan to attend the Special Meeting, Braze urges you to submit a proxy by following the instructions on the accompanying proxy card. We encourage you to submit your vote as soon as possible. If you have internet access, we encourage you to record your vote via the internet. You may revoke your proxy or change your vote at any time before it is voted at the Special Meeting. If you are a beneficial owner, i.e., your shares of Class A Common Stock are held in “street name” in the name of a bank, brokerage firm or other nominee, you should instruct your bank, brokerage firm or other nominee how to vote your shares in accordance with the voting instruction form furnished by such bank, brokerage firm or other nominee. Your bank, brokerage firm or other nominee cannot vote on any of the proposals on your behalf, including the Merger Agreement Proposal, without your instructions. If you do not provide your bank, brokerage firm or other nominee with voting instructions, your shares of Class A Common Stock will not be counted for purposes of determining whether a quorum is present and will not be voted at the Special Meeting, which will have the same effect as a vote “AGAINST” the Merger Agreement Proposal. More information about Salesforce, Braze, the Special Meeting, the Merger and the other proposals for consideration at the Special Meeting is contained in the accompanying proxy statement and notice of the Special Meeting.

TABLE OF CONTENTS

The enclosed notice of the Special Meeting and the accompanying proxy statement provide detailed information about the Special Meeting, the Merger Agreement and the Merger. A copy of the Merger Agreement is attached as Annex A to the accompanying proxy statement. Please carefully read the entire accompanying proxy statement and the annexes and documents included in the accompanying proxy statement, or incorporated by reference therein, including the full text of the Merger Agreement.
On behalf of the Braze Board of Directors, thank you for your continued support.
William Magnuson
Chief Executive Officer
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THE MERGER, PASSED UPON THE MERITS OF THE MERGER AGREEMENT, THE MERGER OR THE TRANSACTIONS, OR HAS DETERMINED IF THE ACCOMPANYING PROXY STATEMENT IS ACCURATE OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
The accompanying notice of the Special Meeting and the accompanying proxy statement are dated   ,    and are first being mailed to Braze stockholders on or about   ,   .

TABLE OF CONTENTS

PRELIMINARY PROXY STATEMENT – SUBJECT TO COMPLETION
DATED NOVEMBER 20, 2026

 
Braze, Inc.
63 Madison Building
28 E. 28th St., 12th Floor
New York, New York 10016
NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
TO BE HELD ON    ,    
Dear Braze, Inc. Stockholder:
This is a notice that a special meeting of stockholders of Braze, Inc. (referred to as “Braze”) will be held on    ,     beginning at    ,    , Eastern Time (such meeting, and any adjournments, postponements or continuations thereof, is referred to as the “Special Meeting”). The Special Meeting will be a completely virtual, live audio webcast meeting of stockholders and will be held for the following purposes:
1.
to adopt the Agreement and Plan of Merger, dated as of October 19, 2026, as it may be amended, modified or supplemented from time to time (such agreement, as it may be amended, modified or supplemented from time to time, is referred to as the “Merger Agreement”), by and among Braze, Salesforce, Inc., a Delaware corporation (referred to as “Salesforce”), and Banff Acquisition Sub Inc., a Delaware corporation and a wholly owned subsidiary of Salesforce (referred to as “Banff Acquisition Sub”), pursuant to which, upon the terms and subject to the conditions of the Merger Agreement, Banff Acquisition Sub will merge with and into Braze (referred to as the “Merger”), with Braze surviving the Merger as a wholly owned subsidiary of Salesforce (referred to as the “Merger Agreement Proposal”);
2.
to approve on an advisory (non-binding) basis the compensation that may be paid or become payable to Braze’s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated thereby (referred to as the “Merger-Related Compensation Proposal”); and
3.
to approve the adjournment from time to time of the Special Meeting, if deemed necessary or appropriate by the Braze board of directors (referred to as the “Braze Board of Directors”) or any committee thereof, including to solicit additional proxies if there are insufficient votes to approve the Merger Agreement Proposal at the time of the Special Meeting (referred to as the “Adjournment Proposal”).
The accompanying proxy statement of which this notice is a part (a) incorporates important business and financial information about Braze from other documents that Braze has filed with the U.S. Securities and Exchange Commission and that are contained in or incorporated by reference into the proxy statement and (b) provides a detailed description of the Merger and the Merger Agreement and the other matters to be considered at the Special Meeting, including the proposals listed above. Please refer to the accompanying proxy statement, including the Merger Agreement and the other annexes and documents included in, or incorporated by reference into, the accompanying proxy statement for further information with respect to the business to be transacted at the Special Meeting. You are encouraged to read the entire proxy statement carefully before voting. The Braze Board of Directors has unanimously (i) determined that the terms of the Merger Agreement and the transactions contemplated thereby (referred to as the “Transactions”), including the Merger, are fair to, and in the best interests of, Braze and Braze stockholders, (ii) determined that it is fair to and in the best interests of Braze and Braze stockholders, and declared it advisable, to enter into the Merger Agreement, (iii) approved the execution and delivery by Braze of the Merger Agreement and by the stockholders party to the voting and support agreement entered into in connection with the Transactions (referred to as the “Voting and Support Agreement”) of the Voting and Support Agreement, the performance by Braze of its covenants and agreements contained in the Merger Agreement and the consummation of the Merger and the other Transactions upon the terms and subject to the conditions contained in the Merger Agreement and (iv) resolved to recommend that Braze stockholders approve and adopt the Merger Agreement and the Transactions, including the Merger.

TABLE OF CONTENTS

The Braze Board of Directors unanimously recommends that Braze stockholders vote “FOR” the Merger Agreement Proposal, “FOR” the Merger-Related Compensation Proposal and “FOR” the Adjournment Proposal.
The Braze Board of Directors has fixed the close of business on    ,    , as the record date for determination of Braze stockholders entitled to receive notice of, and to vote at, the Special Meeting (including any adjournments, postponements or continuations thereof) (referred to as the “Record Date”). Only holders of record of Class A Common Stock of Braze, par value $0.0001 per share (referred to as the “Class A Common Stock”), as of the close of business on the Record Date are entitled to receive notice of, and to vote at, the Special Meeting.
A holder of Class A Common Stock who does not vote in favor of the Merger Agreement Proposal will have the right to seek appraisal of the fair value of its shares if the Merger is completed, but only if such stockholder or beneficial owner submits a written demand for appraisal to Braze prior to the time the vote is taken on the Merger Agreement Proposal and strictly complies with the procedures set forth in Section 262 (referred to as “Section 262”) of the Delaware General Corporation Law (referred to as the “DGCL”), and does not validly withdraw or otherwise lose its appraisal rights. However, because the Class A Common Stock is currently listed on a national securities exchange, and, assuming such shares of Class A Common Stock remain listed on a national securities exchange immediately prior to the Merger (which is expected to be the case), after an appraisal petition has been filed, the Delaware Court of Chancery will dismiss appraisal proceedings as to all holders of such shares who are otherwise entitled to appraisal rights unless (1) the total number of shares of Class A Common Stock entitled to appraisal exceeds 1% of the outstanding shares of Class A Common Stock eligible for appraisal or (2) the value of the aggregate Merger Consideration in respect of such total number of shares of Class A Common Stock exceeds $1,000,000. A copy of the applicable DGCL statutory provisions may be accessed without subscription or cost at the following publicly available website: https://delcode.delaware.gov/title8/c001/sc09/index.html#262, and a summary of these provisions can be found under the section titled “Appraisal Rights of Braze Stockholders” beginning on page 92 of the accompanying proxy statement. This notice and the accompanying proxy statement shall constitute notice to you from us of the availability of appraisal rights under Section 262 of the DGCL in connection with the Merger.
YOUR VOTE IS VERY IMPORTANT, REGARDLESS OF THE NUMBER OF SHARES THAT YOU OWN.
The Merger cannot be completed unless the Merger Agreement Proposal is approved by the affirmative vote, in person (virtually) or by proxy, of holders of at least a majority of the voting power of the shares of Class A Common Stock outstanding and entitled to vote thereon. Only holders of Class A Common Stock are entitled to vote at the Special Meeting, and each share of Class A Common Stock will be entitled to one vote per share on all matters submitted to stockholders at the Special Meeting.
If you fail to (1) return your proxy card, (2) grant your proxy electronically over the internet or by telephone, (3) attend the Special Meeting in person (virtually) or (4) if you hold your shares beneficially, instruct your bank, brokerage firm or other nominee on how to vote your shares at the Special Meeting in accordance with the bank’s, brokerage firm’s or other nominee’s voting instruction card, your shares will not be counted for purposes of determining whether a quorum is present at the Special Meeting. If a quorum is present and you fail to take one of the foregoing steps, your shares will have the same effect as if they were voted “AGAINST” the proposal to adopt the Merger Agreement but will have no effect on the other proposals.
Whether or not you expect to participate in the Special Meeting, Braze urges you to vote your shares as promptly as possible by following the instructions shown on the enclosed proxy card to vote: (1) via the internet at www.proxyvote.com (see the enclosed proxy card for instructions); (2) by telephone (see the enclosed proxy card for instructions); or (3) by completing, signing and returning the enclosed proxy card in the postage-paid envelope provided, so that your shares may be represented and voted at the Special Meeting. If your shares are held in “street name” by a bank, brokerage firm or other nominee, you should instruct your bank, brokerage firm or other nominees how to vote your shares in accordance with the voting instruction form furnished by such bank, brokerage firm or other nominee.
Braze stockholders of record as of    ,     will be able to attend and participate in the Special Meeting (including by being deemed to be present in person and to vote at the meeting) by visiting www.virtualshareholdermeeting.com/BRZE2027SM and entering the 16-digit control number included on your proxy card that accompanied your proxy materials. If you are a beneficial owner of shares of Class A Common

TABLE OF CONTENTS

Stock (i.e., you hold in “street name”) and your voting instruction form indicates that you may vote those shares through the www.proxyvote.com website, then you may access, attend, participate in and vote at the Special Meeting with the 16-digit control number indicated on that voting instruction form by visiting www.virtualshareholdermeeting.com/BRZE2027SM. If you cannot locate your control number, Braze stockholders who hold their shares in “street name” should contact their bank, broker, or other nominee (preferably at least five days before the Special Meeting) and obtain their 16-digit control number or a legal proxy in order to be able to attend, participate in, or vote at the Special Meeting. Your bank, broker or other nominee cannot vote on any of the proposals, including the Merger Proposal, without your instructions.
If you are a Braze stockholder of record, voting electronically at the Special Meeting will revoke any proxy that you previously submitted. If you hold your shares through a bank, broker or other nominee, you must either follow the instructions above to obtain your 16-digit control number or obtain a legal proxy to vote in person at the Special Meeting. You should contact your bank, broker or other nominee to obtain a legal proxy.
If you have any questions about the Special Meeting, the Merger, the proposals or the accompanying proxy statement, would like additional copies of this proxy statement, need to obtain proxy cards or other information related to this proxy solicitation or need help submitting a proxy or voting your shares of Class A Common Stock, please contact the firm assisting us with the solicitation of proxies:

 
500 Fifth Avenue, 21st Floor
New York, NY 10110
Stockholders May Call:
(877) 456-3524 (toll-free from the U.S. and Canada), or
+1 (412) 232-3651 (from other countries)
Banks and Brokers May Call Collect: (212) 750-5833
The above summary is not complete and is qualified in its entirety by reference to the complete text of this proxy statement, including all annexes. We urge you to read this proxy statement in its entirety for a more complete description of the Merger Agreement and the Transactions, including the Merger, and the actions taken by the Braze Board of Directors.
By order of the Braze Board of Directors,
 
Christopher M. Lal
General Counsel & Corporate Secretary
Dated:    ,    
New York, New York

TABLE OF CONTENTS

TABLE OF CONTENTS
 
 
 
 
 
 
 
PAGE
SUMMARY
 
 
1
The Companies
 
 
1
Braze, Inc.
 
 
1
Salesforce, Inc.
 
 
1
Banff Acquisition Sub Inc.
 
 
2
The Merger
 
 
2
Merger Consideration
 
 
2
Treatment of Braze Equity Awards
 
 
3
Braze’s Reasons for the Merger; Recommendation of the Braze Board of Directors
 
 
4
Opinion of Qatalyst Partners LP
 
 
4
Voting and Support Agreement
 
 
5
Material U.S. Federal Income Tax Consequences of the Merger
 
 
5
Regulatory Clearances and Approvals Required for the Merger
 
 
6
Expected Timing of the Merger
 
 
7
Conditions to the Merger
 
 
7
No Solicitation of Other Offers by Braze
 
 
7
Change of Recommendation; Match Rights
 
 
8
Termination of the Merger Agreement
 
 
9
Termination Fee
 
 
10
Enforcement and Remedies
 
 
12
Appraisal Rights of Braze Stockholders
 
 
12
Special Meeting
 
 
13
Interests of Braze’s Directors and Executive Officers in the Merger
 
 
14
Directors’ and Officers’ Indemnification and Insurance
 
 
14
QUESTIONS AND ANSWERS
 
 
16
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
 
 
26
THE COMPANIES
 
 
28
Braze, Inc.
 
 
28
Salesforce, Inc.
 
 
28
Banff Acquisition Sub Inc.
 
 
28
THE SPECIAL MEETING
 
 
29
General
 
 
29
Date, Time and Place of the Special Meeting
 
 
29
Purposes of the Special Meeting
 
 
29
Recommendation of the Braze Board of Directors
 
 
29
Virtual Participation at Special Meeting
 
 
30
Outstanding Shares as of the Record Date
 
 
30
Record Date; Stockholders Entitled to Vote
 
 
30
Quorum; Abstentions; Broker Non-Votes
 
 
30
Required Vote; Treatment of Abstentions and Failure to Vote
 
 
31
Shares and Voting of Braze Directors and Executive Officers
 
 
31
How to Vote or Have Your Shares Voted
 
 
31
Revocation of Proxies
 
 
33
Delivery of Proxy Materials
 
 
33
Shares Held in Name of Broker
 
 
33
Tabulation of Votes
 
 
33
Solicitation of Proxies
 
 
33
Adjournments
 
 
33
 
 
 
 
i

TABLE OF CONTENTS

 
 
 
 
 
 
 
PAGE
THE MERGER (PROPOSAL 1)
 
 
35
Effects of the Merger
 
 
35
Effect on Braze if the Merger Is Not Completed
 
 
35
Background of the Merger
 
 
36
Braze’s Reasons for the Merger; Recommendation of the Braze Board of Directors
 
 
44
Opinion of Qatalyst Partners LP
 
 
49
Certain Unaudited Projected Financial Information
 
 
55
Interests of Braze’s Directors and Executive Officers in the Merger
 
 
56
Quantification of Potential Payments and Benefits to Braze’s Named Executive Officers in Connection with the Merger
 
 
62
Regulatory Clearances and Approvals Required for the Merger
 
 
63
Expected Timing of the Merger
 
 
65
Delisting and Deregistration of Class A Common Stock
 
 
65
Appraisal Rights of Braze Stockholders
 
 
65
THE MERGER AGREEMENT
 
 
66
Explanatory Note Regarding the Merger Agreement
 
 
66
The Merger
 
 
66
Completion and Effectiveness of the Merger
 
 
66
Merger Consideration
 
 
67
Treatment of Braze Equity Awards and the Braze ESPP
 
 
68
Representations and Warranties
 
 
70
Material Adverse Effect
 
 
71
Conduct of Business Before Completion of the Merger
 
 
72
No Solicitation of Other Offers by Braze
 
 
76
Braze Special Meeting and Board Recommendation
 
 
79
Change of Recommendation; Match Rights
 
 
80
Access
 
 
81
Treatment of Indebtedness
 
 
81
HSR and Other Regulatory Approvals
 
 
82
Employee Matters
 
 
83
Directors’ and Officers’ Indemnification and Insurance
 
 
84
Other Covenants and Agreements
 
 
84
Conditions to the Merger
 
 
85
Termination of the Merger Agreement
 
 
86
Termination Fee
 
 
87
Effect of Termination
 
 
89
Expenses
 
 
89
Amendments, Enforcement and Remedies, Extensions and Waivers
 
 
90
THE VOTING AND SUPPORT AGREEMENT
 
 
91
APPRAISAL RIGHTS OF BRAZE STOCKHOLDERS
 
 
92
ADVISORY VOTE ON NAMED EXECUTIVE OFFICER MERGER-RELATED COMPENSATION ARRANGEMENTS (PROPOSAL 2)
 
 
98
Overview
 
 
98
Vote Required for Approval
 
 
98
Recommendation of the Braze Board of Directors
 
 
98
VOTE ON ADJOURNMENT (PROPOSAL 3)
 
 
99
Overview
 
 
99
Vote Required for Approval
 
 
99
Recommendation of the Braze Board of Directors
 
 
99
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
 
 
100
 
 
 
 
ii

TABLE OF CONTENTS

 
 
 
 
 
 
 
PAGE
MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE MERGER
 
 
102
FUTURE BRAZE STOCKHOLDER PROPOSALS
 
 
105
MULTIPLE STOCKHOLDERS SHARING ONE ADDRESS
 
 
106
WHERE YOU CAN FIND MORE INFORMATION
 
 
107
MISCELLANEOUS
 
 
109
Annex A
 
 
A-1
Annex B
 
 
B-1
Annex C
 
 
C-1
 
 
 
 
iii

TABLE OF CONTENTS

SUMMARY
The following summary highlights selected information described in more detail elsewhere in this proxy statement and the documents incorporated by reference into this proxy statement and may not contain all the information that may be important to you. The summary is not complete and is qualified in its entirety by reference to the complete text of this proxy statement. To understand the Merger and the matters being voted on by Braze stockholders at the Special Meeting more fully, and to obtain a more complete description of the legal terms of the Merger Agreement, you should carefully read this entire proxy statement, including the annexes, and the documents to which we refer you. Each item in this summary includes a page reference directing you to a more complete description of that topic. See the section titled “Where You Can Find More Information.”
All references to “Braze,” “we,” “us” or “our” in this proxy statement refer to Braze, Inc., a Delaware corporation, including, in some cases, its subsidiaries; all references to “Salesforce” refer to Salesforce, Inc., a Delaware corporation; all references to “Banff Acquisition Sub” refer to Banff Acquisition Sub Inc., a Delaware corporation and a wholly owned subsidiary of Salesforce incorporated for the sole purpose of consummating the Merger; all references to “Class A Common Stock” refer to the Class A Common Stock of Braze, par value $0.0001 per share; all references to the “Braze Board of Directors” refer to the board of directors of Braze; all references to the “Special Meeting” refer to the Special Meeting of Braze stockholders described in this proxy statement and any adjournments, postponements or continuations thereof; all references to the “Merger” refer to the Merger of Banff Acquisition Sub with and into Braze, with Braze surviving as a wholly owned subsidiary of Salesforce; all references to the “Closing” refer to the closing of the Merger; all references to the “Closing Date” refer to the date on which the Closing occurs; and, unless otherwise indicated or as the context requires, all references to the “Merger Agreement” refer to the Agreement and Plan of Merger, dated as of October 19, 2026, as may be amended from time to time, by and among Braze, Salesforce and Banff Acquisition Sub. Braze, following the completion of the Merger, is sometimes referred to in this proxy statement as the “Surviving Corporation.”
The Companies (see page 28)
Braze, Inc.
Braze helps marketers build deeper customer relationships by responding to customer behavior in real time, coordinating personalized experiences across mobile apps, websites, email, SMS, WhatsApp, and more. Braze’s cloud-native, event-streaming architecture is optimized for high-volume, real-time B2C engagement, continuously updating customer profiles and adapting customer journeys while powering trillions of messages and journey actions each year. Braze’s artificial intelligence (referred to as “AI”) platform, BrazeAI extends these capabilities with AI-powered optimization across content, offers, channels, and timing, helping marketers make each interaction more relevant.
Braze was founded in 2011. Braze completed its initial public offering in 2021 and its Class A Common Stock is currently listed on The Nasdaq Stock Market LLC (referred to as the “Nasdaq”) under the symbol “BRZE.” Braze’s principal executive offices are located at 63 Madison Building, 28 East 28th Street, Floor 12, New York, New York 10016, and its telephone number is (609) 964-0585.
Salesforce, Inc.
Salesforce is a global leader in customer relationship management technology that brings companies and customers together. With the deeply unified Agentforce 360 Platform, Salesforce delivers a single source of truth, connecting customer data with integrated AI across systems, apps and devices to help companies sell, service, market and conduct commerce from anywhere. Salesforce offers Agentforce, a layer of the trusted Agentforce 360 Platform, that enables companies to build and deploy AI agents that can respond to inputs, make decisions and take action autonomously across business functions. Agentforce includes a suite of customizable agents for use across sales, service, marketing and commerce. Since its founding in 1999, Salesforce has enabled companies of every size and industry to transform their businesses in the digital-first world, pioneering innovations in cloud, mobile, social, analytics and AI.
Salesforce common stock is traded on the New York Stock Exchange under the ticker symbol “CRM.”
1

TABLE OF CONTENTS

Salesforce’s executive offices and principal facilities are located at Salesforce Tower, 415 Mission Street, 3rd Floor, San Francisco, California 94105. Its telephone number is 415-901-7000 and its website is www.salesforce.com. The information provided on Salesforce’s website is not part of this proxy statement and is not incorporated in this proxy statement by reference by this or any other reference to its website provided in this proxy statement.
Banff Acquisition Sub Inc.
Banff Acquisition Sub is a Delaware corporation and a wholly owned subsidiary of Salesforce. Banff Acquisition Sub was formed solely for the purpose of engaging in the Merger and the other transactions contemplated by the Merger Agreement (collectively referred to as the “Transactions”). Banff Acquisition Sub has engaged in no business activities to date and it has no material assets or liabilities of any kind, other than those incident to its formation in connection with the Merger and the Transactions. Upon consummation of the Merger, Banff Acquisition Sub will be merged with and into Braze, with Braze surviving the merger as a wholly owned subsidiary of Salesforce, and Banff Acquisition Sub will cease to exist.
Banff Acquisition Sub’s address is c/o Salesforce, Inc., Salesforce Tower, 415 Mission Street, 3rd Floor, San Francisco, CA 94105.
The Merger (see page 66)
Upon the terms and subject to the conditions of the Merger Agreement, and in accordance with the relevant provisions of the General Corporation Law of the State of Delaware (referred to as the “DGCL”), at the Effective Time (as defined below), Banff Acquisition Sub will merge with and into Braze and the separate existence of Banff Acquisition Sub will cease. Braze will continue as the Surviving Corporation and as a wholly owned subsidiary of Salesforce.
The Merger will become effective at such time as the certificate of merger is duly filed with the Secretary of State of the State of Delaware (or at such later time as may be agreed by Braze and Salesforce and specified in the certificate of merger) (referred to as the “Effective Time”).
If the Merger is completed, Braze will cease to be a publicly traded company as of the Effective Time. As a result, you will not own any shares of capital stock of the Surviving Corporation.
The terms and conditions of the Merger are contained in the Merger Agreement. This summary describes certain material provisions of the Merger Agreement. This summary is not complete and is qualified in its entirety by reference to the complete text of the Merger Agreement, which is attached to this proxy statement as Annex A and is incorporated by reference herein in its entirety. Braze and Salesforce urge you to read the Merger Agreement carefully and in its entirety, as it is the legal document that governs the Merger and because this summary may not contain all the information about the Merger Agreement that may be important to you.
Merger Consideration (see page 67)
At the Effective Time, by virtue of the Merger and without any action on the part of the holder thereof:
•
each share of Class A Common Stock issued and outstanding immediately prior to the Effective Time (other than any Dissenting Shares, Cancelled Shares or Converted Shares) (each such term, as defined below) will be converted into the right to receive $47.50 per share in cash, without interest (referred to as the “Merger Consideration”);
•
each holder of a valid certificate or certificates which immediately prior to the Effective Time represented any shares of Class A Common Stock (a “certificate”) or evidenced by way of book-entry in the register of Braze stockholders immediately prior to the Effective Time (each referred to as a “Book-Entry Share”) will thereafter cease to have any rights with respect to such shares of Class A Common Stock, except the right to receive the Merger Consideration upon the surrender of such shares of Class A Common Stock in accordance with the terms of the Merger Agreement;
•
each share of Class A Common Stock issued and outstanding immediately prior to the Effective Time that is owned or held in treasury by Braze or is owned by Salesforce will be cancelled without any consideration delivered in exchange therefor and will cease to exist (referred to as the “Cancelled Shares”);
2

TABLE OF CONTENTS

•
each share of Class A Common Stock issued and outstanding immediately prior to the Effective Time that is owned by any direct or indirect wholly owned subsidiary of Salesforce or of Braze (referred to as the “Converted Shares”) will be converted into such number of shares of common stock of the Surviving Corporation (referred to as the “Surviving Corporation Stock”) equal to the product of (i) (x) the number of shares of Class A Common Stock held by such subsidiary immediately prior to the Effective Time, divided by (y) the number of shares of Class A Common Stock outstanding immediately prior to the Effective Time, and (ii) the total number of shares of Surviving Corporation Stock outstanding immediately after the consummation of the Merger; and
•
each share of Banff Acquisition Sub common stock issued and outstanding immediately prior to the Effective Time will automatically be converted into and become one validly issued, fully paid and nonassessable share of Surviving Corporation Stock.
From and after the Effective Time, all shares of Class A Common Stock (other than any Dissenting Shares, Cancelled Shares or Converted Shares), will cease to be issued and outstanding and will automatically be cancelled and cease to exist. Each holder of a share of Class A Common Stock that was outstanding immediately prior to the Effective Time will cease to have any rights with respect thereto, except the right to receive the applicable Merger Consideration upon the surrender of such shares of Class A Common Stock in accordance with the Merger Agreement. The Merger Consideration will not be paid, nor will any distribution be made, in respect of any Dissenting Shares, Cancelled Shares or Converted Shares.
For additional information on the consideration Braze stockholders will receive in connection with the Merger, see the section titled “The Merger Agreement—Merger Consideration.”
Treatment of Braze Equity Awards (see page 68)
The Merger Agreement provides that, at the Effective Time, outstanding Braze equity awards will be treated as follows:
Options. Each option to purchase shares of Class A Common Stock (each referred to as a “Braze Option”) granted under either Braze’s 2021 Equity Incentive Plan or Braze’s Amended and Restated 2011 Equity Incentive Plan (together, the “Braze Equity Plans”) that has a per share exercise price that is less than the Merger Consideration (each such Braze Option, an “In-the-Money Braze Option”) and that is outstanding and unexercised immediately prior to the Effective Time will be cancelled and converted into the right to receive the Merger Consideration in respect of each Net Share (as defined in the section titled “The Merger Agreement—Treatment of Braze Equity Awards and the Braze ESPP”) covered by such Braze Option, without interest. Each Braze Option that is not an In-the-Money Braze Option, whether or not vested, will be cancelled for no consideration.
Director RSUs and Vested RSUs. Each restricted stock unit award relating to shares of Class A Common Stock granted under any Braze Equity Plan that is subject solely to service-based vesting requirements (each referred to as a “Braze RSU”) that is held by a non-employee director or that is otherwise vested as of the Closing (together, referred to as the “Vested RSUs”) will be cancelled and converted into the right to receive the Merger Consideration in respect of each share of Class A Common Stock subject to such Braze RSU, without interest.
Unvested RSUs. Each Braze RSU that is not a Vested RSU (referred to as the “Unvested RSUs”) will be assumed and converted into a restricted stock unit award with respect to a number of shares of Salesforce common stock, par value $0.001 per share (an “Adjusted RSU”) equal to the number of shares of Class A Common Stock subject to such Braze RSU multiplied by the Conversion Ratio (as defined in the section titled “The Merger Agreement—Treatment of Braze Equity Awards and the Braze ESPP”) (rounded to the nearest whole share), and will otherwise remain subject to the same terms and conditions (including vesting terms) as applied to the corresponding Braze RSU.
PSUs. Each restricted stock unit award relating to shares of Class A Common Stock granted under any Braze Equity Plan that is subject to performance-based and service-based vesting requirements (each referred to as a “Braze PSU”) that is outstanding and unvested will be assumed and converted into an Adjusted RSU, with the number of shares of Class A Common Stock subject to such Braze PSU determined (i) for any performance period completed prior to the Closing Date, based on actual performance and (ii) for any performance period not completed prior to the Closing Date, at target (except that, if the Closing Date occurs prior to February 1, 2027, the number of Braze PSUs earned for the performance period beginning February 1, 2026 will be based on the greater of target and actual performance), multiplied by the Conversion Ratio (rounded to the nearest whole share). Each such Adjusted
3

TABLE OF CONTENTS

RSU will otherwise remain subject to the same terms and conditions (including vesting terms, but excluding any performance-based vesting conditions) as applied to the corresponding Braze PSU.
Restricted Shares. Each share of Class A Common Stock held by certain specified individuals that is subject to a substantial risk of forfeiture immediately prior to the Effective Time (each referred to as an “Assumed Braze Restricted Share”) will be assumed and converted into a number of shares of restricted Salesforce common stock (an “Adjusted Restricted Share”) based on the Conversion Ratio, on the same terms and conditions (including vesting terms), and each such share held by certain other specified individuals (each referred to as a “Cashout Braze Restricted Share” and, together with the Assumed Braze Restricted Shares, the “Braze Restricted Shares”) will be converted into the right to receive the Merger Consideration, without interest.
Salesforce may, with respect to holders of Braze equity awards (other than Braze Restricted Shares) employed outside the United States, if it determines that the foregoing treatment would reasonably be expected to cause a significant administrative burden to Salesforce, either (i) convert such awards into cash-based awards on the same terms and conditions, in certain specified jurisdictions, or (ii) cash out such awards at the Closing based on the value of the Merger Consideration. For additional information on the treatment of Braze equity awards in connection with the Merger, see the section titled “The Merger Agreement—Treatment of Braze Equity Awards and the Braze ESPP.”
Braze’s Reasons for the Merger; Recommendation of the Braze Board of Directors (see page 44)
At its October 19, 2026 meeting held to evaluate the Merger, the Braze Board of Directors unanimously (i) determined that the terms of the Merger Agreement and the Transactions, including the Merger, are fair to, and in the best interests of, Braze and Braze stockholders, (ii) determined that it is fair to and in the best interests of Braze and Braze stockholders, and declared it advisable, to enter into the Merger Agreement, (iii) approved the execution and delivery by Braze of the Merger Agreement and by the Support Stockholders (as defined below) of the Voting and Support Agreement (as defined below), the performance by Braze of its covenants and agreements contained in the Merger Agreement and the consummation of the Merger and the other Transactions upon the terms and subject to the conditions contained in the Merger Agreement and (iv) resolved to recommend that Braze stockholders approve and adopt the Merger Agreement and the Transactions including the Merger (the recommendation described in clause (iv) is referred to as the “Braze Board Recommendation”).
The Braze Board of Directors unanimously recommends that Braze stockholders vote “FOR” the Merger Agreement Proposal (as defined below), “FOR” the Merger-Related Compensation Proposal (as defined below), and “FOR” the Adjournment Proposal (as defined below).
In evaluating the Merger and the Merger Agreement and arriving at its determination, the Braze Board of Directors consulted with Braze’s senior management, Braze’s financial advisor, Qatalyst Partners LP (referred to as “Qatalyst Partners”), and Braze’s outside legal counsel, Davis Polk & Wardwell LLP (referred to as “Davis Polk”), and considered a number of substantive factors, both positive and negative, and potential benefits and detriments of the Merger to Braze and Braze stockholders, as described in more detail in the section titled “The Merger (Proposal 1)—Braze’s Reasons for the Merger; Recommendation of the Braze Board of Directors.”
Opinion of Qatalyst Partners LP (see page 49)
Braze retained Qatalyst Partners to act as its financial advisor in connection with a potential transaction such as the Merger and to evaluate whether the Merger Consideration, to be received pursuant to, and in accordance with, the terms of the Merger Agreement by the holders of shares of Class A Common Stock (other than Salesforce or any affiliate of Salesforce) (referred to as the “Holders”) was fair, from a financial point of view, to such Holders. Braze selected Qatalyst Partners to act as Braze’s financial advisor based on Qatalyst Partners’ qualifications, reputation and experience, including its familiarity with Braze and its business. Qatalyst Partners has provided its written consent to the reproduction of its opinion in this proxy statement. At the meeting of the Braze Board of Directors on October 19, 2026, Qatalyst Partners rendered to the Braze Board of Directors its oral opinion, subsequently confirmed in writing, to the effect that, as of the date thereof and based upon and subject to the various assumptions, qualifications, limitations and other matters set forth therein, the Merger Consideration to be received by the Holders pursuant to, and in accordance with, the terms of the Merger Agreement was fair, from a financial point of view, to such Holders.
4

TABLE OF CONTENTS

The full text of Qatalyst Partners’ written opinion, dated October 19, 2026, is attached to this proxy statement as Annex C and is incorporated by reference herein. The opinion sets forth, among other things, the assumptions made, procedures followed, matters considered and limitations and qualifications of the review undertaken by Qatalyst Partners in rendering its opinion. Holders should read the opinion carefully in its entirety. Qatalyst Partners’ opinion was provided to the Braze Board of Directors and addresses only, as of the date of the opinion, and based upon and subject to the various assumptions, qualifications, limitations and other matters set forth therein, the fairness, from a financial point of view, of the Merger Consideration to be received by the Holders pursuant to, and in accordance with, the terms of the Merger Agreement, to such Holders, and it does not address any other aspect of the Merger. Qatalyst Partners’ opinion does not constitute a recommendation as to how Braze stockholders should vote with respect to the Merger or any other matter and does not in any manner address the price at which the Class A Common Stock will trade at any time. Qatalyst Partners’ opinion does not address the underlying business decision of Braze to engage in the Merger, or the relative merits of the Merger as compared to any strategic alternatives that may be available to Braze. The summary of Qatalyst Partners’ opinion set forth herein is qualified in its entirety by reference to the full text of the opinion, which is attached to this proxy statement as Annex C and is incorporated by reference herein.
Voting and Support Agreement (see page 91)
In connection with the execution and delivery of the Merger Agreement, and as an inducement for Salesforce and Banff Acquisition Sub to enter into the Merger Agreement, (i) William Magnuson and an entity affiliated with Mr. Magnuson, (ii) Jonathan Hyman and certain trusts affiliated with Mr. Hyman, and (iii) Neeraj Agrawal ((i) through (iii) herein collectively referred to as the “Support Stockholders”) have each entered into the voting and support agreement with Salesforce (referred to as the “Voting and Support Agreement”). Based on information provided by the Support Stockholders, the Support Stockholders beneficially owned, in the aggregate, as of the date of the Voting and Support Agreement, 5,999,825 shares of Class A Common Stock, collectively representing approximately 5.3% of the voting power of Class A Common Stock as of such date. The Support Stockholders have agreed, among other things, on the terms and subject to the conditions set forth in the Voting and Support Agreement, to (a) vote their shares of Class A Common Stock in favor of the approval and adoption of the Merger Agreement and the transactions contemplated thereby, including the Merger, and against any acquisition proposal or any action or agreement that is in opposition to the Merger at any stockholder meeting, however called (including the Special Meeting), (b) not transfer their shares of Class A Common Stock, subject to certain limited exceptions, and (c) comply with the non-solicitation obligations set forth in the Voting and Support Agreement. The Voting and Support Agreement will terminate automatically with respect to a Support Stockholder and Salesforce, without any notice or other action, upon the earliest to occur of (i) the valid termination of the Merger Agreement in accordance with its terms, (ii) the Effective Time, (iii) the entry, without the prior written consent of such Support Stockholder, into any amendment, waiver or modification to the Merger Agreement that results in a decrease in the Merger Consideration or changes the mix of Merger Consideration or (iv) the delivery of written notice of termination by Salesforce to such Support Stockholder. A copy of the form of Voting and Support Agreement is attached to this proxy statement as Annex B.
For additional information on the Voting and Support Agreement, see the section titled “The Voting and Support Agreement.”
Material U.S. Federal Income Tax Consequences of the Merger (see page 102)
The receipt of cash in exchange for Class A Common Stock pursuant to the Merger generally will be a taxable transaction for U.S. federal income tax purposes. U.S. Holders (as defined below under “Material U.S. Federal Income Tax Consequences of the Merger”) generally will recognize gain or loss for U.S. federal income tax purposes in an amount equal to the difference, if any between (a) the amount of cash received and (b) the U.S. Holder’s adjusted tax basis in the Class A Common Stock surrendered in exchange. Non-U.S. Holders (as defined below under “Material U.S. Federal income Tax Consequences of the Merger”) generally will not be subject to U.S. federal income tax unless the Non-U.S. Holder has certain connections to the United States.
You should read the section titled “Material U.S. Federal Income Tax Consequences of the Merger” for a more complete discussion of the U.S. federal income tax consequences of the Merger. Tax matters can be complicated and the tax consequences of the Merger to you will depend on your particular tax situation. You should consult your tax advisor to determine the applicable U.S. federal, state, local and non-U.S. tax consequences of the Merger to you.
5

TABLE OF CONTENTS

Regulatory Clearances and Approvals Required for the Merger (see page 63)
The completion of the Merger is conditioned on, among other things, (i) the expiration or termination of any applicable waiting period (and any commitment not to close before a certain date under a timing agreement with governmental authorities) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (referred to as the “HSR Act”), (ii) certain specified regulatory approvals having been obtained and remaining in effect (or, in the case of certain specified regulatory approvals that are statutory waiting periods, having expired or been terminated) without the imposition of a Burdensome Condition (as defined below) and (iii) no governmental authority having enacted any law or issued any order that prohibits the consummation of the Merger or imposes a Burdensome Condition (unless agreed to in writing by Salesforce). Subject to the terms and conditions of the Merger Agreement, each of Braze and Salesforce has agreed to use reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable law to consummate the Transactions, including the Merger, as soon as practicable, including using reasonable best efforts to prepare and file as promptly as practicable with any governmental authority or other third party all documentation to effect all necessary applications, notices, petitions, filings and other documents and to obtain as promptly as reasonably practicable all regulatory approvals necessary or advisable to consummate the Merger.
Each of Braze and Salesforce has agreed to (x) make an appropriate filing of a Notification and Report Form pursuant to the HSR Act with respect to the Transactions as promptly as practicable, and in any event within 20 business days after the execution of the Merger Agreement (unless a later date is mutually agreed between the parties), and to supply as promptly as reasonably practicable and advisable any additional information and documentary materials that may be requested pursuant to the HSR Act and to take all other actions necessary to cause the expiration or termination of the applicable waiting periods under the HSR Act as soon as reasonably practicable and (y) make all other necessary or advisable filings as promptly as reasonably practicable, and to supply as promptly as reasonably practicable and advisable any additional information and documentary materials that may be requested under any applicable regulatory law. On November 12, 2026, each of Salesforce and Braze filed a notification of the proposed merger under the HSR Act.
If and to the extent necessary to obtain clearance of the Merger under the HSR Act and the regulatory laws of certain specified jurisdictions, Salesforce, Banff Acquisition Sub and their respective subsidiaries have agreed to (and will direct Braze and its subsidiaries to) offer, negotiate, commit to and effect, by consent decree, hold separate order or otherwise, any requirement, condition, limitation, understanding, agreement or order to (A) sell, license, assign, transfer, divest, hold separate or otherwise dispose of any assets, business or portion of business of Braze or any subsidiary of Braze, (B) conduct, restrict, operate, invest or otherwise change the assets, the business or portion of the business of Braze or any subsidiary of Braze in any manner or (C) impose any restriction, requirement or limitation on the operation of the business or portion of the business of Braze or any subsidiary of Braze, and Braze and its subsidiaries have agreed to take any such action solely to the extent directed by Salesforce. However, none of Salesforce, Braze or their respective subsidiaries is required to take any action that would reasonably be expected to, individually or in the aggregate, (x) impact Salesforce, Braze or their respective subsidiaries in an adverse manner or amount that is material relative to the value of Braze and its subsidiaries, taken as a whole, (y) have any impact on any asset, business (or portions thereof), product lines or product of Salesforce or any subsidiary of Salesforce (excluding any asset, business (or portions thereof), product lines or product of Braze and its subsidiaries) or (z) materially reduce the reasonably anticipated benefits to Salesforce and its subsidiaries, taken as a whole (including anticipated synergies), of the Transactions (each referred to as a “Burdensome Condition”); provided that if requested by Salesforce, Braze and its subsidiaries will become subject to, consent to or offer or agree to, and otherwise take any action with respect to, any such requirement, condition, limitation, understanding, agreement or order so long as such requirement, condition, limitation, understanding, agreement or order is only binding on Braze or its subsidiaries in the event the Merger closes. In addition, none of Salesforce, Braze or their respective subsidiaries is required to propose, negotiate, commit to or effect any such action unless such action is conditioned upon the consummation of the Merger and does not take effect until the Effective Time. As part of their reasonable best efforts obligations, and subject to the limitations described above, the parties have also agreed to defend through litigation on the merits any claim asserted in court by any U.S. federal governmental entity under the HSR Act, the Sherman Act, the Clayton Act or the Federal Trade Commission Act to avoid entry of, or to have vacated or terminated, any decree, order or judgment (whether temporary, preliminary or permanent) that would prevent the closing of the Merger from occurring prior to the Outside Date. Salesforce will, on behalf of the parties, control and direct all communications and strategy in dealing with any governmental authority under the HSR Act or other regulatory laws, subject to considering in good faith the views and comments of Braze and its outside counsel, and
6

TABLE OF CONTENTS

Salesforce has the right, after consultation with Braze, to voluntarily withdraw and refile its HSR Act notification on one occasion during the initial waiting period, so long as it refiles within two business days. Salesforce has agreed to pay all filing fees under the HSR Act and any other applicable regulatory law relating to the Transactions.
For more information about regulatory clearance relating to the Merger, see the section titled “The Merger Agreement—Conditions to the Merger.”
Although the parties expect that the required regulatory clearance will be obtained, the parties cannot assure you that regulatory clearance will be timely obtained or obtained at all or that the granting of regulatory clearance will not involve the imposition of additional conditions on the completion of the Merger, including the requirement to divest assets, create or modify contractual rights or obligations or enter into supply or services agreements. Any such additional conditions could result in the conditions to the Merger not being satisfied.
Expected Timing of the Merger (see page 65)
Salesforce and Braze are working to complete the Merger as quickly as possible. Subject to the satisfaction or waiver of the conditions described in the section titled “The Merger Agreement—Conditions to the Merger,” including the adoption of the Merger Agreement by Braze stockholders at the Special Meeting and the receipt of required regulatory clearances, the Merger is expected to close in Braze’s fiscal year beginning on February 1, 2027. However, neither Salesforce nor Braze can predict the actual date on which the Merger will be completed, nor can the parties assure you that the Merger will be completed at all, because completion is subject to conditions beyond either company’s control, including receipt of required regulatory clearances. In addition, if the Merger is not completed by October 19, 2027, subject to two automatic 90-day extensions if required in order to obtain required regulatory approvals, either Salesforce or Braze may choose not to proceed with the Merger by terminating the Merger Agreement.
Conditions to the Merger (see page 85)
The obligations of Salesforce and Braze to consummate the Merger will be subject to the satisfaction on or prior to the Closing Date of certain conditions, including the following: (i) the approval of the Merger and the adoption of the Merger Agreement by the affirmative vote of the holders of a majority of the outstanding shares of Class A Common Stock entitled to vote thereon (referred to as the “Braze stockholder approval”); (ii) the expiration, termination or waiver of any waiting period (or extensions thereof), and any commitments not to close before a certain date under a timing agreement entered into with governmental entities, applicable to the consummation of the Merger under the HSR Act; (iii) the making, expiration, termination or receipt of, as applicable, all applicable filings, registrations, waiting periods (or extensions thereof), approvals and clearances under certain specified antitrust and foreign investment laws, and such approvals and clearances remaining in effect, without the imposition, individually or in the aggregate, of a Burdensome Condition; and (iv) no governmental entity of competent jurisdiction has (a) enacted, issued or promulgated any law that is in effect as of immediately prior to the Effective Time or (b) issued or granted any order, injunction, decree or ruling (whether temporary, preliminary or permanent) that is in effect as of immediately prior to the Effective Time, which, in each case, has the effect of restraining, enjoining, making illegal or otherwise prohibiting the consummation of the Merger or imposing a Burdensome Condition, unless agreed to in writing by Salesforce.
The obligations of Salesforce and Banff Acquisition Sub, on the one hand, and Braze, on the other hand, to consummate the Merger are also conditioned upon (i) the accuracy of the other party’s representations and warranties in the Merger Agreement (subject to the materiality standards set forth in the Merger Agreement), (ii) the performance and compliance by the other party in all material respects with its covenants, obligations and agreements required to be performed or complied with by it under the Merger Agreement at or prior to the Closing and (iii) the delivery of officer certificates by the other party certifying satisfaction of certain of the conditions described in this paragraph. In addition, the obligations of Salesforce and Banff Acquisition Sub to consummate the Merger are conditioned upon there not having occurred individually or in the aggregate, any material adverse effect (with such term as described under the section titled “The Merger Agreement—Material Adverse Effect”) with respect to Braze since October 19, 2026, and that is continuing as of immediately prior to the Closing.
See “The Merger Agreement—Conditions to the Merger.”
No Solicitation of Other Offers by Braze (see page 76)
Under the terms of the Merger Agreement, subject to certain exceptions described below, Braze has agreed that, from October 19, 2026 until the earlier of the Effective Time or the date (if any) on which the Merger Agreement is
7

TABLE OF CONTENTS

validly terminated, Braze will not, and will cause its subsidiaries and its and their respective officers and directors not to, and Braze will use its reasonable best efforts to cause its and its subsidiaries’ other representatives not to, directly or indirectly:
(a)
solicit, initiate or knowingly encourage or facilitate (including by way of providing information or taking any other action) any inquiry, proposal or offer, or the making, submission or announcement of any inquiry, proposal or offer which constitutes or would reasonably be expected to lead to an acquisition proposal (as defined in the section titled “The Merger Agreement—No Solicitation of Other Offers by Braze”);
(b)
participate in any negotiations regarding, or provide to any person any information relating to Braze or any of its subsidiaries in connection with, an actual or potential acquisition proposal;
(c)
adopt, approve, endorse or recommend, or propose to adopt, approve, endorse or recommend, any acquisition proposal;
(d)
withdraw, change, amend, modify or qualify, or otherwise propose to withdraw, change, amend, modify or qualify, in a manner adverse to Salesforce, the Braze Board Recommendation, or resolve or agree to take any such action;
(e)
if an acquisition proposal has been publicly disclosed, fail to publicly recommend against any such acquisition proposal and reaffirm the Braze Board Recommendation within 10 business days (or, if earlier, by the second business day prior to the Special Meeting) after the public disclosure of such acquisition proposal (or subsequently withdraw, change, amend, modify or qualify, in a manner adverse to Salesforce, such rejection of such acquisition proposal), subject to certain limited exceptions;
(f)
include any adverse amendment, withdrawal, alteration, modification or qualification of the Braze Board Recommendation in this proxy statement or any other legally required disclosure to Braze stockholders with regard to an acquisition proposal;
(g)
approve, or authorize, or cause or permit Braze or any of its subsidiaries to enter into, any merger agreement, acquisition agreement, reorganization agreement, letter of intent, memorandum of understanding, agreement in principle, option agreement, joint venture agreement, partnership agreement or similar agreement or document with respect to, or any other agreement or commitment providing for, any acquisition proposal (other than certain confidentiality agreements, as set forth in the Merger Agreement);
(h)
call or convene a meeting of Braze stockholders to consider a proposal that would reasonably be expected to materially impair, prevent or delay the consummation of the Transactions; or
(i)
resolve or agree to do any of the foregoing.
We refer to each action set forth in clauses (c), (d), (e), (f), (g), (h) and (i) (to the extent clause (i) is related to the foregoing clauses (c), (d), (e), (f), (g) or (h)) above as a “change of recommendation.”
In addition, under the Merger Agreement, Braze has agreed that it will and will cause its subsidiaries, and its and their respective officers and directors to, and Braze will use its reasonable best efforts to cause its and its subsidiaries’ other representatives to, immediately cease any and all solicitations, encouragements, discussions or negotiations with any persons, or provision of any information to any persons, with respect to any inquiry, proposal or offer that constitutes, or would reasonably be expected to lead to, an acquisition proposal.
See “The Merger Agreement—No Solicitation of Other Offers by Braze.”
Change of Recommendation; Match Rights (see page 80)
At any time prior to the time the Braze stockholder approval is obtained, the Braze Board of Directors may (i) make a change of recommendation in response to an intervening event (as defined in the section titled “The Merger Agreement––Change of Recommendation; Match Rights”) if the Braze Board of Directors has determined in good faith, after consultation with Braze’s outside legal counsel and financial advisors, that the failure to take such action would be reasonably likely to violate the directors’ fiduciary duties under applicable law, or (ii) make a change of recommendation and cause Braze to terminate the Merger Agreement in order to enter into a definitive agreement providing for an unsolicited acquisition proposal received after the date of the Merger Agreement (which
8

TABLE OF CONTENTS

did not result from a breach of Braze’s non-solicitation obligations and is not withdrawn) if the Braze Board of Directors determines in good faith, after consultation with Braze’s outside legal counsel and financial advisors, that such acquisition proposal constitutes a superior proposal and that the failure to take such action would be reasonably likely to violate the directors’ fiduciary duties under applicable law (subject to payment by Braze to Salesforce of the termination fee described under the section titled “The Merger Agreement—Termination Fee”). Braze may not enter into any definitive agreement providing for an acquisition proposal unless the Merger Agreement has been validly terminated in accordance with its terms.
Prior to making a change of recommendation as permitted by the Merger Agreement and as described above, Braze must provide Salesforce with four business days’ prior written notice (which period will expire at 11:59 p.m., Pacific Time, on the fourth business day) advising Salesforce that the Braze Board of Directors intends to take such action and specifying, in the case of a change of recommendation in response to an intervening event, in reasonable detail, the reasons therefor, and in the case of a change of recommendation due to a superior proposal, the material terms and conditions of the acquisition proposal (including a copy of any proposed definitive documentation). During such four business day period, Braze must cause its representatives (including its executive officers) to negotiate in good faith (to the extent Salesforce desires to negotiate) any proposal by Salesforce to amend the terms and conditions of the Merger Agreement in a manner that would obviate the need to effect such change of recommendation or such that such acquisition proposal would no longer constitute a superior proposal, as applicable, and the Braze Board of Directors must make the required determination again at the end of such four business day period (after taking into account in good faith any amendments to the Merger Agreement proposed by Salesforce). With respect to a superior proposal, if there is any material amendment, revision or change to the terms of such superior proposal (including any revision to the amount, form or mix of consideration Braze stockholders would receive as a result of such superior proposal), Braze must notify Salesforce of each such amendment, revision or change and the applicable four business day period will be extended until at least three business days after the time that Salesforce receives notification of such revision.
See “The Merger Agreement—Change of Recommendation; Match Rights.”
Termination of the Merger Agreement (see page 86)
The Merger Agreement may be terminated, and the Merger and the other Transactions may be abandoned, at any time before the Closing:
•
by mutual written consent of Salesforce and Braze; or
•
by either Salesforce or Braze, if:
•
any governmental entity of competent jurisdiction has issued a final, non-appealable order, injunction, decree or ruling, in each case permanently restraining, enjoining or otherwise prohibiting the consummation of the Transactions or any law that permanently makes consummation of the Transactions illegal or otherwise prohibited is in effect; or
•
the Closing has not occurred on or before October 19, 2027 (the first anniversary of the date of the Merger Agreement), except that (a) if on such date all of the conditions to closing, other than the conditions related to the expiration or termination of the waiting period under the HSR Act and the approvals and clearances under certain specified antitrust and foreign investment laws, the absence of any injunction or other legal prohibition (in respect of the HSR Act or any other regulatory law) and those conditions that by their nature are to be satisfied at closing (provided they are capable of being satisfied), have been satisfied or waived, then such date will automatically be extended one time for an additional 90 days and (b) if on such extended date all such conditions (other than such excluded conditions) have been satisfied or waived, then such date will automatically be extended one additional time for an additional 90 days (such date, as it may be extended, the “Outside Date”). Notwithstanding the foregoing, Salesforce and Braze may mutually agree in writing to amend the Outside Date to such other date as is agreed; provided, further, that the right to terminate the Merger Agreement at the Outside Date will not be available to any party whose action or failure to fulfill any obligation under the Merger Agreement has been a proximate cause of the failure of the Transactions to be consummated by the Outside Date, and such action or failure to act constitutes a material breach of the Merger Agreement; or
•
the Braze stockholder approval has not been obtained upon a vote taken thereon at the Special Meeting duly convened therefor or at any adjournment, postponement or continuation thereof.
See “The Merger Agreement—Termination of the Merger Agreement.”
9

TABLE OF CONTENTS

Termination by Braze
The Merger Agreement may be terminated, and the Merger and other Transactions may be abandoned, at any time before the Closing by Braze if:
•
prior to the time the Braze stockholder approval is obtained, the Braze Board of Directors effects a change of recommendation in order to substantially concurrently enter into a definitive agreement providing for a superior proposal, as long as (1) Braze has complied in all material respects with its non-solicitation obligations, as described under the sections titled “The Merger Agreement—No Solicitation of Other Offers by Braze” and “The Merger Agreement—Change of Recommendation; Match Rights” and (2) substantially concurrently with or prior to (and as a condition to) such termination, Braze pays to Salesforce the $191,390,000 termination fee described below; or
•
there has been a breach by Salesforce and/or Banff Acquisition Sub of any of their covenants or agreements, or any of the representations and warranties of Salesforce or Banff Acquisition Sub have become inaccurate, in either case in a manner that would give rise to the failure of certain conditions to the consummation of the Merger, and such breach or inaccuracy is not capable of being cured by the Outside Date or, if capable of being cured, is not cured by the earlier of (x) the business day immediately prior to the Outside Date and (y) the 30th calendar day following receipt of written notice from Braze of such breach or inaccuracy; provided, however, that Braze may not terminate the Merger Agreement in this way if Braze is then in breach of any of its representations, warranties, covenants or agreements and such breach would give rise to the failure of a condition to close.
See “The Merger Agreement—Termination of the Merger Agreement—Termination by Braze.”
Termination by Salesforce
The Merger Agreement may be terminated, and the Merger and other Transactions may be abandoned, by Salesforce if:
•
prior to the time the Braze stockholder approval is obtained, the Braze Board of Directors has effected a change of recommendation (whether or not in compliance with the Merger Agreement) or Braze has materially breached its obligations described under the section titled “The Merger Agreement—No Solicitation of Other Offers by Braze”; or
•
there has been a breach by Braze of any of its covenants or agreements, or any of the representations and warranties of Braze have become inaccurate, in either case in a manner that would give rise to the failure of certain conditions to the consummation of the Merger, and such breach or inaccuracy is not capable of being cured by the Outside Date or, if capable of being cured, is not cured by the earlier of (x) the business day immediately prior to the Outside Date and (y) the 30th calendar day following receipt of written notice from Salesforce of such breach or inaccuracy; provided, however, that Salesforce may not terminate the Merger Agreement in this way if Salesforce or Banff Acquisition Sub is then in breach of any of its representations, warranties, covenants or agreements and such breach would give rise to the failure of a condition to close.
See “The Merger Agreement—Termination of the Merger Agreement—Termination by Salesforce.”
Termination Fee (see page 87)
Regulatory Reverse Termination Fee
The Merger Agreement provides that Salesforce will pay Braze a regulatory reverse termination fee of $300,000,000 in cash (referred to as the “Regulatory Reverse Termination Fee”) if:
(1)
the Merger Agreement is terminated (a) by Salesforce or Braze as a result of the Closing having not occurred on or before the Outside Date or (b) by Salesforce or Braze because a governmental entity of competent jurisdiction has issued a final, non-appealable order, injunction, decree or ruling permanently restraining, enjoining or otherwise prohibiting the consummation of the Transactions or any law that permanently makes such consummation illegal or otherwise prohibited is in effect, solely to the extent that any such injunction, order, decree or ruling is in respect of, or any such law relates to, the HSR Act or any other applicable regulatory law (provided that, in the case of a termination by Braze under this clause (b),
10

TABLE OF CONTENTS

Braze must deliver written notice to Salesforce that such termination will not be effective until five business days following receipt, and such termination will be null and void if, within such period, Salesforce and Banff Acquisition Sub irrevocably waive the condition relating to the absence of such injunction, order, decree, ruling or law);
(2)
on the date of the termination of the Merger Agreement as described in clause (1), all of the conditions to Closing (other than the conditions of Braze’s obligation to consummate the Merger) have been satisfied or waived (other than those conditions that by their nature are to be satisfied at the Closing, provided that such conditions are capable of being satisfied if the Closing were to take place on such date), other than the conditions related to the expiration, termination or waiver of the waiting period applicable to the Merger under the HSR Act and receipt of all other approvals and clearances under specified antitrust and foreign investment laws and the absence of any legal prohibition (solely to the extent in respect of the HSR Act or any other applicable regulatory law); and
(3)
in the case of a termination by Braze, (a) Braze has delivered written notice to Salesforce irrevocably waiving the condition relating to the absence of such legal prohibition, if any, and irrevocably confirming that it is ready, willing and able to consummate the Closing (and, in the case of a termination at the Outside Date, upon delivery of such notice the Outside Date will be extended by five business days) and (b) Salesforce and Banff Acquisition Sub fail to effect the Closing (or, in the case of a termination in respect of a legal prohibition, fail to effect the Closing or to deliver a notice waiving such condition) within five business days following receipt of such notice.
In no event will Salesforce be obligated to pay the Regulatory Reverse Termination Fee on more than one occasion.
Braze Termination Fee
The Merger Agreement provides that Braze will pay Salesforce a termination fee of $191,390,000 in cash (referred to as the “Termination Fee”) if:
(1)
the Merger Agreement is terminated by Salesforce or Braze as a result of the Closing having not occurred on or before the Outside Date or the Braze stockholder approval not having been obtained at the Special Meeting, or by Salesforce as a result of a breach, failure to perform or violation of the Merger Agreement by Braze that (except for a breach of Braze’s non-solicitation obligations) first occurred following the making of an acquisition proposal of the type described in clause (2) immediately below;
(2)
after the date of the Merger Agreement and prior to the date of such termination (or prior to the Braze stockholder approval, in the case of a termination as a result of the Braze stockholder approval not having been obtained), a bona fide acquisition proposal (with references to “15%” and “85%” in the definition thereof deemed to be references to “50%”) has been publicly disclosed (whether by Braze or a third party) or otherwise made known to the Braze Board of Directors or Braze management and, in each case, is not withdrawn (publicly, if publicly disclosed) at least three business days prior to the earlier of the date of the Special Meeting and the date of such termination; and
(3)
within 12 months of such termination, an acquisition proposal is consummated or a definitive agreement providing for an acquisition proposal is entered into (with references to “15%” and “85%” in the definition thereof deemed to be references to “50%” for this purpose).
In addition, the Merger Agreement requires Braze to pay Salesforce the Termination Fee if any of the following occurs:
(1)
Salesforce terminates the Merger Agreement because, prior to the time the Braze stockholder approval is obtained, the Braze Board of Directors has effected a change of recommendation or Braze has materially breached its non-solicitation obligations, or Braze terminates the Merger Agreement as a result of the Closing having not occurred on or before the Outside Date at a time when Salesforce would be permitted to terminate the Merger Agreement for such reasons; or
(2)
Braze terminates the Merger Agreement prior to the time the Braze stockholder approval is obtained in order to effect a change of recommendation and substantially concurrently enter into a definitive agreement providing for a superior proposal.
In no event will Braze be obligated to pay the Termination Fee on more than one occasion. See “The Merger Agreement—Termination Fee.”
11

TABLE OF CONTENTS

Enforcement and Remedies (see page 90)
Under the Merger Agreement, the parties have agreed that each party will be entitled to:
•
an injunction or injunctions to prevent or remedy any breaches or threatened breaches of the Merger Agreement;
•
a decree or order of specific performance specifically enforcing the terms and provisions of the Merger Agreement; and
any further equitable relief, in each case, in addition to any other remedy to which a party is entitled at law or in equity.
See the section titled “The Merger Agreement—Enforcement and Remedies.”
Appraisal Rights of Braze Stockholders (see page 65)
If the Merger is completed, stockholders and beneficial owners of Class A Common Stock who do not vote in favor of the adoption of the Merger Agreement and who properly demand, and do not validly withdraw such demand for, or otherwise lose their rights to, appraisal of their shares of Class A Common Stock will be entitled to appraisal rights in connection with the Merger under Section 262. Failure to strictly comply with the procedures and requirements specified in Section 262 in a timely and proper manner will result in the loss of your appraisal rights under the DGCL.
The following discussion is not intended to be a complete statement of the law pertaining to appraisal rights under the DGCL and is qualified in its entirety by the full text of Section 262, which may be accessed without subscription or cost at the following publicly available website: https://delcode.delaware.gov/title8/c001/sc09/index.html#262. The following summary does not constitute any legal or other advice and does not constitute a recommendation that stockholders or beneficial owners exercise their appraisal rights under Section 262.
Under Section 262, stockholders of record and beneficial owners of shares of Class A Common Stock held either in voting trust or by a nominee on behalf of such person who (1) do not vote in favor of or otherwise consent to the adoption of the Merger Agreement; (2) continuously hold or own such shares of Class A Common Stock through the Effective Time; and (3) otherwise follow the procedures set forth in Section 262 and do not validly withdraw their demand for appraisal or otherwise lose their appraisal rights will be entitled to have their shares of Class A Common Stock appraised by the Delaware Court of Chancery and to receive in lieu of the Merger Consideration payment in cash of the “fair value” of the shares of Class A Common Stock, exclusive of any element of value arising from the accomplishment or expectation of the Merger, together with interest, if any, to be paid on the amount determined to be the fair value of their shares as determined by the Delaware Court of Chancery. However, because the Class A Common Stock is currently listed on a national securities exchange, and, assuming such shares of Class A Common Stock remain listed on a national securities exchange immediately prior to the Merger (which is expected to be the case), after an appraisal petition has been filed, the Delaware Court of Chancery will dismiss appraisal proceedings as to all holders of such shares who are otherwise entitled to appraisal rights unless (1) the total number of shares of Class A Common Stock entitled to appraisal exceeds 1% of the outstanding shares of Class A Common Stock eligible for appraisal or (2) the value of the aggregate Merger Consideration in respect of such total number of shares of Class A Common Stock exceeds $1,000,000.
Stockholders and beneficial owners considering seeking appraisal should be aware that the fair value of their shares of Class A Common Stock as determined pursuant to Section 262 could be more than, the same as or less than the Merger Consideration.
Under Section 262, when a merger agreement is to be submitted for adoption at a meeting of stockholders, the corporation, not less than 20 days prior to the meeting, must notify each of its stockholders of record entitled to appraisal rights that appraisal rights are available and include in the notice a copy of Section 262 or information directing the stockholders to a publicly available electronic resource at which Section 262 may be accessed without subscription or cost. This proxy statement constitutes Braze’s notice to holders of Class A Common Stock that appraisal rights are available in connection with the Merger, and the full text of Section 262 may be accessed without subscription or cost at the following publicly available website: https://delcode.delaware.gov/title8/c001/sc09/index.html#262. In connection with the Merger, any stockholder or beneficial owner who wishes to exercise appraisal rights or who wishes to preserve such stockholder’s or beneficial owner’s right to do so should review the text of this proxy statement and of Section 262 carefully and in its entirety. Failure to strictly comply with the requirements of Section 262 in a timely and proper manner
12

TABLE OF CONTENTS

will result in the loss of appraisal rights under the DGCL. A stockholder or beneficial owner who validly withdraws his, her or its demand for appraisal or otherwise loses his, her or its appraisal rights will be entitled to receive the Merger Consideration (subject to applicable tax withholding) if Braze stockholders approve the Merger Agreement Proposal and the Merger is subsequently consummated. Moreover, because of the complexity of the procedures for exercising the right to seek appraisal of shares of Class A Common Stock in connection with the Merger, Braze believes that if a stockholder or beneficial owner considers exercising such rights, that stockholder or beneficial owner should seek the advice of legal counsel.
See the section titled “The Merger Agreement—Merger Consideration” and “Appraisal Rights of Braze Stockholders.”
Special Meeting (see page 29)
Purposes of the Special Meeting
At the Special Meeting, Braze stockholders will be asked to vote upon the following proposals:
•
Proposal 1—The Merger Agreement Proposal: the proposal to adopt the Merger Agreement (referred to as the “Merger Agreement Proposal”), which is further described in the sections titled “The Merger (Proposal 1)” and “The Merger Agreement” of this proxy statement and a copy of which is attached to this proxy statement as Annex A;
•
Proposal 2—The Merger-Related Compensation Proposal: the proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Braze’s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated thereby (referred to as the “Merger-Related Compensation Proposal”), which is further described in the sections titled “Advisory Vote on Named Executive Officer Merger-Related Compensation Arrangements (Proposal 2)” and “The Merger (Proposal 1)—Interests of Braze’s Directors and Executive Officers in the Merger”; and
•
Proposal 3—The Adjournment Proposal: the proposal to approve the adjournment from time to time of the Special Meeting, if deemed necessary or appropriate by the Braze Board of Directors or any committee thereof, including to solicit additional proxies if there are insufficient votes to approve the Merger Agreement Proposal at the time of the Special Meeting (referred to as the “Adjournment Proposal”) which is further described in the section titled “Vote on Adjournment (Proposal 3).”
•
Only the approval of the Merger Agreement Proposal is required for completion of the Merger. Braze will transact no other business at the Special Meeting, except such business as may properly be brought before the Special Meeting or any adjournment, postponement or continuation thereof.
Record Date; Stockholders Entitled to Vote
Only holders of record of Class A Common Stock at the close of business on   ,   , the Record Date, are entitled to receive notice of the Special Meeting and to vote the shares of Class A Common Stock that they held as of the Record Date at the meeting, including any adjournment, postponement or continuation of the meeting. Each share of Class A Common Stock is entitled to one vote on each proposal. Braze official stock ownership records will conclusively determine whether a stockholder is a “holder of record” as of the Record Date.
Required Vote; Treatment of Abstentions and Failure to Vote
The votes required for each proposal are as follows:
Proposal 1—The Merger Agreement Proposal: The affirmative vote (in person (virtually) or by proxy) of the holders of a majority of the outstanding shares of Class A Common Stock entitled to vote thereon is required to approve the Merger Agreement Proposal. Abstentions, failures to vote (including a failure to authorize a proxy to vote on your behalf) and broker non-votes will have the same effect as a vote “AGAINST” the Merger Agreement Proposal.
Proposal 2—The Merger-Related Compensation Proposal: The affirmative vote of a majority of the votes cast affirmatively or negatively (excluding abstentions and broker non-votes) (in person (virtually) or by proxy) at the Special Meeting is required to approve, on an advisory (non-binding) basis, the Merger-Related Compensation Proposal. Assuming a quorum is present, abstentions, failures to vote (including a failure to authorize a proxy to vote on your behalf) and broker non-votes will have no effect on the Merger-Related Compensation Proposal.
13

TABLE OF CONTENTS

Proposal 3—The Adjournment Proposal: Whether or not a quorum is present, the affirmative vote of a majority of the votes cast affirmatively or negatively (excluding abstentions and broker non-votes) (in person (virtually) or by proxy) at the Special Meeting is required to approve the Adjournment Proposal. Abstentions, failures to vote (including a failure to authorize a proxy to vote on your behalf) and broker non-votes will have no effect on the Adjournment Proposal.
See the section titled “The Special Meeting—Required Vote; Treatment of Abstentions and Failure to Vote.”
Interests of Braze’s Directors and Executive Officers in the Merger (see page 56)
Braze’s directors and executive officers have interests in the Merger that may be different from, or in addition to, those of Braze stockholders generally. These interests include, among others, the treatment of their equity awards in connection with the Merger, potential severance payments and benefits under the Amended and Restated Executive Severance Plan (referred to as the “Executive Severance Plan”) upon a qualifying termination of employment in connection with the Merger, retention bonus payments, new employment arrangements with Salesforce and rights to ongoing indemnification and insurance coverage. The Braze Board of Directors was aware of and considered these interests, among other matters, in evaluating and negotiating the Merger Agreement and the Merger, in approving the Merger Agreement, and in recommending the adoption of the Merger Agreement by Braze stockholders. See the section titled “The Merger (Proposal 1)—Interests of Braze’s Directors and Executive Officers in the Merger.”
Directors’ and Officers’ Indemnification and Insurance (see page 84)
Under the Merger Agreement, for six years from and after the Effective Time, Salesforce must, or must cause the Surviving Corporation to, indemnify and hold harmless, to the fullest extent permitted under applicable law and the organizational documents of Braze or its subsidiaries, or any indemnification agreements in existence as of October 19, 2026 that were provided to Salesforce prior to such date, all past and present directors and officers of Braze and its subsidiaries (each referred to as an “Indemnified Party”) against any costs or expenses (including advancing attorneys’ fees and expenses, subject to an undertaking to repay if it is ultimately determined that the Indemnified Party is not entitled thereto), judgments, fines, losses, claims, damages, liabilities and amounts paid in settlement in connection with any actual or threatened claim, action, investigation, suit or proceeding in respect of acts or omissions occurring or alleged to have occurred at or prior to the Effective Time, whether asserted or claimed prior to, at or after the Effective Time (including acts or omissions occurring in connection with the approval of the Merger Agreement and the consummation of the Merger or any of the other Transactions), in connection with such person serving as an officer, director or other fiduciary of Braze, any of its subsidiaries or any other person if such service was at the request or for the benefit of Braze or any of its subsidiaries.
In addition, for a period of six years following the Effective Time, Salesforce is required to maintain in effect the provisions in the organizational documents of Braze and any indemnification agreements in existence as of October 19, 2026 that were provided to Salesforce prior to October 19, 2026 (except to the extent such agreement provides for an earlier termination), in each case, regarding elimination of liability, indemnification of executive officers and directors and advancement of expenses that are in existence as of October 19, 2026.
At or prior to the Effective Time, Braze is required to purchase a six-year prepaid directors’ and officers’ liability insurance and fiduciary liability insurance “tail” policy (on terms and conditions providing coverage retentions, limits and other material terms substantially equivalent to Braze’s and its subsidiaries’ current directors’ and officers’ liability insurance and fiduciary liability insurance) with respect to matters arising at or prior to the Effective Time, provided that Braze may not commit or spend on such “tail” policy, in the aggregate, more than 300% of the last aggregate annual premium paid by Braze prior to October 19, 2026 for such insurance, and if the cost of such “tail” policy would otherwise exceed such amount, Braze may purchase only as much coverage as reasonably practicable for such amount.
See the section titled “The Merger (Proposal 1)—Interests of Braze’s Directors and Executive Officers in the Merger—Indemnification and Insurance” and “The Merger Agreement—Directors’ and Officers’ Indemnification and Insurance.”
Delisting and Deregistration of Class A Common Stock (see page 65)
Upon completion of the Merger, the Class A Common Stock currently listed on Nasdaq will cease to be listed and will subsequently be deregistered under the Exchange Act. At that time, we will no longer be required to file periodic reports, current reports and proxy and information statements with the U.S. Securities and Exchange Commission (referred to as the “SEC”) with respect to the Class A Common Stock.
14

TABLE OF CONTENTS

Effect on Braze if the Merger is Not Completed (see page 35)
If the Merger is not completed for any reason, Braze stockholders will not receive any Merger Consideration for shares of Class A Common Stock in connection with the Merger. Instead: (1) Braze will remain an independent public company; (2) the Class A Common Stock will continue to be listed and traded on Nasdaq and registered under the Securities Exchange Act of 1934, as amended (referred to as the “Exchange Act”); and (3) Braze will continue to file periodic reports with the SEC. Under certain specific circumstances, Braze is required to pay Salesforce a termination fee of $191,390,000. See the section titled “The Merger Agreement—Termination Fee.”
15

TABLE OF CONTENTS

QUESTIONS AND ANSWERS
The following are some questions that you, as a Braze stockholder, may have regarding the Merger and the Special Meeting and the answers to those questions. Braze urges you to carefully read the remainder of this proxy statement because the information in this section does not provide all the information that might be important to you with respect to the Merger and the Special Meeting. Additional important information is also contained in the annexes to, and the documents incorporated by reference into, this proxy statement.
Q:
What is the purpose of the Special Meeting?
A:
At the Special Meeting, Braze stockholders will consider and act upon the matters outlined in the notice of meeting on the cover page of this proxy statement, namely:
•
a proposal to adopt the Merger Agreement, which is further described in the sections titled “The Merger (Proposal 1)” and “The Merger Agreement,” beginning on pages 35 and 66, respectively, of this proxy statement;
•
a proposal to approve on an advisory (non-binding) basis the compensation that may be paid or become payable to Braze’s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated thereby, discussed under the sections titled “Advisory Vote on Named Executive Officer Merger-Related Compensation Arrangements (Proposal 2)” and “The Merger (Proposal 1)—Interests of Braze’s Directors and Executive Officers in the Merger” beginning on pages 98 and 56 respectively, of this proxy statement; and
•
the proposal to approve the adjournment from time to time of the Special Meeting, if deemed necessary or appropriate by the Braze Board of Directors or any committee thereof, including to solicit additional proxies if there are insufficient votes to approve the Merger Agreement Proposal at the time of the Special Meeting, which is further described in the section titled “Vote on Adjournment (Proposal 3)” beginning on page 99.
Q:
Where and when is the Special Meeting?
A:
The Special Meeting will be held on   ,   , beginning at   , Eastern Time, unless adjourned or postponed to a later date, via live audio webcast at www.virtualshareholdermeeting.com/BRZE2027SM. You will need the 16-digit control number provided on your proxy card in order to participate in the Special Meeting. If your shares are held in “street name” and your voting instruction form indicates that you may vote those shares through the www.proxyvote.com website, then you may access, attend, participate in and vote at the Special Meeting with the 16-digit control number indicated on that voting instruction form by visiting www.virtualshareholdermeeting.com/BRZE2027SM. If you cannot locate your control number, Braze stockholders who hold their shares in “street name” should contact their bank, broker, or other nominee (preferably at least five days before the Special Meeting) and obtain their 16-digit control number or a legal proxy in order to be able to attend, participate in, or vote at the Special Meeting. Because the Special Meeting is being conducted virtually via live webcast, stockholders will not be able to attend the meeting in person.
Q:
How does the Braze Board of Directors recommend that I vote on the proposals?
A:
The Braze Board of Directors unanimously recommends that Braze stockholders vote “FOR” the Merger Agreement Proposal, “FOR” the Merger-Related Compensation Proposal and “FOR” the Adjournment Proposal.
Q:
How does the Merger Consideration compare to the market price of Class A Common Stock prior to announcement of the Merger?
A:
The Merger Consideration of $47.50 per share represented a significant premium of approximately 58% to the closing price of the Class A Common Stock on October 19, 2026, the last trading day prior to the announcement of the Merger Agreement, and premiums of approximately 81%, 81%, 104% and 94% to the volume-weighted average price of the Class A Common Stock for the 30-trading day, 90-trading day, 180-trading day and twelve-month periods, respectively, ended October 19, 2026. The closing price of Class A Common Stock on Nasdaq on November 19, 2026, the most recent practicable date prior to the date of this proxy statement, was $46.24 per share. You are encouraged to obtain current market prices of Class A Common Stock in connection with voting your shares of Class A Common Stock.
16

TABLE OF CONTENTS

Q:
What will happen in the Merger?
A:
Pursuant to the Merger Agreement, Banff Acquisition Sub will merge with and into Braze, with Braze surviving the Merger as a wholly owned subsidiary of Salesforce. After the Merger, Braze’s securities will be delisted from Nasdaq and deregistered under the Exchange Act, and, as a result, Braze will no longer be a publicly held company.
Q:
Who will own Braze after the Merger?
A:
Immediately following the Merger, Braze will be a wholly owned subsidiary of Salesforce.
Q:
What will I receive in the Merger?
A:
At the Effective Time, you will be entitled to receive, for each share of Class A Common Stock that you hold (other than the Dissenting Shares, the Cancelled Shares and the Converted Shares, in each case, as defined in the section titled “The Merger (Proposal 1)—Effects of the Merger”), $47.50 in cash, without interest. Certain shares of Class A Common Stock subject to stock-based awards will be treated in the manner described under the heading “The Merger (Proposal 1)—Interests of Braze’s Directors and Executive Officers in the Merger.”
Q:
What will happen in the Merger to Braze equity awards?
A:
Pursuant to the Merger Agreement, at the Effective Time, outstanding Braze equity awards will be treated as follows:
•
Options. Each In-the-Money Braze Option that is outstanding and unexercised immediately prior to the Effective Time will be cancelled and converted into the right to receive the Merger Consideration in respect of each Net Share covered by such Braze Option, without interest. Each Braze Option that is not an In-the-Money Braze Option, whether or not vested, will be cancelled for no consideration.
•
Vested RSUs. Each Braze RSU that is held by a non-employee director or that is vested as of the Closing will be cancelled and converted into the right to receive the Merger Consideration in respect of each share of Class A Common Stock subject to such Braze RSU, without interest.
•
Unvested RSUs. Each other Braze RSU will be assumed and converted into an Adjusted RSU with respect to a number of shares of Salesforce common stock equal to the number of shares of Class A Common Stock subject to such Braze RSU multiplied by the Conversion Ratio (rounded to the nearest whole share), and will otherwise remain subject to the same terms and conditions (including vesting terms) as applied to the corresponding Braze RSU.
•
PSUs. Each unvested Braze PSU will be assumed and converted into an Adjusted RSU, with the number of shares of Class A Common Stock subject to such Braze PSU determined (i) for any performance period completed prior to the Closing Date, based on actual performance and (ii) for any performance period not completed prior to the Closing Date, at target (except that, if the Closing Date occurs prior to February 1, 2027, the number of Braze PSUs earned for the performance period beginning February 1, 2026 will be based on the greater of target and actual performance), multiplied by the Conversion Ratio (rounded to the nearest whole share). Each such Adjusted RSU will otherwise remain subject to the same terms and conditions (including vesting terms, but excluding any performance-based vesting conditions) as applied to the corresponding Braze PSU.
•
Restricted Shares. Each Assumed Braze Restricted Share will be assumed and converted into Adjusted Restricted Shares (that is, a number of shares of restricted Salesforce common stock based on the Conversion Ratio) on the same terms and conditions (including vesting terms), and each Cashout Braze Restricted Share will be converted into the right to receive the Merger Consideration, without interest.
•
Non-U.S. Jurisdictions. With respect to holders of Braze equity awards (other than Braze Restricted Shares) employed outside the United States, if Salesforce determines that the foregoing treatment would reasonably be expected to cause a significant administrative burden to Salesforce, Salesforce may either (i) convert such awards into cash-based awards on the same terms and conditions, in certain specified jurisdictions, or (ii) cash out such awards at the Closing based on the value of the Merger Consideration.
In addition, the Braze 2021 Employee Stock Purchase Plan (referred to as the “Braze ESPP”) will terminate effective immediately prior to the Closing, subject to the consummation of the Merger. If any current offering
17

TABLE OF CONTENTS

period under the Braze ESPP is still in effect at the Effective Time, the last day of such offering period will be accelerated to a date that is no later than three business days prior to the Closing Date. If any current offering period under the Braze ESPP ends prior to the Effective Time, no new offering period will commence thereafter. For additional information, see the section titled “The Merger Agreement—Treatment of Braze Equity Awards and the Braze ESPP.”
Q:
Am I entitled to exercise appraisal rights instead of receiving the Merger Consideration for my shares of Class A Common Stock?
A:
Yes. Braze stockholders and beneficial owners of Class A Common Stock held either in voting trust or by a nominee on behalf of such person are entitled to appraisal rights under Section 262 of the DGCL in connection with the Merger, provided they follow the procedures and satisfy the conditions and requirements set forth in Section 262 of the DGCL. However, because the Class A Common Stock is currently listed on a national securities exchange, and, assuming such shares of Class A Common Stock remain listed on a national securities exchange immediately prior to the Merger (which is expected to be the case), after an appraisal petition has been filed, the Delaware Court of Chancery will dismiss appraisal proceedings as to all holders of such shares who are otherwise entitled to appraisal rights unless (1) the total number of shares of Class A Common Stock entitled to appraisal exceeds 1% of the outstanding shares of Class A Common Stock eligible for appraisal or (2) the value of the aggregate Merger Consideration in respect of such total number of shares of Class A Common Stock exceeds $1,000,000.
For more information regarding appraisal rights, see the sections titled “The Merger (Proposal 1)—Appraisal Rights of Braze Stockholders” and “Appraisal Rights of Braze Stockholders.” In addition, a copy of Section 262 of the DGCL can be accessed without subscription or cost at the following publicly available website: https://delcode.delaware.gov/title8/c001/sc09/index.html#262. Failure to strictly comply with Section 262 of the DGCL may result in your waiver of, or inability to exercise, appraisal rights.
Q:
How many votes do I have?
A:
In connection with each matter to be voted upon at the Special Meeting, each share of Class A Common Stock owned as of the Record Date is entitled to one vote.
Q:
What vote is required to adopt the Merger Agreement?
A:
The votes required for each proposal are as follows:
•
Proposal 1—The Merger Agreement Proposal: The affirmative vote (in person (virtually) or by proxy) of the holders of a majority of the voting power of the outstanding shares of Class A Common Stock entitled to vote thereon is required to approve the Merger Agreement Proposal.
•
Proposal 2—The Merger-Related Compensation Proposal: The affirmative vote of a majority of the votes cast affirmatively or negatively (excluding abstentions and broker non-votes) (in person (virtually) or by proxy) at the Special Meeting is required to approve, on an advisory (non-binding) basis, the Merger-Related Compensation Proposal.
•
Proposal 3—The Adjournment Proposal: The affirmative vote of a majority of the votes cast affirmatively or negatively (excluding abstentions and broker non-votes) (in person (virtually) or by proxy) at the Special Meeting, whether or not a quorum is present, is required to approve the Adjournment Proposal.
As of   ,   , the Record Date, Braze directors and executive officers, as a group, owned and were entitled to vote    shares of Class A Common Stock. Braze currently expects that these directors and executive officers will vote their shares in favor of the Merger Agreement Proposal and each of the other proposals described in this proxy statement, although none of them are obligated to do so other than the Support Stockholders pursuant to the terms of the Voting and Support Agreement. See the section titled “The Voting and Support Agreement.”
Q:
Do any of Braze’s directors or executive officers have interests in the Merger that may differ from or be in addition to my interests as a stockholder?
A:
Yes. In considering the recommendation of the Braze Board of Directors with respect to the Merger Agreement Proposal, you should be aware that Braze’s directors and executive officers have certain interests in the Merger
18

TABLE OF CONTENTS

that may be different from, or in addition to, the interests of Braze stockholders generally. The Braze Board of Directors was aware of and considered these interests, among other matters, in evaluating and negotiating the Merger Agreement and the Merger, in approving the Merger Agreement, and in recommending that the Merger Agreement be adopted by Braze stockholders. See the sections titled “The Merger (Proposal 1)—Interests of Braze’s Directors and Executive Officers in the Merger” and “Advisory Vote on Named Executive Officer Merger-Related Compensation Arrangements (Proposal 2).”
Q:
When do you expect the Merger to be completed?
A:
The parties to the Merger Agreement currently expect to complete the Merger in Braze’s fiscal year beginning on February 1, 2027, subject to the satisfaction or waiver of closing conditions. However, the exact timing of completion of the Merger cannot be predicted because the Merger is subject to a number of conditions specified in the Merger Agreement and summarized in this proxy statement, many of which are outside our control.
Q:
What conditions must be satisfied to complete the Merger?
A:
Each party’s obligation to complete the Merger is subject to the satisfaction or waiver (to the extent permitted under applicable law) of certain customary conditions, including the following: (i) the approval of the Merger Agreement Proposal by Braze stockholders; (ii) the expiration, termination or waiver of the waiting period (and any extensions thereof) and of any commitment not to close before a certain date under a timing agreement entered into with any governmental authority applicable to the consummation of the Merger under the HSR Act; (iii) the making, expiration, termination or receipt, as applicable, of all applicable filings, registrations, waiting periods (and any extensions thereof), approvals and clearances under the antitrust and foreign investment laws of certain specified jurisdictions, and such approvals and clearances remaining in effect, in the case of each of clauses (ii) and (iii), without the imposition of a Burdensome Condition; and (iv) the absence of any law, order or injunction issued by any governmental authority of competent jurisdiction and in effect immediately prior to the Effective Time that restrains, enjoins, makes illegal or otherwise prohibits the consummation of the Merger, or that imposes a Burdensome Condition (unless Salesforce has agreed to it in writing).
The obligation of each party to consummate the Merger is also conditioned upon (i) the accuracy of the other party’s representations and warranties in the Merger Agreement (subject to the materiality standards set forth in the Merger Agreement), (ii) the performance and compliance by the other party in all material respects with its covenants, obligations and agreements required to be performed or complied with by it under the Merger Agreement at or prior to the closing of the Merger, and (iii) delivery of officer certificates by the other party certifying satisfaction of certain of the conditions described above. The obligation of Salesforce to consummate the Merger is also subject to there not having occurred since the date of the Merger Agreement a material adverse effect on Braze (as described in the section titled “The Merger Agreement—Material Adverse Effect”) that is continuing as of immediately prior to the Closing.
See the section titled “The Merger Agreement—Conditions to the Merger.”
Q:
Why am I being asked to consider and act upon a proposal to approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Braze’s named executive officers that is based on or otherwise relates to the Merger?
A:
Section 14A of the Exchange Act and the applicable SEC rules thereunder require Braze to seek a non-binding, advisory vote to approve compensation that may be paid or become payable to Braze’s named executive officers that is based on or otherwise relates to the Merger. Approval of this proposal by Braze stockholders is not a condition to completion of the Merger.
Q:
What happens if Braze stockholders do not approve, on a non-binding, advisory basis, the Merger-Related Compensation Proposal?
A:
The vote on the Merger-Related Compensation Proposal is separate and apart from the vote on the Merger Agreement Proposal. Because the vote is advisory only, it will not be binding on Braze, the Braze Board of Directors or Salesforce. Accordingly, if the Merger Agreement Proposal is approved and the Merger is completed, the merger-related compensation will be paid to Braze’s named executive officers to the extent payable in accordance with the terms of the applicable compensation agreements and arrangements, even if Braze stockholders do not approve the Merger-Related Compensation Proposal.
19

TABLE OF CONTENTS

Q:
Do you expect the Merger to be taxable to Braze stockholders?
A:
The receipt of cash in exchange for Class A Common Stock pursuant to the Merger generally will be a taxable transaction for U.S. federal income tax purposes. U.S. Holders generally will recognize gain or loss for U.S. federal income tax purposes in an amount equal to the difference, if any, between (a) the amount of cash received and (b) the U.S. Holder’s adjusted tax basis in the Class A Common Stock surrendered in exchange. Non-U.S. Holders generally will not be subject to U.S. federal income tax unless the Non-U.S. Holder has certain connections to the United States.
You should read the section titled “Material U.S. Federal Income Tax Consequences of the Merger” for a more complete discussion of the U.S. federal income tax consequences of the Merger. Tax matters can be complicated and the tax consequences of the Merger to you will depend on your particular tax situation. You should consult your tax advisor to determine the applicable U.S. federal, state, local and non-U.S. tax consequences of the Merger to you.
Q:
Who is entitled to vote at the Special Meeting?
A:
Only Braze stockholders of record who held shares as of the Record Date are entitled to receive notice of and to vote at the Special Meeting.
Participating stockholders who log on to the Special Meeting using their unique 16-digit control number will also be able to examine the complete list of stockholders entitled to vote at the Special Meeting during the Special Meeting by following the instructions provided on the meeting website at www.virtualshareholdermeeting.com/BRZE2027SM.
Each share of Class A Common Stock is entitled to one vote on each proposal.
As of the Record Date, there were    shares of Class A Common Stock outstanding. Only record holders of Class A Common Stock and their proxies are entitled to vote at the Special Meeting, and each share of Class A Common Stock will be entitled to one vote per share on all matters submitted to stockholders at the Special Meeting.
Q:
Who may attend the Special Meeting?
A:
Only Braze stockholders as of the Record Date, or their duly appointed proxies, and invited guests of Braze may attend the meeting. If your shares are held in “street name” and your voting instruction form indicates that you may vote those shares through the www.proxyvote.com website, then you may access, attend, participate in and vote at the Special Meeting with the 16-digit control number indicated on that voting instruction form by visiting www.virtualshareholdermeeting.com/BRZE2027SM. If you cannot locate your control number, Braze stockholders who hold their shares in “street name” should contact their bank, broker, or other nominee (preferably at least five days before the Special Meeting) and obtain their 16-digit control number or a legal proxy in order to be able to attend, participate in, or vote at the Special Meeting. Braze has retained Broadridge Financial Solutions, Inc. (referred to as “Broadridge”) to host our Special Meeting and to distribute, receive, count and tabulate proxies.
Q:
Who is soliciting my vote?
A:
The Braze Board of Directors is soliciting your proxy, and Braze will bear the cost of soliciting proxies. The solicitation initially will be made by mail or by email to certain holders who have previously consented to receiving proxy materials by email. Some of our officers and other employees also may, but without compensation other than their regular compensation, solicit proxies by mail or personal conversations, or by telephone, facsimile or other electronic means. Braze will also, upon request, reimburse brokers and other persons holding stock in their names, or in the names of nominees, for their reasonable out-of-pocket expenses for forwarding proxy materials to the beneficial owners of the capital stock and to obtain proxies. Additionally, we have retained Innisfree M&A Incorporated, a proxy solicitation firm (referred to as the “Proxy Solicitor”), to assist in soliciting proxies in connection with the Special Meeting.
Q:
What do I need to do now?
A:
After carefully reading and considering the information contained in this proxy statement, please submit your proxy as soon as possible so that your shares of Class A Common Stock will be represented and voted at the Special Meeting. Please follow the instructions set forth on the enclosed proxy card or voting instruction form.
20

TABLE OF CONTENTS

Q:
How do I vote if my shares are registered directly in my name?
A:
If you are a stockholder of record, we encourage you to submit your proxy in advance of the Special Meeting by following the instructions on the enclosed proxy card to vote via the internet, by telephone or by signing, dating and returning the enclosed proxy card in the postage-paid envelope provided. If we receive your signed proxy card before the Special Meeting, we will vote your shares as you direct or, in the absence of such direction, according to the recommendation of the Braze Board of Directors. We encourage you to vote over the internet, which is a convenient, cost-effective and reliable alternative compared to returning a proxy card by mail.
Whether or not you plan to attend the meeting, we urge you to promptly vote by proxy to ensure your vote is counted. You may still participate in the Special Meeting and vote virtually even if you have already voted by proxy. To vote virtually at the Special Meeting, visit www.virtualshareholdermeeting.com/BRZE2027SM and enter the 16-digit control number included on your proxy card or voting instruction form that accompanied your proxy materials.
If you submit a proxy and later decide to vote at the Special Meeting, your proxy prior to the Special Meeting will be revoked; however, attending the Special Meeting will not revoke your written, internet or telephone proxy, as the case may be, unless you specifically request revocation or cast a ballot at the Special Meeting.
Q:
How do I vote if my shares are held in the name of my broker (referred to as the “street name”)?
A:
If your shares are held in “street name” by your bank, brokerage firm or other nominee, you must direct your bank, brokerage firm or other nominee on how to vote your shares of Class A Common Stock in accordance with the instructions furnished by your bank, brokerage firm or other nominee. The availability of internet or telephonic voting will depend on your nominee’s voting process. We urge you to provide your nominee with your voting instructions in advance of the Special Meeting to ensure your shares are represented and voted at the Special Meeting. Your nominee cannot vote your shares on your behalf absent your instructions.
If your shares are held in “street name” and your voting instruction form indicates that you may vote those shares through the www.proxyvote.com website, then you may access, attend, participate in and vote at the Special Meeting with the 16-digit control number indicated on that voting instruction form by visiting www.virtualshareholdermeeting.com/BRZE2027SM. If you cannot locate your control number, Braze stockholders who hold their shares in “street name” should contact their bank, broker, or other nominee (preferably at least five days before the Special Meeting) and obtain their 16-digit control number or a legal proxy in order to be able to attend, participate in, or vote at the Special Meeting.
In accordance with the rules of Nasdaq, your bank, brokerage firm or other nominee can vote your shares of Class A Common Stock on “routine” matters when they have not received voting instructions from you. However, such banks, brokerage firms and other nominees are precluded from exercising their voting discretion with respect to “non-routine” matters. All proposals described in this proxy statement to be voted on at the Special Meeting are considered “non-routine” matters. Accordingly, if you are a beneficial holder and you do not provide your bank, brokerage firm or other nominee instructions on how to vote your shares of Class A Common Stock at the Special Meeting, your bank, brokerage firm or other nominee will not be permitted to vote your shares on any of the proposals at the Special Meeting, and your shares will not be counted as present for purposes of determining whether a quorum is present. Because there are no “routine” matters to be voted on at the Special Meeting, Braze does not expect any “broker non-votes.” If you are a beneficial holder, Braze strongly encourages you to promptly provide voting instructions to your bank, brokerage firm or other nominee so that your vote will be counted on all matters.
Q:
Can I change my vote after I submit my proxy?
A:
Yes. You can change or revoke your proxy with respect to any proposal at any time before the final vote at the Special Meeting or any adjournment, postponement or continuation thereof with respect to such proposal. If you are the record holder of your shares, you may change or revoke your proxy in any one of three ways:
•
You may submit another properly completed proxy bearing a later date, whether over the internet, by telephone or by mail until 11:59 PM ET on   ,   , the day before the Special Meeting;
21

TABLE OF CONTENTS

•
You may deliver a written notice prior to the Special Meeting (or any adjournment, postponement or continuation thereof) that you are revoking your proxy to Braze, Inc., Attention: Investor Relations, 63 Madison Building, 28 East 28th Street, Floor 12, New York, New York 10016; or
•
You may attend and vote at the virtual Special Meeting (or any adjournment, postponement or continuation thereof). If you previously voted via the internet (or by telephone or mail), you are not precluded from voting online at the Special Meeting.
If your shares are held by your bank, brokerage firm or other nominee, you will have to follow the instructions provided by your broker, bank or other nominee to change or revoke your proxy.
Q:
What happens if I sell or transfer my shares of Class A Common Stock before the Special Meeting?
A:
If you sell or otherwise transfer your shares after the Record Date but before the Special Meeting, you will retain the right to vote such shares at the Special Meeting, but you will have transferred the right to receive the Merger Consideration to the person to whom you sell or otherwise transfer your shares. In order to receive the Merger Consideration, you must hold your shares of Class A Common Stock through completion of the Merger.
Q:
What happens if I sell or transfer my shares of Class A Common Stock after the Special Meeting but before the Effective Time?
A:
If you sell or otherwise transfer your shares after the Special Meeting but before the Effective Time, you will have transferred the right to receive the Merger Consideration to the person to whom you sell or otherwise transfer your shares. In order to receive the Merger Consideration, you must hold your shares of Class A Common Stock through completion of the Merger.
Q:
How many shares must be present to constitute a quorum for the meeting?
A:
Holders of a majority of the voting power of all outstanding shares of Class A Common Stock as of the Record Date and entitled to vote at the Special Meeting must be present or represented by proxy at the Special Meeting to constitute a quorum for the transaction of business at the Special Meeting. If you fail to submit a proxy or to vote at the Special Meeting, or fail to instruct your bank, brokerage firm or other nominee how to vote, your shares of Class A Common Stock will not be counted towards a quorum. Abstentions (meaning shares present in person (virtually) or by proxy but not voted) will be counted as shares present and entitled to vote for the purposes of determining a quorum. Because all proposals described in this proxy statement are considered “non-routine” matters, Braze does not expect any broker non-votes at the Special Meeting, and broker non-votes, if any, will not be counted as shares present for purposes of determining the presence of a quorum.
Q:
What if I abstain from voting or fail to vote or submit a proxy?
A:
If you attend the Special Meeting or send in your signed proxy card, but abstain from voting on any proposal, (via proxy, by checking the “abstain” box) your shares will still be counted for purposes of determining whether a quorum exists, but it will have the same effect as a vote “AGAINST” the Merger Agreement Proposal, no effect on the Merger-Related Compensation Proposal and no effect on the Adjournment Proposal (whether or not a quorum is present).
Q:
Will my shares be voted if I do not sign and return my proxy card or vote over the internet, by mail, by telephone or by attendance in person (virtually) and voting electronically at the Special Meeting?
A:
If you are a stockholder of record and you do not sign and return your proxy card by mail or vote over the internet, by telephone or by attendance in person (virtually) and voting at the Special Meeting, your shares will not be voted at the Special Meeting and will not be counted for purposes of determining whether a quorum exists.
If you are a beneficial owner of shares held in “street name” by your bank, brokerage firm or other nominee, you should have received a voting instruction form with these proxy materials from that organization. Follow the instructions from your bank, brokerage firm or other nominee to see which of the above choices are available to you to ensure that your vote is counted. If your shares are held in “street name” and your voting instruction form indicates that you may vote those shares through the www.proxyvote.com website, then you may access, attend, participate in and vote at the Special Meeting with the 16-digit control number indicated on
22

TABLE OF CONTENTS

that voting instruction form by visiting www.virtualshareholdermeeting.com/BRZE2027SM. If you cannot locate your control number, Braze stockholders who hold their shares in “street name” should contact their bank, broker, or other nominee (preferably at least five days before the Special Meeting) and obtain their 16-digit control number or a legal proxy in order to be able to attend, participate in, or vote at the Special Meeting.
If you fail to submit a proxy or to vote at the Special Meeting or fail to instruct your bank, brokerage firm or other nominee how to vote with respect to the Merger Agreement Proposal, it will have the same effect as a vote “AGAINST” such proposal. If you fail to submit a proxy or to vote at the Special Meeting or fail to instruct your bank, brokerage firm or other nominee how to vote with respect to the Merger-Related Compensation Proposal or the Adjournment Proposal, it will have no effect on the outcome of such proposal (assuming, in the case of the Merger-Related Compensation Proposal, a quorum is present).
Q:
What is a broker non-vote?
A:
A so-called “broker non-vote” results when banks, brokerage firms and other nominees return a valid proxy but do not vote on a particular proposal because they do not have discretionary authority to vote on the matter and have not received specific voting instructions from the beneficial owner of those shares. Broker non-votes count toward a quorum only if at least one proposal is presented at a stockholder meeting with respect to “routine” matters to which the bank, brokerage firm or other nominee has discretionary authority. Because all proposals described in this proxy statement to be voted on at the Special Meeting are considered “non-routine” matters, Braze does not expect any broker non-votes at the Special Meeting, and shares held in “street name” for which no voting instructions are provided will not be counted as present and entitled to vote for purposes of determining a quorum at the Special Meeting. The effect of not instructing your broker how you wish your shares to be voted will have the same effect as if they were voted “AGAINST” the Merger Agreement Proposal but will not have an effect on the Adjournment Proposal or the Merger-Related Compensation Proposal (assuming, in the case of the Merger-Related Compensation Proposal, a quorum is present).
Q:
Will my shares held in “street name” or another form of record ownership be combined for voting purposes with shares I hold of record?
A:
No. Because any shares you may hold in “street name” will be deemed to be held by a different stockholder than any shares you hold of record, any shares so held will not be combined for voting purposes with shares you hold of record. Similarly, if you own shares in various registered forms, such as jointly with your spouse, as trustee of a trust or as custodian for a minor, you will receive, and will need to sign and return, a separate proxy card for those shares because they are held in a different form of record ownership. Shares held by a corporation or business entity must be voted by an authorized officer of the entity. Shares held in an individual retirement account must be voted under the rules governing the account. Please submit a vote with respect to every account through which you own Class A Common Stock.
Q:
What does it mean if I receive more than one set of proxy materials?
A:
You may receive more than one set of voting materials for the Special Meeting, including multiple copies of this proxy statement and multiple proxy cards or voting instruction forms. For example, if you hold your Class A Common Stock in more than one brokerage account, you will receive a separate voting instruction form for each brokerage account in which you hold shares. If you are a stockholder of record and your shares are registered in more than one name, you will receive more than one proxy card. Please submit your vote with respect to each separate proxy card or voting instruction form that you receive by following the instructions set forth in each separate proxy card or voting instruction form.
Q:
Who will count the votes?
A:
A representative from Broadridge will serve as the inspector of election.
Q:
Can I participate if I am unable to attend the Special Meeting?
A:
If you are unable to attend the virtual Special Meeting, you may vote your shares of Class A Common Stock by completing, signing and returning your proxy card or voting instruction form or by voting over the internet, by telephone or by mail.
23

TABLE OF CONTENTS

Q:
Where can I find the voting results of the Special Meeting?
A:
Braze intends to announce preliminary voting results at the Special Meeting and publish final results in a Current Report on Form 8-K that will be filed with the SEC following the Special Meeting. All reports that Braze files with the SEC are publicly available when filed.
Q:
What happens if the Merger is not completed?
A:
If the Merger Agreement Proposal is not approved by Braze stockholders or if the Merger is not completed for any other reason, Braze stockholders will not receive any consideration for their shares of Class A Common Stock in connection with the Merger. Instead, Braze will remain an independent public company, the Class A Common Stock will continue to be listed and traded on Nasdaq and registered under the Exchange Act and Braze will continue to file periodic reports with the SEC. Under certain specific circumstances, Braze is required to pay Salesforce a termination fee of $191,390,000. See the section titled “The Merger Agreement—Termination Fee.”
Q:
How many copies of this proxy statement and related voting materials should I receive if I share an address with another stockholder?
A:
The SEC has adopted rules that permit companies and intermediaries, such as brokers, to satisfy the delivery requirements for proxy statements and annual reports with respect to two or more stockholders sharing the same address by delivering a single annual report or proxy statement, as applicable, addressed to those stockholders (this process is referred to as “householding”); provided that, for registered stockholders, householding is only permitted if consented to. Consent is considered to have been given if a stockholder does not object in writing within 60 days of having been given notice of the issuer’s intent to household such stockholder. Householding potentially provides extra convenience for stockholders and cost savings for companies.
Braze and some brokers may be householding our proxy materials by delivering proxy materials to multiple stockholders who request a copy and share an address, unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker or us that they or we will be householding materials to your address, householding will continue until you are notified otherwise or until you revoke your consent. If at any time you no longer wish to participate in householding and would prefer to receive a separate proxy statement and annual report, please notify your broker if your shares are held in a brokerage account or Braze if you are a stockholder of record. You can notify us by sending a written request to Braze, Inc., 63 Madison Building, 28 East 28th Street, Floor 12, New York, New York 10016, Attention: Investor Relations, or emailing ir@braze.com. Stockholders who share a single address, but receive multiple copies of this proxy statement, may request that in the future they receive a single copy by notifying Braze at the email address or mailing address set forth in the prior sentence. In addition, Braze will promptly deliver, upon written or oral request to the address or telephone number above, a separate copy of this proxy statement to a stockholder at a shared address to which a single copy of the documents was delivered pursuant to a prior request.
Q:
Whom should I contact if I have any questions?
A:
If you have any questions about the Special Meeting, the Merger, the proposals or this proxy statement, would like additional copies of this proxy statement, need to obtain proxy cards or other information related to this proxy solicitation or need help submitting a proxy or voting your shares of Class A Common Stock, please contact the firm assisting us with the solicitation of proxies:

 
500 Fifth Avenue, 21st Floor
New York, NY 10110
Stockholders May Call:
(877) 456-3524 (toll-free from the U.S. and Canada), or
+1 (412) 232-3651 (from other countries)
Banks and Brokers May Call Collect: (212) 750-5833
24

TABLE OF CONTENTS

Q:
Where can I find more information about Salesforce, Braze and the Merger?
A:
Braze will provide copies of this proxy statement and its most recent Annual Report to Stockholders, including its Annual Report on Form 10-K, without charge, to any stockholder who makes a written request to Investor Relations at Braze, Inc., 63 Madison Building, 28 East 28th Street, Floor 12, New York, New York 10016. Braze’s Annual Report on Form 10-K and other SEC filings may also be accessed at www.sec.gov or on the Investor Relations section of Braze’s website at www.braze.com. Salesforce’s Annual Report on Form 10-K and other SEC filings may also be accessed at www.sec.gov or on the Investor Relations section of Braze’s website at www.investor.salesforce.com. The information provided on or accessible through Braze’s website or Salesforce’s website is not part of this proxy statement and is not incorporated by reference in this proxy statement by this or any other reference to Braze’s or Salesforce’s respective website provided in this proxy statement.
You can find out more information about Salesforce, Braze and the Merger by reading this proxy statement and, with respect to Salesforce and Braze, from various sources described in the section entitled “Where You Can Find More Information.”
25

TABLE OF CONTENTS

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This proxy statement and the documents incorporated by reference into this proxy statement contain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this proxy statement that are not statements of historical fact, including statements regarding the proposed Merger, including the expected timing and closing of the proposed Merger; Braze’s ability to consummate the proposed Merger; the expected benefits to Salesforce, Braze and their respective customers from completing the Merger and other considerations taken into account by the Braze Board of Directors in approving the proposed Merger; the amounts to be received by stockholders and expectations for Braze prior to and following the closing of the proposed Merger; plans for future investment and capital allocation, the expected financial performance of Salesforce following the expected completion of the Merger, and the expected completion of the Merger, may be deemed to be forward-looking statements. All such forward-looking statements are intended to provide management’s current expectations for the future of Braze based on current expectations and assumptions relating to Braze’s business, the economy and other future conditions. Forward-looking statements generally can be identified through the use of words such as “expects,” “anticipates,” “aims,” “projects,” “intends,” “plans,” “believes,” “estimates,” “seeks,” “assumes,” “may,” “should,” “could,” “would,” “foresees,” “forecasts,” “predicts,” “targets,” “will,” “commitments,” variations of such words and similar expressions in connection with current plans, assumptions, beliefs, and expectations.
Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and changes in circumstances that are difficult to predict. Such risks, uncertainties and changes in circumstances include, among others:
•
the completion of the Merger on the anticipated terms and timing, or at all, including Salesforce’s and Braze’s ability to obtain regulatory approvals and the Braze stockholder approval and satisfy other conditions to the completion of the Merger;
•
the effect of the announcement or pendency of the Merger on Braze’s business, operating results, ability to retain and hire key personnel, and relationships with customers, suppliers, competitors and others;
•
risks that the Merger may disrupt Braze’s current plans and business operations or divert management’s attention from ongoing business operations;
•
the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement;
•
the possibility that the Merger Agreement may be terminated in circumstances requiring Salesforce or Braze to pay a termination fee;
•
the possibility and outcome of any legal or regulatory proceedings related to the Merger;
•
the potential effects on the accounting of the Merger;
•
legislative, regulatory and economic developments;
•
general economic conditions;
•
restrictions during the pendency of the Merger that may impact Braze’s ability to pursue certain business opportunities or strategic transactions;
•
the ability of Salesforce to successfully integrate Braze’s market opportunities and technology, personnel and operations and to achieve expected benefits, including the possibility that the expected benefits from the Merger will not be realized or will not be realized within the expected time period;
•
the possibility that competing offers may be made;
•
negative effects of the announcement or the consummation of the Merger on the market price of Salesforce’s common stock and/or operating results;
•
significant transaction costs and expenses; and
•
unknown liabilities.
Braze cautions that the foregoing list of factors is not exhaustive. Additional information concerning these and other risk factors is contained in Braze’s most recently filed Annual Report on Form 10-K for the fiscal year ended
26

TABLE OF CONTENTS

January 31, 2026 and subsequently filed Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and Form 8-K/A and other SEC filings, as such filings may be amended from time to time. All of the forward-looking statements made by Braze contained or incorporated by reference in this proxy statement and all subsequent written and oral forward-looking statements concerning Braze, the Merger or other matters attributable to Braze or any person acting on its behalf are expressly qualified in their entirety by the cautionary statement above.
If any of these risks materialize or any of Braze’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that Braze presently does not know of or that Braze currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Braze’s expectations, plans or forecasts of future events and views as of the date of this proxy statement. Braze anticipates that subsequent events and developments will cause Braze’s assessments to change. However, while Braze may elect to update these forward-looking statements at some point in the future, Braze specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Braze’s assessments as of any date subsequent to the date of this proxy statement. Accordingly, undue reliance should not be placed upon the forward-looking statements.
27

TABLE OF CONTENTS

THE COMPANIES
Braze, Inc.
Braze, Inc. helps marketers build deeper customer relationships by responding to customer behavior in real time, coordinating personalized experiences across mobile apps, websites, email, SMS, WhatsApp, and more. Braze’s cloud-native, event-streaming architecture is optimized for high-volume, real-time B2C engagement, continuously updating customer profiles and adapting customer journeys while powering trillions of messages and journey actions each year. BrazeAI extends these capabilities with AI-powered optimization across content, offers, channels, and timing, helping marketers make each interaction more relevant.
Braze was founded in 2011. Braze completed its initial public offering in 2021 and its Class A Common Stock is currently listed on Nasdaq under the symbol “BRZE.” Braze’s principal executive offices are located at 63 Madison Building, 28 East 28th Street, Floor 12, New York, New York 10016, and its telephone number is (609) 964-0585.
Salesforce, Inc.
Salesforce is a global leader in customer relationship management technology that brings companies and customers together. With the deeply unified Agentforce 360 Platform, Salesforce delivers a single source of truth, connecting customer data with integrated AI across systems, apps and devices to help companies sell, service, market and conduct commerce from anywhere. Salesforce offers Agentforce, a layer of the trusted Agentforce 360 Platform, that enables companies to build and deploy AI agents that can respond to inputs, make decisions and take action autonomously across business functions. Agentforce includes a suite of customizable agents for use across sales, service, marketing and commerce. Since its founding in 1999, Salesforce has enabled companies of every size and industry to transform their businesses in the digital-first world, pioneering innovations in cloud, mobile, social, analytics and AI.
Salesforce common stock is traded on the New York Stock Exchange under the ticker symbol “CRM.”
Salesforce’s executive offices and principal facilities are located at Salesforce Tower, 415 Mission Street, 3rd Floor, San Francisco, California 94105. Its telephone number is 415-901-7000 and its website is www.salesforce.com. The information provided on Salesforce’s website is not part of this proxy statement and is not incorporated in this proxy statement by reference by this or any other reference to its website provided in this proxy statement.
Banff Acquisition Sub Inc.
Banff Acquisition Sub is a Delaware corporation and a wholly owned subsidiary of Salesforce. Banff Acquisition Sub was formed solely for the purpose of engaging in the Transactions. Banff Acquisition Sub has engaged in no business activities to date and it has no material assets or liabilities of any kind, other than those incident to its formation in connection with the Merger and the Transactions. Upon consummation of the Merger, Banff Acquisition Sub will be merged with and into Braze, with Braze surviving the merger as a wholly owned subsidiary of Salesforce, and Banff Acquisition Sub will cease to exist.
Banff Acquisition Sub’s address is c/o Salesforce, Inc., Salesforce Tower, 415 Mission Street, 3rd Floor, San Francisco, CA 94105.
28

TABLE OF CONTENTS

THE SPECIAL MEETING
General
This proxy statement is first being mailed on or about   ,   , and constitutes notice of the Special Meeting in conformity with the requirements of the DGCL and Braze’s bylaws.
This proxy statement is being provided to Braze stockholders as part of a solicitation of proxies by the Braze Board of Directors for use at the Special Meeting of Braze stockholders and at any adjournments, postponements or continuations of such Special Meeting. This proxy statement provides Braze stockholders with information about the Special Meeting and should be read carefully in its entirety.
Date, Time and Place of the Special Meeting
The Special Meeting will be held on   ,   , beginning at   , Eastern Time, unless adjourned or postponed to a later date, via live audio webcast at www.virtualshareholdermeeting.com/BRZE2027SM. To virtually participate in the Special Meeting, visit such website and enter the 16-digit control number provided on your proxy card or voting instruction form. If your shares are held in “street name” and your voting instruction form indicates that you may vote those shares through the www.proxyvote.com website, then you may access, attend, participate in and vote at the Special Meeting with the 16-digit control number indicated on that voting instruction form by visiting www.virtualshareholdermeeting.com/BRZE2027SM. If you cannot locate your control number, Braze stockholders who hold their shares in “street name” should contact their bank, broker, or other nominee (preferably at least five days before the Special Meeting) and obtain their 16-digit control number or a legal proxy in order to be able to attend, participate in, or vote at the Special Meeting.
Purposes of the Special Meeting
At the Special Meeting, Braze stockholders will be asked to vote upon the following proposals:
•
Proposal 1—The Merger Agreement Proposal: the proposal to adopt the Merger Agreement, which is further described in the sections titled “The Merger (Proposal 1)” and “The Merger Agreement” of this proxy statement and a copy of which is attached to this proxy statement as Annex A;
•
Proposal 2—The Merger-Related Compensation Proposal: the proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Braze’s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated thereby, which is further described in the sections titled “Advisory Vote on Named Executive Officer Merger-Related Compensation Arrangements (Proposal 2)” and “The Merger (Proposal 1)—Interests of Braze’s Directors and Executive Officers in the Merger”; and
•
Proposal 3—The Adjournment Proposal: the proposal to approve the adjournment from time to time of the Special Meeting, if deemed necessary or appropriate by the Braze Board of Directors or any committee thereof, including to solicit additional proxies if there are insufficient votes to approve the Merger Agreement Proposal at the time of the Special Meeting, which is further described in the section titled “Vote on Adjournment (Proposal 3).”
Only the approval of the Merger Agreement Proposal is required for completion of the Merger. Braze will transact no other business at the Special Meeting, except such business as may properly be brought before the Special Meeting or any adjournment, postponement or continuation thereof.
Recommendation of the Braze Board of Directors
At a meeting held on October 19, 2026, the Braze Board of Directors unanimously (i) determined that the terms of the Merger Agreement and the Transactions, including the Merger, are fair to, and in the best interests of, Braze and Braze stockholders, (ii) determined that it is fair to and in the best interests of Braze and Braze stockholders, and declared it advisable, to enter into the Merger Agreement, (iii) approved the execution and delivery by Braze of the Merger Agreement and by the Support Stockholders of the Voting and Support Agreement, the performance by Braze of its covenants and agreements contained in the Merger Agreement and the consummation of the Merger and the other Transactions upon the terms and subject to the conditions contained in the Merger Agreement and (iv) resolved to recommend that Braze stockholders approve and adopt the Merger Agreement and the Transactions, including the Merger.
29

TABLE OF CONTENTS

Accordingly, the Braze Board of Directors unanimously recommends that Braze stockholders vote “FOR” the Merger Agreement Proposal, “FOR” the Merger-Related Compensation Proposal and “FOR” the Adjournment Proposal.
Braze stockholders should carefully read this proxy statement, including any documents incorporated by reference, and the annexes in their entirety for more detailed information concerning the Merger and the Transactions.
Virtual Participation at Special Meeting
The Special Meeting will be a completely virtual meeting of stockholders conducted via live audio webcast through the website described above under the heading “Date, Time and Place of the Special Meeting.”
Braze will have technicians ready to assist Braze stockholders with any technical difficulties they may have accessing the virtual meeting. If Braze stockholders encounter any difficulties accessing the virtual meeting or during the meeting time, Braze stockholders should navigate to www.virtualshareholdermeeting.com/BRZE2027SM, where a phone number for IT support will be posted.
Outstanding Shares as of the Record Date
As of the Record Date, there were    shares of Class A Common Stock outstanding. Each share of Class A Common Stock is entitled to one vote on each matter considered at the Special Meeting. No shares of any series of preferred stock of Braze were outstanding as of the Record Date.
Stockholders may request an appointment to inspect a complete list of stockholders entitled to vote at the Special Meeting for any purpose germane to the Special Meeting at Braze’s principal executive offices located at 63 Madison Building, 28 East 28th Street, Floor 12, New York, New York 10016, Attention: Investor Relations, during ordinary business hours within ten days prior to the Special Meeting. This list will also be made available at the Special Meeting for examination by any stockholder virtually present at the Special Meeting.
Record Date; Stockholders Entitled to Vote
Only holders of record of Class A Common Stock at the close of business on   ,   , the Record Date, are entitled to receive notice of the Special Meeting and to vote the shares of Class A Common Stock that they held on that date at the meeting, or any adjournment, postponement or continuation of the meeting. Each share of Class A Common Stock is entitled to one vote on each proposal. Braze official stock ownership records will conclusively determine whether a stockholder is a “holder of record” as of the Record Date.
Quorum; Abstentions; Broker Non-Votes
Holders of a majority of the voting power of all outstanding shares of Class A Common Stock as of the Record Date and entitled to vote at the Special Meeting must be present (virtually) or represented by proxy at the Special Meeting to constitute a quorum for the transaction of business at the Special Meeting. Shares that you own of record will be counted for purposes of determining if there is a quorum, whether representing votes for, against or abstained, if you (1) attend the Special Meeting or (2) have voted via the internet, by telephone or by properly submitting a proxy card or voting instruction form by mail. If you fail to submit a proxy or to be present (virtually) at the Special Meeting, or (if you hold your shares beneficially through a bank, brokerage firm or other nominee) fail to instruct your bank, brokerage firm or other nominee how to vote, your shares of Class A Common Stock will not be counted towards a quorum. An abstention occurs when a stockholder attends a meeting, either by attendance in person (virtually) or by proxy, but abstains from voting (by, in the case of proxy, checking the box to abstain). At the Special Meeting, such abstentions will be counted in determining whether a quorum is present.
Banks, brokerage firms and other nominees who hold shares in “street name” for the accounts of their clients may vote such shares either as directed by their clients or in their own discretion on “routine” matters. When a broker does not receive instructions from a beneficial owner on how to vote shares with respect to a “non-routine” matter, a “broker non-vote” may occur with respect to that matter if at least one “routine” matter is presented at the meeting. Because all proposals described in this proxy statement to be voted on at the Special Meeting are considered “non-routine” matters, Braze does not expect any “broker non-votes” at the Special meeting, and shares held in “street name” for which no voting instructions are provided will not be treated as present for purposes of determining whether a quorum is present.
30

TABLE OF CONTENTS

In the event that a quorum is not present at the Special Meeting, it is expected that the Special Meeting will be adjourned or postponed. Whether or not a quorum is present, the Special Meeting may be adjourned by either the chairperson of the Special Meeting or by the affirmative vote of a majority of the votes cast affirmatively or negatively (excluding abstentions and broker non-votes). If the Special Meeting is postponed or adjourned, it will not affect the ability of holders of record of Class A Common Stock as of the Record Date (unless a new record date is set in accordance with Delaware law) to exercise their voting rights or to revoke any previously granted proxy using the methods described below; however, if a new record date is set for an adjourned meeting, a quorum based upon stock ownership as of such new record date will be required to be established.
Required Vote; Treatment of Abstentions and Failure to Vote
The votes required for each proposal are as follows:
Proposal 1—The Merger Agreement Proposal: The affirmative vote (in person (virtually) or by proxy) of the holders of a majority of the outstanding shares of Class A Common Stock entitled to vote thereon is required to approve the Merger Agreement Proposal. Abstentions, failures to vote (including a failure to authorize a proxy to vote on your behalf) and broker non-votes will have the same effect as a vote “AGAINST” the Merger Agreement Proposal.
Proposal 2—The Merger-Related Compensation Proposal: The affirmative vote of a majority of the votes cast affirmatively or negatively (excluding abstentions and broker non-votes) (in person (virtually) or by proxy) at the Special Meeting is required to approve, on an advisory (non-binding) basis, the Merger-Related Compensation Proposal. Assuming a quorum is present, abstentions, failures to vote (including a failure to authorize a proxy to vote on your behalf) and broker non-votes will have no effect on the Merger-Related Compensation Proposal.
Proposal 3—The Adjournment Proposal: Whether or not a quorum is present, the affirmative vote of a majority of the votes cast affirmatively or negatively (excluding abstentions and broker non-votes) (in person (virtually) or by proxy) at the Special Meeting is required to approve the Adjournment Proposal. Abstentions, failures to vote (including a failure to authorize a proxy to vote on your behalf) and broker non-votes will have no effect on the Adjournment Proposal.
Shares and Voting of Braze Directors and Executive Officers
As of the Record Date, Braze directors and executive officers, as a group, owned and were entitled to vote     shares of Class A Common Stock, or approximately   % of the outstanding shares of Class A Common Stock. Braze currently expects that these directors and executive officers will vote their shares in favor of the Merger Agreement Proposal and each of the other proposals described in this proxy statement, although none of them are obligated to do so other than William Magnuson and an entity affiliated with Mr. Magnuson, Jonathan Hyman and certain trusts affiliated with Mr. Hyman, and Neeraj Agrawal pursuant to the terms of the Voting and Support Agreement. See the section titled “The Voting and Support Agreement.”
How to Vote or Have Your Shares Voted
Holders of Record
If, as of the Record Date, your shares of Class A Common Stock are registered directly in your name with the transfer agent of Braze,   , you are considered the stockholder of record with respect to those shares. As the stockholder of record, you have the right to vote or to grant a proxy for your vote directly to Braze or to a third party to vote at the Special Meeting.
Braze stockholders of record may vote their shares of Class A Common Stock or submit a proxy to have their shares of Class A Common Stock voted at the Special Meeting in one of the following ways:
•
Internet: Braze stockholders may submit their proxy by using the internet at www.proxyvote.com. Internet voting is available 24 hours a day and will be accessible until 11:59 p.m., Eastern Time, on   ,   , the day before the Special Meeting.
•
Telephone: Braze stockholders may submit their proxy by telephone by following the instructions on the enclosed proxy card and calling 1-800-690-6903. Telephone voting is available 24 hours a day and will be accessible until 11:59 p.m., Eastern Time, on   ,   , the day before the Special Meeting.
31

TABLE OF CONTENTS

•
Mail: Braze stockholders may submit their proxy by properly completing, signing and mailing their proxy card in the postage-paid envelope (if mailed in the United States) included with this proxy statement. Braze stockholders who vote this way should mail the proxy card early enough so that it is received before the date of the Special Meeting.
•
Vote Virtually at the Special Meeting: To vote virtually at the Special Meeting, visit www.virtualshareholdermeeting.com/BRZE2027SM and enter the 16-digit control number included on your proxy card that accompanied your proxy materials.
Whether or not you plan to attend the Special Meeting, Braze urges you to submit your proxy by completing and returning the proxy card as promptly as possible, or by submitting your proxy by telephone or via the internet, prior to the Special Meeting to ensure that your shares of Class A Common Stock will be represented and voted at the Special Meeting if you are unable to participate.
The Braze Board of Directors has appointed certain persons as proxy holders to vote proxies in accordance with the instructions of Braze stockholders. If you are a stockholder of record and you authorize these proxy holders to vote your shares of Class A Common Stock with respect to any matter to be acted upon, your shares will be voted in accordance with your instructions in your proxy. If you are a stockholder of record and you authorize these proxy holders to vote your shares but do not specify how your shares should be voted on a proposal, these proxy holders will vote your shares on such proposals as the Braze Board of Directors recommends. If any other matter properly comes before the Special Meeting, these proxy holders will vote on that matter in their discretion.
“Street Name” Holders
If, as of the Record Date, your shares were held in an account at a bank, brokerage firm or other nominee, you are the beneficial owner of shares held in “street name,” and, for the purposes of this proxy statement, a beneficial owner, and your bank, brokerage firm or other nominee is considered the stockholder of record with respect to those shares. If you are a beneficial owner, you have a right to direct your bank, brokerage firm or other nominee on how to vote the shares held in your account. The availability of internet or telephonic voting will depend on the nominee’s voting process. Please check with your bank, brokerage firm or other nominee and follow the voting procedures your bank, brokerage firm or other nominee provides.
In accordance with the rules of Nasdaq, your bank, brokerage firm or other nominee may generally vote on “routine” matters when they have not received voting instructions from you. However, such banks, brokerage firms and other nominees are precluded from exercising their voting discretion with respect to “non-routine” matters. All proposals described in this proxy statement to be voted on at the Special Meeting are considered “non-routine” matters. Accordingly, if you are a beneficial owner and do not provide your bank, brokerage firm or other nominee instructions on how to vote your shares of Class A Common Stock, your bank, brokerage firm or other nominee will not be permitted to vote your shares on any of the proposals, your shares will not be counted as present for purposes of determining whether a quorum is present, and Braze does not expect any “broker non-votes” at the Special Meeting. Not instructing your broker how you wish your shares to be voted will have the same effect as if they were voted “AGAINST” the Merger Agreement Proposal but will not have an effect on the Adjournment Proposal or the Merger-Related Compensation Proposal (assuming, in the case of the Merger-Related Compensation Proposal, that a quorum is present). If you are a beneficial holder, Braze strongly encourages you to provide voting instructions to your bank, brokerage firm or other nominee so that your vote will be counted on all matters.
If you are a beneficial owner, you are invited to participate in the Special Meeting. If your voting instruction form indicates that you may vote those shares through the www.proxyvote.com website, then you may access, attend, participate in and vote at the Special Meeting with the 16-digit control number indicated on that voting instruction form by visiting www.virtualshareholdermeeting.com/BRZE2027SM. If you cannot locate your control number, Braze stockholders who hold their shares in “street name” should contact their bank, broker, or other nominee (preferably at least five days before the Special Meeting) and obtain their 16-digit control number or a legal proxy in order to be able to attend, participate in, or vote at the Special Meeting.
32

TABLE OF CONTENTS

Revocation of Proxies
Braze stockholders of record may revoke their proxies at any time prior to the voting at the Special Meeting in any of the following ways:
•
submitting another properly completed proxy bearing a later date, whether over the internet, by telephone or by mail, in accordance with the instructions detailed in the section of this proxy statement titled “The Special Meeting—How to Vote or Have Your Shares Voted”;
•
delivering a written notice prior to the Special Meeting (or any adjournment, postponement or continuation thereof) that you are revoking your proxy to Braze, Inc., Attention: Investor Relations, 63 Madison Building, 28 East 28th Street, Floor 12, New York, New York 10016; or
•
attending the meeting online and voting virtually during the meeting. Attendance at the Special Meeting will not, in itself, constitute revocation of a previously granted proxy. If you previously voted via the internet (or by telephone or mail), you are not precluded from voting online at the Special Meeting.
If you are a street name stockholder, please contact the broker, bank, or other nominee that holds your shares for information on how to change your vote.
Delivery of Proxy Materials
As permitted by applicable law, only one copy of this proxy statement is being delivered to holders of Class A Common Stock residing at the same address who have consented to householding, unless such holders of Class A Common Stock have notified Braze of their desire to receive multiple copies of this proxy statement. A stockholder of record is deemed to have consented to householding if the stockholder did not object in writing within 60 days after receiving notice of Braze’s intent to household.
Braze will promptly deliver, upon oral or written request, a separate copy of this proxy statement to any holder of Class A Common Stock residing at an address to which only one copy of this proxy statement was mailed. Requests for additional copies should be directed to Braze by mail at Braze, Inc., Attention: Investor Relations, 63 Madison Building, 28 East 28th Street, Floor 12, New York, New York 10016 or by emailing ir@braze.com.
Shares Held in Name of Broker
If your shares are held by your broker, bank or other nominee, often referred to as held in “street name,” you will receive a form from your broker, bank or other nominee seeking instruction as to how your shares should be voted. You should contact your broker, bank or other nominee with questions about how to provide or revoke your instructions.
Tabulation of Votes
A representative from Broadridge will serve as the inspector of election.
Solicitation of Proxies
The expense of soliciting proxies will be borne by Braze. We have retained Innisfree M&A Incorporated, a proxy solicitation firm (referred to as the “Proxy Solicitor”), to solicit proxies in connection with the Special Meeting at a cost of $  , plus certain expenses. We will also indemnify the Proxy Solicitor against certain losses arising out of its provision of these services on our behalf. In addition, we may reimburse banks, brokers and other nominees representing beneficial owners of shares for their expenses in forwarding soliciting materials to such beneficial owners. Proxies may also be solicited by our directors, officers and employees, personally or by telephone, email, fax, over the internet or by other means of communication. No additional compensation will be paid for such services.
Adjournments
Whether or not a quorum is present, the Special Meeting may be adjourned from time to time by the chairperson of the Special Meeting or by the affirmative vote of a majority of the votes cast affirmatively or negatively (in person (virtually) or by proxy) at the Special Meeting (excluding abstentions and broker non-votes).
33

TABLE OF CONTENTS

When a meeting is adjourned to another time or place (including an adjournment taken to address a technical failure to convene or continue a meeting using remote communication), notice need not be given of the adjourned meeting if the time and place, if any, thereof and the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting are (i) announced at the meeting at which the adjournment is taken, (ii) displayed, during the time scheduled for the meeting, on the same electronic network used to enable stockholders and proxy holders to participate in the meeting by means of remote communication or (iii) set forth in the notice of meeting, unless the adjournment is for more than 30 days, in which case a notice of the adjourned meeting will be given to each stockholder of record entitled to vote at the meeting. If, after any adjournment, a new record date for the determination of the stockholders entitled to vote is fixed for the adjourned meeting, the Braze Board of Directors will fix a record date for notice of the adjourned meeting and notice of the adjourned meeting will be given to each stockholder of record as of such record date for notice of such adjourned meeting.
Under the Merger Agreement, Braze may not adjourn or postpone the Special Meeting without Salesforce’s prior written consent, except (i) after consultation with Salesforce, to the extent necessary to ensure that any supplement or amendment to this proxy statement required by law is provided to Braze stockholders within a reasonable amount of time in advance of the Special Meeting or (ii) if there are not sufficient affirmative votes to constitute a quorum or to approve the Merger Agreement Proposal, to allow reasonable additional time for the solicitation of proxies. Unless otherwise agreed to in writing by Salesforce, any adjournment, postponement or continuation under clause (ii) will be for a period of no more than ten business days, and Braze will be permitted to effect no more than one such adjournment, postponement or continuation. In addition, if requested by Salesforce, Braze will adjourn, postpone or continue the Special Meeting under the circumstances described in clause (ii) for up to ten business days (with Salesforce permitted to make no more than one such request), and no such adjournment, postponement or continuation will be permitted if it would require a change to the record date for the Special Meeting.
34

TABLE OF CONTENTS

THE MERGER (PROPOSAL 1)
This section of this proxy statement describes the material aspects of the Merger. This section may not contain all of the information that is important to you. You should carefully read this entire proxy statement and the documents incorporated by reference into this proxy statement, including the full text of the Merger Agreement, a copy of which is attached to this proxy statement as Annex A, for a more complete understanding of the Merger. In addition, important information about Braze is included in or incorporated by reference into this proxy statement. See the section titled “Where You Can Find More Information.”
Effects of the Merger
Upon the terms and subject to the conditions set forth in the Merger Agreement and in accordance with the DGCL, at the Effective Time, Banff Acquisition Sub will merge with and into Braze, whereupon the separate existence of Banff Acquisition Sub will cease, and Braze will survive the Merger as a wholly owned subsidiary of Salesforce. The Merger will become effective at such time as the certificate of merger is duly filed with the Secretary of State of the State of Delaware in accordance with the relevant provisions of the DGCL (or at such later time as may be agreed by Braze and Salesforce and specified in the certificate of merger).
At the Effective Time, each share of Class A Common Stock issued and outstanding immediately prior to the Effective Time (other than shares of Class A Common Stock that are (i) Dissenting Shares, (ii) Cancelled Shares or (iii) Converted Shares) will automatically be converted into the right to receive $47.50 in cash, without interest.
Pursuant to the Merger Agreement, at the Effective Time:
•
Each In-the-Money Braze Option that is outstanding and unexercised will be cancelled and converted into the right to receive $47.50 in cash in respect of each Net Share covered by such Braze Option, without interest and less applicable tax withholdings, and each other Braze Option, whether or not vested, will be cancelled for no consideration.
•
Each Braze RSU that is held by a non-employee director or that is vested at such time will be cancelled and converted into the right to receive $47.50 in cash in respect of each underlying share, without interest and less applicable tax withholdings.
•
Each other Braze RSU will be assumed and converted into an Adjusted RSU based on the Conversion Ratio, on the same terms and conditions (including vesting terms).
•
Each unvested Braze PSU will be assumed and converted into an Adjusted RSU based on the Conversion Ratio, with the number of underlying shares determined based on actual performance for completed performance periods and target performance for incomplete performance periods (or, for the performance period beginning February 1, 2026, if the Closing Date occurs prior to February 1, 2027, the greater of target and actual performance), on the same terms and conditions (including vesting terms, but excluding performance-based vesting conditions).
•
Each Assumed Braze Restricted Share will be assumed and converted into an Adjusted Restricted Share based on the Conversion Ratio, on the same terms and conditions (including vesting terms), and each Cashout Braze Restricted Share will be converted into the right to receive $47.50 in cash without interest.
•
Each Braze equity award (other than a Braze Restricted Share) held by an employee outside the United States may instead be converted into a cash-based award on the same terms and conditions (in certain specified jurisdictions) or cashed out at the Closing based on the value of the Merger Consideration, if Salesforce determines that the foregoing treatment would reasonably be expected to cause a significant administrative burden.
If the Merger is completed, the Class A Common Stock will be delisted from Nasdaq and deregistered under the Exchange Act, as promptly as practicable after the Effective Time, and Braze will cease to be a publicly traded company as of the Effective Time. As a result, you will not own any shares of the Surviving Corporation.
Effect on Braze if the Merger Is Not Completed
If the Merger Agreement is not adopted by Braze stockholders or if the Merger is not completed for any other reason, Braze stockholders will not receive any payment for their shares (or interests in shares) of Class A Common Stock in connection with the Merger. Instead, Braze will remain an independent public company, the Class A
35

TABLE OF CONTENTS

Common Stock will continue to be listed and traded on Nasdaq and registered under the Exchange Act and Braze will continue to file periodic reports with the SEC. In addition, if the Merger is not completed, Braze stockholders will continue to be subject to the same risks and opportunities to which they are currently subject, including risks related to the highly competitive industry in which Braze operates and risks related to adverse economic conditions.
Furthermore, if the Merger is not completed, and depending on the circumstances that would have caused the Merger not to be completed, it is likely that the price of the Class A Common Stock will decline significantly, as the current market price of the Class A Common Stock reflects a market assumption that the Merger will be consummated. If that were to occur, it is uncertain when, if ever, the price of Class A Common Stock would return to the price at which it trades as of the date of this proxy statement.
Accordingly, if the Merger is not completed, there can be no assurance as to the effect of these risks and opportunities on the future value of your shares of Class A Common Stock. If the Merger Agreement is not approved by Braze stockholders or if the Merger is not completed for any other reason, there can be no assurance that any other transaction acceptable to Braze will be offered or that Braze’s business, prospects or results of operation will not be adversely impacted.
In addition, the Merger Agreement provides that, upon termination of the Merger Agreement under certain circumstances, Braze will be required to pay Salesforce a termination fee of $191,390,000. See the section titled “The Merger Agreement—Termination Fee” for a discussion of the circumstances under which such termination fee would be required to be paid. The Merger Agreement further provides that, upon termination of the Merger Agreement under certain circumstances, Salesforce will be required to pay Braze a reverse termination fee of $300,000,000. See the section titled “The Merger Agreement—Regulatory Reverse Termination Fee” for a discussion of the circumstances under which such reverse termination fee would be required to be paid.
Background of the Merger
The following chronology summarizes the key meetings and events that led to the signing of the Merger Agreement. This chronology does not purport to catalogue every conversation of or among Braze, the Braze Board of Directors, Braze’s representatives, Salesforce, the board of directors of Salesforce (referred to as the “Salesforce Board of Directors”), Salesforce’s representatives and other parties.
The Braze Board of Directors and management regularly review and assess Braze’s performance, strategy, financial position, opportunities and risks in light of business and economic conditions, as well as developments in the technology industry and across a range of scenarios and potential future industry developments. These regular reviews have, at the direction of the Braze Board of Directors, included the evaluation of Braze’s current business plans and the potential risks and benefits of maintaining the status quo and continuing to execute on its business plan, as well as review of a range of strategic and operating alternatives and opportunities.
In December 2025, at the request of John Somorjai, President, Corporate Development and Investments of Salesforce, a member of the Braze Board of Directors introduced Mr. Somorjai to William Magnuson, the Chairman, Chief Executive Officer, President and Co-Founder of Braze, so that Mr. Somorjai could arrange a time for Mr. Magnuson to speak with Marc Benioff, the Chair, Chief Executive Officer and Co-Founder of Salesforce. During a subsequent videoconference on February 23, 2026, Mr. Magnuson, Mr. Benioff and Mr. Somorjai discussed, at a high level, their respective companies’ histories, developments in the software industry and the potential for a partnership between the two companies.
On April 8, 2026, Mr. Magnuson met in person in New York with Mr. Somorjai and other representatives of Salesforce. During the meeting, the representatives of Salesforce expressed Salesforce’s interest in a potential transaction between Braze and Salesforce and requested that Mr. Magnuson meet in person with Mr. Benioff.
On May 18, 2026, Mr. Magnuson attended a social dinner in Hawaii hosted by Mr. Benioff, at which the potential transaction was not discussed. The following day, Mr. Magnuson met in person with Mr. Benioff, Mr. Somorjai and another representative of Salesforce to discuss, at a high level, a potential transaction between Braze and Salesforce, including the potential strategic benefits of a combination of the two companies.
On May 22, 2026, the Braze Board of Directors held a special meeting by videoconference to discuss the outreach from Salesforce. A representative of Braze senior management was also present at the meeting by invitation of the Braze Board of Directors. Mr. Magnuson informed the Braze Board of Directors of Salesforce’s outreach regarding a potential transaction, as well as his meeting with Mr. Benioff earlier that week. After discussion, the
36

TABLE OF CONTENTS

Braze Board of Directors formed a committee (the “Transaction Committee”), consisting of Mr. Magnuson, Neeraj Agrawal and Yvonne Wassenaar, to assist the Braze Board of Directors with day-to-day matters in connection with its evaluation of opportunities available to Braze and Braze’s stockholders, including a potential transaction with Salesforce, which could increase stockholder value and be in the best interests of its stockholders. The decision to form the Transaction Committee was not the result of any actual or potential conflict of interest of any member of the Braze Board of Directors with respect to a potential transaction with Salesforce. The Braze Board of Directors also discussed potentially engaging Qatalyst Partners LP (“Qatalyst Partners”), which had previously advised Braze and with which members of the Braze Board of Directors and Braze management were familiar, as a financial advisor in connection with Braze’s consideration of certain strategic matters, including a potential transaction with Salesforce, and having representatives of Qatalyst Partners present to the Braze Board of Directors at a meeting the following week.
On May 28, 2026, the Braze Board of Directors held a special meeting by videoconference to continue its discussion regarding the outreach from Salesforce. Representatives of Qatalyst Partners were also present at the meeting by invitation of the Braze Board of Directors. Representatives of Qatalyst Partners reviewed with the Braze Board of Directors certain public equity market trends and the current environment for strategic and sponsor transactions, as well as a preliminary perspective on Braze’s valuation, based on publicly available information and consensus estimates. The Braze Board of Directors also discussed potential responses to Salesforce’s outreach. The same day, Mr. Benioff contacted Mr. Magnuson to reiterate Salesforce’s interest in a potential transaction with Braze and expressed a desire to continue discussions between the two companies. Mr. Magnuson promptly informed the Braze Board of Directors of Mr. Benioff’s additional outreach.
On June 1, 2026, the Braze Board of Directors held a regularly scheduled meeting in person. Among other things, Mr. Magnuson updated the Braze Board of Directors on the outreach from Salesforce, and the Braze Board of Directors further discussed the preliminary valuation perspectives that representatives of Qatalyst Partners had reviewed with the Braze Board of Directors at its May 28, 2026 meeting.
On June 2, 2026, Mr. Somorjai contacted Mr. Magnuson and expressed Salesforce’s interest in advancing discussions regarding a potential transaction between Salesforce and Braze, including by entering into a confidentiality agreement and commencing a preliminary exchange of information. Thereafter, representatives of Salesforce delivered an initial due diligence request list to representatives of Braze. Mr. Magnuson promptly informed the Braze Board of Directors of his telephone call with Mr. Somorjai.
On June 8, 2026, Braze and Salesforce executed a confidentiality agreement (the “Confidentiality Agreement”) in order to facilitate the exchange of non-public information by both parties so that they could further explore whether a potential transaction would be in the best interests of both companies and their respective stockholders. Among other things, the Confidentiality Agreement included a customary 12-month “standstill” applicable to Salesforce, which contained a fall-away provision pursuant to which the standstill would automatically expire upon the entry by Braze into an acquisition agreement with a third party and similar customary events.
On June 13, 2026, Mr. Magnuson and another member of Braze senior management spoke by telephone with Mr. Somorjai and another representative of Salesforce regarding next steps in Salesforce’s due diligence review, including an in-person due diligence meeting scheduled for June 16, 2026 (the “June 16 Diligence Meeting”). During the call, Mr. Magnuson informed the representatives of Salesforce that Qatalyst Partners was expected to act as Braze’s financial advisor in connection with a potential transaction.
Beginning on June 13, 2026, members of Braze management provided due diligence materials to Salesforce and responded to supplemental due diligence requests from Salesforce, including at the June 16 Diligence Meeting at the offices of J.P. Morgan Securities LLC (“J.P. Morgan”), Salesforce’s financial advisor, and, over the following weeks, to follow-up requests from Salesforce for additional business and financial information.
On June 30, 2026, the Transaction Committee held a meeting by videoconference to review a preliminary financial plan for Braze’s fiscal years 2027 and 2028, which was subsequently incorporated into the Five-Year Plan (as defined in the section titled “—Certain Unaudited Projected Financial Information”). Representatives of Braze senior management were also present at the meeting by invitation of the Transaction Committee. Mr. Magnuson provided an overview of the preliminary financial plan, and the Transaction Committee discussed the plan with members of Braze management.
37

TABLE OF CONTENTS

On July 1, 2026, the Braze Board of Directors held a special meeting by videoconference to discuss the status of discussions with Salesforce. Representatives of Braze senior management were also present at the meeting by invitation of the Braze Board of Directors. Mr. Magnuson and other representatives of Braze senior management provided an overview of discussions with Salesforce to date. The Braze Board of Directors also authorized Braze management to provide certain financial information regarding Braze to Salesforce in connection with its due diligence review. Subsequently, representatives of Braze provided such financial information to representatives of Salesforce. Also on July 1, 2026, Braze executed an engagement letter with Qatalyst Partners to act as Braze’s financial advisor. The Braze Board of Directors selected Qatalyst Partners based on Qatalyst Partners’ qualifications, reputation and experience, including its familiarity with Braze and its business. Qatalyst Partners subsequently provided Braze with written relationship disclosure letters, dated July 16, September 28 and October 16, 2026, which were shared with the Braze Board of Directors and which confirmed that Qatalyst Partners had no material relationship with Salesforce.
On July 6, 2026, representatives of Braze and representatives of Salesforce held a due diligence call to discuss certain financial matters relating to Braze.
On July 13, 2026, representatives of Braze and representatives of Salesforce held a follow-up due diligence call, during which Braze responded to Salesforce’s due diligence questions.
On July 14, 2026, Mr. Somorjai, on behalf of Salesforce, delivered to Mr. Magnuson a preliminary non-binding proposal (the “July 14 Proposal”) to acquire all of the outstanding shares of Class A Common Stock for $35.00 per share in cash, which represented an approximately 56% premium to the 1-month volume-weighted average price of Class A Common Stock for the period ending July 14, 2026 and an approximately 62% premium to the 6-month volume-weighted average price of Class A Common Stock for the period ending July 14, 2026. The July 14 Proposal stated that the transaction would not be subject to any financing condition, proposed an exclusivity period of 30 days and was subject to, among other things, completion of additional customary due diligence, final approval by the Salesforce Board of Directors and the negotiation of mutually acceptable definitive transaction documents, including a voting and support agreement to be signed by certain stockholders of Braze. On the same day, Mr. Magnuson provided the July 14 Proposal to the Braze Board of Directors.
On July 16, 2026, the Braze Board of Directors held a special meeting by videoconference to discuss the July 14 Proposal. Representatives of each of Braze senior management and Davis Polk & Wardwell LLP (“Davis Polk”), outside legal counsel to Braze, were also present at the meeting, and representatives of Qatalyst Partners were present for a portion of the meeting, in each case by invitation of the Braze Board of Directors. Representatives of Qatalyst Partners presented a preliminary financial analysis of the July 14 Proposal, including as compared to Braze’s preliminary financial plan as presented at the June 30, 2026 meeting of the Transaction Committee. The Braze Board of Directors discussed, with input from representatives of Qatalyst Partners, Salesforce’s request for exclusivity, Salesforce’s likely approach to valuing Braze and potential negotiation strategies. The Braze Board of Directors also discussed whether to contact other potential acquirors at that time. The Braze Board of Directors discussed, with input from representatives of Qatalyst Partners, that only a limited number of other strategic parties had the financial capacity to acquire Braze, that the most likely of those parties to be able to consummate a transaction of this size was unlikely to be interested in pursuing an acquisition of Braze in light of its then-current business priorities, and that constrained debt markets would continue to present significant challenges for a financial sponsor considering an acquisition of Braze. The Braze Board of Directors considered, with input from representatives of Qatalyst Partners and Davis Polk, that broader outreach would increase the risk of a leak and that, in the event of a leak, Salesforce would likely withdraw its proposal and cease discussions, thereby likely depriving Braze stockholders of the opportunity for a meaningful premium transaction. After discussion, the Braze Board of Directors determined that the risks of broader outreach outweighed the potential benefits, including in light of the low likelihood that any other party with the requisite financial capacity would be interested in acquiring Braze. A representative of Davis Polk reviewed with the members of the Braze Board of Directors their fiduciary duties under Delaware law and provided a preliminary view of the likely regulatory review of the potential transaction. Following the departure of the representatives of Qatalyst Partners, the Braze Board of Directors continued to discuss the July 14 Proposal and potential responses to Salesforce. After discussion, the Braze Board of Directors directed Mr. Magnuson to respond to, and instructed Qatalyst Partners to respond to, Mr. Somorjai that Salesforce would need to improve the terms of the July 14 Proposal, including with respect to price and deal certainty. The Braze Board of Directors also authorized Braze to enter into an exclusivity agreement with Salesforce if the terms of the July 14 Proposal were improved.
38

TABLE OF CONTENTS

On July 19, 2026, at the direction of the Braze Board of Directors, Mr. Magnuson contacted Mr. Somorjai and conveyed that the July 14 Proposal undervalued Braze, but that Braze was open to receiving a revised proposal, and that any revised proposal should address deal certainty. Also on July 19, 2026, at the direction of the Braze Board of Directors, a representative of Qatalyst Partners conveyed the same message to Mr. Somorjai.
On July 21, 2026, Mr. Somorjai and representatives of J.P. Morgan contacted representatives of Qatalyst Partners to request guidance on next steps and a potential revised proposal. Representatives of Qatalyst Partners responded that they had not been authorized at this time by the Braze Board of Directors to provide any guidance on price, and discussed with Mr. Somorjai and representatives of J.P. Morgan valuation multiples for software companies generally.
On July 22, 2026, Mr. Magnuson and Mr. Somorjai spoke by telephone to discuss next steps, during which Mr. Somorjai provided an update on Salesforce’s evaluation of a potential transaction with Braze.
On July 23, 2026, Mr. Magnuson and Mr. Somorjai met in person in New York, during which Mr. Magnuson reiterated the Braze Board of Directors’ response to the July 14 Proposal and Mr. Somorjai indicated that Salesforce was considering increasing the price offered in the July 14 Proposal.
On August 3, 2026, Mr. Somorjai contacted Mr. Magnuson and informed him that Salesforce had obtained the necessary internal approvals to submit a revised proposal at an increased price. Mr. Somorjai also expressed Salesforce’s desire to move quickly and requested that Braze provide a specific and prompt response to the revised proposal.
On August 4, 2026, Mr. Somorjai, on behalf of Salesforce, delivered to Mr. Magnuson a revised non-binding proposal (the “August 4 Proposal”) to acquire all of the outstanding shares of Class A Common Stock for $41.00 per share in cash, which represented an approximately 60% premium to the closing price of Class A Common Stock on August 3, 2026. The August 4 Proposal stated that the transaction would not be subject to any financing condition, contemplated that the definitive agreement would include a reverse termination fee payable by Salesforce in the event that regulatory approvals were not obtained in an amount to be agreed, and was subject to, among other things, completion of additional customary due diligence, final approval by the Salesforce Board of Directors and the negotiation of mutually acceptable definitive transaction documents, including a voting and support agreement to be signed by certain stockholders of Braze. On the same day, Mr. Magnuson provided the August 4 Proposal to the Braze Board of Directors.
Later on August 4, 2026, Mr. Somorjai separately contacted each of Mr. Magnuson and a representative of Qatalyst Partners to discuss the August 4 Proposal, including to provide additional context regarding the proposal. Also on August 4, 2026, a representative of J.P. Morgan contacted a representative of Qatalyst Partners to discuss the August 4 Proposal, including the considerations underlying Salesforce’s determination of the proposed price.
On August 5, 2026, the Transaction Committee held a meeting by videoconference to discuss the August 4 Proposal. Representatives of Braze senior management were also present at the meeting, and representatives of each of Qatalyst Partners and Davis Polk were present for a portion of the meeting, in each case by invitation of the Transaction Committee. Mr. Magnuson provided the Transaction Committee with additional background regarding the August 4 Proposal and his recent discussions with Mr. Somorjai. Representatives of Qatalyst Partners then discussed Qatalyst Partners’ preliminary financial analysis of the August 4 Proposal and updated the Transaction Committee on Qatalyst Partners’ discussions with Mr. Somorjai and representatives of J.P. Morgan. A representative of Davis Polk provided an update on the likely regulatory review of the potential transaction. The Transaction Committee discussed with representatives of Qatalyst Partners and Davis Polk potential considerations for the Braze Board of Directors in evaluating the August 4 Proposal, as well as potential responses to Salesforce. After discussion, the Transaction Committee determined to brief the Braze Board of Directors on its deliberations and recommendations at the next meeting of the Braze Board of Directors, which was scheduled for August 6, 2026. 
On August 6, 2026, the Braze Board of Directors held a special meeting by videoconference to discuss the August 4 Proposal and to review the Five-Year Plan. Representatives of each of Braze senior management and Davis Polk were also present at the meeting, and representatives of Qatalyst Partners were present for a portion of the meeting, in each case by invitation of the Braze Board of Directors. Mr. Magnuson updated the Braze Board of Directors on his recent interactions with representatives of Salesforce. Pankaj Malik, Interim Chief Financial Officer of Braze, then reviewed with the Braze Board of Directors the Five-Year Plan, including the projections, underlying assumptions and risks therein. After discussion, the Braze Board of Directors approved the Five-Year Plan, including
39

TABLE OF CONTENTS

for use by Qatalyst Partners in connection with its valuation analyses and fairness opinion, and authorized providing all or portions of the Five-Year Plan to Salesforce in connection with its due diligence review, if requested. Following approval of the Five-Year Plan, representatives of Qatalyst Partners joined the meeting. A representative of Qatalyst Partners discussed Qatalyst Partners’ preliminary financial analysis of the August 4 Proposal and updated the Braze Board of Directors on representatives of Qatalyst Partners’ discussions with Mr. Somorjai and representatives of J.P. Morgan. A representative of Davis Polk reviewed with the members of the Braze Board of Directors their fiduciary duties under Delaware law. The Braze Board of Directors discussed the August 4 Proposal as compared to Braze’s alternatives, including continuing as an independent company and executing on its standalone plan, as well as potential responses to Salesforce. Following the departure of the representatives of Qatalyst Partners, the Braze Board of Directors continued to discuss the August 4 Proposal and potential responses to Salesforce. After discussion, the Braze Board of Directors directed Mr. Magnuson to instruct representatives of Qatalyst Partners to respond to Salesforce with a counterproposal of $49.00 per share in cash and to seek to cause Salesforce to improve the terms of the August 4 Proposal. The Braze Board of Directors discussed that Salesforce was unlikely to agree to a price of $49.00 per share in cash, and directed the Transaction Committee and Braze management to seek to obtain a price as high above $41.00 per share in cash as possible.
Later on August 6, 2026, at the direction of the Braze Board of Directors, a representative of Qatalyst Partners contacted Mr. Somorjai and conveyed that the August 4 Proposal remained below a level that the Braze Board of Directors would be prepared to support and delivered, on behalf of the Braze Board of Directors, Braze’s counterproposal of $49.00 per share in cash. Mr. Somorjai responded that it was unlikely Salesforce would be willing to agree to that price. A representative of J.P. Morgan subsequently communicated that same message to a representative of Qatalyst Partners.
On August 11, 2026, at the request of a representative of J.P. Morgan, Mr. Agrawal met in person in Boston with the representative of J.P. Morgan, during which they discussed, among other things, the potential transaction, including valuation and precedent transactions, and Mr. Agrawal reiterated Braze’s counterproposal of $49.00 per share in cash.
Between August 12 and August 19, 2026, in response to supplemental due diligence requests from Salesforce, Braze provided additional due diligence materials regarding, among other things, financial and employee matters. On August 17, 2026, representatives of each of Braze, Qatalyst Partners, Salesforce and J.P. Morgan held a due diligence meeting, at which the parties discussed, among other things, Braze’s financial and operating metrics and the potential benefits of a combination of the two companies. Later that day, Mr. Somorjai contacted a representative of Qatalyst Partners and requested certain additional information, which Mr. Somorjai indicated would assist Salesforce in evaluating potential synergies and whether it could improve the terms of the August 4 Proposal. Over the next two days, Braze provided the requested additional information to representatives of Salesforce and J.P. Morgan.
On August 20, 2026, Mr. Somorjai, on behalf of Salesforce, delivered to Mr. Magnuson a revised non-binding proposal (the “August 20 Proposal”) to acquire all of the outstanding shares of Class A Common Stock for $44.00 per share in cash, which represented an approximately 44% premium to the closing price of Class A Common Stock on August 19, 2026. The August 20 Proposal stated that the transaction would not be subject to any financing condition, contemplated that the definitive agreement would include a reverse termination fee in an amount to be agreed and was subject to, among other things, completion of additional customary due diligence, final approval by the Salesforce Board of Directors and the negotiation of mutually acceptable definitive transaction documents, including a voting and support agreement to be signed by certain stockholders of Braze. On the same day, Mr. Magnuson provided the August 20 Proposal to the Braze Board of Directors.
Later on August 20, 2026, the Transaction Committee held a meeting by videoconference to discuss the August 20 Proposal. Another member of the Braze Board of Directors and representatives of each of Braze senior management and Davis Polk were also present at the meeting, and representatives of Qatalyst Partners were present for a portion of the meeting, in each case by invitation of the Transaction Committee. Mr. Magnuson reviewed with the Transaction Committee his discussions with Salesforce since receiving the August 4 Proposal. Representatives of Qatalyst Partners then discussed, among other things, Qatalyst Partners’ views as to Salesforce’s likely approach to valuation, timing considerations for each of Braze and Salesforce and potential approaches the Transaction Committee could consider to seek to cause Salesforce to improve the terms of the August 20 Proposal. The Transaction Committee also discussed, among other things, Braze’s standalone plan and prospects, Braze’s earnings release for the second quarter of fiscal year 2027, which was scheduled for September 8, 2026, and whether to
40

TABLE OF CONTENTS

propose a specific reverse termination fee. After discussion, and consistent with the Braze Board of Directors’ direction on August 6, 2026, the Transaction Committee instructed Mr. Magnuson to seek to cause Salesforce to improve the terms of the August 20 Proposal, including by proposing a price of $47.50 per share in cash and a reverse termination fee of $500 million. The Transaction Committee briefed the Braze Board of Directors on the foregoing.
Later on August 20, 2026, consistent with the Transaction Committee’s instruction, Mr. Magnuson contacted Mr. Somorjai and conveyed the view that $47.50 per share in cash was the lowest price that he would be prepared to recommend to the Braze Board of Directors and that any transaction should include a reverse termination fee of $500 million, payable by Salesforce in certain circumstances. Mr. Magnuson also indicated that the parties would need to move quickly toward signing in the next few weeks. Mr. Somorjai did not respond to the price or the reverse termination fee and discussed further with Mr. Magnuson certain timing considerations.
On August 22, 2026, Mr. Somorjai, on behalf of Salesforce, delivered to Mr. Magnuson a revised non-binding proposal (the “August 22 Proposal”) to acquire all of the outstanding shares of Class A Common Stock for $47.50 per share in cash, which represented an approximately 53% premium to the closing price of Class A Common Stock on August 21, 2026. The August 22 Proposal stated that the transaction would not be subject to any financing condition, contemplated that the definitive agreement would include a reverse termination fee of $277 million, was accompanied by a proposed exclusivity agreement and was subject to, among other things, completion of additional customary due diligence, final approval by the Salesforce Board of Directors and the negotiation of mutually acceptable definitive transaction documents, including a voting and support agreement to be signed by certain stockholders of Braze. On the same day, Mr. Magnuson provided the August 22 Proposal to the Braze Board of Directors.
Also on August 22, 2026, following receipt of the August 22 Proposal, a representative of J.P. Morgan spoke with a representative of Qatalyst Partners regarding the August 22 Proposal, including certain timing considerations relating to the negotiation of the definitive transaction documents.
Later on August 22, 2026, the Transaction Committee held a meeting by videoconference to discuss the August 22 Proposal. Representatives of each of Braze senior management, Qatalyst Partners and Davis Polk were also present at the meeting by invitation of the Transaction Committee. Mr. Magnuson reviewed with the Transaction Committee the August 22 Proposal, the anticipated timing of signing and Salesforce’s request for exclusivity through September 28, 2026 to negotiate a definitive agreement. Representatives of Qatalyst Partners then discussed, among other things, the premium that the proposed price of $47.50 per share in cash represented to the then-current trading price of Class A Common Stock, including an approximately 53% premium to the closing price of Class A Common Stock on August 21, 2026, the last trading day prior to the delivery of the August 22 Proposal, Qatalyst Partners’ views as to Salesforce’s likely approach to valuation, timing considerations for each of Braze and Salesforce and the $277 million reverse termination fee proposed by Salesforce. A representative of Davis Polk reviewed with the members of the Transaction Committee their fiduciary duties under Delaware law. The Transaction Committee also discussed, among other things, Braze’s standalone plan and prospects, Braze’s upcoming earnings release and potential counterproposals with respect to the reverse termination fee, including by seeking an increase in the reverse termination fee, initially by asking for a $385 million reverse termination fee, and negotiating for the highest reverse termination fee reasonably attainable. After discussion, noting that the proposed price of $47.50 per share in cash matched the price that the Transaction Committee instructed Mr. Magnuson to convey to Mr. Somorjai on August 20, 2026, the Transaction Committee instructed Mr. Magnuson to seek to improve the other terms of the August 22 Proposal, including by seeking an increase in the $277 million reverse termination fee.
Later on August 22, 2026, Mr. Magnuson contacted Mr. Somorjai and proposed that the reverse termination fee be increased to $385 million. Mr. Magnuson also conveyed Braze’s expectation that Salesforce would commit to robust efforts to obtain the required regulatory clearances. Following discussion, Mr. Magnuson, at the authorization of the Braze Board of Directors, and Mr. Somorjai agreed to a reverse termination fee of $300 million.
On August 23, 2026, following negotiations between Davis Polk and Wachtell, Lipton, Rosen & Katz (“Wachtell Lipton”), outside legal counsel to Salesforce, and consistent with the Braze Board of Directors’ authorization on July 16, 2026 to enter into an exclusivity agreement with Salesforce if the terms of the July 14 Proposal were improved, Braze and Salesforce entered into an exclusivity agreement (the “Exclusivity Agreement”), pursuant to which Braze agreed to exclusivity until 11:59 p.m., Pacific Time, on September 23, 2026.
41

TABLE OF CONTENTS

On August 24, 2026, the Braze Board of Directors held a regularly scheduled meeting in person. During an executive session of the meeting, Mr. Magnuson reviewed with the Braze Board of Directors the status of discussions with Salesforce and next steps in the potential transaction.
Also on August 24, 2026, members of Braze management and representatives of Qatalyst Partners held a due diligence call to discuss the next phase of Salesforce’s due diligence review with representatives of Salesforce and J.P. Morgan, and representatives of Salesforce delivered a due diligence request list to representatives of Braze and the parties continued to engage in ongoing diligence until the execution of the Merger Agreement. On August 26, 2026, Braze granted representatives of Salesforce and its advisors access to a virtual data room to conduct additional due diligence in connection with the potential transaction. On August 31, September 1, September 2 and September 9, 2026, members of Braze management and representatives of Davis Polk participated in virtual due diligence sessions with representatives of Salesforce, Wachtell Lipton and Salesforce’s other advisors covering, among other things, technology and product, security, finance and tax, legal, intellectual property, employee, go-to-market and communications matters.
Late in August 2026, at Salesforce’s request in connection with its due diligence review of Braze, and with the approval of the Braze Board of Directors, Braze provided Salesforce with portions of the Five-Year Plan.
On September 4, 2026, Wachtell Lipton delivered an initial draft of the Merger Agreement to Davis Polk, and on September 9, 2026, Wachtell Lipton delivered an initial draft of the Voting and Support Agreement to be entered into by the Support Stockholders.
On September 10, 2026, Davis Polk delivered revised drafts of the Merger Agreement and the Voting and Support Agreement, together with an initial draft of Braze’s disclosure letter to the Merger Agreement (the “Company Disclosure Letter”), to Wachtell Lipton. Thereafter, and continuing until the Merger Agreement was executed and delivered, the parties and their respective counsel negotiated the terms of the Merger Agreement, the Voting and Support Agreement, the Company Disclosure Letter and, following its delivery by Wachtell Lipton, the Parent Disclosure Letter (as defined below), and representatives of Braze and Salesforce, including Mr. Magnuson and Mr. Somorjai, discussed the remaining open points in the transaction documents. The key terms of the Merger Agreement negotiated by the parties included, among other things: (i) the nature and scope of Salesforce’s obligations to obtain the regulatory approvals required to consummate the Merger; (ii) the circumstances under which the Braze Board of Directors could consider and accept a Superior Proposal, the circumstances in which a termination fee would be payable by Braze to Salesforce, the amount of such termination fee and the circumstances in which a reverse termination fee would be payable by Salesforce to Braze; (iii) the conditions to each party’s obligations to consummate the Merger, including the jurisdictions in which regulatory approvals must be obtained, and each party’s right to terminate the Merger Agreement, including for a failure to consummate the Merger by the Outside Date; (iv) the nature and scope of the interim operating covenants applicable to Braze between the signing of the Merger Agreement and the Closing; (v) the treatment of Braze Equity Awards and other employee compensation and retention matters; (vi) the approach to certain third-party consent and related issues and (vii) each party’s representations, warranties and covenants in the Merger Agreement.
On September 16, 2026, the Braze Board of Directors held a special meeting by videoconference to discuss the status of the potential transaction. Representatives of each of Braze senior management, Qatalyst Partners and Davis Polk were also present at the meeting by invitation of the Braze Board of Directors. Mr. Magnuson updated the Braze Board of Directors on the status of the potential transaction. Representatives of Davis Polk reviewed with the Braze Board of Directors certain antitrust and regulatory considerations relating to the potential transaction, including the anticipated timing of required regulatory clearances. A representative of Davis Polk also reviewed with the members of the Braze Board of Directors their fiduciary duties under Delaware law and updated the Braze Board of Directors on the status of negotiations of the Merger Agreement, including the principal open issues. After discussion, the Braze Board of Directors instructed Braze management and Davis Polk to continue to negotiate the transaction documents.
On September 23, 2026, Mr. Agrawal spoke with each of Mr. Somorjai and a representative of J.P. Morgan regarding the status of the potential transaction.
Also on September 23, 2026, the Exclusivity Agreement expired in accordance with its terms and was not extended.
42

TABLE OF CONTENTS

On September 24 and September 25, 2026, following agreement on the material terms of the potential transaction, including the proposed price of $47.50 per share in cash, and in response to a requirement by Salesforce to discuss with certain members of Braze management the terms of their potential employment with Salesforce following Closing, the Braze Board of Directors authorized members of Braze management to engage in such discussions with Salesforce.
By late September 2026, the parties were working toward signing the Merger Agreement and announcing the potential transaction in early October 2026.
On September 30, 2026, Salesforce delivered initial draft offer letters to certain members of Braze management, which Salesforce had requested that such members of management execute in connection with the potential transaction. Thereafter, the parties negotiated the offer letters until the execution and delivery of the Merger Agreement. For more information, see “—Interests of Braze’s Directors and Executive Officers in the Merger.”
On October 1, 2026, Wachtell Lipton delivered to Davis Polk an initial draft of Salesforce’s disclosure letter to the Merger Agreement (the “Parent Disclosure Letter”).
On October 5, 2026, the Braze Board of Directors held a special meeting by videoconference to discuss the status of the potential transaction. Representatives of each of Braze senior management, Qatalyst Partners and Davis Polk were also present at the meeting by invitation of the Braze Board of Directors. Representatives of Qatalyst Partners discussed Qatalyst Partners’ financial analysis of the proposed price of $47.50 per share in cash. A representative of Davis Polk reviewed with the members of the Braze Board of Directors their fiduciary duties under Delaware law, the most recent relationship disclosure provided by Qatalyst Partners and the agreed material terms of the transaction documents and the issues that remained open. After discussion, the Braze Board of Directors instructed management and Davis Polk to continue to negotiate the transaction documents.
Later on October 5, 2026, Mr. Benioff relayed his views concerning pre-closing integration planning matters to Mr. Magnuson. Mr. Magnuson promptly informed the Braze Board of Directors of Mr. Benioff’s views.
On October 7, 2026, Mr. Magnuson spoke by telephone with Mr. Benioff regarding the timing of an announcement of the potential transaction. Later that day, Mr. Somorjai discussed with a representative of Qatalyst Partners certain timing considerations for the potential transaction.
On October 12, 2026, Mr. Somorjai informed a representative of Qatalyst Partners that Salesforce wished to work toward signing the transaction the following week and would come back the next day with a more specific timeline.
On October 13, 2026, representatives of Qatalyst Partners spoke by telephone with a representative of J.P. Morgan, who outlined Salesforce’s anticipated process for the potential transaction, under which the Salesforce Board of Directors would meet early the following week to consider the potential transaction. Representatives of Qatalyst Partners discussed with the representative of J.P. Morgan related process matters.
Also on October 13, 2026, the Braze Board of Directors held a special meeting by videoconference to discuss the status of discussions with Salesforce. Representatives of each of Braze senior management, Qatalyst Partners and Davis Polk were also present at the meeting by invitation of the Braze Board of Directors. At the meeting, Mr. Magnuson and representatives of Qatalyst Partners updated the Braze Board of Directors on discussions with Salesforce and a representative of Davis Polk updated the Braze Board of Directors on the status of negotiations of the transaction documents. After discussion, the Braze Board of Directors instructed management and Davis Polk to finalize the transaction documents.
On October 19, 2026, the Braze Board of Directors held a special meeting by videoconference to consider the proposed transaction. Representatives of each of Braze senior management, Qatalyst Partners and Davis Polk were also present at the meeting by invitation of the Braze Board of Directors. Prior to the meeting, the directors received proposed final drafts of the Merger Agreement, the Voting and Support Agreement, the Company Disclosure Letter and the Parent Disclosure Letter. Representatives of Qatalyst Partners reviewed with the Braze Board of Directors Qatalyst Partners’ financial analyses of the Merger Consideration payable to the holders of shares of Class A Common Stock in the Merger and, at the request of the Braze Board of Directors, rendered to the Braze Board of Directors Qatalyst Partners’ oral opinion, which was subsequently confirmed by delivery of its written opinion, dated October 19, 2026, which is attached to this proxy statement as Annex C, that, as of that date and based upon and subject to the various assumptions, qualifications, limitations and other matters set forth therein, the Merger
43

TABLE OF CONTENTS

Consideration to be received by the Holders pursuant to, and in accordance with, the terms of the Merger Agreement was fair, from a financial point of view, to such Holders, as more fully described in the section of this proxy statement captioned “—Opinion of Qatalyst Partners LP.” A representative of Davis Polk reviewed with the members of the Braze Board of Directors their fiduciary duties under Delaware law, the most recent relationship disclosure provided by Qatalyst Partners and the material terms of the Merger Agreement, the Voting and Support Agreement and the other transaction documents, and another representative of Davis Polk summarized the executive compensation and employee benefits provisions and the interests of Braze’s executive officers in the transaction. After discussion, including of the factors described under “—Reasons for the Merger; Recommendation of the Braze Board of Directors,” the Braze Board of Directors unanimously (i) determined that the terms of the Merger Agreement and the Transactions, including the Merger, were fair to, and in the best interests of, Braze and Braze stockholders, (ii) determined that it was fair to and in the best interests of Braze and Braze stockholders, and declared it advisable, to enter into the Merger Agreement, (iii) approved the execution and delivery by Braze of the Merger Agreement and by the Support Stockholders of the Voting and Support Agreement, the performance by Braze of its covenants and agreements contained in the Merger Agreement and the consummation of the Merger and the other Transactions, in each case upon the terms and subject to the conditions contained in the Merger Agreement and (iv) resolved to recommend that Braze stockholders approve and adopt the Merger Agreement and the Transactions, including the Merger.
Also on October 19, 2026, the Salesforce Board of Directors approved the transaction, and following the meetings of the Braze Board of Directors and the Salesforce Board of Directors, Braze and Salesforce executed and delivered the Merger Agreement and Salesforce and the Support Stockholders executed the Voting and Support Agreement. Simultaneously with the execution of the Merger Agreement, Salesforce and certain members of Braze management entered into their respective offer letters.
On October 20, 2026, prior to the opening of trading on the Nasdaq Global Select Market, Braze and Salesforce issued a joint press release announcing the execution of the Merger Agreement.
Braze’s Reasons for the Merger; Recommendation of the Braze Board of Directors
At a special meeting held on October 19, 2026 to evaluate the Merger, the Braze Board of Directors, after careful consideration, unanimously (i) determined that the terms of the Merger Agreement and the Transactions, including the Merger, are fair to, and in the best interests of, Braze and Braze stockholders, (ii) determined that it is fair to and in the best interests of Braze and Braze stockholders, and declared it advisable, to enter into the Merger Agreement, (iii) approved the execution and delivery by Braze of the Merger Agreement and by the Support Stockholders of the Voting and Support Agreement, the performance by Braze of its covenants and agreements contained in the Merger Agreement and the consummation of the Merger and the other Transactions, in each case, upon the terms and subject to the conditions contained in the Merger Agreement and (iv) resolved to recommend that Braze stockholders approve and adopt the Merger Agreement and the Transactions, including the Merger. The Braze Board of Directors unanimously recommends that Braze stockholders vote:
1.
“FOR” the Merger Agreement Proposal;
2.
“FOR” the Merger-Related Compensation Proposal; and
3.
“FOR” the Adjournment Proposal.
In evaluating the Merger Agreement and the Transactions, including the Merger, and arriving at its determination, the Braze Board of Directors consulted with Braze’s senior management, representatives of Braze’s financial advisor, Qatalyst Partners, and Braze’s outside legal counsel, Davis Polk, and considered a number of substantive factors, both positive and negative, and potential benefits and detriments of the Merger to Braze and Braze stockholders. The Braze Board of Directors believed that, taken as a whole, the following factors (which are not presented in any relative order of importance) supported its decision to approve the Merger:
•
Merger Consideration. The Braze Board of Directors’ belief that the Merger Consideration provides Braze stockholders with attractive and compelling value for their shares of Class A Common Stock. The Braze Board of Directors considered the current and historical market prices, volatility and trading information of Class A Common Stock, in light of current industry conditions, the competitive landscape, publicly available analyst expectations and other factors.
44

TABLE OF CONTENTS

•
Business, Financial Condition, Prospects, and Execution Risks. The Braze Board of Directors’ belief that the Merger was more favorable to Braze stockholders than the alternative of remaining a standalone, independent company, which belief was based on and informed by consideration of a number of factors, risks and uncertainties, including:
○
general industry, economic and market conditions, both on a historical and on a prospective basis;
○
current information regarding (i) Braze’s business, prospects, financial condition, operations, technology, products, services, competitive position, and strategic business goals and objectives, (ii) geopolitical conditions and changing laws and regulations that could affect Braze’s business, and (iii) opportunities and competitive factors within Braze’s industry;
○
the perspective that Braze’s stock price was not likely to trade at or above the Merger Consideration for any extended period in the near future based on a consideration of all of the factors enumerated above; and
○
the uncertain returns to Braze stockholders if Braze were to remain independent, taking into account, in particular, the financial projections of the future financial performance and earnings of Braze, including those set forth below under the section titled “The Merger (Proposal 1)—Certain Unaudited Projected Financial Information” and the risks involved in achieving those returns.
•
Premium to Trading Price of Class A Common Stock. The fact that the Merger Consideration of $47.50 per share represented a premium of approximately 58% to the closing price of the Class A Common Stock on October 19, 2026, the last trading day prior to the announcement of the Merger, and premiums of approximately 81%, 81%, 104% and 94% to the volume-weighted average price of the Class A Common Stock for the 30-trading day, 90-trading day, 180-trading day and twelve-month periods, respectively, ended October 19, 2026.
•
Negotiations with Salesforce. The benefits that Braze and its advisors were able to obtain during its negotiations with Salesforce, including the price increase reflected in the August 22 Proposal of $47.50 per share as compared to the July 14 Proposal of $35.00 per share, and contractual protections to increase closing certainty, including the $300,000,000 Regulatory Reverse Termination Fee. The Braze Board of Directors believed that the Merger Consideration was the best proposal and economic value available to Braze stockholders and the best transaction that could be obtained by Braze stockholders at the time, and that there was no assurance that a more favorable opportunity to sell Braze would arise later or through any alternative transaction.
•
Merger Consideration in Cash. The fact that the Merger Consideration is all cash, giving Braze stockholders the opportunity to realize near-term value certainty and liquidity at the consummation of the Merger.
•
Financial Analysis and Opinion of Qatalyst Partners. The financial analysis reviewed and discussed with the Braze Board of Directors by representatives of Qatalyst Partners, as well as the oral opinion of Qatalyst Partners rendered to the Braze Board of Directors on October 19, 2026, which was subsequently confirmed by delivery of a written opinion dated such date that, as of that date and based upon and subject to the various assumptions, qualifications, limitations and other matters set forth therein, the Merger Consideration to be received by the Holders pursuant to, and in accordance with, the terms of the Merger Agreement was fair, from a financial point of view, to such Holders, as more fully described below under the section titled “—Opinion of Qatalyst Partners LP.”
•
Consideration of Potential Alternatives. The Braze Board of Directors’ consideration of whether to contact other potential acquirors and belief, informed by input from representatives of Qatalyst Partners, that only a limited number of other strategic parties had the financial capacity to acquire Braze, that the most likely of those parties to be able to consummate a transaction was unlikely to be interested in pursuing an acquisition of Braze in light of its then-current business priorities, that constrained debt markets would continue to present significant challenges for a financial sponsor considering an acquisition of Braze, and that broader outreach would increase the risk of a leak and that, in the event of a leak, Salesforce would likely withdraw its proposal and cease discussions. The
45

TABLE OF CONTENTS

Braze Board of Directors determined that the risks of broader outreach, which, if it resulted in a leak and Salesforce withdrawing its proposal and ceasing discussions, would deprive Braze stockholders of the opportunity for a meaningful premium transaction, outweighed the potential benefits.
•
Likelihood of Consummation. The likelihood that the Merger with Salesforce would be completed, in light of, among other things, the conditions to the Merger (including the Braze Board of Directors’ belief, after consultation with Braze senior management and Davis Polk, that there is a reasonable likelihood that the regulatory approvals and clearances necessary to the Merger would be obtained), the absence of a financing condition, the efforts required to obtain regulatory approvals, including the obligation of the parties to defend through litigation on the merits any claim asserted in court by a U.S. federal governmental entity under the U.S. antitrust laws, the presence and quantum of the $300,000,000 Regulatory Reverse Termination Fee payable by Salesforce and the Outside Date, which is subject to two automatic 90-day extensions if required in order to obtain required regulatory approvals.
•
Business Reputation of Salesforce. The business reputation of Salesforce, Salesforce’s financial capacity to complete an acquisition of this size, its prior track record of successfully completing acquisitions, and the representation by Salesforce in the Merger Agreement that it will have at the Closing access to all of the funds that are necessary for it to pay the aggregate Merger Consideration and consummate the Merger, and to perform its obligations under the Merger Agreement. 
•
Terms of the Merger Agreement. The terms and conditions of the Merger Agreement, including:
○
the representations, warranties and covenants of the parties, the conditions to the parties’ obligations to complete the Merger and their ability to terminate the Merger Agreement in certain circumstances;
○
the provisions of the Merger Agreement permit Braze, prior to the receipt of Braze stockholder approval, to furnish non-public information with respect to Braze to (subject to an acceptable confidentiality agreement), and engage in discussions or negotiations with, a third party that makes an unsolicited bona fide written Acquisition Proposal (as defined in the section titled “The Merger Agreement—No Solicitation of Other Offers by Braze”) that did not result from a breach of Braze’s non-solicitation obligations, if the Braze Board of Directors determines in good faith, after consultation with its outside legal counsel and financial advisor, that such proposal constitutes, or would reasonably be expected to result in, a Superior Proposal (as defined in the section titled “The Merger Agreement—No Solicitation of Other Offers by Braze”), and in each case that the failure to take such action would be reasonably likely to violate the directors’ fiduciary duties under applicable law;
○
the provisions of the Merger Agreement that allow the Braze Board of Directors, prior to the receipt of Braze stockholder approval, to make a Change of Recommendation (but not terminate the Merger Agreement) in response to an Intervening Event (as defined in the section titled “The Merger Agreement—Change of Recommendation; Match Rights”) if the Braze Board of Directors has determined in good faith, after consultation with Braze’s outside legal counsel and financial advisors, that the failure to take such action would be reasonably likely to violate the directors’ fiduciary duties under applicable law;
○
the provisions of the Merger Agreement that allow the Braze Board of Directors, prior to the receipt of Braze stockholder approval, to (A) make a Change of Recommendation in response to, or (B) cause Braze to terminate the Merger Agreement in order to enter into a definitive agreement providing for, in the case of (A) and (B), an unsolicited Acquisition Proposal received after October 19, 2026 (the date of the Merger Agreement) that did not result from a breach of Braze’s non-solicitation obligations, and such Acquisition Proposal is not withdrawn, provided that (x) Braze gives prior notice to Salesforce and provides Salesforce with matching rights as set forth in the Merger Agreement, (y) Braze pays to Salesforce a termination fee of $191,390,000 (which represents approximately 3.2% of the fully diluted equity value of Braze implied by the Merger Consideration), as described under the section titled “The Merger Agreement—Termination Fee”, and (z) the Braze Board of Directors has determined in good faith after consultation with Braze’s outside legal counsel and financial advisor that such
46

TABLE OF CONTENTS

Acquisition Proposal constitutes a Superior Proposal, and the Braze Board of Directors has determined in good faith, after consultation with Braze’s outside legal counsel and financial advisor, that the failure to take such action would be reasonably likely to violate the directors’ fiduciary duties under applicable law;
○
the limited number of closing conditions included in the Merger Agreement, including the absence of a financing condition or similar contingency that is based on Salesforce’s ability to obtain financing, the exceptions to the events that would constitute a material adverse effect on Braze for purposes of the Merger Agreement, as well as the likelihood of satisfaction of all conditions to completion of the transactions;
○
the belief of the Braze Board of Directors that Braze’s obligation to pay a $191,390,000 termination fee in certain circumstances (as described under the section titled “The Merger Agreement—Termination Fee”) was not likely to unduly discourage additional competing third-party proposals or reduce the price of any such proposals, as such termination fee is customary for transactions of this size and type and the size of the termination fee is reasonable in the context of comparable transactions;
○
the obligation of Salesforce to pay Braze the $300,000,000 Reverse Regulatory Termination Fee if the Merger Agreement is terminated under certain circumstances relating to the failure to obtain required regulatory approvals;
○
the fact that Salesforce is subject to various remedies available to Braze under the Merger Agreement in certain circumstances, including that, in the event of a breach of the Merger Agreement by Salesforce, Braze may be able to seek damages on behalf of Braze stockholders and holders of Braze equity awards (which may include the benefit of the bargain lost by such Braze stockholders, taking into account any Reverse Regulatory Termination Fee paid), and that payment of the Regulatory Reverse Termination Fee does not limit Braze’s ability to seek damages for fraud or willful breach; and
○
the ability of Braze to specifically enforce the terms of the Merger Agreement under certain circumstances.
•
Stockholder Approval. The fact that the Merger is subject to approval by Braze stockholders, who are free to evaluate the Merger and vote for or against the Merger Agreement Proposal at the Special Meeting (subject to the terms and conditions of the Voting and Support Agreement).
•
Voting and Support Agreement. The fact that the Voting and Support Agreement entered into by the Support Stockholders (who together beneficially owned approximately 5% of the voting power of the outstanding shares of Class A Common Stock as of the date of the Voting and Support Agreement) will terminate automatically upon (i) the valid termination of the Merger Agreement in accordance with its terms, (ii) the Effective Time, (iii) the entry, without the prior written consent of such Support Stockholder, into any amendment, waiver or modification to the Merger Agreement that results in a decrease in the Merger Consideration or changes the mix of the Merger Consideration or (iv) the delivery of written notice of termination by Salesforce to such Support Stockholder.
•
Timing Considerations. The timing of the Merger and the risk that if Braze did not accept the offer by Salesforce (as provided for in the Merger Agreement), it may not have another opportunity to do so or to accept a comparable opportunity. The Braze Board of Directors also observed that Braze retained the ability to consider unsolicited proposals until Braze stockholders adopt the Merger Agreement at the Special Meeting and to enter into an agreement with respect to an Acquisition Proposal under certain circumstances, subject to Braze terminating the Merger Agreement and paying a $191,390,000 termination fee (which represents approximately 3.2% of the fully diluted equity value of Braze implied by the Merger Consideration) to Salesforce (as described under the section titled “The Merger Agreement—Termination Fee”).
•
Availability of Appraisal Rights. The fact that appraisal rights would be available to holders of Class A Common Stock under the DGCL and that there is no condition in the Merger Agreement relating to the maximum number of shares of Class A Common Stock that could exercise appraisal rights.
47

TABLE OF CONTENTS

The Braze Board of Directors also considered certain potentially negative factors in its deliberations concerning the Merger Agreement and the Merger, including the following (which are not presented in any relative order of importance):
•
Tax Treatment. The fact that the Merger Consideration will generally be taxable to Braze stockholders that are U.S. holders for U.S. federal income tax purposes.
•
No Stockholder Participation in Future Growth or Earnings. The nature of the Merger as a cash transaction, meaning Braze stockholders will not have an opportunity to participate in the Surviving Corporation’s future earnings or growth and will not benefit from any appreciation in the value of the Surviving Corporation.
•
Risk of Non-Completion and Delay. The possibility that the Merger might not be completed at all, or that its completion may be delayed for reasons beyond the control of Braze or Salesforce, including as a result of the failure to obtain, or delays in obtaining, the required regulatory approvals, or the failure to satisfy or delays in satisfying other closing conditions, and the effect the resulting public announcement of the termination of the Merger Agreement may have on:
•
the trading price of the Class A Common Stock; and
•
Braze’s business and operating results, particularly in light of the costs incurred in connection with the Merger.
•
No Ability to Solicit an Alternative Transaction. The restrictions in the Merger Agreement on Braze’s ability to solicit competing Acquisition Proposals.
•
Possible Deterrence of Competing Offers. The risk that various provisions of the Merger Agreement, including the restrictions on Braze’s ability to solicit competing Acquisition Proposals and Braze’s obligation to pay to Salesforce a termination fee of $191,390,000 (which represents approximately 3.2% of the fully diluted equity value of Braze implied by the Merger Consideration) if the Merger Agreement is terminated under certain circumstances (including if the Braze Board of Directors makes a Change of Recommendation or exercises its right to terminate the Merger Agreement to enter into a transaction that constitutes a Superior Proposal), which termination fee, although the Braze Board of Directors believed is reasonable and consistent with fees payable in comparable transactions, may discourage other parties potentially interested in an acquisition of, or combination with, Braze from pursuing that opportunity.
•
Possible Disruption of the Business and Costs and Expenses. The possible disruption to Braze’s business that may result from the Merger, the resulting distraction of Braze’s management from day-to-day operations and the potential attrition of Braze’s employees, as well as the costs and expenses associated with completing the Merger.
•
Restrictions on Operation of Braze’s Business. The requirement that Braze use reasonable best efforts to conduct its business in all material respects in the ordinary course of business consistent with past practice and the other restrictions on Braze’s activities and operations prior to completion of the Merger. The Braze Board of Directors considered that such restrictions may delay or prevent Braze from pursuing business strategies or opportunities that may arise pending completion of the Merger.
•
Impact of Announcement. The uncertainty about the effect of the Merger, regardless of whether the Merger is completed, on Braze’s employees, customers and other parties, including as a result of the expected time period for satisfying the conditions to the closing of the Merger and the risk of potential delays in satisfying such conditions beyond the anticipated time frames, which may impair Braze’s ability to attract, retain and motivate key personnel, could cause customers, suppliers and others to seek to change existing business relationships with Braze and could lead to litigation in connection with the Merger.
•
Need to Obtain Required Regulatory Clearances. The fact that completion of the Merger requires, among other things, (i) the expiration or termination of all waiting periods (and any extensions thereof), and any commitment not to close before a certain date under a timing agreement with a governmental entity, applicable to the consummation of the Merger under the HSR Act and (ii) the receipt of approvals and clearances under the applicable antitrust and foreign investment laws of certain specified jurisdictions, in each case without the imposition of a Burdensome Condition. There is also a risk that the Federal Trade
48

TABLE OF CONTENTS

Commission, the U.S. Department of Justice or other governmental entities responsible for the enforcement of applicable antitrust, competition, merger control or foreign investment laws may not approve the Merger or may impose terms and conditions on their approval, including remedial actions, that could result in a condition to the Closing failing to be satisfied, and that the Regulatory Reverse Termination Fee may not fully compensate Braze for the harm it might suffer if the Merger is not completed.
•
Remedies Available to Salesforce. The fact that Braze is subject to various remedies available to Salesforce under the Merger Agreement in certain circumstances.
•
Enforcement of Remedies. The fact that Braze’s rights and remedies under the Merger Agreement may be expensive and difficult to enforce through litigation, and the uncertain outcome of any such action.
The Braze Board of Directors concluded that the potentially negative factors associated with the Merger were significantly outweighed by the potential benefits that it expected Braze stockholders would achieve as a result of the Merger. The Braze Board of Directors believed that the Merger would maximize the value of the shares held by Braze stockholders and minimize the risks and uncertainty affecting the future prospects of Braze, including the potential execution risks associated with its standalone financial plan. Accordingly, the Braze Board of Directors unanimously (i) determined that the terms of the Merger Agreement and the Transactions, including the Merger, are fair to, and in the best interests of, Braze and Braze stockholders, (ii) determined that it is fair to and in the best interests of Braze and Braze stockholders, and declared it advisable, to enter into the Merger Agreement, (iii) approved the execution and delivery by Braze of the Merger Agreement and by the Support Stockholders of the Voting and Support Agreement, the performance by Braze of its covenants and agreements contained in the Merger Agreement and the consummation of the Merger and the other Transactions, in each case, upon the terms and subject to the conditions contained in the Merger Agreement and (iv) resolved to recommend that the Braze stockholders approve and adopt the Merger Agreement and the Transactions, including the Merger.
In addition, the Braze Board of Directors was aware of and considered the interests that Braze’s directors and executive officers may have with respect to the Merger that differ from, or are in addition to, the interests of Braze stockholders generally, as described below under “—Interests of Braze’s Directors and Executive Officers in the Merger.”
The foregoing discussion of the information and factors considered by the Braze Board of Directors is not exhaustive, but Braze believes it includes all the material factors considered by the Braze Board of Directors. In view of the wide variety of factors considered in connection with its evaluation of the Merger and the complexity of these matters, the Braze Board of Directors did not consider it practicable to, and did not attempt to, quantify or otherwise assign relative or specific weight or values to any of these factors. Rather, the Braze Board of Directors viewed its position and recommendation as being based on an overall analysis and on the totality of the information presented to and factors considered by it. In addition, in considering the factors described above, individual directors may have given different weights to different factors. The Braze Board of Directors based its unanimous recommendation on the totality of the information presented.
This explanation of Braze’s reasons for the Merger and other information presented in this section is forward-looking in nature and, therefore, should be read in light of the factors described under “Cautionary Statement Regarding Forward-Looking Statements.”
Opinion of Qatalyst Partners LP
Braze retained Qatalyst Partners to act as its financial advisor in connection with a potential transaction such as the Merger and to evaluate whether the Merger Consideration to be received by the Holders pursuant to, and in accordance with, the terms of the Merger Agreement was fair, from a financial point of view, to such Holders. Braze selected Qatalyst Partners to act as financial advisor to Braze based on Qatalyst Partners’ qualifications, reputation and experience, including its familiarity with Braze and its business. Qatalyst Partners has provided its written consent to the reproduction of its opinion in this proxy statement. At the meeting of the Braze Board of Directors on October 19, 2026, Qatalyst Partners rendered to the Braze Board of Directors its oral opinion, subsequently confirmed in writing, to the effect that, as of the date thereof and based upon and subject to the various assumptions, qualifications, limitations and other matters set forth therein, the Merger Consideration to be received by the Holders pursuant to, and in accordance with, the terms of the Merger Agreement was fair, from a financial point of view, to such Holders. Qatalyst Partners delivered its written opinion, dated October 19, 2026, to the Braze Board of Directors following the meeting of the Braze Board of Directors.
49

TABLE OF CONTENTS

The full text of Qatalyst Partners’ written opinion, dated October 19, 2026, is attached as Annex C to this proxy statement and is incorporated by reference herein. The opinion sets forth, among other things, the assumptions made, procedures followed, matters considered and limitations and qualifications of the review undertaken by Qatalyst Partners in rendering its opinion. Holders should read the opinion carefully in its entirety. Qatalyst Partners’ opinion was provided to the Braze Board of Directors and addresses only, as of the date of the opinion, and based upon and subject to the various assumptions, qualifications, limitations and other matters set forth therein, the fairness, from a financial point of view, of the Merger Consideration to be received by the Holders pursuant to, and in accordance with, the terms of the Merger Agreement, to such Holders, and it does not address any other aspect of the Merger. Qatalyst Partners’ opinion does not constitute a recommendation as to how any Holder should vote with respect to the Merger or any other matter and does not in any manner address the price at which Class A Common Stock will trade at any time. Qatalyst Partners’ opinion does not address the underlying business decision of Braze to engage in the Merger, or the relative merits of the Merger as compared to any strategic alternatives that may be available to Braze. The summary of Qatalyst Partners’ opinion set forth herein is qualified in its entirety by reference to the full text of the opinion, which is attached as Annex C to this proxy statement.
In arriving at its opinion, Qatalyst Partners reviewed a draft of the Merger Agreement dated October 18, 2026, certain related documents and certain publicly available financial statements and other business and financial information of Braze. Qatalyst Partners also reviewed certain forward-looking information relating to Braze prepared by Braze management, including non-public financial forecasts prepared by Braze senior management regarding the potential future performance of Braze on a standalone basis for the third and fourth fiscal quarters of fiscal year 2027 and for fiscal years 2028 through 2032 (referred to as the “Five-Year Plan”). Additionally, Qatalyst Partners discussed the past and current operations and financial condition and the prospects of Braze with Braze senior management, and participated in and advised Braze on, certain of the negotiations relating to the Merger. Qatalyst Partners also reviewed the historical market prices and trading activity for Class A Common Stock and compared the financial performance of Braze and the prices and trading activity of Class A Common Stock with that of certain other selected publicly-traded companies and their securities. In addition, Qatalyst Partners reviewed the financial terms, to the extent publicly available, of selected acquisition transactions, participated in certain discussions and negotiations among representatives of Braze, Salesforce and their respective financial and legal advisors and performed such other analyses, reviewed such other information and considered such other factors as Qatalyst Partners deemed appropriate.
In arriving at its opinion, Qatalyst Partners assumed and relied upon, without independent verification, the accuracy and completeness of the information that was publicly available or supplied or otherwise made available to, or discussed with, Qatalyst Partners by Braze. With respect to the Five-Year Plan, Qatalyst Partners was advised by Braze management, and Qatalyst Partners assumed based on discussions with Braze management and the Braze Board of Directors, that the Five-Year Plan had been reasonably prepared on bases reflecting the best currently available estimates and judgments of Braze management of the future financial performance of Braze and other matters covered thereby. Qatalyst Partners expressed no view as to the Five-Year Plan or the assumptions on which it was based. Qatalyst Partners assumed that the terms of the draft Merger Agreement reviewed by Qatalyst Partners would not differ materially from the final executed Merger Agreement, and that the Merger will be consummated in accordance with the terms set forth in the Merger Agreement, without any modification, waiver or delay of any terms or conditions. In addition, Qatalyst Partners assumed that in connection with the receipt of all the necessary approvals of the Merger, no delays, limitations, conditions or restrictions will be imposed that could have an adverse effect on Braze or the contemplated benefits expected to be derived in the proposed Merger. Qatalyst Partners relied upon, without independent verification, the assessment of Braze and its legal, tax or regulatory advisors with respect to legal, tax or regulatory matters. Qatalyst Partners did not make any independent evaluation or appraisal of the assets or liabilities (contingent or otherwise) of Braze or its affiliates nor was Qatalyst Partners furnished with any such evaluation or appraisal. In addition, Qatalyst Partners relied, without independent verification, upon the assessment of Braze management as to the existing and future technology and products of Braze and the risks associated with such technology and products. In arriving at its opinion, Qatalyst Partners was not authorized to solicit, and did not solicit, interest from any party with respect to an acquisition, business combination or other extraordinary transaction involving Braze. Qatalyst Partners’ opinion has been approved by its opinion committee in accordance with its customary practice.
Qatalyst Partners’ opinion is necessarily based on financial, economic, market and other conditions as in effect on, and the information made available to it as of, the date of the opinion. Events occurring after the date of the
50

TABLE OF CONTENTS

opinion may affect Qatalyst Partners’ opinion and the assumptions used in preparing it, and Qatalyst Partners has not assumed any obligation to update, revise or reaffirm its opinion. Qatalyst Partners’ opinion does not address the underlying business decision of Braze to engage in the Merger, or the relative merits of the Merger as compared to any strategic alternatives that may be available to Braze. Qatalyst Partners has not been asked to, nor does Qatalyst Partners express any view on, and Qatalyst Partners’ opinion does not address, any other term or aspect of the Merger Agreement, the Merger or any of the other transactions contemplated by the Merger Agreement, including, without limitation, the structure or form of the Merger, or any other agreements or arrangements contemplated by the Merger Agreement or entered into in connection with or otherwise contemplated by the Merger or any of the other transactions contemplated by the Merger Agreement, including, without limitation, the fairness of the Merger or any other term or aspect of the Merger or any of the other transactions contemplated by the Merger Agreement to, or any consideration to be received in connection therewith by, or the impact of the Merger or any of the other transactions contemplated by the Merger Agreement on, the holders (other than the Holders) of any class of securities, creditors or other constituencies of Braze or any other party. Qatalyst Partners’ opinion is limited to the fairness, from a financial point of view, of the Merger Consideration to be received by the Holders pursuant to, and in accordance with, the terms of the Merger Agreement, and Qatalyst Partners expresses no opinion with respect to the fairness of the amount or nature of the compensation to any of the officers, directors or employees of Braze or any of its affiliates, or any class of such persons, relative to such consideration.
Summary of Qatalyst Partners’ Financial Analyses
The following is a brief summary of the material analyses performed by Qatalyst Partners in connection with its opinion dated October 19, 2026. The analyses and factors described below must be considered as a whole; considering any portion of such analyses or factors, without considering all analyses and factors, could create a misleading or incomplete view of the process underlying Qatalyst Partners’ opinion. For purposes of its analyses, Qatalyst Partners utilized, among other things, the Five-Year Plan, described in the section titled “The Merger (Proposal 1)––Certain Unaudited Projected Financial Information,” and third-party research analyst consensus estimates of the future financial performance of Braze as of October 19, 2026 (which are referred to as the “Analyst Estimates”). Some of the summaries of the financial analyses include information presented in tabular format. The tables are not intended to stand alone, and in order to more fully understand the financial analyses used by Qatalyst Partners, the tables must be read together with the full text of each summary. Considering the data set forth below without considering the full narrative description of the financial analyses, including the methodologies and assumptions underlying the analyses, could create a misleading or incomplete view of Qatalyst Partners’ financial analyses.
Discounted Cash Flow Analysis
Qatalyst Partners performed an illustrative discounted cash flow analysis, which is designed to imply a range of potential per-share present values for Class A Common Stock as of July 31, 2026 (which was the end of Braze’s most recently completed fiscal quarter and the most recent publicly available balance sheet date), using mid-period convention, by:
•
Adding:
(a)
the implied net present value of the estimated future unlevered free cash flows (which are referred to as the “UFCF”) of Braze based on the Five-Year Plan for the second half of fiscal year 2027 through fiscal year 2032 (which implied present value was calculated using a range of discount rates of 13.5% to 16.5%, based on an estimated weighted average cost of capital for Braze);
(b)
the implied net present value of a corresponding terminal value of Braze, calculated by multiplying Braze’s estimated UFCF in fiscal year 2032, based on the Five-Year Plan by a range of fully diluted enterprise value to next-twelve-months’ estimated UFCF multiples of 14.0x to 20.0x (which were chosen based on Qatalyst Partners’ professional judgment and experience), and discounted to present value using the same range of discount rates used in item (a) above;
(c)
the cash and cash equivalents of Braze as of July 31, 2026, as disclosed in Braze’s quarterly report on Form 10-Q for the period ended July 31, 2026;
(d)
the implied net present value of estimated federal tax savings due to Braze’s net operating losses for the fiscal year 2032, discounted to present value using the same range of discount rates used in item (a) above; and
51

TABLE OF CONTENTS

•
subtracting:
(a)
the redeemable non-controlling interest in Braze Kabushiki Kaisha and value of the finance leases of Braze, as of July 31, 2026, as provided by Braze management; and
•
dividing the resulting amount by the number of fully diluted shares of Class A Common Stock outstanding (calculated using the treasury stock method), taking into account the restricted stock units, performance stock units, and in-the money stock options, as of October 15, 2026, all as provided by Braze management, with each of the above-referenced estimated future UFCFs and terminal value having also been adjusted for the degree of estimated dilution to current Braze stockholders through each respective applicable period (approximately 22% cumulative dilution throughout the projection period) due to the estimated net effects of equity issuances and cancellations related to future equity compensation, in each case, based on estimates of future dilution provided by Braze management.
Based on the calculations set forth above, this analysis implied a range of values for shares of Class A Common Stock of approximately $34.75 to $50.55 per share.
Selected Publicly Traded Companies Analysis
Qatalyst Partners reviewed and compared selected financial information and public market multiples for Braze with publicly available financial information and public market multiples for selected companies. The companies used in this comparison were those companies listed below, which were selected by Qatalyst Partners in its professional judgment, based on factors including that they are publicly traded companies in similar lines of business to Braze, have a similar business model, have similar financial performance, or have other relevant or similar characteristics.
Based upon third-party research analyst consensus estimates as of October 19, 2026 and using the closing prices as of October 19, 2026 for shares of the selected companies, Qatalyst Partners calculated, among other things, the fully diluted enterprise value divided by the estimated consensus revenue for calendar year 2027 (which are referred to as the “CY27E Revenue Multiples”) for each of the selected companies, as shown below:
 
 
 
 
Selected Front Office Software
 
 
CY27E Revenue Multiples
Twilio Inc.
 
 
6.1x
Amplitude, Inc.
 
 
4.5x
Freshworks Inc.
 
 
3.2x
Klaviyo, Inc.
 
 
2.5x
HubSpot, Inc.
 
 
2.5x
Five9, Inc.
 
 
2.1x
Wix.com Ltd.
 
 
1.7x
 
 
 
 
 
 
 
 
Selected Other Horizontal Application Software
 
 
CY27E Revenue Multiples
Atlassian Corp
 
 
7.4x
Figma, Inc.
 
 
6.2x
Workday, Inc.
 
 
4.3x
Workiva Inc.
 
 
3.7x
Vertex, Inc.
 
 
2.6x
BILL Holdings, Inc.
 
 
2.1x
Monday.com Ltd.
 
 
1.9x
 
 
 
 
 
 
 
 
Selected Software Leaders
 
 
CY27E Revenue Multiples
ServiceNow, Inc.
 
 
8.2x
Salesforce, Inc.
 
 
4.6x
Adobe Inc.
 
 
3.5x
 
 
 
 
Based on an analysis of the CY27E Revenue Multiples for the selected companies and the application of its professional judgment, Qatalyst Partners selected a representative multiple range of 2.5x to 6.0x. Qatalyst Partners used Braze’s fiscal year ending January 31, 2028, as a proxy for calendar year 2027. Qatalyst Partners then applied this range to Braze’s estimated revenue for calendar year 2027, based on the Five-Year Plan and the Analyst
52

TABLE OF CONTENTS

Estimates. Based on the fully diluted shares of Class A Common Stock outstanding as of October 15, 2026 (calculated utilizing the same methodology as used in the above discounted cash flow analysis), as provided by Braze management, this analysis implied (a) a range of values for Class A Common Stock of approximately $24.44 to $53.97 per share based on the Analyst Estimates and (b) a range of values for Class A Common Stock of approximately $26.28 to $58.32 per share based on the Five-Year Plan.
No company included in the selected companies analysis is identical to Braze. In evaluating the selected companies, Qatalyst Partners made judgments and assumptions with regard to industry performance, general business, economic, market and financial conditions and other matters. Many of these matters are beyond the control of Braze, such as the impact of competition on Braze’s business or the industry in general, industry growth and the absence of any material adverse change in Braze’s financial condition and prospects or the industry or in the financial markets in general. Individual multiples or mathematical analysis, such as determining the arithmetic mean, median, or the high or low, is not in itself a meaningful method of using selected company data.
Selected Transactions Analysis
Qatalyst Partners compared fourteen selected public company transactions, including transactions involving companies participating in similar lines of business to Braze or with similar business models, similar financial performance or other relevant or similar characteristics.
For each of the selected transactions listed below, Qatalyst Partners reviewed, among other things, the implied fully diluted enterprise value of the target company as a multiple of third-party research analyst consensus estimates of the next-twelve-months’ revenue of the target company (which are referred to as the “NTM Revenue Multiples”).
 
 
 
 
 
 
 
 
 
 
Announcement Date
 
 
Target
 
 
Acquiror
 
 
NTM Revenue
Multiple
05/17/26
 
 
LiveRamp Holdings, Inc.
 
 
Publicis Groupe S.A.
 
 
2.4x
11/19/25
 
 
Semrush Holdings, Inc.
 
 
Adobe Inc.
 
 
3.4x
09/09/24
 
 
Squarespace, Inc.
 
 
Permira Advisers LLC
 
 
5.6x
03/14/23
 
 
Cvent Holding Corp.
 
 
Blackstone Inc.
 
 
6.5x
10/15/18
 
 
SendGrid, Inc.
 
 
Twilio Inc.
 
 
11.5x
01/29/18
 
 
Callidus Software Inc.
 
 
SAP America, Inc.
 
 
8.3x
08/31/16
 
 
Interactive Intelligence Group, Inc.
 
 
Genesys Telecommunications Laboratories, Inc. (Permira Advisers LLC)
 
 
3.2x
05/31/16
 
 
Marketo, Inc.
 
 
Vista Equity Partners Management, LLC
 
 
5.9x
05/18/16
 
 
inContact, Inc.
 
 
NICE-Systems Ltd.
 
 
3.6x
04/18/16
 
 
Cvent, Inc.
 
 
Vista Equity Partners Management, LLC
 
 
6.5x
11/02/15
 
 
Constant Contact, Inc.
 
 
Endurance International Group Holdings, Inc.
 
 
2.3x
12/20/13
 
 
Responsys, Inc.
 
 
Oracle Corporation
 
 
6.9x
06/04/13
 
 
ExactTarget, Inc.
 
 
Salesforce.com, Inc.
 
 
6.5x
10/24/11
 
 
RightNow Technologies, Inc.
 
 
Oracle Corporation
 
 
6.2x
 
 
 
 
 
 
 
 
 
 
Based on an analysis of the NTM Revenue Multiples for the selected transactions and the application of its professional judgment, Qatalyst Partners selected a representative multiple range of 3.5x to 7.0x, then applied this range to Braze’s estimated next-twelve-months’ revenue (calculated as the 12-month period ending July 31, 2027) based on the Analyst Estimates. Based on the fully diluted shares of Class A Common Stock outstanding as of October 15, 2026 (calculated utilizing the same methodology as used in the above discounted cash flow analysis), as provided by Braze management, this analysis implied a range of values for Class A Common Stock of approximately $30.68 to $57.87 per share.
No company or transaction utilized in the selected transactions analysis is identical to Braze or the Merger. In evaluating the selected transactions, Qatalyst Partners made judgments and assumptions with regard to industry performance, general business, economic, market and financial conditions and other matters, many of which are beyond Braze’s control, such as the impact of competition on Braze’s business or the industry generally, industry
53

TABLE OF CONTENTS

growth and the absence of any material adverse change in Braze’s financial condition and prospects or the industry or in the financial markets in general, which could affect the public trading value of the companies and the aggregate value of the transactions to which they are being compared. Individual multiples or mathematical analysis, such as determining the arithmetic mean, median, or the high or low, is not in itself a meaningful method of using selected transactional data. Because of the unique circumstances of each of these transactions and the Merger, Qatalyst Partners cautioned against placing undue reliance on this information.
Miscellaneous
In connection with the review of the Merger by the Braze Board of Directors, Qatalyst Partners performed a variety of financial and comparative analyses for purposes of rendering its opinion. The preparation of a financial opinion is a complex process and is not necessarily amenable to a partial analysis or summary description. In arriving at its opinion, Qatalyst Partners considered the results of all its analyses as a whole and did not attribute any particular weight to any analysis or factor it considered. Qatalyst Partners believes that selecting any portion of its analyses, without considering all analyses as a whole, could create a misleading or incomplete view of the process underlying its analyses and opinion. In addition, Qatalyst Partners may have given various analyses and factors more or less weight than other analyses and factors, and may have deemed various assumptions more or less probable than other assumptions. As a result, the ranges of valuations resulting from any particular analysis described above should not be taken to be Qatalyst Partners’ view of the actual value of Braze. In performing its analyses, Qatalyst Partners made numerous assumptions with respect to industry performance, general business, economic, market and financial conditions and other matters, many of which are beyond the control of Braze. Any estimates contained in Qatalyst Partners’ analyses are not necessarily indicative of future results or actual values, which may be significantly more or less favorable than those suggested by such estimates.
Qatalyst Partners conducted the analyses described above solely as part of its analysis of the fairness, from a financial point of view, of the Merger Consideration to be received by the Holders pursuant to, and in accordance with, the terms of the Merger Agreement. These analyses do not purport to be appraisals or to reflect the price at which Class A Common Stock might actually trade or otherwise be transferable at any time.
Qatalyst Partners’ opinion and its presentation to the Braze Board of Directors were one of many factors considered by the Braze Board of Directors in deciding to approve the Merger Agreement. Consequently, the analyses as described above should not be viewed as determinative of the opinion of the Braze Board of Directors with respect to the Merger Consideration to be received by the Holders pursuant to, and in accordance with, the terms of the Merger Agreement or of whether the Braze Board of Directors would have been willing to agree to different consideration. The Merger Consideration payable in the Merger was determined through arm’s-length negotiations between Braze and Salesforce, and was approved by the Braze Board of Directors. Qatalyst Partners provided advice to Braze during these negotiations. Qatalyst Partners did not, however, recommend any specific consideration to Braze or that any specific consideration constituted the only appropriate consideration for the Merger.
Qatalyst Partners provides investment banking and other services to a wide range of entities and individuals, domestically and offshore, from which conflicting interests or duties may arise. In the ordinary course of these activities, affiliates of Qatalyst Partners may at any time hold long or short positions and may trade or otherwise effect transactions in debt or equity securities or loans of Braze, Salesforce or certain of their respective affiliates. During the two-year period prior to the date of Qatalyst Partners’ opinion, no material relationship existed between Qatalyst Partners or any of its affiliates, on the one hand, and Braze or Salesforce, on the other hand, pursuant to which compensation was received by Qatalyst Partners or its affiliates. Qatalyst Partners and/or its affiliates may in the future provide investment banking and other financial services to Braze or Salesforce and their respective affiliates for which it would expect to receive compensation.
Under the terms of its engagement letter, Qatalyst Partners provided Braze with financial advisory services in connection with the Merger for which it will be paid an aggregate amount currently estimated at approximately $69 million, $250,000 of which was payable upon the execution of the engagement letter and $5 million of which was payable upon delivery of its opinion (regardless of the conclusion reached in the opinion), and the remaining portion of which will be paid upon, and subject to, the Closing. Braze has also agreed to reimburse Qatalyst Partners for certain expenses incurred in performing its services. Braze has also
54

TABLE OF CONTENTS

agreed to indemnify Qatalyst Partners and its affiliates, their respective members, directors, officers, partners, agents and employees and any person controlling Qatalyst Partners or any of its affiliates against certain liabilities, including liabilities under the federal securities laws, and certain expenses related to or arising out of Qatalyst Partners’ engagement.
Certain Unaudited Projected Financial Information
As part of its strategic and financial planning, Braze senior management periodically prepares multi-year financial plans. In connection with the Braze Board’s evaluation of a potential transaction with Salesforce, Braze senior management prepared non-public financial forecasts as to the potential future performance of Braze on a standalone basis for the third and fourth fiscal quarters of fiscal year 2027 and for fiscal years 2028 through 2032 (referred to as the “Five-Year Plan”). Braze’s fiscal year ends on January 31. Braze senior management presented the Five-Year Plan to the Braze Board at its meeting on August 6, 2026, and the Braze Board reviewed and approved the Five-Year Plan, including for use by Qatalyst Partners in connection with its financial analyses and opinion, as more fully described in the section titled “—Opinion of Qatalyst Partners LP.” In addition, in August 2026, at Salesforce’s request in connection with its due diligence review of Braze, and with the approval of the Braze Board, Braze provided Salesforce with portions of the Five-Year Plan.
While Braze has from time to time provided certain financial guidance to investors, Braze does not, as a matter of course, otherwise publicly disclose its long-term plans or projections as to future revenue, earnings or other results given, among other reasons, the uncertainty, unpredictability and subjectivity of the underlying assumptions and estimates, including the difficulty of predicting general economic and market conditions. The Five-Year Plan was not prepared with a view to public disclosure and is included in this proxy statement only because such information was made available as described above. The Five-Year Plan was not prepared with a view to compliance with generally accepted accounting principles as applied in the United States (referred to as “GAAP”), the published guidelines of the SEC regarding projections and forward-looking statements or the guidelines established by the American Institute of Certified Public Accountants for preparation and presentation of prospective financial information. The Five-Year Plan is not, and should not be viewed as, public guidance.
Although a summary of the Five-Year Plan is presented with numerical specificity, the Five-Year Plan reflects numerous assumptions and estimates as to future events made by Braze senior management, including with respect to demand for Braze’s products and services, working capital, capital expenditure levels (including capitalized software) for the applicable periods, tax rates and the utilization of net operating loss carryforwards and other matters, many of which are difficult to predict and subject to significant economic and competitive uncertainties beyond Braze’s control, that Braze senior management believed in good faith were reasonable when the Five-Year Plan was prepared, taking into account relevant information available to Braze senior management at the time. However, this information is not fact and should not be relied upon as necessarily indicative of actual future results. Important factors that may affect actual results and cause the Five-Year Plan not to be achieved include general economic and financial conditions, industry performance, accuracy of certain accounting assumptions, changes in actual or projected cash flows, competitive pressures and other factors described or referenced under the section titled “Cautionary Statement Regarding Forward-Looking Statements” beginning on page 26. In addition, the Five-Year Plan does not take into account any circumstances or events occurring after the date that it was prepared or last updated and does not give effect to the Merger. As a result, there can be no assurance that the Five-Year Plan will or would be realized, and actual results may be materially better or worse than those contained in the Five-Year Plan.
The Five-Year Plan is the responsibility of Braze senior management. Neither Ernst & Young LLP, Braze’s independent registered public accounting firm, nor any other independent accountant, has audited, reviewed, examined, compiled, performed any other assurance procedures or expressed any form of assurance with respect to the Five-Year Plan.
None of Braze or Qatalyst Partners, or any of their respective affiliates, officers, directors, advisors and other representatives, makes any representation to readers of this proxy statement concerning the ultimate performance of Braze or the Surviving Corporation compared to the Five-Year Plan. Braze is including the Five-Year Plan in this proxy statement solely because it was made available to the Braze Board, Qatalyst Partners and portions of it to Salesforce, and not to influence your decision on how to vote on any proposal.
The Five-Year Plan should be evaluated, if at all, in conjunction with the historical financial statements and other information regarding Braze contained in Braze’s public filings with the SEC. The Five-Year Plan constitutes
55

TABLE OF CONTENTS

forward-looking statements. For information on factors that may cause Braze’s future results to materially vary, see the section titled “Cautionary Statement Regarding Forward-Looking Statements” beginning on page 26.
Except to the extent required by applicable federal securities laws, Braze does not intend, and expressly disclaims any responsibility, to update or otherwise revise the Five-Year Plan to reflect circumstances existing after the date when Braze prepared or last updated the Five-Year Plan or to reflect the occurrence of future events or changes in general economic or industry conditions, even in the event that any of the assumptions underlying the Five-Year Plan are shown to no longer be appropriate. The Five-Year Plan does not include any transaction-related expenses.
Certain of the measures included in the Five-Year Plan may be considered non-GAAP financial measures, including Non-GAAP Operating Income and Unlevered Free Cash Flow (each as defined below). Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in compliance with GAAP, and non-GAAP financial measures as used by Braze may not be comparable to similarly titled amounts used by other companies.
Financial measures included in forecasts provided to a financial advisor and a board of directors in connection with a business combination transaction, such as the Merger, are excluded from the SEC’s definition of non-GAAP financial measures and therefore are not subject to SEC rules regarding disclosures of non-GAAP financial measures, which may otherwise require a reconciliation of a non-GAAP financial measure to a GAAP financial measure to be presented. Reconciliations of these financial measures were not relied upon by Qatalyst Partners for purposes of performing its financial analyses in connection with rendering its opinion to the Braze Board (as described in the section titled “—Opinion of Qatalyst Partners”) or by the Braze Board. Accordingly, a reconciliation of the financial measures included in the Five-Year Plan is not provided.
The following is a summary of the Five-Year Plan.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Q3-Q4
FY27E (1)
 
 
FY28E
 
 
FY29E
 
 
FY30E
 
 
FY31E
 
 
FY32E
 
 
 
(dollars in millions)
Revenue
 
 
$487
 
 
$1,162
 
 
$1,440
 
 
$1,757
 
 
$2,109
 
 
$2,488
Non-GAAP Operating Income (2)
 
 
$43
 
 
$140
 
 
$230
 
 
$351
 
 
$464
 
 
$597
Unlevered Free Cash Flow (3)
 
 
$37
 
 
$148
 
 
$242
 
 
$362
 
 
$468
 
 
$559
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
Reflects the six-month period from August 1, 2026 through January 31, 2027.
(2)
“Non-GAAP Operating Income” is a non-GAAP financial measure defined as GAAP operating income (loss), adjusted for stock-based compensation expense, employer taxes related to stock-based compensation, charitable contribution expense, acquisition related expense and amortization of intangible assets.
(3)
“Unlevered Free Cash Flow” is a non-GAAP financial measure calculated as Non-GAAP Operating Income, less cash taxes, less capital expenditures (including capitalized software), plus depreciation and amortization, plus amortization of deferred contract costs, less investments in working capital (excluding deferred revenue) and plus the change in deferred revenue.
Interests of Braze’s Directors and Executive Officers in the Merger
Braze’s directors and executive officers have interests in the Merger that may be different from, or in addition to, those of Braze stockholders generally. These interests include, among others, the accelerated vesting and payment of certain outstanding equity awards in connection with the Merger, potential severance payments and benefits under the Executive Severance Plan upon a qualifying termination of employment in connection with the Merger, retention bonus payments, new employment arrangements with Salesforce and rights to ongoing indemnification and insurance coverage. The Braze Board of Directors was aware of and considered these interests, among other matters, in evaluating and negotiating the Merger Agreement and the Merger, in approving the Merger Agreement, and in recommending the adoption of the Merger Agreement by Braze stockholders. Braze stockholders should take these interests into account in deciding how to vote on the Merger Agreement Proposal. These interests are described below, and certain of them are quantified within the narrative disclosure. The Merger will constitute a “change in control” (or similar phrase) for purposes of the Braze compensation and benefit plans and arrangements described below. The amounts presented in the following discussion do not reflect the impact of applicable withholding or other taxes.
56

TABLE OF CONTENTS

For purposes of this disclosure, Braze’s named executive officers (as determined for the fiscal year ended January 31, 2026, together with Mr. Pankaj Malik, Braze’s current Interim Chief Financial Officer) are as follows:
 
 
 
 
Name
 
 
Position
William Magnuson
 
 
Chairman, President and Chief Executive Officer
Pankaj Malik (1)
 
 
Interim Chief Financial Officer and Chief Accounting Officer
Jonathan Hyman
 
 
Chief Technology Officer
Astha Malik
 
 
Chief Business Officer
Edward McDonnell
 
 
Chief Revenue Officer
Isabelle Winkles (1)
 
 
Former Chief Financial Officer
 
 
 
 
(1)
Ms. Winkles resigned as Chief Financial Officer effective May 29, 2026 and is not entitled to any compensation that is based on or otherwise relates to the Merger; therefore, there are no interests disclosed below with respect to Ms. Winkles. Pankaj Malik, Braze’s Chief Accounting Officer, has served as Interim Chief Financial Officer since May 29, 2026.
In accordance with SEC rules, this disclosure also covers individuals who have served as executive officers of Braze at any time since February 1, 2025 and who have interests in the Merger, but who are not named executive officers. Braze’s current executive officers are William Magnuson (Chairman, President and Chief Executive Officer), Pankaj Malik (Interim Chief Financial Officer and Chief Accounting Officer), Jonathan Hyman (Chief Technology Officer), Astha Malik (Chief Business Officer), Edward McDonnell (Chief Revenue Officer) and Christopher M. Lal (General Counsel and Corporate Secretary). Although the SEC disclosure rules require disclosure of any substantial interest of each individual who was an executive officer of Braze at any time since February 1, 2025, the Braze Board of Directors is not aware of any substantial interest regarding the Merger with respect to the following former executive officers of Braze: Isabelle Winkles (former Chief Financial Officer, who resigned effective May 29, 2026); Susan Wiseman (former General Counsel and Corporate Secretary, who retired from those positions effective as of May 19, 2026); and Myles Kleeger (former President and Chief Commercial Officer, who resigned effective June 1, 2025). Any reference to “executive officer” in this proxy statement shall be a reference to Braze’s current executive officers and shall not include any of Braze’s former executive officers.
In addition, Braze’s non-employee directors are as follows:
 
 
 
 
Name
 
 
Position
Phillip Fernandez
 
 
Lead Independent Director
Neeraj Agrawal
 
 
Director
Tara Walpert Levy
 
 
Director
Fernando Machado
 
 
Director
David Obstler
 
 
Director
Yvonne Wassenaar
 
 
Director
 
 
 
 
Certain Assumptions
Except as otherwise specifically noted, for purposes of quantifying the potential payments and benefits described in this section, the following assumptions were used:
•
November 16, 2026 as the assumed date of the closing of the Merger (referred to as the “Assumed Closing Date”);
•
each non-employee director ceases to be a director of Braze upon the consummation of the Merger;
•
each executive officer experiences a termination of employment by Braze without “cause” or by the executive officer for “good reason” (each, as defined in the Executive Severance Plan or, with respect to the Adjusted RSUs held by Messrs. Magnuson, Hyman and McDonnell, as defined in their respective Vesting Acceleration Amendments (as defined below)), in each case, immediately following the Assumed Closing Date (a “qualifying termination”);
•
the total value of each non-employee director’s and executive officer’s equity awards is based on the individual’s unvested Braze equity awards outstanding as of the Assumed Closing Date and a price per share of Class A Common Stock of $47.50, which is the Merger Consideration;
57

TABLE OF CONTENTS

•
the consummation of the Merger will constitute a “change in control” under the terms of the applicable Braze plan, policy or agreement;
•
other than for Messrs. Magnuson, Hyman and McDonnell, the base salary and annual target bonus of each executive officer remains unchanged from those in place as of the Assumed Closing Date and for Messrs. Magnuson, Hyman and McDonnell, the base salary and annual target bonus is consistent with the amounts set forth in their offer letters from Salesforce (as described below);
•
the amounts set forth below do not include amounts that the non-employee directors and executive officers were already entitled to receive or that were vested as of the Assumed Closing Date; and
•
the amounts set forth below do not attempt to forecast any additional equity award grants, issuances or forfeitures that may occur after the Assumed Closing Date and prior to the consummation of the Merger.
As a result of the foregoing assumptions, which may or may not actually occur or be accurate on the relevant date, including the assumptions described in this section and the section titled “The Merger (Proposal 1)— Quantification of Potential Payments and Benefits to Braze’s Named Executive Officers in Connection with the Merger,” the actual amounts, if any, to be received by the non-employee directors and executive officers may materially differ from the amounts set forth below.
Treatment of Braze Equity Awards
The Merger Agreement provides for the treatment at the Effective Time of outstanding Braze equity awards held by Braze’s non-employee directors and executive officers in connection with the Merger, as summarized below:
•
Options. Each In-the-Money Braze Option that is outstanding and unexercised immediately prior to the Effective Time will be cancelled and converted into the right to receive the Merger Consideration in respect of each Net Share covered by such Braze Option, without interest and less applicable tax withholdings. Each Braze Option that is not an In-the-Money Braze Option, whether or not vested, will be cancelled for no consideration.
•
Director RSUs and Vested RSUs. Each Braze RSU that is held by a non-employee director or that is vested as of immediately prior to the Effective Time will be cancelled and converted into the right to receive the Merger Consideration in cash in respect of each share of Class A Common Stock subject to such Braze RSU, without interest and less applicable tax withholdings.
•
Unvested RSUs. Each other Braze RSU will be assumed and converted into an Adjusted RSU with respect to a number of shares of Salesforce common stock equal to the number of shares of Class A Common Stock subject to such Braze RSU multiplied by the Conversion Ratio (rounded to the nearest whole share), and will otherwise remain subject to the same terms and conditions (including vesting terms) as applied to the corresponding Braze RSU.
•
PSUs. Each unvested Braze PSU will be assumed and converted into an Adjusted RSU covering a number of shares of Salesforce common stock equal to the product of (i) the total number of shares of Class A Common Stock subject to such Braze PSU determined (x) for any performance period completed prior to the Closing Date, based on actual performance and (y) for any performance period not completed prior to the Closing Date, at target (except that, if the Closing Date occurs prior to February 1, 2027, the number of Braze PSUs earned for the performance period beginning February 1, 2026 will be based on the greater of target and actual performance) and (ii) the Conversion Ratio. Each such Adjusted RSU will otherwise remain subject to the same terms and conditions (including vesting terms, but excluding any performance-based vesting conditions) as applied to the corresponding Braze PSU.
•
Restricted Shares. Each Assumed Braze Restricted Share will be assumed and converted into Adjusted Restricted Shares (that is, a number of shares of restricted Salesforce common stock based on the Conversion Ratio) on the same terms and conditions (including vesting terms), and each Cashout Braze Restricted Share will be converted into the right to receive the Merger Consideration, without interest and less applicable tax withholdings.
58

TABLE OF CONTENTS

Equity Awards Held by Executive Officers
Each of Braze’s named executive officers has entered into an offer letter with Braze, which provides that the executive officer is eligible for severance benefits under the Executive Severance Plan. Pursuant to the Executive Severance Plan, upon a qualifying termination of employment during the period beginning three months prior to and ending 12 months following a change in control (which will include the Merger), 100% of the outstanding and unvested equity awards held by each executive officer will vest, with any performance-based awards vesting at the target level of performance (in the case of Messrs. Magnuson, Hyman and McDonnell, as modified by the Vesting Acceleration Amendments (as defined below)). See “The Merger (Proposal 1)—Executive Severance Plan” below.
The unvested equity awards held by Braze’s executive officers as of the Assumed Closing Date, and the estimated value of such unvested equity awards (calculated by multiplying the number of shares of Class A Common Stock subject to unvested Braze RSUs and Braze PSUs by the Merger Consideration of $47.50, rounded to the nearest whole dollar, and based on the assumptions described above under “The Merger (Proposal 1)—Interests of Braze’s Directors and Executive Officers in the Merger—Certain Assumptions”), are as follows:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options
 
 
RSU Awards
 
 
PSU Awards
 
 
 
Name
 
 
Number of
Shares (#)
 
 
Value ($)
 
 
Number of
Shares (#)
 
 
Value ($)
 
 
Number of
Shares (#)(1)
 
 
Value ($)
 
 
Total Value ($)
William Magnuson
 
 
—
 
 
—
 
 
501,871
 
 
23,838,873
 
 
125,944
 
 
5,982,340
 
 
29,821,213
Pankaj Malik
 
 
—
 
 
—
 
 
47,214
 
 
2,242,665
 
 
—
 
 
—
 
 
2,242,665
Jonathan Hyman
 
 
—
 
 
—
 
 
158,649
 
 
7,535,828
 
 
38,412
 
 
1,824,570
 
 
9,360,398
Astha Malik
 
 
—
 
 
—
 
 
198,824
 
 
9,444,140
 
 
50,377
 
 
2,392,908
 
 
11,837,048
Edward McDonnell
 
 
—
 
 
—
 
 
315,760
 
 
14,998,600
 
 
44,080
 
 
2,093,800
 
 
17,092,400
Christopher Lal
 
 
—
 
 
—
 
 
230,184
 
 
10,933,740
 
 
—
 
 
—
 
 
10,933,740
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
Reflects Braze PSUs at target performance. With respect to any Braze PSUs for which the performance period has been completed, such Braze PSUs have been treated as Braze RSUs in this table, with such number determined based on actual performance.
Mr. Magnuson also holds fully vested Braze Options covering 1,251,658 shares of Class A Common Stock, consisting of Braze Options covering 51,658 shares with an exercise price of $3.46 per share and Braze Options covering 1,200,000 shares with an exercise price of $35.01 per share, and Mr. Hyman also holds fully vested Braze Options covering 325,213 shares of Class A Common Stock with an exercise price of $35.01 per share, all of which are In-the-Money Braze Options. Because these Braze Options are fully vested, they are not reflected in the table above. None of Braze’s other executive officers holds Braze Options.
Equity Awards Held by Non-Employee Directors
Pursuant to Braze’s Non-Employee Director Compensation Policy (referred to as the “Director Compensation Policy”), all unvested Braze RSUs granted to a non-employee director under the Director Compensation Policy will become fully vested immediately prior to a change in control, provided that the non-employee director remains in continuous service until immediately prior to the change in control. Similarly, pursuant to the Merger Agreement, at the Effective Time, each Braze RSU held by a non-employee director will be cancelled and converted into the right to receive the Merger Consideration in respect of each share of Class A Common Stock subject to such Braze RSU, without interest and less applicable tax withholdings. None of Braze’s non-employee directors holds Braze PSUs or unvested Braze Options. For a description of the compensation that Braze may continue to pay to its non-employee directors prior to the Closing, see “The Merger (Proposal 1)—Non-Employee Director Compensation” below.
The number of unvested Braze RSUs held by each of Braze’s non-employee directors as of the Assumed Closing Date, and the estimated value of such Braze RSUs (calculated by multiplying the number of unvested Braze RSUs by the Merger Consideration of $47.50, rounded to the nearest whole dollar, and based on the assumptions described above under “The Merger (Proposal 1)—Interests of Braze’s Directors and Executive Officers in the Merger—Certain Assumptions”), are as follows:
 
 
 
 
 
 
 
Name
 
 
Unvested Braze RSUs (#)
 
 
Value ($)
Phillip Fernandez
 
 
7,753
 
 
368,268
Neeraj Agrawal
 
 
7,753
 
 
368,268
Tara Walpert Levy
 
 
7,753
 
 
368,268
 
 
 
 
 
 
 
59

TABLE OF CONTENTS

 
 
 
 
 
 
 
Name
 
 
Unvested Braze RSUs (#)
 
 
Value ($)
Fernando Machado
 
 
7,753
 
 
368,268
David Obstler
 
 
7,753
 
 
368,268
Yvonne Wassenaar
 
 
9,566
 
 
454,385
Aggregate Value of Unvested Braze Equity Awards
 
 
48,331
 
 
2,295,725
 
 
 
 
 
 
 
Mr. Fernandez also holds fully vested Braze Options covering 145,692 shares of Class A Common Stock with an exercise price of $3.83 per share, which are In-the-Money Braze Options and, because they are fully vested, are not reflected in the table above.
Salesforce Offer Letters; Vesting Acceleration Amendments; Good Reason Letters
Offer Letters
Each of Messrs. Magnuson, Hyman and McDonnell entered into an offer letter with Salesforce (collectively referred to as the “Salesforce Offer Letters”), contingent upon the Closing, providing for each such individual’s employment with Salesforce following the Closing as Chief Executive Officer, Braze (in the case of Mr. Magnuson), EVP, Engineering (in the case of Mr. Hyman) and EVP, Global Chief Revenue Officer, Braze (in the case of Mr. McDonnell).
The Salesforce Offer Letters provide for an initial annual base salary of $645,750 for Mr. Magnuson, $500,000 for Mr. Hyman and $510,000 for Mr. McDonnell. Messrs. Magnuson and Hyman will be eligible for an annual discretionary bonus under Salesforce’s Annual Performance Bonus Plan with an initial target of 100% and 70% of base salary, respectively, and Mr. McDonnell will be eligible for incentive compensation under a Salesforce incentive compensation plan once such plan becomes effective, with annual on-target earnings (base salary plus incentive pay) of $1,020,000, provided that, until such time, Mr. McDonnell will continue to participate in Braze’s incentive compensation plan in accordance with the terms in effect as of immediately prior to Closing. Each Salesforce Offer Letter also provides that Salesforce intends to recommend to its board of directors a grant of Salesforce restricted stock units with a value of $12,000,000 (for Mr. Magnuson), $6,500,000 (for Mr. Hyman) and $4,500,000 (for Mr. McDonnell) (with the number of restricted stock units determined by dividing such value by the average closing price of Salesforce common stock over a one-month period prior to the grant date), which will vest as to 25% on the first anniversary of the grant date and as to 1/16th of the award each quarter thereafter, subject to continued employment and the terms of the applicable Salesforce equity plan, and any unvested restricted stock units will be forfeited upon a termination of employment for any reason. Mr. McDonnell’s Salesforce Offer Letter further provides that Salesforce intends to recommend to its board of directors (or a committee thereof) a $4,000,000 retention bonus, which will be advanced in a lump sum within two pay periods after he commences employment with Salesforce and is subject to prorated repayment if he resigns for any reason or is terminated for “cause” (as defined in his Salesforce Offer Letter) prior to the second anniversary of the date he commences employment with Salesforce. Each Salesforce Offer Letter provides that the executive officer will remain eligible to participate in the Executive Severance Plan (as modified by his Vesting Acceleration Amendment) until the first anniversary of the Closing and will be eligible to participate in Salesforce’s executive severance plan thereafter.
Vesting Acceleration Amendments
As required by the Salesforce Offer Letters, each of Messrs. Magnuson, Hyman and McDonnell also entered into a vesting acceleration acknowledgement and amendment with Salesforce (collectively referred to as the “Vesting Acceleration Amendments”), which is contingent upon the Closing and the applicable individual’s acceptance of his Salesforce Offer Letter. Under the Vesting Acceleration Amendments, each individual has agreed that the Merger, his continued employment with Salesforce following the Closing (including any transfer within the Salesforce group) and the other Transactions will not entitle him to accelerated vesting of his equity awards under the Executive Severance Plan and will not constitute “good reason” or a termination without “cause” under the Executive Severance Plan. Instead, each executive officer’s Adjusted RSUs will vest in full upon a termination of his employment by Salesforce other than for “cause” or his resignation for “good reason” (each as defined in his Vesting Acceleration Amendment rather than the Executive Severance Plan) at any time following the Closing and prior to the 36-month anniversary of the Closing, subject to his execution and non-revocation of Salesforce’s then-standard separation agreement and release of claims.
60

TABLE OF CONTENTS

Good Reason Letters and Tier 1
Braze entered into letter agreements (collectively referred to as the “Good Reason Letters”) with each of Messrs. Pankaj Malik and Lal. Mr. Pankaj Malik’s Good Reason Letter provides that, effective as of and contingent upon the Closing, he is elevated from a Tier 2 participant to a Tier 1 participant in the Executive Severance Plan. Mr. Lal’s Good Reason Letter confirms that he is a Tier 1 participant in the Executive Severance Plan. Each Good Reason Letter further provides that the executive officer will be deemed to have “good reason” under the Executive Severance Plan, without any notice requirement or opportunity for Braze to cure, as of the date that is three months following the Closing, and that if he resigns within the 30-day period following such date and timely delivers a release of claims, he will be entitled to the severance benefits and full equity vesting provided to Tier 1 participants under the Executive Severance Plan. If the executive officer remains employed beyond such 30-day period, his rights will continue to be governed by the terms of the Executive Severance Plan as a Tier 1 participant.
Executive Severance Plan
Each of Braze’s executive officers is eligible for severance benefits under the Executive Severance Plan. Mr. Magnuson participates in the Executive Severance Plan as a Tier 1A participant, and each of Mr. Hyman, Mr. McDonnell, Mr. Lal and Ms. Astha Malik and, effective as of and contingent upon the Closing, Mr. Pankaj Malik, participates as a Tier 1 participant. Under the Executive Severance Plan, upon a termination of employment by Braze without “cause” (other than due to death or disability) or by the executive officer for “good reason” (each, as defined in the Executive Severance Plan), in each case, during the period beginning three months prior to and ending 12 months following a “change in control” (which will include the Merger), and subject to the executive officer’s execution and non-revocation of a release of claims and continued compliance with applicable restrictive covenants, the executive officer will be eligible to receive:
•
Cash Severance. A lump-sum cash payment equal to the sum of (i) 1.0 times the executive officer’s annual base salary (disregarding any reduction constituting good reason), (ii) any earned but unpaid annual bonus for any performance year completed as of the date of termination, (iii) a pro-rated target annual bonus for the year of termination (based on the number of days worked in the performance year) and (iv) for Mr. Magnuson, as a Tier 1A participant, his target annual bonus for the year of termination.
•
Health and Welfare Benefits. Payment of COBRA premiums for the executive officer and his or her eligible dependents for up to 12 months, or, if earlier, until the executive officer becomes eligible for health coverage from another employer (or, in certain circumstances, a taxable monthly cash payment in lieu thereof).
•
Equity Vesting. Accelerated vesting of 100% of the executive officer’s then-outstanding and unvested equity awards, with any performance-based awards vesting at the target level of performance; provided, however, that with respect to Messrs. Magnuson, Hyman and McDonnell, their Adjusted RSUs shall vest in accordance with the terms of their Vesting Acceleration Amendments as set forth in the section above titled “The Merger (Proposal 1)—Vesting Acceleration Amendments.”
The Executive Severance Plan also contains a “best net” provision, pursuant to which, if any payment or benefit to an executive officer would constitute a “parachute payment” within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (referred to as the “Code”) and would be subject to the excise tax imposed by Section 4999 of the Code, such payments and benefits will either be provided in full or reduced to the extent necessary so that no portion is subject to the excise tax, whichever results in the greater after-tax benefit to the executive officer. No executive officer is entitled to a tax gross-up or make-whole payment in respect of such excise tax.
Annual Bonuses
Subject to prior consultation with Salesforce, Braze may determine actual performance under its annual performance-based cash bonus programs for fiscal year 2027 in the ordinary course of business consistent with past practice and may pay annual cash bonuses for fiscal year 2027 based on the greater of (i) 100% of the employee’s target annual cash bonus opportunity and (ii) the amount earned based on actual performance.
In the event the Closing has not occurred on or prior to January 31, 2027, Braze may establish performance goals and targets applicable with respect to fiscal year 2028 under Braze’s performance-based cash bonus programs or other short-term incentive programs in the ordinary course of business consistent with past practice.
61

TABLE OF CONTENTS

Annual Equity Awards
If the Closing does not occur on or prior to January 31, 2027, Braze may grant its annual equity incentive awards in the ordinary course of business subject to certain limitations set forth in the confidential disclosure letter to the Merger Agreement. Such awards will vest on a three-year schedule (and Braze may determine to grant only Braze RSUs vesting quarterly over three years), and any Braze PSUs so granted will have their performance goals deemed achieved at 100% of target as of the Closing.
Section 280G Mitigation Actions
Under the Merger Agreement, Braze may, after consultation with Salesforce, take specified actions to mitigate any adverse tax consequences under Sections 280G and 4999 of the Code.
No mitigation action may include a tax gross-up or similar make-whole payment, and no Braze director or executive officer is entitled to any gross-up, make-whole or other additional payment with respect to any tax under Section 4999 or 409A of the Code.
Employee Benefits Following the Merger
Salesforce has agreed to provide certain compensation and benefits to continuing employees of Braze (including executive officers) for a period of 12 months following the Effective Time, as described in the section titled “The Merger Agreement—Employee Matters.”
Non-Employee Director Compensation
Braze may continue to pay compensation to its non-employee directors in the ordinary course of business consistent with past practice (including, if the Closing has not occurred by June 30, 2027 or the annual meeting is delayed beyond June 30, 2027, granting equity awards) and implement market-based increases to non-employee director compensation in the ordinary course of business consistent with past practice, and, prior to the Closing, may make a payment to each non-employee director in respect of any period prior to or ending at the Closing to the extent not otherwise paid.
Indemnification and Insurance
Pursuant to the terms of the Merger Agreement, for six years following the Effective Time, Salesforce will, or will cause the Surviving Corporation to, indemnify and hold harmless the current and former directors and officers of Braze and its subsidiaries in respect of acts or omissions occurring at or prior to the Effective Time, and, at or prior to the Effective Time, Braze will purchase a six-year prepaid “tail” policy of directors’ and officers’ liability insurance and fiduciary liability insurance (subject to a cap on the aggregate cost of 300% of the last annual premium paid by Braze for such policies). For additional information with respect to the indemnification and insurance coverage, see the section titled “The Merger Agreement—Directors’ and Officers’ Indemnification and Insurance.”
Quantification of Potential Payments and Benefits to Braze’s Named Executive Officers in Connection with the Merger
The information set forth below is required by Item 402(t) of Regulation S-K regarding compensation for each named executive officer of Braze that is based on, or otherwise relates to, the Merger. This compensation is referred to as “golden parachute” compensation by the applicable SEC disclosure rules, and in this section, such term is used to describe the merger-related compensation payable to Braze’s named executive officers. For additional details regarding the terms of the payments and benefits described below, see the section titled “The Merger (Proposal 1)—Interests of Braze’s Directors and Executive Officers in the Merger” above. Such amounts have been calculated based on the assumptions described above under “The Merger (Proposal 1)—Interests of Braze’s Directors and Executive Officers in the Merger—Certain Assumptions” and assuming (i) the payments to the named executive officers are not reduced as a result of Sections 280G and 4999 of the Code; (ii) each named executive officer has properly executed any required release of claims and complied with all requirements (including any applicable restrictive covenants) necessary to receive all payments and benefits; and (iii) each named executive officer is a Tier 1 participant in the Executive Severance Plan (other than Mr. Magnuson, who is a Tier 1A participant).
62

TABLE OF CONTENTS

The amounts shown below are estimates of the payments and benefits (on a pre-tax basis) that each named executive officer would receive based on multiple assumptions that may or may not actually occur or be accurate on the relevant date, and do not reflect certain compensation actions that may occur before the Closing. As a result, the actual amounts, if any, to be received by Braze’s named executive officers may differ materially from the amounts set forth below.
Golden Parachute Compensation
 
 
 
 
 
 
 
 
 
 
 
 
 
Name
 
 
Cash ($)(1)
 
 
Equity ($)(2)
 
 
Perquisites/Benefits ($)(3)
 
 
Total ($)
William Magnuson
 
 
1,802,792
 
 
33,808,268
 
 
27,667
 
 
35,638,727
Pankaj Malik
 
 
571,328
 
 
2,521,775
 
 
37,455
 
 
3,130,558
Jonathan Hyman
 
 
777,123
 
 
10,715,810
 
 
39,840
 
 
11,532,773
Astha Malik
 
 
774,604
 
 
13,362,083
 
 
9,660
 
 
14,146,347
Edward McDonnell
 
 
4,913,808
 
 
18,529,940
 
 
39,840
 
 
23,483,588
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
Cash. Represents the cash severance payable under the Executive Severance Plan, which is “double-trigger” (i.e., payable only upon a qualifying termination), subject to the named executive officer’s execution and non-revocation of a release of claims and compliance with applicable restrictive covenants, consisting of (i) a lump-sum payment equal to 1.0 times the named executive officer’s annual base salary, (ii) for Mr. Magnuson, as the Tier 1A participant, a lump-sum payment equal to his target annual bonus and (iii) for each named executive officer, a lump-sum payment equal to the pro-rated target annual bonus for fiscal year 2027, based on the number of days worked in fiscal year 2027 through the Assumed Closing Date. For Mr. McDonnell, also includes the $4,000,000 retention bonus, which is “single-trigger,” that Salesforce intends to recommend to its board of directors (or a committee thereof) under his Salesforce Offer Letter, which will be advanced in a lump-sum within two pay periods after he commences employment with Salesforce following the Closing, subject to his continued employment through such date; provided that, if he resigns for any reason (which would include a resignation for “good reason” under the Executive Severance Plan) or is terminated for “cause” (as defined in his Salesforce Offer Letter) prior to the second anniversary of the date he commences employment with Salesforce, he will be required to repay a prorated portion of the retention bonus, and upon any other termination of employment prior to such date, the retention bonus will be deemed earned. The following provides a summary of the cash severance amounts (which do not include Mr. McDonnell’s retention bonus):
 
 
 
 
 
 
 
 
 
 
 
 
 
Name
 
 
Base Salary
Severance ($)
 
 
Target Bonus
Severance ($)
 
 
Pro-Rated FY2027
Target Bonus ($)
 
 
Total ($)
William Magnuson
 
 
645,750
 
 
645,750
 
 
511,292
 
 
1,802,792
Pankaj Malik
 
 
409,013
 
 
 
 
 
162,315
 
 
571,328
Jonathan Hyman
 
 
500,000
 
 
 
 
 
277,123
 
 
777,123
Astha Malik
 
 
486,000
 
 
 
 
 
288,604
 
 
774,604
Edward McDonnell
 
 
510,000
 
 
 
 
 
403,808
 
 
913,808
 
 
 
 
 
 
 
 
 
 
 
 
 
(2)
Equity. Represents the estimated value of the unvested Braze RSUs and Braze PSUs held by each named executive officer as of the Assumed Closing Date, based on the Merger Consideration of $47.50. As of the Assumed Closing Date, none of the outstanding Braze Options held by named executive officers was unvested. Upon the consummation of the Merger, (i) each unvested Braze RSU will be converted into an Adjusted RSU and (ii) each unvested Braze PSU (with the number of Braze PSUs based on target performance) will be converted into an Adjusted RSU based on actual performance for completed performance periods and target performance for incomplete performance periods (or, for the performance period beginning February 1, 2026, the greater of target and actual performance if the Closing occurs prior to February 1, 2027). Amounts attributable to Adjusted RSUs are “double-trigger” and would vest in full only upon a qualifying termination under the Executive Severance Plan (or, in the case of Messrs. Magnuson, Hyman and McDonnell, upon a qualifying termination under their respective Vesting Acceleration Amendments). The equity awards set forth in the table above do not include the Salesforce equity grants to Messrs. Magnuson, Hyman and McDonnell pursuant to their Salesforce Offer Letters because they will be forfeited upon a termination for any reason following the Closing to the extent they have not vested based on continued service. Details of the equity award values are shown in the table under “The Merger (Proposal 1)—Equity Awards Held by Executive Officers” above.
(3)
Perquisites/Benefits. Represents the estimated value of COBRA premium payments for 12 months under the Executive Severance Plan, which is “double-trigger.”
Regulatory Clearances and Approvals Required for the Merger
The completion of the Merger is conditioned on, among other things, (i) the expiration or termination of any applicable waiting period (and any commitment not to close before a certain date under a timing agreement with governmental authorities) under the HSR Act, (ii) certain specified regulatory approvals having been obtained and remaining in effect (or, in the case of certain specified regulatory approvals that are statutory waiting periods, having expired or been terminated) without the imposition of a Burdensome Condition and (iii) no governmental authority having enacted any law or issued any order that prohibits the consummation of the Merger or imposes a Burdensome Condition (unless agreed to in writing by Salesforce). Subject to the terms and conditions of the Merger Agreement, each of Braze and Salesforce has agreed to use reasonable best efforts to take, or cause to be
63

TABLE OF CONTENTS

taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable law to consummate the Transactions, including the Merger, as soon as practicable, including using reasonable best efforts to prepare and file as promptly as practicable with any governmental authority or other third party all documentation to effect all necessary applications, notices, petitions, filings and other documents and to obtain as promptly as reasonably practicable all regulatory approvals necessary or advisable to consummate the Merger.
Each of Braze and Salesforce has agreed to (x) make an appropriate filing of a Notification and Report Form pursuant to the HSR Act with respect to the Transactions as promptly as practicable, and in any event within 20 business days after the execution of the Merger Agreement (unless a later date is mutually agreed between the parties), and to supply as promptly as reasonably practicable and advisable any additional information and documentary materials that may be requested pursuant to the HSR Act and to take all other actions necessary to cause the expiration or termination of the applicable waiting periods under the HSR Act as soon as reasonably practicable and (y) make all other necessary or advisable filings as promptly as reasonably practicable, and to supply as promptly as reasonably practicable and advisable any additional information and documentary materials that may be requested under any applicable regulatory law. On November 12, 2026, each of Salesforce and Braze filed a notification of the proposed merger under the HSR Act.
If and to the extent necessary to obtain clearance of the Merger under the HSR Act and the regulatory laws of certain specified jurisdictions, Salesforce, Banff Acquisition Sub and their respective subsidiaries have agreed to (and will direct Braze and its subsidiaries to) offer, negotiate, commit to and effect, by consent decree, hold separate order or otherwise, any requirement, condition, limitation, understanding, agreement or order to (A) sell, license, assign, transfer, divest, hold separate or otherwise dispose of any assets, business or portion of business of Braze or any subsidiary of Braze, (B) conduct, restrict, operate, invest or otherwise change the assets, the business or portion of the business of Braze or any subsidiary of Braze in any manner or (C) impose any restriction, requirement or limitation on the operation of the business or portion of the business of Braze or any subsidiary of Braze, and Braze and its subsidiaries have agreed to take any such action solely to the extent directed by Salesforce. However, none of Salesforce, Braze or their respective subsidiaries is required to take any action that would reasonably be expected to, individually or in the aggregate, (x) impact Salesforce, Braze or their respective subsidiaries in an adverse manner or amount that is material relative to the value of Braze and its subsidiaries, taken as a whole, (y) have any impact on any asset, business (or portions thereof), product lines or product of Salesforce or any subsidiary of Salesforce (excluding any asset, business (or portions thereof), product lines or product of Braze and its subsidiaries) or (z) materially reduce the reasonably anticipated benefits to Salesforce and its subsidiaries, taken as a whole (including anticipated synergies), of the Transactions; provided that if requested by Salesforce, Braze and its subsidiaries will become subject to, consent to or offer or agree to, and otherwise take any action with respect to, any such requirement, condition, limitation, understanding, agreement or order so long as such requirement, condition, limitation, understanding, agreement or order is only binding on Braze or its subsidiaries in the event the Merger closes. In addition, none of Salesforce, Braze or their respective subsidiaries is required to propose, negotiate, commit to or effect any such action unless such action is conditioned upon the consummation of the Merger and does not take effect until the Effective Time. As part of their reasonable best efforts obligations, and subject to the limitations described above, the parties have also agreed to defend through litigation on the merits any claim asserted in court by any U.S. federal governmental entity under the HSR Act, the Sherman Act, the Clayton Act or the Federal Trade Commission Act to avoid entry of, or to have vacated or terminated, any decree, order or judgment (whether temporary, preliminary or permanent) that would prevent the closing of the Merger from occurring prior to the Outside Date. Salesforce will, on behalf of the parties, control and direct all communications and strategy in dealing with any governmental authority under the HSR Act or other regulatory laws, subject to considering in good faith the views and comments of Braze and its outside counsel, and Salesforce has the right, after consultation with Braze, to voluntarily withdraw and refile its HSR Act notification on one occasion during the initial waiting period, so long as it refiles within two business days. Salesforce has agreed to pay all filing fees under the HSR Act and any other applicable regulatory law relating to the Transactions.
For more information about regulatory clearance relating to the Merger, see the section titled “The Merger Agreement—Conditions to the Merger.”
Although the parties expect that the required regulatory clearance will be obtained, the parties cannot assure you that regulatory clearance will be timely obtained or obtained at all or that the granting of regulatory clearance will not involve the imposition of additional conditions on the completion of the Merger, including the requirement to divest assets, create or modify contractual rights or obligations or enter into supply or services agreements. Any such additional conditions could result in the conditions to the Merger not being satisfied.
64

TABLE OF CONTENTS

Expected Timing of the Merger
Salesforce and Braze are working to complete the Merger as quickly as possible. Subject to the satisfaction or waiver of the conditions described in the section titled “The Merger Agreement—Conditions to the Merger,” including the adoption of the Merger Agreement by Braze stockholders at the Special Meeting and the receipt of required regulatory clearances, the transaction is expected to close in Braze’s fiscal year beginning February 1, 2027. However, neither Salesforce nor Braze can predict the actual date on which the Merger will be completed, nor can the parties assure you that the Merger will be completed at all, because completion is subject to conditions beyond either company’s control, including receipt of required regulatory clearances. In addition, if the Merger is not completed by October 19, 2027, subject to two automatic 90-day extensions if required in order to obtain required regulatory approvals, either Salesforce or Braze may choose not to proceed with the Merger by terminating the Merger Agreement.
Delisting and Deregistration of Class A Common Stock
Upon completion of the Merger, the Class A Common Stock currently listed on Nasdaq will cease to be listed and will subsequently be deregistered under the Exchange Act. At that time, we will no longer be required to file periodic reports, current reports and proxy and information statements with the SEC with respect to the Class A Common Stock.
Appraisal Rights of Braze Stockholders
Braze stockholders and beneficial owners of Class A Common Stock held either in voting trust or by a nominee on behalf of such person who do not vote in favor of approval of the Merger Agreement Proposal, who continuously hold their shares of Class A Common Stock and who otherwise comply precisely with the applicable provisions of Section 262 of the DGCL and do not validly withdraw their demand for appraisal or otherwise lose their appraisal rights will be entitled to seek appraisal of the fair value of their shares of Class A Common Stock, as determined by the Delaware Court of Chancery, if the Merger is completed, in lieu of receiving the Merger Consideration in respect of such shares. However, because the Class A Common Stock is currently listed on a national securities exchange, and, assuming such shares of Class A Common Stock remain listed on a national securities exchange immediately prior to the Merger (which is expected to be the case), after an appraisal petition has been filed, the Delaware Court of Chancery will dismiss appraisal proceedings as to all holders of such shares who are otherwise entitled to appraisal rights unless (1) the total number of shares of Class A Common Stock entitled to appraisal exceeds 1% of the outstanding shares of Class A Common Stock eligible for appraisal or (2) the value of the aggregate Merger Consideration in respect of such total number of shares of Class A Common Stock exceeds $1,000,000.
The “fair value” of your shares of Class A Common Stock as determined by the Delaware Court of Chancery could be greater than, the same as, or less than the value of the Merger Consideration that you would otherwise be entitled to receive under the terms of the Merger Agreement. Braze stockholders and beneficial owners who wish to exercise the right to seek an appraisal of their shares must so advise Braze by submitting a written demand for appraisal in the form required by Section 262 prior to the vote to approve the Merger Agreement Proposal, and must otherwise follow the procedures prescribed by Section 262 of the DGCL. For more information, see the section titled “Appraisal Rights of Braze Stockholders”.
A copy of Section 262 of the DGCL may be accessed without subscription or cost at the following publicly available website: https://delcode.delaware.gov/title8/c001/sc09/index.html#262. You are encouraged to read the discussions of appraisal rights in this proxy statement and the full text of Section 262 carefully and in their entirety. Due to the complexity of the procedures for exercising appraisal rights, Braze stockholders and beneficial owners who are considering exercising such rights are encouraged to seek the advice of their legal counsel and financial advisors. Failure to strictly comply with these provisions may result in the loss of appraisal rights.
65

TABLE OF CONTENTS

THE MERGER AGREEMENT
The following summary describes certain material provisions of the Merger Agreement entered into by and among Salesforce, Banff Acquisition Sub and Braze, a copy of which is attached hereto as Annex A and is incorporated by reference herein in its entirety. This summary does not purport to be complete and may not contain all of the information about the Merger Agreement that is important to you. You are encouraged to read the Merger Agreement carefully and in its entirety because it is the legal document that governs the Merger. The description of the Merger Agreement in this section and elsewhere in this proxy statement is qualified in its entirety by reference to the complete text of the Merger Agreement. The legal rights and obligations of the parties are governed by the specific language of the Merger Agreement and not this summary.
Explanatory Note Regarding the Merger Agreement
The Merger Agreement has been included with this proxy statement to apprise you of its terms. It is not intended to provide any other factual information about Braze, Salesforce or Banff Acquisition Sub or their respective businesses. The Merger Agreement contains representations and warranties that the parties thereto made to and solely for the benefit of each other. These representations and warranties were made as of specific dates and are in some cases subject to important qualifications, limitations and supplemental information agreed to by Braze, Salesforce and Banff Acquisition Sub in connection with negotiating the terms of the Merger Agreement. Information concerning the subject matter of such representations and warranties may change after the dates specified in the Merger Agreement, which subsequent information may or may not be disclosed by Braze. In addition, the representations and warranties may have been included in the Merger Agreement for the purpose of allocating risk between Braze, on the one hand, and Salesforce and Banff Acquisition Sub, on the other hand, or establishing the circumstances in which a party is not obligated to complete the Merger if the representations and warranties of the other party prove to be inaccurate due to a change in circumstance or otherwise, rather than to establish matters as facts. Moreover, the representations and warranties may also be subject to a contractual standard of materiality different from those generally applicable to stockholders. Accordingly, you should not rely on the representations and warranties in the Merger Agreement as disclosures or characterizations of the actual state of facts or circumstances regarding Braze, Salesforce or Banff Acquisition Sub.
The Merger
Upon the terms and subject to the conditions of the Merger Agreement, Banff Acquisition Sub, a wholly owned subsidiary of Salesforce, will merge with and into Braze. Following the Merger, the separate existence of Banff Acquisition Sub will cease and Braze will continue as the Surviving Corporation and as a wholly owned subsidiary of Salesforce.
Completion and Effectiveness of the Merger
Under the Merger Agreement, the Closing of the Merger will take place virtually by exchange of documents and signatures at 4:00 a.m., Pacific Time, on the fifth business day after the satisfaction or, to the extent permitted by applicable law, waiver of the last of the conditions to the Merger (other than any such conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or, to the extent permitted by applicable law, waiver of such conditions at the Closing), unless another date or place is agreed to in writing by Salesforce and Braze. For more information on the conditions to the Merger, please see the section titled “The Merger Agreement—Conditions to the Merger.”
On the Closing Date, the parties will cause a certificate of merger with respect to the Merger, satisfying the applicable requirements of the DGCL and in a form reasonably satisfactory to Salesforce and Braze (referred to as the “certificate of merger”), to be duly executed and filed with the Secretary of State of the State of Delaware as provided under the DGCL and make any other filings, recordings or publications required to be made under the DGCL in connection with the Merger. The Merger will become effective at such time as the certificate of merger is duly filed with the Secretary of State of the State of Delaware or, if otherwise agreed to by Braze and Salesforce, at such later time as may be specified in the certificate of merger. At the Effective Time, all of the property, rights, privileges, immunities, powers and franchises of Braze and Banff Acquisition Sub will vest in Braze as the Surviving Corporation, and all of the liabilities, obligations and duties of Braze and Banff Acquisition Sub will become liabilities, obligations and duties of Braze as the Surviving Corporation.
66

TABLE OF CONTENTS

Merger Consideration
At the Effective Time, by virtue of the Merger and without any action on the part of the holder thereof:
•
each share of Class A Common Stock issued and outstanding immediately prior to the Effective Time (other than any Dissenting Shares, Cancelled Shares or Converted Shares) will be converted into the right to receive $47.50 per share in cash, without interest;
•
each holder of a valid certificate or certificates evidenced by way of a Book-Entry Share will thereafter cease to have any rights with respect to such shares of Class A Common Stock, except the right to receive the applicable Merger Consideration upon the surrender of such shares of Class A Common Stock, as applicable, in accordance with the terms of the Merger Agreement;
•
the Cancelled Shares will be cancelled without any consideration delivered in exchange therefor and will cease to exist;
•
the Converted Shares will be converted into such number of shares of the Surviving Corporation Stock equal to the product of (i) (x) the number of shares of Class A Common Stock held by such subsidiary immediately prior to the Effective Time, divided by (y) the number of shares of Class A Common Stock outstanding immediately prior to the Effective Time, and (ii) the total number of shares of Surviving Corporation Stock outstanding immediately after the consummation of the Merger; and
•
each share of Banff Acquisition Sub common stock issued and outstanding immediately prior to the Effective Time will automatically be converted into and become one validly issued, fully paid and nonassessable share of Surviving Corporation Stock.
From and after the Effective Time, all such shares of Class A Common Stock (other than any Dissenting Shares, Cancelled Shares or Converted Shares), when so converted, will cease to be issued and outstanding and will automatically be cancelled and cease to exist. Each holder of a share of Class A Common Stock that was outstanding immediately prior to the Effective Time (excluding any Dissenting Shares, Cancelled Shares or Converted Shares) will cease to have any rights with respect thereto, except the right to receive the applicable Merger Consideration to which such holder is entitled by virtue of the Merger.
Notwithstanding anything to the contrary in the Merger Agreement, the Dissenting Shares will not be converted into the right to receive the Merger Consideration unless and until the holders thereof shall have failed to perfect any available right of appraisal under applicable law, but, instead, the holders thereof will be entitled to payment of the appraised value of such Dissenting Shares in accordance with Section 262. Notwithstanding the foregoing, if any such holder has failed to perfect or has effectively withdrawn or lost such right of appraisal, the shares of Class A Common Stock held by such holder will not be deemed Dissenting Shares for purposes of the Merger Agreement and will be deemed to have been converted into the Merger Consideration at the Effective Time. Braze has agreed to give Salesforce prompt notice of any demands for appraisal received by Braze, and the opportunity to participate in all negotiations and proceedings with respect to such demands (with Braze directing and controlling such negotiations and proceedings, subject to good-faith consultation with Salesforce), and Braze may not, without Salesforce’s prior written consent, make any payment with respect to, or settle or offer to settle, any such demand, or waive any failure to timely deliver a written demand for appraisal or to take any other action to perfect appraisal rights.
Exchange of Class A Common Stock for the Merger Consideration
Prior to the Effective Time, Salesforce will designate a bank or trust company reasonably acceptable to Braze to act as the paying agent for the Merger to handle the exchange of Class A Common Stock for the Merger Consideration (referred to as the “paying agent”). The paying agent will also act as the agent for the holders of Class A Common Stock for the purpose of receiving and holding their certificates and Book-Entry Shares, as applicable.
Book-Entry Shares
Any holder of Book-Entry Shares of Class A Common Stock whose shares were converted into the right to receive the applicable Merger Consideration will not be required to deliver a certificate or letter of transmittal to the paying agent, or to surrender such Book-Entry Shares of Class A Common Stock to the paying agent to receive the applicable Merger Consideration. In lieu thereof, each registered holder of one or more Book-Entry Shares of
67

TABLE OF CONTENTS

Class A Common Stock will automatically upon the Effective Time be entitled to receive, and Salesforce will direct the paying agent to pay and deliver in exchange therefor as promptly as reasonably practicable after the Effective Time (and in any event within five business days following the Effective Time), the applicable Merger Consideration for each share of Class A Common Stock formerly represented by such Book-Entry Share, and the Book-Entry Share so exchanged will be cancelled.
No Interest
No interest will be paid or will accrue on any portion of the Merger Consideration payable in respect of any Book-Entry Share or certificated share of Class A Common Stock.
Termination of Rights
At the Effective Time, the stock transfer books of Braze will be closed immediately, and there will be no further registration of transfers of Class A Common Stock on the records of Braze. Braze will issue a stop transfer order to its transfer agent solely with respect to shares of Class A Common Stock of record five business days prior to the anticipated closing date or such shorter period as requested by Salesforce. Until surrendered, each certificate and Book-Entry Share representing Class A Common Stock will be deemed at any time after the Effective Time to represent only the right to receive the Merger Consideration as contemplated in the Merger Agreement. If, after the Effective Time, certificates or Book-Entry Shares representing Class A Common Stock are presented to Salesforce for any reason, they will no longer be outstanding and will be automatically cancelled and exchanged as provided for in the Merger Agreement.
Treatment of Braze Equity Awards and the Braze ESPP
Options
At the Effective Time, each In-the-Money Braze Option that is outstanding and unexercised immediately prior to the Effective Time will, without any action on the part of Salesforce, Braze or the holder, be cancelled, and the holder will become entitled to receive the Merger Consideration in respect of each Net Share covered by such Braze Option, without interest and less applicable tax withholdings. “Net Share” means, with respect to a Braze Option, the quotient obtained by dividing (a) the product of (i) the excess, if any, of the Merger Consideration over the per share exercise price of such Braze Option, multiplied by (ii) the number of shares of Class A Common Stock subject to such Braze Option immediately prior to the Effective Time, by (b) the Merger Consideration. At the Effective Time, each Braze Option that is not an In-the-Money Braze Option, whether or not vested, will be cancelled for no consideration.
RSU Awards
At the Effective Time, each Braze RSU that is outstanding immediately prior to the Effective Time and that (i) is held by a non-employee member of the Braze Board of Directors or (ii) is vested as of the Closing will be cancelled, and the holder will become entitled to receive the Merger Consideration in respect of each share of Class A Common Stock subject to such Braze RSU immediately prior to the Effective Time, without interest and less applicable tax withholdings. Each other Braze RSU will be assumed and converted automatically into an Adjusted RSU with respect to a number of shares of Salesforce common stock equal to the product of (i) the total number of shares of Class A Common Stock subject to such Braze RSU and (ii) the Conversion Ratio, with any fractional shares rounded to the nearest whole share. Each Adjusted RSU will otherwise be subject to the same terms and conditions (including vesting terms) as applied to the corresponding Braze RSU. “Conversion Ratio” means the quotient (rounded to the fourth decimal place) obtained by dividing (i) the Merger Consideration by (ii) the volume weighted average closing sale price of one share of Salesforce common stock as reported on the New York Stock Exchange for the 20 consecutive trading days ending on the trading day immediately preceding the Closing Date (as adjusted as appropriate to reflect any stock splits, stock dividends, combinations, reorganizations, reclassifications or similar events).
PSU Awards
At the Effective Time, each Braze PSU that is outstanding and unvested immediately prior to the Effective Time will be assumed and converted automatically into an Adjusted RSU covering a number of shares of Salesforce common stock equal to the product of (i) the total number of shares of Class A Common Stock subject to such Braze
68

TABLE OF CONTENTS

PSU immediately prior to the Effective Time (with such number of shares determined, (x) with respect to any performance period completed prior to the Closing Date (including the fiscal year beginning February 1, 2026, if the Closing Date is on or after February 1, 2027), based on actual performance (as determined by the Compensation and Leadership Development Committee of the Braze Board of Directors as of the latest practicable date prior to the Effective Time) and (y) with respect to any performance period not completed prior to the Closing Date, at the target level of performance (except that, if the Closing Date occurs prior to February 1, 2027, the number of Braze PSUs earned for the performance period beginning February 1, 2026 will be determined based on the greater of target and actual performance)), and (ii) the Conversion Ratio, with any fractional shares rounded to the nearest whole share. Each such Adjusted RSU will otherwise be subject to the same terms and conditions (including vesting terms, but excluding any performance-based vesting conditions) as applied to the corresponding Braze PSU.
Restricted Shares
At the Effective Time, (i) each Assumed Braze Restricted Share that is outstanding immediately prior to the Effective Time will be assumed and converted automatically into a number of shares of restricted Salesforce common stock equal to the number of Assumed Braze Restricted Shares multiplied by the Conversion Ratio, with any fractional shares rounded to the nearest whole share, and will otherwise be subject to the same terms and conditions (including vesting terms), and (ii) each Cashout Braze Restricted Share that is outstanding immediately prior to the Effective Time will be converted into the right to receive the Merger Consideration, without interest and less applicable tax withholdings.
Non-U.S. Awards
If Salesforce determines that, for holders of Braze equity awards (other than Braze Restricted Shares) employed outside of the United States, the treatment described above would reasonably be expected to cause a significant administrative burden to Salesforce, Salesforce may either (i) require that such awards be converted into cash-based awards, in any jurisdiction in which Salesforce has provided cash-based awards in lieu of equity-based awards to similarly situated employees or does not have a material employee population, which cash-based awards will otherwise have the same terms and conditions as the corresponding Braze equity awards, or (ii) cash out such awards at the Closing based on the value of the Merger Consideration.
Timing of Payments; Registration of Salesforce Shares
Salesforce will, or will cause the Surviving Corporation to, pay the cash amounts payable in respect of In-the-Money Braze Options, Braze RSUs that are held by non-employee directors or that are vested, Cashout Braze Restricted Shares and, if applicable, Braze equity awards held by non-U.S. employees that are cashed out, as promptly as practicable following the Closing Date (but in no event later than the first payroll date that is at least ten business days after the Closing Date), except that, to the extent any Braze RSU or Braze PSU constitutes nonqualified deferred compensation subject to Section 409A of the Internal Revenue Code of 1986, as amended (referred to as the “Code”), such payment will be made at the earliest time permitted under the terms of the award that will not result in the application of a tax or penalty under Section 409A of the Code. Salesforce will file with the SEC, at or as soon as reasonably practicable after the Effective Time, a registration statement on Form S-8 (to the extent such form is available) relating to the shares of Salesforce common stock issuable with respect to the Adjusted RSUs and Adjusted Restricted Shares, and will use commercially reasonable efforts to maintain its effectiveness for so long as any Adjusted RSUs or Adjusted Restricted Shares remain outstanding.
Braze ESPP
Braze will take all actions necessary with respect to the Braze ESPP to provide that (i) with respect to the offering periods in effect as of October 19, 2026, no employee who was not a participant as of such date may become a participant, and no participant may increase his or her payroll deduction election from that in effect on such date, (ii) subject to the consummation of the Merger, the Braze ESPP will terminate effective immediately prior to the Effective Time, (iii) if the current offering periods terminate prior to the Effective Time, the Braze ESPP will be suspended and no new offering period will commence prior to the termination of the Merger Agreement and (iv) if any current offering period is still in effect at the Effective Time, the last day of such offering period will be accelerated to a date that is no later than three business days prior to the Closing Date.
69

TABLE OF CONTENTS

Representations and Warranties
The Merger Agreement contains customary representations and warranties of the parties. These include representations and warranties of Braze with respect to:
a.
organization and qualification;
b.
subsidiaries;
c.
capitalization;
d.
corporate authority relative to the Merger Agreement;
e.
requisite stockholder approval;
f.
due execution, delivery and enforceability of the Merger Agreement;
g.
required consents and approvals, including governmental consents;
h.
no violations;
i.
SEC reports and filings;
j.
financial statements;
k.
internal controls and procedures;
l.
the absence of undisclosed liabilities;
m.
the absence of certain changes or events;
n.
compliance with laws and permits;
o.
employee benefit plans;
p.
labor matters;
q.
tax matters;
r.
litigation and orders;
s.
intellectual property;
t.
privacy and data protection;
u.
real and personal property;
v.
material contracts;
w.
environmental matters;
x.
customers, suppliers, resellers and government entities;
y.
insurance;
z.
information supplied for SEC filings;
aa.
opinion of financial advisor;
bb.
state takeover statutes and anti-takeover laws;
cc.
related party transactions; and
dd.
finders and brokers.
The Merger Agreement also contains customary representations and warranties of Salesforce and Banff Acquisition Sub, including with respect to:
a.
organization and qualification;
b.
corporate authority relative to the Merger Agreement;
c.
due execution, delivery and enforceability of the Merger Agreement;
70

TABLE OF CONTENTS

d.
required consents and approvals, including governmental consents;
e.
no violations;
f.
litigation and orders;
g.
information supplied for SEC filings;
h.
sufficient funds to pay the Merger Consideration;
i.
finders and brokers; and
j.
not being an “interested stockholder” of Braze as defined in Section 203 of the DGCL.
Certain representations and warranties contained in the Merger Agreement are qualified by “material adverse effect,” as described below. The representations and warranties contained in the Merger Agreement will expire at the Effective Time. The representations, warranties and covenants made by Braze in the Merger Agreement are qualified by information contained in Braze’s confidential disclosure letter delivered to Salesforce in connection with the execution of the Merger Agreement and by filings that Braze has made with the SEC since February 1, 2025 and publicly available prior to October 19, 2026. The representations, warranties and covenants made by Salesforce and Banff Acquisition Sub in the Merger Agreement are qualified by information contained in Salesforce’s confidential disclosure letter delivered to Braze in connection with the execution of the Merger Agreement and by filings that Salesforce has made with the SEC since February 1, 2025 and publicly available prior to October 19, 2026. The representations, warranties and covenants of each party in the Merger Agreement were made only for the purposes of, and were and are solely for the benefit of the parties to, the Merger Agreement, may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential disclosure letters made for the purposes of allocating contractual risk between the parties to the Merger Agreement instead of establishing these matters as facts, and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to holders of Class A Common Stock. Accordingly, the representations and warranties may not describe the actual state of affairs as of October 19, 2026, or at any other time, and holders of Class A Common Stock should not rely on them as statements of fact. These confidential disclosure letters contain information that modifies, qualifies and creates exceptions to the representations and warranties and certain covenants set forth in the Merger Agreement. Holders of Class A Common Stock are not third-party beneficiaries of these representations, warranties and covenants under the Merger Agreement and should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of Braze or any of its affiliates or of Salesforce or any of its affiliates.
Material Adverse Effect
A “material adverse effect” with respect to Braze means any change, effect, development, circumstance, condition, state of facts, event or occurrence that, individually or in the aggregate, has had or would reasonably be expected to have, individually or in the aggregate, a material adverse effect on the business, financial condition, or operations of Braze and the Braze subsidiaries, taken as a whole, except that no such change, effect, development, circumstance, condition, state of facts, event or occurrence to the extent resulting or arising from any of the following will be deemed to constitute a material adverse effect or will be taken into account when determining whether a material adverse effect exists or has occurred:
(a)
any changes in United States, regional, global or international economic conditions, including any changes affecting financial, credit, foreign exchange or capital market conditions;
(b)
any changes in conditions generally affecting the cross-channel customer messaging software industry;
(c)
any changes in political, geopolitical, regulatory or legislative conditions in the United States or any other country or region of the world;
(d)
any changes after October 19, 2026 in U.S. generally accepted accounting principles (referred to as “GAAP”) or the authoritative interpretation thereof;
(e)
any changes after October 19, 2026 in applicable law or the authoritative interpretation thereof;
(f)
any failure by Braze to meet any internal or published projections, estimates or expectations of Braze revenue, earnings or other financial performance or results of operations for any period, in and of itself, or any failure by Braze to meet its internal budgets, plans or forecasts of its revenues, earnings or other
71

TABLE OF CONTENTS

financial performance or results of operations, in and of itself (it being understood that the facts or occurrences giving rise or contributing to such failure that are not otherwise excluded from the definition of a “material adverse effect” may be taken into account);
(g)
any acts of terrorism or sabotage, war (whether or not declared), the commencement, continuation or escalation of a war, acts of armed hostility, weather conditions, natural disasters, epidemics or pandemics or similar force majeure events, including any material worsening of such conditions threatened or existing as of October 19, 2026, or any action taken by any governmental entity in response to any of the foregoing;
(h)
the execution and delivery of the Merger Agreement, the identity of Salesforce or any of its subsidiaries, the pendency or consummation of the Merger Agreement, the Merger and the other Transactions, including the effect thereof on Braze’s relationships with current or prospective customers, suppliers, distributors, partners, financing sources, employees or sales representatives, or the public announcement of the Merger Agreement or the Transactions, including the initiation or settlement of any litigation arising out of or relating to the Merger Agreement or the Transactions commenced by or involving (i) any governmental entity in connection with the Merger Agreement or the Transactions or (ii) any current or former stockholder of Braze (on their own or on behalf of Braze), to the extent relating to the Merger Agreement or the Transactions, the identity of Salesforce or any of its subsidiaries, the pendency or consummation of the Merger Agreement, the Merger or the other Transactions, or the public announcement of the Merger Agreement or the Transactions, as applicable (except that this clause (h) will not apply to any representation or warranty to the extent the purpose of such representation or warranty is to address, as applicable, the consequences resulting from the execution and delivery or public announcement of the Merger Agreement, the pendency or consummation of the Merger Agreement, the Merger and the other Transactions); and
(i)
any action or failure to take any action which action or failure to act is requested in writing by Salesforce or otherwise expressly required to be taken by the Merger Agreement (other than pursuant to Braze’s covenant to use reasonable best efforts to conduct its business in all material respects in the ordinary course of business until the earlier of the Effective Time or the date (if any) the Merger Agreement is terminated).
Notwithstanding the definition above, with respect to the exceptions set forth in clauses (a), (b), (c), (d), (e) and (g), if such change, effect, development, circumstance, condition, state of facts, event or occurrence has had, or would reasonably be expected to have, a disproportionate adverse effect on Braze or any subsidiary of Braze relative to other companies operating in the cross-channel customer messaging software industry, then only the incremental disproportionate adverse effect of such change, effect, development, circumstance, condition, state of facts, event or occurrence that would reasonably be expected to occur will be taken into account for the purpose of determining whether a material adverse effect exists or has occurred.
A “material adverse effect” with respect to Salesforce means any change, effect, development, circumstance, condition, state of facts, event or occurrence that prevents, materially impairs or materially delays, or has a material adverse effect on, the ability of Salesforce or Banff Acquisition Sub to consummate the Transactions, including the Merger, by the Outside Date.
Conduct of Business Before Completion of the Merger
Restrictions on Braze’s Operations
The Merger Agreement provides for certain restrictions on Braze’s and its subsidiaries’ activities until the earlier of the Effective Time or the date (if any) the Merger Agreement is terminated. In general, except as specifically permitted, set forth in Braze’s confidential disclosure letter, required by the Merger Agreement, required by applicable law or consented to in writing by Salesforce, subject to specified exceptions, Braze and each of its subsidiaries is required to use reasonable best efforts to (i) conduct its business in all material respects in the ordinary course of business consistent with past practice, (ii) preserve intact its and their present business organizations, goodwill and ongoing business, (iii) keep available the services of its and their present officers and other key employees (other than where termination of such services is for cause or due to resignation) and (iv) preserve its and their relationships with customers, suppliers, vendors, resellers, licensors, licensees, governmental entities, employees and other persons with whom it and they have material business relations. In addition, except as specifically permitted or required by the Merger Agreement, as required by applicable law or as
72

TABLE OF CONTENTS

consented to in writing by Salesforce (which, in certain specified cases, may not be unreasonably withheld, conditioned or delayed), subject to specified exceptions, Braze must not and must cause each of its subsidiaries not to, directly or indirectly:
•
amend, modify, waive, rescind, change or otherwise restate Braze’s or any of its subsidiaries’ certificate of incorporation, bylaws or organizational documents;
•
authorize, declare, set aside, make or pay any dividends on or make any distribution with respect to Braze’s outstanding shares of capital stock or other equity interests (whether in cash, assets, shares or other securities of Braze or any of its subsidiaries), other than dividends or distributions between wholly owned Braze subsidiaries;
•
enter into any agreement or arrangement with respect to voting or registration;
•
file any registration statement with the SEC with respect to any of Braze’s capital stock or other equity interests or securities of Braze;
•
split, combine, subdivide, reduce or reclassify any of Braze’s capital stock or other equity interests, or redeem, purchase or otherwise acquire any of Braze’s capital stock or other equity interests;
•
issue or authorize the issuance of any of Braze’s capital stock or other equity interests or any other securities in respect of, in lieu of or in substitution for, shares of Braze’s capital stock or other equity interests, except for (a) the acceptance of shares of Class A Common Stock as payment of the exercise price of Braze options or for withholding taxes in respect of Braze equity awards, in each case, in accordance with past practice and the terms of such Braze equity awards, or (b) any transaction by a wholly owned Braze subsidiary which remains a wholly owned Braze subsidiary after consummation of such transaction;
•
issue, deliver, grant, sell, pledge, modify, transfer, dispose of or encumber, or authorize the issuance, delivery, grant, sale, pledge, modification, transfer, disposition or encumbrance of, directly or indirectly, any shares in the capital stock, voting securities or other equity interest in Braze or any of its subsidiaries or any securities convertible into or exchangeable or exercisable for any such shares, voting securities or equity interest, or any rights, warrants or options to acquire any such shares, voting securities or equity interest or any “phantom” stock, “phantom” stock rights, stock appreciation rights or stock-based performance units, or take any action to cause to be exercisable or vested any otherwise unexercisable or unvested Braze equity award under any existing Braze Equity Plan (except pursuant to the express terms of any Braze equity award), other than (a) issuances of Class A Common Stock in respect of any exercise of Braze Options outstanding on October 19, 2026 or the vesting and settlement of Braze equity awards outstanding on such date, in all cases in accordance with their respective terms as of such date, (b) issuances of shares of Class A Common Stock pursuant to the exercise of Braze Options if necessary to effectuate an optionee direction upon exercise or pursuant to the settlement of Braze equity awards in order to satisfy tax withholding obligations, (c) issuances of Class A Common Stock in respect of any options outstanding under the Braze ESPP in respect of any current offering periods or granted under any future offering periods under the Braze ESPP or (d) transactions solely between Braze and a wholly owned subsidiary of Braze or solely between wholly owned subsidiaries of Braze;
•
take any action to cause to be exercisable or vested any otherwise unexercisable or unvested Braze equity award under any existing Braze equity plan (except pursuant to the express terms of any Braze equity award), other than (a) issuances of Class A Common Stock in respect of any exercise of Braze options outstanding on October 19, 2026 or the vesting and settlement of Braze equity awards outstanding on October 19, 2026, in all cases in accordance with their respective terms as of October 19, 2026, (b) issuance of shares of Class A Common Stock pursuant to the exercise of Braze options if necessary to effectuate an optionee direction upon exercise or pursuant to the settlement of Braze equity awards in order to satisfy tax withholding obligations, (c) issuances of Class A Common Stock in respect of any options outstanding under the ESPP in respect of any current ESPP offering periods or granted under any future ESPP offering periods or (d) transactions solely between Braze and a wholly owned subsidiary or solely between wholly owned Braze subsidiaries;
•
except as required by any Braze employee benefit plan or other benefit or compensation plan, policy, program, agreement or arrangement in existence as of October 19, 2026, (a) increase or commit to
73

TABLE OF CONTENTS

increase the compensation, bonus, incentive compensation, severance, termination pay or other benefits payable or to become payable to any of its directors, officers, employees or individual independent contractors, (b) pay, grant or award, or commit to pay, grant or award, any bonuses, retention or incentive compensation, including any Braze equity awards, to any of its directors, officers, employees or individual independent contractors, (c) establish, adopt, enter into, amend or terminate any collective bargaining agreement or Braze benefit plan (or any arrangement that would be a Braze benefit plan if in effect on October 19, 2026), except for (x) amendments to health and welfare plans in the ordinary course of business consistent with past practice that do not contravene the other restrictions described in this bullet and do not materially increase the cost to Braze of maintaining such plan or the benefits provided thereunder and (y) entry into at-will offer letters that do not provide for severance or change-in-control (or similar) entitlements, (d) take any action to amend or waive any performance or vesting criteria or accelerate vesting, exercisability or funding under any Braze benefit plan, (e) make any contributions or payments to any rabbi trust or other funding vehicle with respect to any Braze benefit plan, (f) change any actuarial or other assumptions used to calculate funding obligations with respect to any Braze benefit plan or change the manner in which such contributions are determined, except as may be required by GAAP, (g) loan or advance money or other property to any director, officer, employee or individual independent contractor (other than advances for reimbursable employee expenses in the ordinary course of business consistent with past practice and in accordance with Braze’s expense reimbursement policies), (h) terminate the employment of any employee at the level of Vice President or above, other than for cause, (i) promote any employee to the level of Vice President or above, or hire any new employee or engage any individual independent contractor, (j) enter into, materially amend, renegotiate, renew or extend any contract or relationship with a professional employer organization, employer-of-record or similar arrangement, (k) form or otherwise establish any employing entity in any country that does not currently have an employing entity, or (l) waive, release or limit the scope of any restrictive covenant or similar post-termination obligation by which any current or former director, officer, employee or individual independent contractor is bound;
•
acquire (including by merger, consolidation or acquisition of stock or assets or any other means), authorize or announce an intention to acquire, or enter into any agreements providing for any acquisitions of, any equity interests in or assets of any person or any business or division thereof, or otherwise engage in any mergers, consolidations or business combinations, except for (a) transactions solely between Braze and a wholly owned subsidiary or solely between wholly owned Braze subsidiaries, (b) acquisitions of supplies or equipment in the ordinary course of business consistent with past practice or (c) transactions involving an amount up to $15,000,000 of cash consideration in the aggregate that would not reasonably be expected to materially delay, impede or prevent the consummation of the Transactions on or before the Outside Date;
•
merge or consolidate Braze or any Braze subsidiary with any person or liquidate (completely or partially), dissolve, restructure, recapitalize or effect any other reorganization (including any restructuring, recapitalization or reorganization between or among any of Braze and/or Braze subsidiaries), or adopt any plan or resolution providing for any of the foregoing;
•
make any loans, advances or capital contributions to, or investments in, any other person, except for (a) loans solely among Braze and its wholly owned subsidiaries or solely among Braze’s wholly owned subsidiaries, (b) advances for reimbursable employee expenses, in the ordinary course of business consistent with past practice or pursuant to any advancement obligations under Braze’s governing documents or indemnification agreements with directors or officers of Braze or its subsidiaries in existence on October 19, 2026, or (c) capital contributions to or investments in wholly owned Braze subsidiaries;
•
sell, lease, license, assign, abandon, permit to lapse, transfer, exchange, swap or otherwise dispose of any of Braze’s material properties, rights or assets (including shares in the capital of Braze or its subsidiaries), subject to any lien (other than certain permitted liens as set forth in the Merger Agreement), any of its material properties, rights or assets (including shares of Braze or its subsidiaries) or enter into any contract requiring any of the foregoing, except (a) dispositions of obsolete or worthless equipment, in the ordinary course of business consistent with past practice, (b) non-exclusive licenses of Braze’s intellectual property
74

TABLE OF CONTENTS

entered into in the ordinary course of business consistent with past practice with customers or resellers of Braze or its subsidiaries in connection with Braze products, and (c) pursuant to transactions solely among Braze and its wholly owned subsidiaries or solely among its wholly owned subsidiaries;
•
terminate or materially amend or modify any written policies or procedures with respect to (a) the use or distribution by Braze or any of its subsidiaries of any open source software or (b) the use by or for Braze or any of its subsidiaries of AI systems, except to comply with applicable law;
•
(a) enter into certain specified types of material contracts (as set forth in the Merger Agreement) or (b) (1) materially (x) modify, (y) amend, (z) extend or terminate such material contracts (other than renewals and non-renewals, and other than certain vendor or service provider contracts, in each case occurring in the ordinary course of business consistent with past practice), or (2) waive, release or assign any material (x) rights or (y) claims thereunder, in the case of this clause (2), other than in the ordinary course of business consistent with past practice;
•
except in accordance with Braze’s capital budget provided to Salesforce on October 19, 2026, make any capital expenditure or expenditures, enter into agreements or arrangements providing for capital expenditure or expenditures or otherwise commit to do so;
•
commence (other than any collection action in the ordinary course of business consistent with past practice), waive, release, assign, compromise or settle any threatened or pending claim, litigation, investigation or proceeding (for the avoidance of doubt, including with respect to matters in which Braze or any of its subsidiaries is a plaintiff, or in which any of their officers or directors in their capacities as such are parties), other than the compromise or settlement of any claim, litigation or proceeding that is not brought by governmental entities and that (a) is for an amount not to exceed, for any such compromise or settlement individually, $1,000,000, or in the aggregate, $2,000,000, (b) does not impose any injunctive relief on Braze and its subsidiaries and does not involve the admission of wrongdoing by Braze, any of its subsidiaries or any of their respective officers or directors or otherwise establish a materially adverse precedent for similar settlements by Salesforce or any of its subsidiaries (including, following the Effective Time, Braze and its subsidiaries) and (c) does not provide for the license of any intellectual property or the termination, modification or amendment of any license of intellectual property;
•
change Braze’s fiscal year or make any change in financial accounting policies, practices, principles or procedures or any of its methods of reporting income, deductions or other material items for financial accounting purposes, except as required by GAAP or Regulation S-X;
•
amend or modify in any material respect any privacy statement of Braze or any of its subsidiaries;
•
(a) make, change or revoke any material tax election, other than in the ordinary course of business consistent with past practice (b) adopt or change any annual tax accounting period or material method of tax accounting, (c) amend any material tax return, (d) except as required by law, file any material tax return that is inconsistent in any material respect with a previously filed material tax return of the same type, (e) settle or compromise any material tax audit, claim or proceeding for an amount in excess of the amount accrued or reserved therefor in Braze SEC Documents (plus interest), (f) enter into any material closing agreement (or any similar provision of state, local or non-U.S. law) or advance pricing arrangement with any tax authority, (g) surrender any right to claim a material tax refund, (h) request a private letter ruling or comparable ruling from any tax authority with respect to a material amount of taxes, or (i) agree to an extension or waiver of the statute of limitations with respect to a material amount of taxes (other than automatic extensions of time to file tax returns);
•
redeem, repurchase, repay, prepay, defease, incur, assume, endorse, guarantee or otherwise become liable for or modify in any material respect the terms of any indebtedness or any derivative financial instruments or arrangements (including swaps, caps, floors, futures, forward contracts and option agreements), or issue or sell any debt securities or calls, options, warrants or other rights to acquire any debt securities (directly, contingently or otherwise), in each case except for the incurrence and repayment of any indebtedness solely among Braze and its wholly owned subsidiaries or solely among wholly owned Braze subsidiaries, in each case in the ordinary course of business;
•
enter into any transactions or contracts with any affiliate or other person that would be required to be disclosed by Braze under Item 404 of Regulation S-K of the SEC;
75

TABLE OF CONTENTS

•
fail to use commercially reasonable efforts to maintain Braze’s insurance policies or comparable replacement policies with respect to the material assets, operations and activities of Braze and its subsidiaries;
•
(a) (i) acquire any real property or (ii) enter into any lease or sublease of real property (whether as a lessor, sublessor, lessee or sublessee) that if in existence as of October 19, 2026 would constitute a material contract, (b) materially modify or amend or exercise any right to renew any Braze lease (other than entering into an amendment or extension agreement to extend the term of a Braze lease in accordance with its terms), or waive any material term or condition thereof or grant any material consents thereunder, or (c) grant or otherwise knowingly create or consent to the creation of any material easement, covenant, restriction, assessment or charge affecting any real property leased by Braze, or any interest therein or part thereof, other than certain permitted liens, in the case of each of clauses (b) and (c), other than in the ordinary course of business consistent with past practice;
•
other than the Special Meeting, convene any special meeting (or any adjournment, postponement or continuation thereof) of Braze stockholders;
•
other than in the ordinary course of business consistent with past practice, abandon, withdraw, suspend, abrogate, terminate or modify, amend or waive in any material respect any right under any material Braze permit;
•
adopt or otherwise implement any stockholder rights plan, “poison pill” or other comparable agreement;
•
forgive any material loans or advances to any officers, employees, directors or other individual service providers of Braze or any of its subsidiaries, or any of their respective affiliates, or change their respective existing borrowing or lending arrangements for or on behalf of any of such persons in accordance with an employee benefit plan or otherwise, except in the ordinary course of business consistent with past practice in connection with (a) relocation activities to any employees of Braze or its subsidiaries or (b) expense or indemnification reimbursement pursuant to any advancement obligations under the Braze governing documents or indemnification agreements with directors or officers of Braze or its subsidiaries in existence on October 19, 2026;
•
use or make available any high-risk AI systems or engage in activities that are “unacceptable” or “prohibited” under the European Union Artificial Intelligence Act (or that are subject to a similar designation under applicable law in other jurisdictions); or
•
agree, commit or authorize, in writing or otherwise, or announce an intention, to take any of the foregoing actions.
No Solicitation of Other Offers by Braze
Under the terms of the Merger Agreement, subject to certain exceptions described below, Braze has agreed that, from October 19, 2026 until the earlier of the Effective Time or the date (if any) on which the Merger Agreement is terminated, Braze will not, and will cause its subsidiaries and its and their respective officers and directors not to, and Braze will use its reasonable best efforts to cause its and its subsidiaries’ other representatives not to, directly or indirectly:
(a)
solicit, initiate or knowingly encourage or facilitate (including by way of providing information or taking any other action) any inquiry, proposal or offer, or the making, submission or announcement of any inquiry, proposal or offer which constitutes or would reasonably be expected to lead to an acquisition proposal;
(b)
participate in any negotiations regarding, or provide to any person any information relating to Braze or any of its subsidiaries in connection with, an actual or potential acquisition proposal;
(c)
adopt, approve, endorse or recommend, or propose to adopt, approve, endorse or recommend, any acquisition proposal;
(d)
withdraw, change, amend, modify or qualify, or otherwise propose to withdraw, change, amend, modify or qualify, in a manner adverse to Salesforce, the Braze Board Recommendation, or resolve or agree to take any such action;
76

TABLE OF CONTENTS

(e)
if an acquisition proposal has been publicly disclosed, fail to publicly recommend against any such acquisition proposal and reaffirm the Braze Board Recommendation within 10 business days (or, if earlier, by the second business day prior to the Special Meeting) after the public disclosure of such acquisition proposal (or subsequently withdraw, change, amend, modify or qualify, in a manner adverse to Salesforce, such rejection of such acquisition proposal) (provided that Braze will not be required to reaffirm more than once per acquisition proposal unless the terms of such acquisition proposal change in any material respect and such change is publicly announced or disclosed);
(f)
include any adverse amendment, withdrawal, alteration, modification or qualification of the Braze Board Recommendation in this proxy statement or any other legally required disclosure to Braze stockholders with regard to an acquisition proposal;
(g)
approve, or authorize, or cause or permit Braze or any of its subsidiaries to enter into, any merger agreement, acquisition agreement, reorganization agreement, letter of intent, memorandum of understanding, agreement in principle, option agreement, joint venture agreement, partnership agreement or similar agreement or document with respect to, or any other agreement or commitment providing for, any acquisition proposal (other than certain confidentiality agreements, as set forth in the Merger Agreement);
(h)
call or convene a meeting of Braze stockholders to consider a proposal that would reasonably be expected to materially impair, prevent or delay the consummation of the Transactions; or
(i)
resolve or agree to do any of the foregoing.
We refer to each action set forth in clauses (c), (d), (e), (f), (g), (h) and (i) (to the extent clause (i) is related to the foregoing clauses (c), (d), (e), (f), (g) or (h)) above as a “change of recommendation.”
In addition, under the Merger Agreement, Braze has agreed that:
•
it will and will cause its subsidiaries, and its and their respective officers and directors to, and Braze will use its reasonable best efforts to cause its and its subsidiaries’ other representatives to, immediately cease any and all solicitations, encouragements, discussions or negotiations with any persons, or provision of any information to any persons, with respect to any inquiry, proposal or offer that constitutes, or would reasonably be expected to lead to, an acquisition proposal;
•
it will promptly, and in any event within two business days following October 19, 2026, request in writing that each person that had previously executed a confidentiality agreement with Braze in connection with its consideration of an acquisition proposal or a potential acquisition proposal promptly destroy or return to Braze all nonpublic information provided by Braze or any of its representatives to such person or any of its representatives in accordance with the terms of such confidentiality agreement; and
•
it will, within the same two-business-day period, terminate access to any physical or electronic data rooms relating to a possible acquisition proposal by such person and its representatives.
Under the Merger Agreement, Braze must enforce, and not waive, terminate or modify without Salesforce’s prior written consent, any confidentiality, standstill or similar provision in any confidentiality, standstill or other agreement. However, if the Braze Board of Directors determines in good faith after consultation with Braze’s outside legal counsel that the failure to waive a particular standstill provision would be reasonably likely to violate the directors’ fiduciary duties under applicable law, Braze may, with prior written notice to Salesforce, waive such standstill solely to the extent necessary to permit the applicable person (if it has not been solicited in violation of the Merger Agreement) to make, on a confidential basis to the Braze Board of Directors, an acquisition proposal, conditioned upon such person agreeing to disclosure of such acquisition proposal to Salesforce, in each case as contemplated by the Merger Agreement.
Notwithstanding the prohibitions described above, if Braze receives, prior to the time the Braze stockholder approval is obtained, an unsolicited bona fide written acquisition proposal that did not result from a breach of Braze’s non-solicitation obligations under the Merger Agreement, then Braze, its subsidiaries and its representatives are permitted to contact the person or any of its representatives who has made such acquisition proposal solely to clarify (and not to negotiate or engage in any discussions regarding or relating to) the material terms and conditions of such acquisition proposal so that Braze may determine whether such acquisition proposal constitutes or would
77

TABLE OF CONTENTS

reasonably be expected to result in a superior proposal. For the avoidance of doubt, breaches of the prohibitions described above by any Braze subsidiary, any director or officer of Braze or any Braze subsidiary or any other representative acting on behalf or at the direction of Braze or any Braze subsidiary are considered breaches by Braze itself.
Additionally, if prior to the time the Braze stockholder approval is obtained, Braze receives an unsolicited bona fide written acquisition proposal that did not result from a breach of Braze’s non-solicitation obligations under the Merger Agreement, Braze may provide nonpublic information to the person making such acquisition proposal and its representatives and engage in discussions or negotiations with such person with respect to the acquisition proposal, as long as:
•
the Braze Board of Directors determines in good faith, after consultation with Braze’s outside legal counsel and financial advisors, that such proposal constitutes, or would reasonably be expected to result in, a superior proposal and that the failure to take such action would be reasonably likely to violate the directors’ fiduciary duties under applicable law;
•
prior to providing any such nonpublic information, the person making the acquisition proposal enters into a confidentiality agreement that contains terms that are no less favorable in the aggregate to Braze than those contained in the confidentiality agreement between Salesforce and Braze , so long as the confidentiality agreement does not in any way restrict Braze or its representatives from complying with its disclosure obligations under the Merger Agreement; and
•
Braze also provides Salesforce, prior to or substantially concurrently with the time such information is provided or made available to such person, that same nonpublic information (if not previously provided to Salesforce).
Under the Merger Agreement, Braze will notify Salesforce promptly (and in any event within 24 hours) of Braze’s or any of Braze’s controlled affiliates’ or its or their respective representatives’ receipt of any acquisition proposal, any proposals or inquiries that would reasonably be expected to lead to an acquisition proposal, or any inquiry or request for nonpublic information relating to Braze or any of its subsidiaries by any person who has made or would reasonably be expected to make any acquisition proposal. The notice must include the identity of the person making the acquisition proposal, inquiry or request, and the material terms and conditions of any such proposal or offer, or the nature of the information requested pursuant to any such inquiry or request, including unredacted copies of all written requests, proposals, correspondence or offers (including any proposed agreements received by Braze or its representatives relating to such acquisition proposal) or, if such acquisition proposal is not in writing, a reasonably detailed written description of the material terms and conditions thereof. Without limiting the foregoing, Braze must keep Salesforce reasonably informed on a prompt and timely basis of the status and material terms (including any amendments or proposed amendments to such material terms) of any acquisition proposal or potential acquisition proposal, and as to the nature of any information requested of Braze with respect thereto, and must promptly (and in any event within 24 hours) provide to Salesforce copies of all proposals, offers and proposed agreements relating to an acquisition proposal received by Braze or its representatives or, if such information or communication is not in writing, a reasonably detailed written description of the material contents thereof. Without limiting the foregoing, Braze also must promptly provide (and in any event within 24 hours) Salesforce with any material nonpublic information concerning Braze provided to any other person in connection with any acquisition proposal that was not previously provided to Salesforce. Without limiting the foregoing, Braze will promptly (and in any event within 24 hours after such determination) inform Salesforce in writing if Braze determines to begin providing information or to engage in discussions or negotiations concerning an acquisition proposal to the extent otherwise permitted by the Merger Agreement.
An “acquisition proposal” for purposes of the Merger Agreement means any offer, proposal or indication of interest from any person or entity, other than a proposal or offer by Salesforce or a subsidiary of Salesforce, at any time relating to any transaction or series of related transactions (other than the Transactions) involving:
•
any acquisition or purchase by any person, directly or indirectly, of more than 15% of any class of outstanding Braze voting or equity securities (whether by voting power or number of shares);
•
any tender offer (including a self-tender offer) or exchange offer that, if consummated, would result in any person beneficially owning more than 15% of any class of outstanding Braze voting or equity securities (whether by voting power or number of shares);
78

TABLE OF CONTENTS

•
any merger, consolidation, share exchange, business combination, joint venture, recapitalization, reorganization or other similar transaction involving Braze and a person pursuant to which Braze stockholders immediately preceding such transaction hold less than 85% of the equity interests in the surviving, resulting or ultimate parent entity of such transaction (whether by voting power or number of shares); or
•
any sale, lease, exchange, transfer or other disposition to a person of more than 15% of the consolidated assets of Braze and its subsidiaries (measured by the fair market value thereof).
A “superior proposal” for purposes of the Merger Agreement means a bona fide, unsolicited written acquisition proposal made by a third party, which the Braze Board of Directors determines in good faith, after consultation with Braze’s outside legal counsel and financial advisors, to be more favorable to Braze stockholders from a financial point of view than the Merger, taking into account all relevant factors, including all terms and conditions of such proposal or offer (including the transaction consideration, conditionality, timing, certainty of financing and/or regulatory approvals and likelihood of consummation) and the Merger Agreement (and, if applicable, any changes to the terms of the Merger Agreement proposed by Salesforce as permitted by the Merger Agreement). When determining whether an offer constitutes a superior proposal, references in the definition of the term “acquisition proposal” to “15%” and “85%” will be replaced with references to “80%” and “20%,” respectively.
Braze Special Meeting and Board Recommendation
The Merger Agreement requires Braze to (a) as soon as reasonably practicable after the date of the Merger Agreement, duly call, give notice of, convene (and use its reasonable best efforts to cause such meeting to be held no later than 45 days following the date on which Braze learns that this proxy statement will not be reviewed or that the SEC staff has no further comments thereon) and hold a meeting of its stockholders for the purpose of seeking the Braze stockholder approval, (b) submit the Merger Agreement Proposal to its stockholders at such meeting and (c) not submit any other proposal in connection with such meeting (other than the Merger-Related Compensation Proposal and the Adjournment Proposal) without the prior written consent of Salesforce. Braze has also agreed to prepare and file this proxy statement in preliminary form with the SEC as promptly as reasonably practicable after the date of the Merger Agreement (and to use its reasonable best efforts to cause such filing to occur no later than 35 days following the execution of the Merger Agreement), to conduct a “broker search” in accordance with Rule 14a-13 under the Exchange Act as promptly as reasonably practicable after the date of the Merger Agreement and to provide Salesforce with periodic updates concerning proxy solicitation results (including, if requested, daily voting reports in the last seven days prior to the special meeting). Braze is only entitled to adjourn or postpone the special meeting without Salesforce’s consent (x) after consultation with Salesforce, to the extent necessary to ensure that any supplement or amendment to this proxy statement required by law is provided to stockholders within a reasonable amount of time in advance of the special meeting, or (y) if there are not sufficient affirmative votes at such meeting to constitute a quorum or to obtain the Braze stockholder approval (to allow reasonable additional time for solicitation of proxies), subject to a limit of one such adjournment, postponement or continuation, for a period of no more than 10 business days, that does not require a change to the record date. In addition, Salesforce has the right to require Braze to effect one adjournment, postponement or continuation for a period of up to 10 business days under the circumstances described in the foregoing clause (y) so long as no resulting change in the record date would be required.
Braze will use its reasonable best efforts to (A) solicit from the Braze stockholders proxies in favor of the adoption of the Merger Agreement and approval of the Transactions, including the Merger, and (B) take all other action necessary or advisable to secure the Braze stockholder approval, including, unless the Braze Board of Directors has validly made a change of recommendation in accordance with the terms of the Merger Agreement, communicating the Braze Board Recommendation to Braze stockholders and including the Braze Board Recommendation in this proxy statement.
Even if a change of recommendation has been made pursuant to the terms of the Merger Agreement, unless the Merger Agreement has been terminated in accordance with its terms, the special meeting will be convened and the Merger Agreement will be submitted to the Braze stockholders for approval at the special meeting, and the obligations of the parties under the Merger Agreement will continue in full force and effect and will not be affected by the commencement, public proposal, public disclosure or communication to Braze of any acquisition proposal (whether or not a superior proposal), as defined above under the section titled “The Merger Agreement—No Solicitation of Other Offers by Braze.”
79

TABLE OF CONTENTS

Change of Recommendation; Match Rights
At any time prior to the time the Braze stockholder approval is obtained, the Braze Board of Directors may (i) make a change of recommendation in response to an intervening event (as defined below) if the Braze Board of Directors has determined in good faith, after consultation with Braze’s outside legal counsel and financial advisors, that the failure to take such action would be reasonably likely to violate the directors’ fiduciary duties under applicable law, or (ii) make a change of recommendation and cause Braze to terminate the Merger Agreement in order to enter into a definitive agreement providing for an unsolicited acquisition proposal received after the date of the Merger Agreement (which did not result from a breach of Braze’s non-solicitation obligations and is not withdrawn) if the Braze Board of Directors determines in good faith, after consultation with Braze’s outside legal counsel and financial advisors, that such acquisition proposal constitutes a superior proposal and that the failure to take such action would be reasonably likely to violate the directors’ fiduciary duties under applicable law (subject to payment by Braze to Salesforce of the termination fee described under the section titled “The Merger Agreement—Termination Fee”). Braze may not enter into any definitive agreement providing for an acquisition proposal unless the Merger Agreement has been validly terminated in accordance with its terms.
An “intervening event” means any change, effect, development, circumstance, condition, state of facts, event or occurrence that is material to Braze and its subsidiaries (taken as a whole) and was not known by or reasonably foreseeable to the Braze Board of Directors as of or prior to the date of the Merger Agreement, except that none of the following will constitute an intervening event: (A) the receipt, existence or terms of an acquisition proposal or any inquiry or communications relating thereto or any matter relating thereto or consequence thereof, (B) changes in the market price or trading volume of the Class A Common Stock or any other securities of Braze or its subsidiaries, or any change in credit rating or the fact that Braze meets or exceeds internal or published estimates, projections, forecasts or predictions for any period, (C) changes in general economic, political or financial conditions or markets (including changes in interest rates, exchange rates, stock, bond and/or debt prices), (D) changes in GAAP, other applicable accounting rules or applicable law or, in any such case, changes in the interpretation thereof or (E) natural disasters, epidemics or pandemics.
Prior to making a change of recommendation as permitted by the Merger Agreement and as described above, Braze must provide Salesforce with four business days’ prior written notice (which period will expire at 11:59 p.m., Pacific Time, on the fourth business day) advising Salesforce that the Braze Board of Directors intends to take such action and specifying, in the case of a change of recommendation in response to an intervening event, in reasonable detail, the reasons therefor, and in the case of a change of recommendation due to a superior proposal, the material terms and conditions of the acquisition proposal (including a copy of any proposed definitive documentation). During such four business day period, Braze must cause its representatives (including its executive officers) to negotiate in good faith (to the extent Salesforce desires to negotiate) any proposal by Salesforce to amend the terms and conditions of the Merger Agreement in a manner that would obviate the need to effect such change of recommendation or such that such acquisition proposal would no longer constitute a superior proposal, as applicable, and the Braze Board of Directors must make the required determination again at the end of such four business day period (after taking into account in good faith any amendments to the Merger Agreement proposed by Salesforce). With respect to a superior proposal, if there is any material amendment, revision or change to the terms of such superior proposal (including any revision to the amount, form or mix of consideration Braze stockholders would receive as a result of such superior proposal), Braze must notify Salesforce of each such amendment, revision or change and the applicable four business day period will be extended until at least three business days after the time that Salesforce receives notification of such revision.
Nothing in the Merger Agreement prohibits Braze or the Braze Board of Directors from (a) disclosing to Braze stockholders a position contemplated by Rules 14d-9 and 14e-2(a) promulgated under the Exchange Act, (b) making any “stop, look and listen” communication to Braze stockholders pursuant to Rule 14d-9(f) promulgated under the Exchange Act, or (c) making any legally required disclosure to Braze stockholders with regard to an acquisition proposal, which actions will not constitute a change of recommendation so long as any such disclosure (x) includes an express reaffirmation, and does not include any adverse amendment, withdrawal, alteration, modification or qualification, of the Braze Board Recommendation and (y) does not include any statement that constitutes, and does not otherwise constitute, a change of recommendation under the Merger Agreement. A factually accurate statement by Braze or the Braze Board of Directors that confirms the receipt of an acquisition proposal and that no position has been taken as to the advisability or desirability of such acquisition proposal will not constitute a change of recommendation, unless such statement has the substantive effect of withdrawing, qualifying or modifying the Braze Board Recommendation and does not expressly reaffirm the Braze Board Recommendation.
80

TABLE OF CONTENTS

Access
From October 19, 2026 until the earlier of the Effective Time or the date (if any) on which the Merger Agreement is terminated, to the extent permitted by applicable law, Braze will give, and will cause each of its subsidiaries to give, Salesforce and its representatives reasonable access during normal business hours and upon reasonable advance notice to Braze’s and its subsidiaries’ offices, properties, contracts, personnel, books and records (so long as such access does not unreasonably interfere with Braze’s business). During such period, Braze will, and will cause each of its subsidiaries to, provide as promptly as practicable to Salesforce all information concerning Braze’s business, properties, offices, contracts and personnel as Salesforce reasonably requests, solely for purposes of consummating the Transactions and for reasonable transition and integration planning. However, Braze is not required to provide access to or to disclose information:
•
that is prohibited from being disclosed pursuant to the terms of a confidentiality agreement with, or contractual obligations to, a third party entered into prior to October 19, 2026 or after such date in the ordinary course of business consistent with past practice; provided, that at Salesforce’s written request, Braze will use commercially reasonable efforts to obtain the consent of such third party to such access or disclosure, or to make appropriate substitute arrangements to permit reasonable access or disclosure not in violation of such restrictions;
•
the disclosure of which, in the reasonable good-faith judgment of Braze after consultation with legal counsel, would violate applicable law; provided, that Braze will use its commercially reasonable efforts to make appropriate substitute arrangements to permit reasonable disclosure not in violation of such law; or
•
the disclosure of which, in the reasonable good-faith judgment of Braze after consultation with legal counsel, would cause the loss of any attorney-client, attorney work product or other legal privilege; provided, that Braze will use its commercially reasonable efforts to allow for such access or disclosure to the maximum extent that such access or disclosure would not jeopardize attorney-client, attorney work product or other legal privilege.
Notwithstanding the foregoing, Braze may, as it deems advisable and necessary, reasonably designate any competitively sensitive information provided to Salesforce and Salesforce’s representatives as “outside counsel only,” and any such materials designated as “outside counsel only” and the information contained therein shall be given only to outside counsel of Salesforce and will not be disclosed by such outside counsel to employees, officers or directors of Salesforce and its affiliates unless advance, express permission is given by Braze.
Treatment of Indebtedness
The Merger Agreement requires Braze and its subsidiaries to deliver all notices and take all other actions within its or their sole control required to facilitate, at or prior to the Effective Time, the termination of all commitments, if any, under a potential new credit agreement that Braze is permitted to enter into after the date of the Merger Agreement and prior to the Closing Date, the repayment in full of all obligations outstanding thereunder and the release of any guarantees in connection therewith. Such termination, repayment and releases is referred to as the “credit facility termination.” If and only if any such indebtedness exists, Braze must use reasonable best efforts to deliver to Salesforce a draft payoff letter (and, if applicable, draft related guarantee release documentation) at least three business days prior to the Closing Date and an executed payoff letter (and, if applicable, executed related guarantee release documentation) at least one business day prior to the Closing Date.
The Merger Agreement does not require Braze or any Braze subsidiaries to cause the credit facility termination to be effective unless and until the Effective Time has occurred and Salesforce has provided or caused to be provided to Braze or its subsidiaries funds (or Salesforce has directed Braze or any of its subsidiaries to use funds on their balance sheets) to pay in full the then-outstanding principal amount of and accrued and unpaid interest and fees with respect to such indebtedness. At Salesforce’s request, Braze will, and will cause its subsidiaries to, make its and their available cash available to be used on the Closing Date to fund any payments with respect to such indebtedness designated by Salesforce to be made on or after such date.
81

TABLE OF CONTENTS

HSR and Other Regulatory Approvals
Under the Merger Agreement, Salesforce and Braze are each required to use reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable law to consummate the Transactions, including the Merger, as soon as practicable, including:
•
preparing and filing or otherwise providing, in consultation with the other party and as promptly as practicable and advisable, all documentation to effect all necessary applications, notices, petitions, filings, and other documents and to obtain as promptly as reasonably practicable all waiting period expirations or terminations, consents, clearances, waivers, licenses, orders, registrations, approvals, permits and authorizations necessary or advisable to be obtained from any governmental entity and/or any third party in order to consummate the Transactions, including the Merger; and
•
taking all actions and steps as may be necessary, subject to the limitations in the Merger Agreement, to obtain (and cooperating with each other in obtaining) all such waiting period expirations or terminations, consents, clearances, waivers, licenses, registrations, permits, authorizations, orders and approvals, including defending through litigation on the merits any claim asserted in court by any governmental entity of the federal government of the United States under the HSR Act, the Sherman Act, the Clayton Act and the Federal Trade Commission Act, in each case, as amended, to avoid entry of, or to have vacated or terminated, any decree, order or judgment (whether temporary, preliminary or permanent) that would prevent the Closing from occurring prior to the Outside Date.
Further, Salesforce and Braze each agree to:
•
make an appropriate filing of a Notification and Report Form pursuant to the HSR Act with respect to the Transactions as promptly as practicable, and in any event within 20 business days after the execution of the Merger Agreement, unless a later date is mutually agreed between the parties, and supply as promptly as reasonably practicable and advisable any additional information and documentary materials that may be requested pursuant to the HSR Act, and take all other actions necessary to cause the expiration or termination of the applicable waiting periods under the HSR Act as soon as reasonably practicable; and
•
make all other necessary or advisable filings as promptly as reasonably practicable, and supply as promptly as reasonably practicable and advisable any additional information and documentary materials that may be requested under any other applicable regulatory laws.
In furtherance and not in limitation of the foregoing, if and to the extent necessary to obtain clearance of the Merger pursuant to the HSR Act and any other regulatory laws of the jurisdictions contemplated by the Merger Agreement, (1) Salesforce, Banff Acquisition Sub and their respective subsidiaries will (and will direct Braze and its subsidiaries to) and (2) Braze and its subsidiaries will, solely to the extent directed by Salesforce, offer, negotiate, commit to and effect, by consent decree, hold separate order or otherwise, any requirement, condition, limitation, understanding, agreement or order to (A) sell, license, assign, transfer, divest, hold separate or otherwise dispose of any assets, business or portion of business of Braze or any Braze subsidiary, (B) conduct, restrict, operate, invest or otherwise change the assets, the business or portion of the business of Braze or any Braze subsidiary in any manner, or (C) impose any restriction, requirement or limitation on the operation of the business or portion of the business of Braze or any Braze subsidiary. Notwithstanding anything in the Merger Agreement to the contrary, Salesforce, Braze and their respective subsidiaries will not be required, either pursuant to the Merger Agreement or otherwise, to offer, negotiate, commit to, effect or otherwise take any action that would reasonably be expected to, individually or in the aggregate, (x) impact Salesforce, Braze or their respective subsidiaries in an adverse manner or amount that is material relative to the value of Braze and its subsidiaries, taken as a whole, (y) have any impact on any asset, business (or portions thereof), product lines or product of Salesforce or any Salesforce subsidiary (excluding any asset, business (or portions thereof), product lines or product of Braze and its subsidiaries) or (z) materially reduce the reasonably anticipated benefits to Salesforce and its subsidiaries, taken as a whole (including anticipated synergies), of the Transactions. However, if requested by Salesforce, Braze and its subsidiaries will become subject to, consent to or offer or agree to, and otherwise take any action with respect to, any requirement, condition, limitation, understanding, agreement or order so long as such requirement, condition, limitation, understanding, agreement or order is only binding on Braze or its subsidiaries in the event the Closing occurs. In no event will Salesforce, Braze or their respective subsidiaries be required to propose, negotiate, commit to or effect any action with respect to any such requirement, condition, limitation, understanding, agreement or order unless such action is conditioned upon the consummation of the Merger and does not take effect until the Effective Time.
82

TABLE OF CONTENTS

Under the Merger Agreement, in connection with and without limiting the efforts referenced above to obtain all waiting period expirations or terminations, consents, clearances, waivers, licenses, orders, registrations, approvals, permits and authorizations for the Transactions under the HSR Act or any other regulatory laws to the extent not prohibited by applicable law, Salesforce and Braze each also agree to:
•
cooperate in all respects and consult with each other in connection with any filing or submission and in connection with any investigation or other inquiry, including any proceeding initiated by a private party, including by allowing the other party to have a reasonable opportunity to review in advance and comment on drafts of filings and submissions and reasonably considering in good faith comments of the other party;
•
provide the other party with such necessary information and reasonable assistance as the other party may reasonably request in connection with its preparation of necessary filings or submissions of information to any governmental entity;
•
promptly inform the other party of any communication with the Antitrust Division of the U.S. Department of Justice (referred to as the “DOJ”), the U.S. Federal Trade Commission (referred to as the “FTC”) or any other governmental entity, by promptly providing copies to the other party of any such written communications (or, in the case of oral communications, advise the other party of such communications), and of any communication received or given in connection with any proceeding by a private party, in each case regarding any of the Transactions; and
•
permit the other party to review in advance any communication that it gives to, and consult with each other in advance of any meeting, substantive telephone call or conference with, the DOJ, the FTC or any other applicable governmental entity, or, in connection with any proceeding by a private party, with any other person, and to the extent permitted by the DOJ, the FTC or other applicable governmental entity or other person, give the other party the opportunity to attend and participate in any in-person meetings, substantive telephone calls or conferences with the DOJ, the FTC or any other governmental entity or other person.
Notwithstanding anything in the Merger Agreement to the contrary, but without limiting Salesforce’s and Banff Acquisition Sub’s obligations set forth in the Merger Agreement, Salesforce will, on behalf of the parties, control and direct all communications and strategy in dealing with any governmental entity under the HSR Act or other regulatory laws; provided, that Salesforce will consider in good faith the views and comments of Braze and its outside counsel with respect to such communications and strategies. After consultation with Braze and its outside counsel, Salesforce may, without Braze’s consent, voluntarily withdraw its HSR Act notification on one occasion during the initial waiting period, so long as Salesforce refiles its HSR Act notification within two business days after such withdrawal (unless otherwise agreed by the parties).
Employee Matters
Salesforce has agreed to assume, honor and fulfill all Braze benefit plans in accordance with their terms as in effect immediately prior to the Closing (if in effect as of the date of the Merger Agreement or amended, adopted, entered into or terminated prior to the Closing as permitted by such plans and the Merger Agreement), and has acknowledged that a “change in control” (or similar phrase) within the meaning of each Braze benefit plan containing change in control provisions will occur as of the Effective Time.
For a period of 12 months following the Effective Time, Salesforce has agreed to provide each employee of Braze and its subsidiaries who continues to be employed by Salesforce or any of its subsidiaries (each referred to as a “Continuing Employee”) (i) on-target earnings, consisting of base pay or wage rate, as applicable, and target incentive cash compensation opportunities, that are, in the aggregate, no less favorable than those in effect for such Continuing Employee immediately prior to the Closing (provided that such Continuing Employee’s base pay or wage rate during such 12-month period will be no less than that in effect immediately prior to the Closing), (ii) other employee benefits, including retirement and health and welfare benefits but excluding cash and equity incentive opportunities, that are, in the aggregate, no less favorable than those in effect for similarly situated employees of Salesforce and its subsidiaries and (iii) severance entitlements upon a severance-qualifying termination that are no less favorable than those disclosed to Salesforce on October 19, 2026.
Salesforce will credit each Continuing Employee’s years of service with Braze and its subsidiaries for purposes of vesting, eligibility to participate and level of benefits under Salesforce’s employee benefit plans, to the same extent such service was credited under the corresponding Braze plan, subject to applicable law and tax qualification
83

TABLE OF CONTENTS

requirements and except to the extent such credit would result in a duplication of benefits or for purposes of any pension plan, frozen plan or plan providing grandfathered benefits, and will cause each Continuing Employee to be immediately eligible to participate in Salesforce benefit plans of the same type as the Braze plans in which such Continuing Employee participated, subject to administrative delays in connection with any transition to Salesforce’s tax-qualified defined contribution plan. Salesforce will waive applicable preexisting-condition exclusions and actively-at-work requirements under its medical, dental, pharmaceutical and vision plans, subject to the corresponding Braze-plan limitations, and will use commercially reasonable efforts to credit eligible expenses incurred during the portion of the plan year before participation in Salesforce’s plans for purposes of satisfying deductibles and out-of-pocket maximums. Braze has agreed to take all actions necessary or appropriate to terminate its 401(k) plan effective as of the day immediately preceding the Closing Date, unless Salesforce instructs otherwise in writing at least ten business days prior to the Closing Date. If the Braze 401(k) plan is terminated, Salesforce will permit eligible Continuing Employees to participate in Salesforce’s 401(k) plan and to elect to roll over their account balances (including any outstanding participant loans), subject to applicable limitations.
Braze has also agreed to use commercially reasonable efforts to terminate its professional employer organization relationships effective as of the Closing Date, unless otherwise agreed in writing by Salesforce. The parties have agreed to cooperate in good faith on employee, compensation and benefits integration planning, and Salesforce will have the opportunity to review and comment on broad-based or otherwise material employee notices and communications from Braze regarding the Transactions prior to distribution. Nothing in the Merger Agreement confers on any employee any right to continued employment, amends or prohibits the amendment or termination of any benefit plan or creates any third-party beneficiary rights in any Continuing Employee or other service provider.
Directors’ and Officers’ Indemnification and Insurance
Under the Merger Agreement, for six years from and after the Effective Time, Salesforce must, or must cause the Surviving Corporation to, indemnify and hold harmless, to the fullest extent permitted under applicable law and the organizational documents of Braze or its subsidiaries, or any indemnification agreements in existence as of October 19, 2026 that were provided to Salesforce prior to such date, the Indemnified Parties against any costs or expenses (including advancing attorneys’ fees and expenses, subject to an undertaking to repay if it is ultimately determined that the Indemnified Party is not entitled thereto), judgments, fines, losses, claims, damages, liabilities and amounts paid in settlement in connection with any actual or threatened claim, action, investigation, suit or proceeding in respect of acts or omissions occurring or alleged to have occurred at or prior to the Effective Time, whether asserted or claimed prior to, at or after the Effective Time (including acts or omissions occurring in connection with the approval of the Merger Agreement and the consummation of the Merger or any of the other Transactions), in connection with such person serving as an officer, director or other fiduciary of Braze, any of its subsidiaries or any other person if such service was at the request or for the benefit of Braze or any of its subsidiaries.
In addition, for a period of six years following the Effective Time, Salesforce is required to maintain in effect the provisions in the organizational documents of Braze and any indemnification agreements in existence as of October 19, 2026 that were provided to Salesforce prior to October 19, 2026 (except to the extent such agreement provides for an earlier termination), in each case, regarding elimination of liability, indemnification of executive officers and directors and advancement of expenses that are in existence as of October 19, 2026.
At or prior to the Effective Time, Braze is required to purchase a six-year prepaid directors’ and officers’ liability insurance and fiduciary liability insurance “tail” policy (on terms and conditions providing coverage retentions, limits and other material terms substantially equivalent to Braze’s and its subsidiaries’ current directors’ and officers’ liability insurance and fiduciary liability insurance) with respect to matters arising at or prior to the Effective Time, provided that Braze may not commit or spend on such “tail” policy, in the aggregate, more than 300% of the last aggregate annual premium paid by Braze prior to October 19, 2026 for such insurance, and if the cost of such “tail” policy would otherwise exceed such amount, Braze may purchase only as much coverage as reasonably practicable for such amount.
Other Covenants and Agreements
The Merger Agreement contains additional covenants and agreements relating to, among other matters:
•
consultation and consent rights regarding any press releases or other public statements with respect to the Merger Agreement, the Merger, and the other Transactions;
84

TABLE OF CONTENTS

•
certain reporting requirements under Section 16(a) of the Exchange Act (prior to the Effective Time, Braze and Salesforce will take all such steps as may be reasonably necessary or advisable to cause any dispositions of Braze equity securities (including derivative securities) and acquisitions of Salesforce equity securities pursuant to the Merger by each individual who is a director or officer of Braze subject to the reporting requirements of Section 16(a) of the Exchange Act to be exempt under Rule 16b-3 under the Exchange Act);
•
the delisting of Class A Common Stock from Nasdaq and termination of its registration under the Exchange Act;
•
eliminating any applicability of state takeover laws;
•
notice, cooperation and coordination relating to transaction-related litigation, if any;
•
resignations of Braze directors; and
•
delivery by Braze of a certificate and notice under the Foreign Investment in Real Property Tax Act of 1980, as amended.
Conditions to the Merger
The obligations of Salesforce and Braze to effect the Merger will be subject to the satisfaction of each of the following conditions, any and all of which may be waived in whole or in part by Salesforce, Banff Acquisition Sub and Braze, as the case may be, to the extent permitted by applicable law:
•
Braze Stockholder Approval: The Braze stockholder approval;
•
Government Consents: (i) The expiration, termination or waiver of any waiting period (or extensions thereof), and any commitments not to close before a certain date under a timing agreement entered into with governmental entities, applicable to the consummation of the Merger under the HSR Act and (ii) the making, expiration, termination or receipt of, as applicable, all applicable filings, registrations, waiting periods (or extensions thereof), approvals and clearances under certain specified antitrust and foreign investment laws, and such approvals and clearances remaining in effect, without the imposition, individually or in the aggregate, of a Burdensome Condition; and
•
No Legal Prohibition: No governmental entity of competent jurisdiction has (i) enacted, issued or promulgated any law that is in effect as of immediately prior to the Effective Time or (ii) issued or granted any order, injunction, decree or ruling (whether temporary, preliminary or permanent) that is in effect as of immediately prior to the Effective Time, which, in each case, has the effect of restraining, enjoining, making illegal or otherwise prohibiting the consummation of the Merger or imposing a Burdensome Condition, unless agreed to in writing by Salesforce.
The obligations of Salesforce and Banff Acquisition Sub to consummate the Merger will be further subject to the satisfaction on or prior to the Closing Date of each of the following conditions, any and all of which may be waived in whole or in part by Salesforce or Banff Acquisition Sub, as the case may be, to the extent permitted by applicable law:
•
Accuracy of Representations and Warranties: (1) certain representations and warranties of Braze related to its qualification, organization and subsidiaries, its corporate authority, the opinion of Braze’s financial advisor, state takeover statutes and anti-takeover laws and finders’ and brokers’ fees being true and correct in all material respects, if not qualified by materiality or material adverse effect, and in all respects, if qualified by materiality or material adverse effect; (2) certain representations and warranties of Braze related to its capitalization being true and correct other than for de minimis inaccuracies; (3) Braze’s representation and warranty that no material adverse effect on Braze has occurred since February 1, 2026 being true and correct in all respects; and (4) the other representations and warranties of Braze in the Merger Agreement (without giving effect to any qualification as to materiality or material adverse effect) being true and correct, except where the failure of such representations and warranties to be true and correct has not had and would not reasonably be expected to have, individually or in the aggregate, a material adverse effect on Braze, in each case, as of October 19, 2026 and as of the Closing as though made as of the Closing (except for representations and warranties that by their terms speak specifically as of another date, in which case as of such date);
85

TABLE OF CONTENTS

•
Compliance with Covenants: Performance or compliance in all material respects by Braze of the obligations, covenants and agreements required to be performed or complied with by it under the Merger Agreement at or prior to the Closing;
•
No Material Adverse Effect: There not having occurred, individually or in the aggregate, any material adverse effect with respect to Braze since October 19, 2026, and that is continuing as of immediately prior to the Closing; and
•
Officer’s Certificate: The receipt by Salesforce of a certificate, dated as of the Closing Date, signed by the chief executive officer, chief financial officer or another executive officer of Braze, certifying that the conditions set forth in the three bullet points immediately above have been satisfied.
The obligations of Braze to consummate the Merger will be further subject to the satisfaction on or prior to the Closing Date of each of the following conditions, any and all of which may be waived in whole or in part by Braze to the extent permitted by applicable law:
•
Accuracy of Representations and Warranties: (1) the representations and warranties of Salesforce and Banff Acquisition Sub related to their qualification and organization (first sentence only) and their corporate authority being true and correct in all material respects, if not qualified by materiality or material adverse effect, and in all respects, if qualified by materiality or material adverse effect; and (2) the other representations and warranties of Salesforce and Banff Acquisition Sub in the Merger Agreement (without giving effect to any qualification as to materiality or material adverse effect) being true and correct, except where the failure of such representations and warranties to be so true and correct has not had and would not reasonably be expected to have, individually or in the aggregate, a material adverse effect on Salesforce (with such term as described under the section titled “The Merger Agreement––Material Adverse Effect”), in each case, as of October 19, 2026 and as of the Closing as though made as of the Closing (except for representations and warranties that by their terms speak specifically as of another date, in which case as of such date);
•
Compliance with Covenants: Performance or compliance in all material respects by Salesforce and Banff Acquisition Sub of the obligations, covenants and agreements required to be performed or complied with by it under the Merger Agreement at or prior to the Closing; and
•
Officer’s Certificate: The receipt by Braze of a certificate, dated as of the Closing Date, signed by the chief executive officer, chief financial officer or another executive officer of Salesforce certifying that the conditions set forth in the two bullet points immediately above have been satisfied.
Termination of the Merger Agreement
The Merger Agreement may be terminated, and the Merger and other Transactions may be abandoned, at any time before the Closing:
•
by mutual written consent of Salesforce and Braze; or
•
by either Salesforce or Braze, if:
•
any governmental entity of competent jurisdiction has issued a final, non-appealable order, injunction, decree or ruling, in each case permanently restraining, enjoining or otherwise prohibiting the consummation of the Transactions or any law that permanently makes consummation of the Transactions illegal or otherwise prohibited is in effect; or
•
the Closing has not occurred on or before October 19, 2027 (the first anniversary of the date of the Merger Agreement), except that (a) if on such date all of the conditions to closing, other than the conditions related to the expiration or termination of the waiting period under the HSR Act and the approvals and clearances under certain specified antitrust and foreign investment laws, the absence of any injunction or other legal prohibition (in respect of the HSR Act or any other regulatory law) and those conditions that by their nature are to be satisfied at closing (provided they are capable of being satisfied), have been satisfied or waived, then such date will automatically be extended one time for an additional 90 days and (b) if on such extended date all such conditions (other than such excluded conditions) have been satisfied or waived, then such date will automatically be extended one additional time for an additional 90 days. Notwithstanding the foregoing, Salesforce and Braze may
86

TABLE OF CONTENTS

mutually agree in writing to amend the Outside Date to such other date as is agreed; provided, further, that the right to terminate the Merger Agreement at the Outside Date will not be available to any party whose action or failure to fulfill any obligation under the Merger Agreement has been a proximate cause of the failure of the Transactions to be consummated by the Outside Date, and such action or failure to act constitutes a material breach of the Merger Agreement; or
•
the Braze stockholder approval has not been obtained upon a vote taken thereon at the Special Meeting duly convened therefor or at any adjournment, postponement or continuation thereof.
Termination by Braze
The Merger Agreement may be terminated, and the Merger and other Transactions may be abandoned, at any time before the Closing by Braze if:
•
prior to the time the Braze stockholder approval is obtained, the Braze Board of Directors effects a change of recommendation in order to substantially concurrently enter into a definitive agreement providing for a superior proposal, as long as (1) Braze has complied in all material respects with its non-solicitation obligations, as described under the sections titled “The Merger Agreement—No Solicitation of Other Offers by Braze” and “The Merger Agreement—Change of Recommendation; Match Rights” and (2) substantially concurrently with or prior to (and as a condition to) such termination, Braze pays to Salesforce the $191,390,000 termination fee described below; or
•
there has been a breach by Salesforce and/or Banff Acquisition Sub of any of their covenants or agreements, or any of the representations and warranties of Salesforce or Banff Acquisition Sub have become inaccurate, in either case in a manner that would give rise to the failure of certain conditions to the consummation of the Merger, and such breach or inaccuracy is not capable of being cured by the Outside Date or, if capable of being cured, is not cured by the earlier of (x) the business day immediately prior to the Outside Date and (y) the 30th calendar day following receipt of written notice from Braze of such breach or inaccuracy; provided, however, that Braze may not terminate the Merger Agreement in this way if Braze is then in breach of any of its representations, warranties, covenants or agreements and such breach would give rise to the failure of a condition to close.
Termination by Salesforce
The Merger Agreement may be terminated, and the Merger and other Transactions may be abandoned, by Salesforce if:
•
prior to the time the Braze stockholder approval is obtained, the Braze Board of Directors has effected a change of recommendation (whether or not in compliance with the Merger Agreement) or Braze has materially breached its obligations described under the section titled “The Merger Agreement—No Solicitation of Other Offers by Braze”; or
•
there has been a breach by Braze of any of its covenants or agreements, or any of the representations and warranties of Braze have become inaccurate, in either case in a manner that would give rise to the failure of certain conditions to the consummation of the Merger, and such breach or inaccuracy is not capable of being cured by the Outside Date or, if capable of being cured, is not cured by the earlier of (x) the business day immediately prior to the Outside Date and (y) the 30th calendar day following receipt of written notice from Salesforce of such breach or inaccuracy; provided, however, that Salesforce may not terminate the Merger Agreement in this way if Salesforce or Banff Acquisition Sub is then in breach of any of its representations, warranties, covenants or agreements and such breach would give rise to the failure of a condition to close.
Termination Fee
Regulatory Reverse Termination Fee
The Merger Agreement provides that Salesforce will pay Braze the Regulatory Reverse Termination Fee if:
(1)
the Merger Agreement is terminated (a) by Salesforce or Braze as a result of the Closing having not occurred on or before the Outside Date or (b) by Salesforce or Braze because a governmental entity of competent jurisdiction has issued a final, non-appealable order, injunction, decree or ruling permanently
87

TABLE OF CONTENTS

restraining, enjoining or otherwise prohibiting the consummation of the Transactions or any law that permanently makes such consummation illegal or otherwise prohibited is in effect, solely to the extent that any such injunction, order, decree or ruling is in respect of, or any such law relates to, the HSR Act or any other applicable regulatory law (provided that, in the case of a termination by Braze under this clause (b), Braze must deliver written notice to Salesforce that such termination will not be effective until five business days following receipt, and such termination will be null and void if, within such period, Salesforce and Banff Acquisition Sub irrevocably waive the condition relating to the absence of such injunction, order, decree, ruling or law);
(2)
on the date of such termination, all of the conditions to Closing (other than the conditions of Braze’s obligation to consummate the Merger) have been satisfied or waived (other than those conditions that by their nature are to be satisfied at the Closing, provided that such conditions are capable of being satisfied if the Closing were to take place on such date), other than the conditions related to the expiration, termination or waiver of the waiting period applicable to the Merger under the HSR Act and receipt of all other approvals and clearances under specified antitrust and foreign investment laws and the absence of any legal prohibition (solely to the extent in respect of the HSR Act or any other applicable regulatory law); and
(3)
in the case of a termination by Braze, (a) Braze has delivered written notice to Salesforce irrevocably waiving the condition relating to the absence of such legal prohibition, if any, and irrevocably confirming that it is ready, willing and able to consummate the Closing (and, in the case of a termination at the Outside Date, upon delivery of such notice the Outside Date will be extended by five business days) and (b) Salesforce and Banff Acquisition Sub fail to effect the Closing (or, in the case of a termination in respect of a legal prohibition, fail to effect the Closing or to deliver a notice waiving such condition) within five business days following receipt of such notice.
In no event will Salesforce be obligated to pay the Regulatory Reverse Termination Fee on more than one occasion.
Except for the right to seek monetary damages for fraud (in each case, solely as it relates to (x) the representations and warranties expressly made by Salesforce and Banff Acquisition Sub in the Merger Agreement, (y) certificates delivered pursuant to the Merger Agreement or (z) filings submitted to governmental entities pursuant to the Merger Agreement (or documents submitted to such governmental entities in connection with such filings)) or willful breach occurring prior to the valid termination of the Merger Agreement, and without limiting Braze’s right to specific performance, the Regulatory Reverse Termination Fee (and any other amounts expressly required by the Merger Agreement in connection therewith, if any) will be the sole and exclusive monetary remedy available to Braze in connection with the Merger Agreement and the Transactions in any circumstance in which the Regulatory Reverse Termination Fee becomes due and payable and is paid by Salesforce. Upon Braze’s receipt of the full Regulatory Reverse Termination Fee (and any such other amounts) in circumstances in which it is payable, none of Salesforce, any of its subsidiaries or any of their respective former, current or future officers, directors, partners, stockholders, managers, members, affiliates or agents will have any further liability or obligation relating to or arising out of the Merger Agreement or the Transactions, except for fraud (solely as it relates to the matters described in clauses (x) through (z) above) or willful breach.
Braze Termination Fee
The Merger Agreement provides that Braze will pay Salesforce the Termination Fee if:
(1)
the Merger Agreement is terminated by Salesforce or Braze as a result of the Closing having not occurred on or before the Outside Date or the Braze stockholder approval not having been obtained at the Special Meeting, or by Salesforce as a result of a breach, failure to perform or violation of the Merger Agreement by Braze that (except for a breach of Braze’s non-solicitation obligations) first occurred following the making of an acquisition proposal of the type described in clause (2) immediately below;
(2)
after the date of the Merger Agreement and prior to the date of such termination (or prior to the Braze stockholder approval, in the case of a termination as a result of the Braze stockholder approval not having been obtained), a bona fide acquisition proposal (with references to “15%” and “85%” in the definition thereof being deemed to be references to “50%”) has been publicly disclosed (whether by Braze or a third party) or otherwise made known to the Braze Board of Directors or Braze management and, in each
88

TABLE OF CONTENTS

case, is not withdrawn (publicly, if publicly disclosed) at least three business days prior to the earlier of the date of the Special Meeting and the date of such termination; and
(3)
within 12 months of such termination, an acquisition proposal is consummated or a definitive agreement providing for an acquisition proposal is entered into (with references to “15%” and “85%” in the definition thereof being deemed to be references to “50%”).
In addition, the Merger Agreement requires Braze to pay Salesforce the Termination Fee if any of the following occurs:
(1)
Salesforce terminates the Merger Agreement because, prior to the time the Braze stockholder approval is obtained, the Braze Board of Directors has effected a change of recommendation or Braze has materially breached its non-solicitation obligations, or Braze terminates the Merger Agreement as a result of the Closing having not occurred on or before the Outside Date at a time when Salesforce would be permitted to terminate the Merger Agreement for such reasons; or
(2)
Braze terminates the Merger Agreement prior to the time the Braze stockholder approval is obtained in order to effect a change of recommendation and substantially concurrently enter into a definitive agreement providing for a superior proposal.
In no event will Braze be obligated to pay the Termination Fee on more than one occasion.
Except for the right to seek monetary damages for fraud (in each case, solely as it relates to (x) the representations and warranties expressly made by Braze in the Merger Agreement, (y) certificates delivered pursuant to the Merger Agreement or (z) filings submitted to governmental entities pursuant to the Merger Agreement (or documents submitted to such governmental entities in connection with such filings)) or willful breach occurring prior to the valid termination of the Merger Agreement, and without limiting Salesforce’s or Banff Acquisition Sub’s right to specific performance, the Termination Fee (and any other amounts expressly required by the Merger Agreement in connection therewith, if any) will be the sole and exclusive monetary remedy available to Salesforce and Banff Acquisition Sub in connection with the Merger Agreement and the Transactions in any circumstance in which the Termination Fee becomes due and payable and is paid by Braze. Upon Salesforce’s receipt of the full Termination Fee (and any such other amounts) in circumstances in which it is payable, none of Braze, any of its subsidiaries or any of their respective former, current or future officers, directors, partners, stockholders, managers, members, affiliates or agents will have any further liability or obligation relating to or arising out of the Merger Agreement or the Transactions, except for fraud (solely as it relates to the matters described in clauses (x) through (z) above) or willful breach.
Effect of Termination
In the event of termination of the Merger Agreement in accordance with its terms, the Merger Agreement will become null and void (except that provisions relating to the effect of termination, payment of the termination fees and certain other miscellaneous provisions, together with the confidentiality agreement, clean room agreement and joint defense agreement between or on behalf of Braze and Salesforce, will survive any such termination), and there will be no liability on the part of any of the parties; provided that no party will be relieved of liability for any fraud or willful breach of the Merger Agreement prior to such termination. For purposes of the Merger Agreement, “willful breach” means an action or omission taken or omitted to be taken that the breaching party intentionally takes (or fails to take) and actually knows would, or would reasonably be expected to, be or cause a material breach of the Merger Agreement, and “fraud” means common law fraud that is committed with actual knowledge of falsity and with the intent to deceive or mislead another. Each of Salesforce and Braze may seek specific performance to cause the other to consummate the Transactions and payment of the Regulatory Reverse Termination Fee or Termination Fee, as applicable, but in no event will it be entitled to both specific performance and payment of such fee.
Expenses
Except as otherwise expressly provided in the Merger Agreement, all costs and expenses incurred in connection with the Merger Agreement and the transactions contemplated thereby will be paid by the party incurring the cost or expense, except that Salesforce will pay all filing fees under the HSR Act and any other applicable regulatory law relating to such transactions.
89

TABLE OF CONTENTS

Amendments, Enforcement and Remedies, Extensions and Waivers
Amendments
Subject to applicable law and except as otherwise provided in the Merger Agreement, the Merger Agreement may be amended, modified and supplemented by written agreement of each of the parties.
Enforcement and Remedies
Under the Merger Agreement, the parties have agreed that each party will be entitled to:
•
an injunction or injunctions to prevent or remedy any breaches or threatened breaches of the Merger Agreement;
•
a decree or order of specific performance specifically enforcing the terms and provisions of the Merger Agreement; and
•
any further equitable relief, in each case, in addition to any other remedy to which a party is entitled at law or in equity.
Extensions and Waivers
Under the Merger Agreement, at any time prior to the Effective Time, any party may (to the extent legally allowed and except as otherwise provided in the Merger Agreement):
•
extend the time for the performance of any of the obligations or other acts of the other parties, as applicable;
•
waive any inaccuracies in the representations and warranties of the other parties; and
•
waive compliance by the other parties with any of the agreements or conditions for the respective benefit of such party.
90

TABLE OF CONTENTS

THE VOTING AND SUPPORT AGREEMENT
The following describes the material provisions of the Voting and Support Agreement, the form of which is attached as Annex B to this proxy statement and is incorporated by reference herein. The summary of the material provisions of the Voting and Support Agreement below and elsewhere in this proxy statement is qualified in its entirety by reference to the text of the form of Voting and Support Agreement. This summary does not purport to be complete and may not contain all of the information about the Voting and Support Agreement that is important to you. Braze encourages you to read carefully the form of Voting and Support Agreement in its entirety before making any decisions regarding the Merger.
In connection with the execution and delivery of the Merger Agreement, and as an inducement for Salesforce and Banff Acquisition Sub to enter into the Merger Agreement, (i) William Magnuson and an entity affiliated with Mr. Magnuson, (ii) Jonathan Hyman and certain trusts affiliated with Mr. Hyman, and (iii) Neeraj Agrawal ((i) through (iii) collectively referred to as the “Support Stockholders”) have each entered into the voting and support agreement with Salesforce (referred to as the “Voting and Support Agreement”). Based on information provided by the Support Stockholders, the Support Stockholders beneficially owned, in the aggregate, as of the date of the Voting and Support Agreement, 5,999,825 shares of Class A Common Stock, collectively representing approximately 5.3% of the voting power of Class A Common Stock as of such date. The Support Stockholders have agreed, among other things, on the terms and subject to the conditions set forth in the Voting and Support Agreement, to (a) vote their shares of Class A Common Stock in favor of the approval and adoption of the Merger Agreement and the transactions contemplated thereby, including the Merger, and against any acquisition proposal or any action or agreement that is in opposition to the Merger at any stockholder meeting, however called (including the Special Meeting), (b) not transfer their shares of Class A Common Stock, subject to certain limited exceptions, and (c) comply with the non-solicitation obligations set forth in the Voting and Support Agreement. The Voting and Support Agreement will terminate automatically with respect to a Support Stockholder and Salesforce, without any notice or other action, upon the earliest to occur of (i) the valid termination of the Merger Agreement in accordance with its terms, (ii) the Effective Time, (iii) the entry, without the prior written consent of such Support Stockholder, into any amendment, waiver or modification to the Merger Agreement that results in a decrease in the Merger Consideration or changes the mix of Merger Consideration or (iv) the delivery of written notice of termination by Salesforce to such Support Stockholder.
91

TABLE OF CONTENTS

APPRAISAL RIGHTS OF BRAZE STOCKHOLDERS
If the Merger is completed, stockholders or beneficial owners who do not vote in favor of or otherwise consent to the adoption of the Merger Agreement and who properly demand appraisal of their shares of Class A Common Stock and do not validly withdraw such demands or otherwise lose their rights to appraisal will be entitled to appraisal rights in connection with the Merger under Section 262. Failure to strictly comply with the procedures and requirements specified in Section 262 in a timely and proper manner will result in the loss of your appraisal rights under the DGCL.
The following discussion is not intended to be a complete statement of the law pertaining to appraisal rights under the DGCL and is qualified in its entirety by the full text of Section 262, which may be accessed without subscription or cost at the following publicly available website: https://delcode.delaware.gov/title8/c001/sc09/index.html#262. Throughout this summary of appraisal rights, the word “stockholder” means a holder of record of Class A Common Stock, the words “beneficial owner” mean a person who is the beneficial owner of shares of Class A Common Stock held either in voting trust or by a nominee on behalf of such person, and the word “person” means any individual, corporation, partnership, unincorporated association or other entity. The following summary does not constitute any legal or other advice and does not constitute a recommendation that stockholders or beneficial owners exercise their appraisal rights under Section 262.
Under Section 262, stockholders and beneficial owners who hold shares of Class A Common Stock on the date of the making of a demand for an appraisal of the fair value of such shares in accordance with Section 262 and (1) do not vote in favor of or otherwise consent to the adoption of the Merger Agreement; (2) continuously hold or own such shares of Class A Common Stock through the Effective Time; and (3) otherwise follow the procedures and requirements set forth in Section 262 will be entitled to have their shares of Class A Common Stock appraised by the Delaware Court of Chancery and to receive in lieu of the Merger Consideration payment in cash of the “fair value” of their shares of Class A Common Stock, exclusive of any element of value arising from the accomplishment or expectation of the Merger, together with interest, if any, to be paid on the amount determined to be the fair value of such shares as determined by the Delaware Court of Chancery. Unless the Delaware Court of Chancery, in its discretion, determines otherwise for good cause shown, interest on an appraisal award will accrue and compound quarterly from the Effective Time through the date the judgment is paid at 5% over the Federal Reserve discount rate (including any surcharge) as established from time to time during such period; provided that at any time before the entry of judgment in the proceedings, Braze may pay to each person entitled to appraisal an amount in cash, in which case interest shall accrue thereafter only upon the sum of (1) the difference, if any, between the amount so paid and the fair value of the Class A Common Stock as determined by the Delaware Court of Chancery, and (2) interest theretofore accrued, unless paid at that time. Stockholders considering seeking appraisal should be aware that the fair value of their shares of Class A Common Stock as determined pursuant to Section 262 could be more than, the same as or less than the Merger Consideration.
Under Section 262, when a merger agreement is to be submitted for adoption at a meeting of stockholders, the corporation, not less than 20 days prior to the meeting, must notify each of its stockholders entitled to exercise appraisal rights that appraisal rights are available and include in the notice a copy of Section 262 or information directing the stockholders to a publicly available electronic resource at which Section 262 may be accessed without subscription or cost. This proxy statement constitutes Braze’s notice to stockholders that appraisal rights are available in connection with the Merger, and the full text of Section 262 may be accessed without subscription or cost at the following publicly available website: https://delcode.delaware.gov/title8/c001/sc09/index.html#262. In connection with the Merger, any stockholder or beneficial owner who wishes to exercise appraisal rights or who wishes to preserve such stockholder’s or beneficial owner’s right to do so should review the text of Section 262 carefully and in its entirety. Failure to strictly comply with the procedures and requirements of Section 262 in a timely and proper manner will result in the loss of appraisal rights under the DGCL. A stockholder or beneficial owner who loses his, her or its appraisal rights will be entitled to receive the Merger Consideration (subject to applicable tax withholding) if Braze stockholders approve the Merger Agreement Proposal and the Merger is subsequently consummated. Moreover, because of the complexity of the procedures and requirements for exercising the right to seek appraisal of shares of Class A Common Stock in connection with the Merger, Braze believes that if a stockholder or beneficial owner considers exercising such rights, that stockholder or beneficial owner should seek the advice of legal counsel.
92

TABLE OF CONTENTS

Stockholders and beneficial owners wishing to exercise the right to seek an appraisal of their shares of Class A Common Stock must do ALL of the following:
•
the stockholder or beneficial owner must not vote in favor of or otherwise consent to the Merger Agreement Proposal;
•
the stockholder or beneficial owner must deliver to Braze a written demand for appraisal containing all the information required to be stated in such demand before the vote on the Merger Agreement Proposal at the Special Meeting;
•
the stockholder or beneficial owner must continuously hold the shares of Class A Common Stock from the date of making the demand through the Effective Time (a stockholder or beneficial owner will lose appraisal rights if the stockholder or beneficial owner transfers the shares of Class A Common Stock before the Effective Time); and
•
the stockholder or beneficial owner, or the Surviving Corporation must file a petition in the Delaware Court of Chancery requesting a determination of the fair value of the shares of Class A Common Stock within 120 days after the Effective Time. The Surviving Corporation is under no obligation to file such a petition and neither Braze, as the predecessor of the Surviving Corporation, has no intention of doing so and Salesforce has no intention of causing the Surviving Corporation to do so.
Filing Written Demand
Any stockholder or beneficial owner wishing to exercise appraisal rights must deliver to Braze, before the vote on the adoption of the Merger Agreement at the Special Meeting at which the Merger Agreement Proposal will be submitted to the stockholders, a written demand for the appraisal of the stockholder’s or beneficial owner’s shares of Class A Common Stock, and that stockholder or beneficial owner must not vote or submit a proxy in favor of (or otherwise consent to) the Merger Agreement Proposal. A holder or owner of shares of Class A Common Stock exercising appraisal rights must hold or own such shares on the date the written demand for appraisal is made and must continue to hold such shares of record, or beneficially own such shares, of Class A Common Stock through the Effective Time. A valid proxy that is properly submitted and does not contain voting instructions will, unless revoked or superseded by a subsequent valid proxy that is properly submitted with voting instructions, be voted in favor of the Merger Agreement Proposal, and it will therefore constitute a waiver of the stockholder’s right of appraisal in connection with the Merger and will nullify any previously delivered written demand for appraisal by or on behalf of such stockholder. Therefore, a stockholder who submits a proxy and who wishes to exercise appraisal rights must submit a proxy containing instructions to vote against the Merger Agreement Proposal or abstain from voting on the Merger Agreement Proposal. Neither voting against the Merger Agreement Proposal nor abstaining from voting or failing to vote on the Merger Agreement Proposal will, in and of itself, constitute a written demand for appraisal satisfying the requirements of Section 262. The written demand for appraisal must be in addition to and separate from any proxy or vote on the Merger Agreement Proposal. A proxy or vote against the Merger Agreement Proposal will not constitute a demand. A stockholder’s or beneficial owner’s failure to make the written demand prior to the taking of the vote on the Merger Agreement Proposal at the Special Meeting will constitute a waiver of appraisal rights.
Demand for Appraisal by a Holder of Record
A demand for appraisal by a holder of record must be executed by or on behalf of the holder of record and must reasonably inform us of the identity of the stockholder and that such stockholder intends thereby to demand appraisal of the stockholder’s shares of Class A Common Stock in connection with the Merger. If a holder of record is submitting a demand with respect to shares of Class A Common Stock owned of record in a fiduciary or representative capacity, such as by a trustee, guardian or custodian, such demand must be executed by or on behalf of the record owner in such capacity, and if the shares of Class A Common Stock are owned of record by more than one person, as in a joint tenancy and tenancy in common, the demand should be executed by or on behalf of all joint owners. An authorized agent, including an authorized agent for two or more joint owners, may execute a demand for appraisal on behalf of a holder of record; however, the agent must identify the record owner or owners and expressly disclose that, in executing the demand, the agent is acting as agent for the record owner or owners. A holder of record, such as a brokerage firm, bank, trust or other nominee, who holds shares of Class A Common Stock as nominee or intermediary for one or more beneficial owners may exercise appraisal rights with respect to shares of Class A Common Stock held for one or more beneficial owners while not exercising appraisal rights for other
93

TABLE OF CONTENTS

beneficial owners. In that case, the written demand should state the number of shares of Class A Common Stock as to which appraisal is sought. Where no number of shares of Class A Common Stock is expressly mentioned, the demand will be presumed to cover all shares of Class A Common Stock held in the name of the holder of record.
Demand for Appraisal by a Beneficial Owner
A beneficial owner may, in such person’s name, demand in writing an appraisal of such beneficial owner’s shares of Class A Common Stock in accordance with the procedures of subsection (d)(1) of Section 262 summarized above, provided that (1) such beneficial owner continuously owns such shares of Class A Common Stock from the date of the making of such demand for an appraisal of such shares through the Effective Time and otherwise satisfies the requirements applicable to a stockholder under the first sentence of subsection (a) of Section 262 and (2) the demand made by such beneficial owner reasonably identifies the holder of record of the shares of Class A Common Stock for which the demand is made, is accompanied by documentary evidence of such beneficial owner’s beneficial ownership of stock and a statement that such documentary evidence is a true and correct copy of what it purports to be, and provides an address at which such beneficial owner consents to receive notices given by the Surviving Corporation as contemplated by Section 262. Although not expressly required by Section 262, the surviving corporation reserves the right to take the position that it may require the submission of all information required of a beneficial owner under subsection (d)(3) of Section 262 with respect to any person sharing beneficial ownership of the shares of Class A Common Stock for which such demand is submitted.
Additional Instructions; Conditions
All written demands for appraisal pursuant to Section 262 should be delivered to:
Braze, Inc.
Attention: Investor Relations
63 Madison Building
28 East 28th Street, Floor 12
New York, NY 10016
Any stockholder or beneficial owner who has not commenced an appraisal proceeding or joined such a proceeding as a named party may withdraw his, her or its demand for appraisal and accept the Merger Consideration by delivering to Braze a written withdrawal of the demand for appraisal within 60 days after the Effective Time. However, any such attempt to withdraw the demand made more than 60 days after the Effective Time will require written approval of the Surviving Corporation. No appraisal proceeding in the Delaware Court of Chancery will be dismissed without the approval of the Delaware Court of Chancery, and such approval may be conditioned upon such terms as the Delaware Court of Chancery deems just, including without limitation, a reservation of jurisdiction for any application to the Court made under subsection (j) of Section 262; provided, that this provision shall not affect the right of any person who has not commenced an appraisal proceeding or joined that proceeding as a named party to withdraw such person’s demand for appraisal and to accept the Merger Consideration within 60 days after the Effective Time.
Notice by the Surviving Corporation
If the Merger is completed, within ten days after the Effective Time, the Surviving Corporation will notify each stockholder who has complied with Section 262(d)(1) and has not voted in favor of (or otherwise consented to) the Merger Agreement Proposal, and any beneficial owner who has demanded appraisal under paragraph (d)(3) of Section 262, that the Merger has become effective and the effective date thereof (i.e., the Effective Time).
Filing a Petition for Appraisal
Within 120 days after the Effective Time, but not thereafter, the Surviving Corporation or any person who has complied with Section 262 and is entitled to appraisal rights under Section 262 may commence an appraisal proceeding by filing a petition in the Delaware Court of Chancery, with a copy served on the Surviving Corporation in the case of a petition filed by a stockholder or beneficial owner, demanding a determination of the fair value of the shares of Class A Common Stock held by all stockholders and beneficial owners entitled to appraisal. The Surviving Corporation is under no obligation, and has no present intention, to file a petition, and stockholders and beneficial owners should not assume that the Surviving Corporation will file a petition or initiate any negotiations with respect to an appraisal of the fair value of the shares of Class A Common Stock. Accordingly, any stockholders
94

TABLE OF CONTENTS

or beneficial owners who desire to have their shares of Class A Common Stock appraised should initiate all necessary action to perfect their appraisal rights in respect of their shares of Class A Common Stock within the time and in the manner prescribed in Section 262. The failure of a stockholder or beneficial owner to file such a petition within the period specified in Section 262 could cause the stockholder or beneficial owner to lose their right to an appraisal of their shares of Class A Common Stock.
Within 120 days after the Effective Time, any person who has complied with the requirements for exercise of appraisal rights under Section 262(a) and Section 262(d), will be entitled, upon written request, to receive from the Surviving Corporation a statement setting forth the aggregate number of shares of Class A Common Stock not voted in favor of the adoption of the Merger Agreement and with respect to which Braze has received demands for appraisal, and the aggregate number of stockholders or beneficial owners of such shares of Class A Common Stock (provided that, where a beneficial owner makes a demand pursuant to paragraph (d)(3) of Section 262, the record holder of such shares shall not be considered a separate stockholder holding such shares for purposes of such aggregate number). The Surviving Corporation must provide this statement to the requesting stockholder within ten days after receipt of the written request for such a statement or within ten days after the expiration of the period for delivery of demands for appraisal, whichever is later.
If a petition for an appraisal is duly filed by a stockholder or beneficial owner and a copy thereof is served upon the Surviving Corporation, the Surviving Corporation will then be obligated within 20 days after such service to file in the office of the Register in Chancery in which the petition was filed a duly verified list containing the names and addresses of all persons who have demanded appraisal for their shares of Class A Common Stock and with whom agreements as to the value of their shares of Class A Common Stock have not been reached (which is referred to as the “Chancery List”). After notice to the stockholders as required by the court, the Delaware Court of Chancery is empowered to conduct a hearing on the petition to determine those stockholders and beneficial owners who have complied with Section 262 and who have become entitled to appraisal rights thereunder. The Delaware Court of Chancery may require the persons who demanded appraisal of their shares of Class A Common Stock and who hold stock represented by certificates to submit their stock certificates to the Register in Chancery for notation thereon of the pendency of the appraisal proceedings, and if any person fails to comply with the direction, the Delaware Court of Chancery may dismiss the proceedings as to such person. Any person whose name appears on the Chancery List may participate fully in all proceedings until it is finally determined that such person is not entitled to appraisal rights under Section 262. Upon application by the Surviving Corporation or by any person entitled to participate in the appraisal proceeding, the Delaware Court of Chancery may, in its discretion, proceed to trial upon the appraisal prior to the final determination of the persons entitled to an appraisal.
Class A Common Stock is currently listed on a national securities exchange, and, assuming such shares of Class A Common Stock remain listed on a national securities exchange immediately prior to the Merger (which is expected to be the case), after an appraisal petition has been filed, the Delaware Court of Chancery will dismiss appraisal proceedings as to all holders of such shares who are otherwise entitled to appraisal rights unless (1) the total number of shares of Class A Common Stock entitled to appraisal exceeds 1% of the outstanding shares of Class A Common Stock eligible for appraisal or (2) the value of the aggregate Merger Consideration in respect of such total number of shares of Class A Common Stock exceeds $1,000,000.
Determination of Fair Value
After determining the stockholders entitled to appraisal, the Delaware Court of Chancery will appraise the “fair value” of the shares of Class A Common Stock, exclusive of any element of value arising from the accomplishment or expectation of the Merger. In determining fair value, the Delaware Court of Chancery will take into account all relevant factors. Unless the court in its discretion determines otherwise for good cause shown, interest from the Effective Time through the date of payment of the judgment will be compounded quarterly and will accrue at 5% over the Federal Reserve discount rate (including any surcharge) as established from time to time during the period between the Effective Time and the date of payment of the judgment. At any time before the entry of judgment in the appraisal proceedings, the Surviving Corporation may pay to each person entitled to appraisal an amount in cash, in which case interest shall accrue after such payment only on the sum of (1) the difference, if any, between the amount so paid and the fair value of the shares of Class A Common Stock as determined by the Delaware Court of Chancery, and (2) interest theretofore accrued, unless paid by the Surviving Corporation as part of the pre-judgment payment to the person.
In Weinberger v. UOP, Inc., the Supreme Court of Delaware discussed the factors that could be considered in determining fair value in an appraisal proceeding, stating that “proof of value by any techniques or methods which
95

TABLE OF CONTENTS

are generally considered acceptable in the financial community and otherwise admissible in court” should be considered, and that “[f]air price obviously requires consideration of all relevant factors involving the value of a company.” The Delaware Supreme Court has stated that, in making this determination of fair value, the court must consider market value, asset value, dividends, earnings prospects, the nature of the enterprise and any other facts that could be ascertained as of the date of the merger that throw any light on future prospects of the merged corporation. Section 262 provides that fair value is to be “exclusive of any element of value arising from the accomplishment or expectation of the merger.” In Cede & Co. v. Technicolor, Inc., the Supreme Court of Delaware stated that such exclusion is a “narrow exclusion [that] does not encompass known elements of value,” but which rather applies only to the speculative elements of value arising from such accomplishment or expectation. In Weinberger, the Supreme Court of Delaware also stated that “elements of future value, including the nature of the enterprise, which are known or susceptible of proof as of the date of the merger and not the product of speculation, may be considered.”
Stockholders and beneficial owners considering seeking appraisal should be aware that the fair value of their shares of Class A Common Stock as so determined by the Delaware Court of Chancery could be more than, the same as or less than the consideration they would receive pursuant to the Merger if they did not seek appraisal of their shares of Class A Common Stock and that an opinion of an investment banking firm as to the fairness from a financial point of view of the consideration payable in a Merger is not an opinion as to, and may not in any manner address, fair value under Section 262. Although Braze believes that the Merger Consideration is fair, no representation is made as to the outcome of the appraisal of fair value as determined by the Delaware Court of Chancery, and stockholders and beneficial owners should recognize that such an appraisal could result in a determination of a value higher or lower than, or the same as, the Merger Consideration. Neither Braze nor Salesforce anticipates offering more than the Merger Consideration to any stockholder or beneficial owner exercising appraisal rights, and each of Braze and Salesforce reserves the right to assert, in any appraisal proceeding, that for purposes of Section 262, the “fair value” of a share of Class A Common Stock is less than the Merger Consideration. If a petition for appraisal is not timely filed, then the right to an appraisal will cease. The costs of the appraisal proceedings (which do not include attorneys’ fees or the fees and expenses of experts) may be determined by the Delaware Court of Chancery and taxed upon the parties as the Delaware Court of Chancery deems equitable under the circumstances. Upon application of a person whose name appears on the Chancery List who participated in the proceeding and incurred expenses in connection therewith, the Delaware Court of Chancery may also order that all or a portion of such expenses, including, without limitation, reasonable attorneys’ fees and the fees and expenses of experts, be charged pro rata against the value of all the shares of Class A Common Stock entitled to be appraised or subject to an award pursuant to a reservation of jurisdiction under Section 262(k).
If any person who demands appraisal of his, her or its shares of Class A Common Stock under Section 262 fails to perfect, or loses or validly withdraws, such person’s right to appraisal, the person’s shares of Class A Common Stock will be deemed to have been converted at the Effective Time into the right to receive the Merger Consideration. A stockholder or beneficial owner will fail to perfect, or effectively lose or withdraw, the stockholder’s or beneficial owner’s right to appraisal if no petition for appraisal is filed within 120 days after the Effective Time or if the stockholder or beneficial owner delivers to the Surviving Corporation a written withdrawal of the stockholder’s demand for appraisal and an acceptance of the Merger Consideration in accordance with Section 262.
From and after the Effective Time, no person who has demanded appraisal rights will be entitled to vote such shares of Class A Common Stock for any purpose or to receive payment of dividends or other distributions on the stock, except dividends or other distributions on a stockholder’s shares of Class A Common Stock, if any, payable to stockholders of record as of a time prior to the Effective Time. If no petition for an appraisal is filed, or if a stockholder or beneficial owner delivers to the Surviving Corporation a written withdrawal of the demand for an appraisal, either within 60 days after the Effective Time or thereafter with the written approval of the Surviving Corporation, then the right of such stockholder or beneficial owner to an appraisal will cease. Once a petition for appraisal is filed with the Delaware Court of Chancery, however, the appraisal proceeding may not be dismissed as to any person who commenced the proceeding or joined that proceeding as a named party without the approval of the Delaware Court of Chancery, and such approval may be conditioned upon such terms as the Delaware Court of Chancery deems just, including without limitation, a reservation of jurisdiction for any application to the Delaware Court of Chancery made under Section 262(j); provided, however that this provision shall not affect the right of any person who has not commenced an appraisal proceeding or joined that proceeding as a named party to withdraw such person’s demand for appraisal and to accept the Merger Consideration within 60 days after the Effective Time.
96

TABLE OF CONTENTS

Failure to comply strictly with all of the procedures set forth in Section 262 may result in the loss of a stockholder’s or beneficial owner’s statutory appraisal rights. Consequently, any stockholder or beneficial owner wishing to exercise appraisal rights is encouraged to consult legal counsel before attempting to exercise those rights.
To the extent there are any inconsistencies between the foregoing summary, on the one hand, and Section 262, on the other hand, Section 262 will govern.
97

TABLE OF CONTENTS

ADVISORY VOTE ON NAMED EXECUTIVE OFFICER MERGER-RELATED COMPENSATION ARRANGEMENTS (PROPOSAL 2)
Overview
Braze is providing its stockholders with the opportunity to cast a vote, on an advisory (non-binding) basis, to approve the compensation that may be paid or become payable to Braze’s named executive officers that is based on or otherwise relates to the Merger, as determined in accordance with Item 402(t) of Regulation S-K, in connection with the Transactions, as disclosed in the section titled “The Merger (Proposal 1)—Quantification of Potential Payments and Benefits to Braze’s Named Executive Officers in Connection with the Merger,” including the table titled “Golden Parachute Compensation” and the accompanying footnotes, and the related narrative disclosure (referred to as the “golden parachute” compensation), as required by Section 14A of the Exchange Act and the applicable SEC rules issued thereunder.
Through this proposal, Braze is asking its stockholders to indicate their approval, on an advisory (non-binding) basis, of the compensation that Braze’s named executive officers may be eligible to receive in connection with the Merger as described in the sections of this proxy statement referred to above.
You should carefully review the golden parachute compensation information disclosed in the sections of this proxy statement referred to above. The Braze Board of Directors unanimously recommends that Braze stockholders approve the following resolution:
“RESOLVED, that the stockholders of Braze, Inc. approve, solely on an advisory, non-binding basis, the compensation that may be paid or become payable to Braze’s named executive officers in connection with the pending Merger transaction, as disclosed pursuant to Item 402(t) of Regulation S-K in the section of the proxy statement mailed to stockholders in connection with such Merger titled ‘The Merger (Proposal 1)—Quantification of Potential Payments and Benefits to Braze’s Named Executive Officers in Connection with the Merger,’ including the table titled ‘Golden Parachute Compensation’ and the accompanying footnotes, and the related narrative disclosure.”
Vote Required for Approval
The vote on the Merger-Related Compensation Proposal is a vote separate and apart from the vote on each of the Merger Agreement Proposal and the Adjournment Proposal. Accordingly, you may vote to approve the Merger Agreement Proposal and/or the Adjournment Proposal and vote not to approve the Merger-Related Compensation Proposal and vice versa. The approval of the Merger-Related Compensation Proposal by holders of Class A Common Stock is not a condition to the completion of the Merger. Because the vote on the Merger-Related Compensation Proposal is advisory only, it will not be binding on either Braze or Salesforce. Accordingly, if the Merger Agreement Proposal is approved and the Merger is completed, the Merger-Related Compensation may be paid to Braze named executive officers to the extent payable in accordance with the terms of the compensation agreements and arrangements even if holders of Class A Common Stock fail to approve the advisory vote regarding the Merger-Related Compensation Proposal.
The Merger-Related Compensation Proposal requires the affirmative vote of the holders of a majority of the votes cast affirmatively or negatively (excluding abstentions and broker non-votes) (in person (virtually) or by proxy) at the Special Meeting. Assuming a quorum is present, abstentions, failures to vote and broker non-votes will have no effect on the vote for the Merger-Related Compensation Proposal.
Recommendation of the Braze Board of Directors
THE BRAZE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT BRAZE
STOCKHOLDERS VOTE “FOR” THE MERGER-RELATED COMPENSATION PROPOSAL.
98

TABLE OF CONTENTS

VOTE ON ADJOURNMENT (PROPOSAL 3)
Overview
Braze stockholders are being asked to approve the adjournment from time to time of the Special Meeting, if deemed necessary or appropriate by the Braze Board of Directors or any committee thereof, including to solicit additional proxies if there are insufficient votes to approve the Merger Agreement Proposal at the time of the Special Meeting.
If, at the Special Meeting, the number of shares of Class A Common Stock present or represented and voting in favor of the Merger Agreement Proposal is insufficient to approve the Merger Agreement Proposal, Braze intends to move to adjourn the Special Meeting in order to enable the Braze Board of Directors to solicit additional proxies for approval of the Merger Agreement Proposal. In that event, Braze will ask holders of Class A Common Stock to vote on the Adjournment Proposal, but not the Merger Agreement Proposal or the Merger-Related Compensation Proposal.
In this proposal, Braze is asking holders of Class A Common Stock to authorize the holder of any proxy solicited by the Braze Board of Directors on a discretionary basis to vote in favor of adjourning the Special Meeting to another time and place, including for the purpose of soliciting additional proxies, including the solicitation of proxies from holders of Class A Common Stock who have previously voted against the Merger Agreement Proposal. Pursuant to the DGCL, the Special Meeting may be adjourned without new notice being given, so long as the new date, time and place of the reconvened Special Meeting are announced at the Special Meeting at which the adjournment is taken or displayed (during the time scheduled for the Special Meeting) on the same electronic network used to enable stockholders and proxy holders to participate in the Special Meeting by means of remote communication, unless the adjournment is for more than 30 days, in which case, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the Special Meeting. Any business may be transacted at the reconvened Special Meeting that might have been transacted at the original Special Meeting. Pursuant to the DGCL, if, however, the adjournment is for more than 30 days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting must be given to each stockholder of record entitled to vote at the meeting. The approval of the Adjournment Proposal by holders of Class A Common Stock is not a condition to the completion of the Merger.
Vote Required for Approval
The Adjournment Proposal requires the affirmative vote of the holders of a majority of the votes cast affirmatively or negatively (excluding abstentions and broker non-votes) (in person (virtually) or by proxy) at the Special Meeting, whether or not a quorum is present. Each share of Class A Common Stock outstanding on the Record Date of the Special Meeting is entitled to vote on this proposal. Failures to vote, abstentions and broker non-votes will have no effect on the vote for this proposal.
Whether or not a quorum is present at the Special Meeting, the Special Meeting may be adjourned from time to time by either the chairperson of the Special Meeting or by the stockholders by the affirmative vote of a majority of the votes cast affirmatively or negatively (excluding abstentions and broker non-votes).
Recommendation of the Braze Board of Directors
THE BRAZE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT BRAZE
STOCKHOLDERS VOTE “FOR” THE ADJOURNMENT PROPOSAL.
99

TABLE OF CONTENTS

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
To Braze’s knowledge, the following table sets forth certain information regarding the beneficial ownership of Class A Common Stock as of the close of business on November 16, 2026 (known as the “beneficial ownership date”), unless otherwise noted, for (a) each person who is known by Braze to own beneficially more than 5% of the shares of Class A Common Stock, (b) each of Braze’s current and incumbent directors, (c) each of Braze’s executive officers identified as “Named Executive Officers” in the table below, and (d) all of Braze’s directors and executive officers as a group, in each case as of the beneficial ownership date.
The percentages of voting shares provided in the table are based on 113,838,216 shares of Class A Common Stock issued and outstanding as of the beneficial ownership date. Under the rules of the SEC, a person is deemed to be a “beneficial owner” of a security if that person has or shares “voting power,” which includes the power to vote or to direct the voting of such security, or “investment power,” which includes the power to dispose of or to direct the disposition of such security. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, shares of Class A Common Stock subject to options held by that person that are currently exercisable or exercisable within 60 days of the beneficial ownership date, if any, are deemed outstanding, as are shares of Class A Common Stock subject to unvested restricted stock units and unvested restricted stock scheduled to vest within 60 days of the beneficial ownership date, but are not deemed outstanding for computing the percentage ownership of any other person. Except as indicated by footnote, the persons named in the table below have sole voting and investment power with respect to all shares of Class A Common Stock shown as beneficially owned by them, subject to community property laws where applicable.
Except as otherwise noted below, the address for persons listed in the table is c/o Braze, Inc. at 63 Madison Building, 28 East 28th Street, Floor 12, New York, New York 10016.
 
 
 
 
 
 
 
Class A
Name
 
 
Shares (#)
 
 
%
5% Stockholders:
 
 
 
 
 
 
BlackRock, Inc.(1)
 
 
7,999,821
 
 
7.03%
Entities affiliated with MCG7 Capital Inc.(2)
 
 
6,709,408
 
 
5.90%
Named Executive Officers and Directors:
 
 
 
 
 
 
William Magnuson(3)
 
 
5,594,617
 
 
4.86%
Neeraj Agrawal(4)
 
 
5,218,934
 
 
4.58%
Jonathan Hyman(5)
 
 
1,594,783
 
 
1.40%
Edward McDonnell(6)
 
 
94,562
 
 
*
Astha Malik(7)
 
 
43,208
 
 
*
Fernando Machado(8)
 
 
13,970
 
 
*
Yvonne Wassenaar(9)
 
 
8,947
 
 
*
David Obstler(10)
 
 
68,052
 
 
*
Phillip Fernandez(11)
 
 
165,994
 
 
*
Tara Levy(12)
 
 
94,240
 
 
*
All executive officers and directors as a group (12 persons)(13)
 
 
12,936,828
 
 
11.18%
 
 
 
 
 
 
 
*
Represents less than one percent (1%).
(1)
Beneficial ownership information is based on information contained in the Schedule 13G/A filed with the SEC on July 27, 2026 by BlackRock, Inc., reporting beneficial ownership as of June 30, 2026. The shares consist of 7,999,821 shares of Class A Common Stock beneficially owned by BlackRock, Inc. and certain of its subsidiaries.
(2)
Beneficial ownership information is based on information contained in the Schedule 13G/A filed with the SEC on May 14, 2026 by MCG7 Capital Inc. (“MCG7”) and certain of its affiliates, reporting beneficial ownership as of March 31, 2026. The shares consist of (i) 6,353,960 shares of Class A Common Stock held by Binder Clip Holdings LLC, an indirect wholly owned subsidiary of MCG7, and (ii) 355,448 shares of Class A Common Stock held by Appboy BH LLC.
100

TABLE OF CONTENTS

(3)
Consists of (i) 4,259,021 shares of Class A Common Stock, including 470 shares of Class A Common Stock held by Scintillating Holdings LLC, (ii) 1,251,658 shares of Class A Common Stock subject to outstanding options that became exercisable within 60 days of November 16, 2026, and (iii) 83,938 shares of Class A Common Stock subject to outstanding RSUs that vested within 60 days of November 16, 2026, in each case held by Mr. Magnuson. Mr. Magnuson is considered to have beneficial ownership of the shares held by Scintillating Holdings LLC.
(4)
Consists of (i) 590,645 shares of Class A Common Stock held by Mr. Agrawal individually and (ii) 4,628,289 shares of Class A Common Stock held by entities affiliated with Battery Ventures, consisting of 714,569 shares held by Battery Ventures XI-A, L.P. (“BVXI-A”), 188,805 shares held by Battery Ventures XI-B, L.P. (“BVXI-B”), 742,400 shares held by Battery Ventures XI-A Side Fund, L.P. (“BVXI-A SF”), 160,974 shares held by Battery Ventures XI-B Side Fund, L.P. (“BVXI-B SF”), 33,116 shares held by Battery Investment Partners XI, LLC (“BIPXI”), 2,537,467 shares held by Battery Ventures Select Fund I, L.P. (“BV Select Fund I”) and 250,958 shares held by Battery Investment Partners Select Fund I, L.P. (“BIP Select Fund I”). Battery Partners XI, LLC (“BPXI”) is the general partner of each of BVXI-A and BVXI-B and the managing member of BIPXI, and Battery Partners XI Side Fund, LLC (“BPXISF”) is the general partner of each of BVXI-A SF and BVXI-B SF. Battery Partners Select Fund I, L.P. (“BP Select Fund I”) is the general partner of BV Select Fund I, and Battery Partners Select Fund I GP, LLC is the general partner of each of BP Select Fund I and BIP Select Fund I. Mr. Agrawal is a managing member of each of BPXI, BPXISF and Battery Partners Select Fund I GP, LLC and shares voting and investment authority over the shares held by such entities with the other managing members thereof. Mr. Agrawal disclaims beneficial ownership of such shares except to the extent of his individual interest therein.
(5)
Consists of (i) 641,035 shares of Class A Common Stock, including 350,000 shares held by the Hyman 2026 Charitable Remainder Trust, 221,436 shares held by the Hyman 2021 GST Descendants Trust and 28,564 shares held by the Hyman 2021 GST Family Trust, (ii) 325,213 shares of Class A Common Stock subject to outstanding options that are exercisable or will become exercisable within 60 days of November 16, 2026, and (iii) 28,535 shares of Class A Common Stock subject to outstanding RSUs that will vest within 60 days of November 16, 2026, in each case held by Mr. Hyman.
(6)
Consists of (i) 64,298 shares of Class A Common Stock and (ii) 30,264 shares of Class A Common Stock subject to outstanding RSUs that will vest within 60 days of November 16, 2026, each held by Mr. McDonnell.
(7)
Consists of (i) 11,102 shares of Class A Common Stock and (ii) 32,106 shares of Class A Common Stock subject to outstanding RSUs that will vest within 60 days of November 16, 2026, each held by Ms. Malik.
(8)
Consists of 13,970 shares of Class A Common Stock held by Mr. Machado.
(9)
Consists of 8,947 shares of Class A Common Stock held by Ms. Wassenaar.
(10)
Consists of 68,052 shares of Class A Common Stock held by Mr. Obstler.
(11)
Consists of (i) 20,302 shares of Class A Common Stock and (ii) 145,692 shares of Class A Common Stock subject to outstanding options that are exercisable or will become exercisable within 60 days of November 16, 2026, each held by Mr. Fernandez.
(12)
Consists of 94,240 shares of Class A Common Stock held by Ms. Levy.
(13)
Consists of 11,033,546 shares of Class A common stock, 1,722,563 shares of Class A Common Stock subject to options that were exercisable or became exercisable within 60 days of November 16, 2026 and 180,719 shares of Class A Common Stock subject to RSUs that vested within 60 days of November 16, 2026, beneficially owned by directors and current executive officers.
101

TABLE OF CONTENTS

MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE MERGER
The following discussion sets forth the material U.S. federal income tax consequences of the Merger to U.S. Holders and Non-U.S. Holders (as defined below) of Class A Common Stock whose shares of Class A Common Stock are converted into the right to receive cash pursuant to the Merger. This discussion does not address any tax consequences arising under the laws of any U.S. state or local or non-U.S. jurisdiction, or under any U.S. federal laws other than those pertaining to income tax. In addition, it does not address any minimum tax consequences of the Merger, the potential application of the Medicare contribution tax on net investment income or any considerations under the Foreign Account Tax Compliance Act of 2010 (including the Treasury Regulations issued thereunder and intergovernmental agreements entered into pursuant thereto or in connection therewith). This discussion is based upon the Code, the Treasury regulations promulgated under the Code and court and administrative rulings and decisions, all as in effect on the date of this proxy statement and all of which are subject to change and to differing interpretation (possibly with retroactive effect), and any such change could affect the accuracy of the statements and conclusions set forth in this discussion.
This discussion addresses only consequences to those holders that hold their shares of Class A Common Stock as a “capital asset” within the meaning of Section 1221 of the Code. Further, this discussion does not address all aspects of U.S. federal income taxation that may be relevant to holders in light of their particular circumstances or that may be applicable to holders that are subject to special treatment under the U.S. federal income tax laws, such as:
•
banks, insurance companies or other financial institutions;
•
tax-exempt organizations or accounts;
•
governmental organizations;
•
S corporations, partnerships and any other entity or arrangement treated as a partnership or a pass-through entity for U.S. federal income tax purposes (and owners therein);
•
passive foreign investment companies, controlled foreign corporations and foreign controlled foreign corporations;
•
real estate investment trusts or regulated investment companies;
•
dealers or brokers in stocks and securities, or currencies;
•
traders in securities that elect mark-to-market method of tax accounting with respect to their Class A Common Stock;
•
persons who hold or receive shares of Class A Common Stock pursuant to the exercise of any employee stock option or otherwise as compensation;
•
U.S. Holders that have a functional currency other than the U.S. dollar;
•
holders of Class A Common Stock that hold Class A Common Stock as part of a hedge, straddle, constructive sale, conversion or other integrated transaction;
•
holders who actually or constructively own (or during the five-year period ending on the date of the Merger own) more than 5% of the Class A Common Stock (by vote or value);
•
persons subject to special tax accounting rules (including rules requiring recognition of gross income based on a taxpayer’s applicable financial statement);
•
certain United States expatriates;
•
holders who hold Class A Common Stock as part of a hedge, straddle, constructive sale, conversion transaction or other integrated investment; or
•
holders that exercise appraisal rights.
The U.S. federal income tax consequences to a partner in an entity or arrangement treated as a partnership for U.S. federal income tax purposes and that holds Class A Common Stock generally will depend on the status of the partner and the activities of the partnership. Partners in a partnership holding Class A Common Stock should consult their own tax advisors.
102

TABLE OF CONTENTS

We have not sought, and do not expect to seek, a ruling from the Internal Revenue Service (referred to as the “IRS”) as to any U.S. federal income tax consequence described herein, and no assurance can be given that the IRS will not take a position contrary to the discussion below, or that a court will not sustain any challenge by the IRS in the event of litigation. Furthermore, no opinion of counsel has been or will be rendered with respect to any tax considerations applicable to the Merger, or any related transactions. If the tax consequences described below are successfully challenged, the tax consequences applicable to the Merger may differ from the tax consequences described below.
Holders should consult with their own tax advisors as to the tax consequences of the Merger in light of their particular circumstances, including the applicability and effect of any alternative minimum tax and any U.S. state or local, non-U.S. or other tax laws and of changes in those laws.
U.S. Holders
For purposes of this proxy statement, the term “U.S. Holder” means a beneficial owner of Class A Common Stock that is (or is treated as), for U.S. federal income tax purposes:
•
a citizen or individual resident of the United States;
•
a corporation, or other entity taxable as a corporation for U.S. federal income tax purposes, created or organized in or under the laws of the United States, any state thereof or the District of Columbia;
•
a trust (a) that is subject to the primary supervision of a court within the United States and all the substantial decisions of which are controlled by one or more “United States persons” (within the meaning of the Code) or (b) that has a valid election in effect under applicable Treasury Regulations to be treated as a United States person; or
•
an estate the income of which is subject to U.S. federal income taxation regardless of its source.
For purposes of this proxy statement, the term “Non-U.S. Holder” means a beneficial owner of Class A Common Stock that is neither a U.S. Holder nor an entity or arrangement treated as a partnership for U.S. federal income tax purposes.
In general, a U.S. Holder receiving cash in exchange for Class A Common Stock pursuant to the Merger will recognize capital gain or loss for U.S. federal income tax purposes on the exchange in an amount equal to the difference, if any, between (a) the amount of cash received and (b) the U.S. Holder’s adjusted tax basis in the Class A Common Stock surrendered in the exchange. A U.S. Holder’s adjusted tax basis generally will equal the amount that such U.S. Holder paid for the shares of Class A Common Stock.
Gain or loss generally will be treated as long-term capital gain or loss if the U.S. Holder’s holding period in the Class A Common Stock is more than one year at the time of the completion of the Merger. Otherwise, such gain or loss will be short-term capital gain or loss. Short-term capital gain is subject to U.S. federal income tax at the same rates as ordinary income. Long-term capital gains of certain non-corporate U.S. Holders, including individuals, are currently subject to U.S. federal income tax at preferential rates of taxation. The deductibility of capital losses is subject to certain limitations.
If a U.S. Holder acquired different blocks of Class A Common Stock at different times or at different prices, any gain or loss and the holding period with respect to the Class A Common Stock exchanged must be determined separately with respect to each block of Class A Common Stock that is exchanged.
Non-U.S. Holders
The receipt of cash by a Non-U.S. Holder in exchange for shares of Class A Common Stock pursuant to the Merger generally will not be subject to U.S. federal income tax unless:
•
the gain, if any, on such shares is effectively connected with a trade or business of the Non-U.S. Holder in the United States (and, if required by an applicable income tax treaty, is attributable to the Non-U.S. Holder’s permanent establishment or fixed base in the United States); or
•
the Non-U.S. Holder is an individual who is present in the United States for 183 days or more in the taxable year of the exchange of shares of Class A Common Stock pursuant to the Merger and certain other conditions are met.
103

TABLE OF CONTENTS

Gain described in the first bullet point immediately above will be subject to U.S. federal income tax on a net income basis at the regular U.S. federal income tax rates in the same manner as if the Non-U.S. Holder were a U.S. Holder, subject to an applicable income tax treaty providing otherwise. If such Non-U.S. Holder is a foreign corporation, it may also be subject to a branch profits tax at a rate of 30% (or such lower rate as may be specified by an applicable income tax treaty) on its “effectively connected earnings and profits” for the taxable year, subject to certain adjustments. Non-U.S. Holders described in the second bullet point immediately above will be subject to tax on any gain realized on the exchange at a rate of 30% (or such lower rate as may be specified by an applicable income tax treaty), which may be offset by certain U.S.-source capital losses recognized in the same taxable year, if any, of the Non-U.S. Holder, provided that such Non-U.S. Holder has timely filed U.S. federal income tax returns with respect to such losses.
Non-U.S. Holders are urged to consult their tax advisors regarding the U.S. federal income tax consequences to them of the exchange of shares of Class A Common Stock for cash pursuant to the Merger, including any applicable income tax treaties that may provide for different rules.
Information Reporting and Backup Withholding
Payments of cash to a holder in the Merger may, under certain circumstances, be subject to information reporting and backup withholding (currently at a rate of 24%), unless the holder provides proof of an applicable exemption or furnishes its taxpayer identification number, and otherwise complies with all applicable requirements of the backup withholding rules (generally, by furnishing a properly completed and executed IRS Form W-9 or applicable IRS Form W-8 to the applicable withholding agent). Certain holders (such as corporations) are exempt from information reporting and backup withholding.
Non-U.S. Holders may be required to comply with certification requirements and identification procedures in order to establish an exemption from information reporting and backup withholding. Non-U.S. Holders should consult their own tax advisors regarding compliance with such requirements and procedures.
Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or credit against a holder’s U.S. federal income tax liability, if any, provided the required information is timely furnished to the IRS.
This discussion of material U.S. federal income tax consequences is not tax advice. Holders of Class A Common Stock should consult their tax advisors with respect to the particular tax consequences to them of the Merger, including the applicability and effect of any federal estate or gift tax rules, any minimum tax and any U.S. state or local, non-U.S. or other tax laws and of changes in those laws.
104

TABLE OF CONTENTS

FUTURE BRAZE STOCKHOLDER PROPOSALS
If the Merger is completed prior to Braze’s 2027 annual meeting of stockholders, Braze will not hold such meeting. If the Merger is not completed by such time, you will continue to be entitled to attend and participate in Braze annual meetings of stockholders, and Braze will hold a 2027 annual meeting of stockholders, in which case Braze will provide notice of or otherwise publicly disclose the date on which such 2027 annual meeting will be held. Braze will hold its annual meeting of stockholders in 2027 only if the Merger has not already been completed. If the 2027 annual meeting is held, stockholder proposals will be eligible for consideration for inclusion in the proxy statement and form of proxy for the 2027 annual meeting of Braze stockholders in accordance with Rule 14a-8 under the Exchange Act and Braze’s bylaws, as described below. On September 16, 2026, the SEC proposed to rescind Rule 14a-8. If the proposal is adopted and effective before the 2027 annual meeting, the deadlines and procedures described below may no longer apply.
Under Rule 14a-8, a stockholder who intends to present a proposal at our annual meeting in 2027, if held, and who wishes the proposal to be included in our proxy statement for that meeting must have submitted the proposal in writing to Braze, Inc., 63 Madison Building, 28 East 28th Street, Floor 12, New York, New York 10016, Attention: Secretary, by January 18, 2027. However, if the date of the 2027 annual meeting is changed by more than 30 days from the anniversary of the 2026 annual meeting (which occurred on June 30, 2026), notice must be delivered at a reasonable time before Braze begins to mail its proxy statement for the 2027 annual meeting. The proposal and its proponent must satisfy all applicable requirements of Rule 14a-8.
Any stockholder who wishes to bring a proposal or nominate a person for election to the Braze Board of Directors at the 2027 annual meeting without inclusion of the proposal in our proxy statement for that meeting must provide written notice of the proposal or nomination to the attention of Braze’s Secretary, not later than the close of business on April 1, 2027, nor earlier than the close of business on March 2, 2027, provided that if the 2027 annual meeting is not held between May 31, 2027 and July 30, 2027, to be timely, notice by the stockholder must be received (A) not earlier than the close of business on the 120th day prior to the 2027 annual meeting and (B) not later than the close of business on the later of the 90th day prior to the 2027 annual meeting or the tenth day following the day on which public announcement of the date of the 2027 annual meeting is first made. In addition to satisfying the foregoing requirements under Braze bylaws, to comply with the universal proxy rules under the Exchange Act, stockholders who intend to solicit proxies in support of director nominees other than Braze nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than May 1, 2027, provided that if the date of the 2027 annual meeting has changed by more than 30 days from the prior year, then notice must be provided by the later of the 60th day prior to the date of the 2027 annual meeting or the tenth day following the day on which public announcement of the date of the 2027 annual meeting is first made. Stockholder proposals should be addressed to: Braze, Inc., 63 Madison Building, 28 East 28th Street, Floor 12, New York, New York 10016, Attention: Secretary.
Stockholders are also advised to review Braze’s bylaws, which contain additional requirements about advance notice of stockholder proposals and director nominations. Braze’s bylaws are on file with the SEC and are available through its website at sec.gov.
105

TABLE OF CONTENTS

MULTIPLE STOCKHOLDERS SHARING ONE ADDRESS
The SEC has adopted rules that permit companies and intermediaries such as brokers to satisfy delivery requirements for proxy statements and annual reports with respect to two or more stockholders sharing the same address by delivering a single proxy statement or annual report, as applicable, addressed to those stockholders; provided that, for registered stockholders, householding is only permitted if consented to. Consent is considered to have been given if a stockholder does not object in writing within 60 days of having been given notice of the issuer’s intent to household such stockholder. As permitted by the Exchange Act, only one copy of this proxy statement is being delivered to Braze stockholders residing at the same address, unless such Braze stockholders have notified Braze of their desire to receive multiple copies of this proxy statement. Householding potentially provides extra convenience for stockholders and cost savings for companies.
Two or more stockholders sharing an address can request delivery of a single copy of Braze’s annual disclosure documents and this proxy statement if they are receiving multiple copies by sending a written request to Braze, Inc., 63 Madison Building, 28 East 28th Street, Floor 12, New York, New York 10016, Attention: Investor Relations or emailing ir@braze.com. In the same way, two or more stockholders sharing an address and receiving only a single copy of Braze’s annual disclosure documents and this proxy statement can request to each receive a separate copy of the disclosure documents. Braze will promptly comply with any such request. If a broker or other nominee holds your shares, please contact your broker or nominee to make such a request. Please be sure to include your name, the name of your brokerage firm and your account number.
106

TABLE OF CONTENTS

WHERE YOU CAN FIND MORE INFORMATION
Braze is subject to the reporting requirements of the Exchange Act. Accordingly, Braze files annual, quarterly and current reports, proxy statements and other information with the SEC. Braze’s SEC filings are available to the public at the internet website maintained by the SEC at www.sec.gov. Braze also makes available free of charge on the Investor Relations section of its website its Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, its definitive proxy statements and Section 16 reports on Forms 3, 4 and 5, as soon as reasonably practicable after it electronically files such reports or amendments with, or furnishes them to, the SEC. Braze’s internet website address is www.braze.com. The information located on, hyperlinked or otherwise connected to Braze’s website is not, and will not be deemed to be, a part of this proxy statement or incorporated into any other filings that Braze makes with the SEC.
The SEC allows Braze to “incorporate by reference” the information Braze files with the SEC into this proxy statement, which means that Braze can disclose important information to you by referring you to other documents filed separately with the SEC. The information incorporated by reference is deemed to be part of this proxy statement, except that information that Braze files later with the SEC will automatically update and supersede this information. This proxy statement incorporates by reference the documents listed below that have been previously filed with the SEC (other than, in each case, documents or information deemed to have been furnished and not filed in accordance with SEC rules):
 
 
 
 
Braze SEC Filings (File No. 001-41065)
 
 
Period or File Date
Annual Report on Form 10-K
 
 
Fiscal year ended January 31, 2026, filed on March 25, 2026
 
 
 
 
Quarterly Reports on Form 10-Q
 
 
Quarters ended April 30, 2026 and July 31, 2026, filed on May 28, 2026, and September 9, 2026, respectively
 
 
 
 
Current Reports on Form 8-K
 
 
Current Reports on Form 8-K, filed on February 2, 2026, April 7, 2026, April 28, 2026 (other than documents or information deemed to have been “furnished” and not “filed”), May 27, 2026 (other than documents or information deemed to have been “furnished” and not “filed”), July 2, 2026 and October 20, 2026
 
 
 
 
Proxy Statement on Schedule 14A
 
 
Filed on May 18, 2026
 
 
 
 
In addition, Braze incorporates by reference any future filings it makes with the SEC under Section 13(a), 13(c), 14 or 15(d) of the Exchange Act, from the date of this proxy statement until the date of the Special Meeting; provided, however, that Braze is not incorporating by reference any additional documents or information furnished and not filed with the SEC.
You can obtain any of these documents free of charge from the SEC through the SEC’s website at the address described above. You can also obtain any of these documents free of charge by sending a written request to Braze, Inc., 63 Madison Building, 28 East 28th Street, Floor 12, New York, New York 10016, Attention: Investor Relations or emailing ir@braze.com.
In the event of conflicting information in this proxy statement in comparison to any document incorporated by reference into this proxy statement, or among documents incorporated by reference, the information in the latest filed document controls.
THIS PROXY STATEMENT DOES NOT CONSTITUTE THE SOLICITATION OF A PROXY IN ANY JURISDICTION WHERE, OR TO OR FROM ANY PERSON TO WHOM OR FROM WHOM IT IS UNLAWFUL TO MAKE SUCH PROXY SOLICITATION IN THAT JURISDICTION. YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED OR INCORPORATED BY REFERENCE INTO THIS PROXY STATEMENT TO VOTE YOUR SHARES AT THE SPECIAL MEETING OR ANY ADJOURNMENT, POSTPONEMENT OR CONTINUATION THEREOF. BRAZE HAS NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH
107

TABLE OF CONTENTS

INFORMATION THAT IS DIFFERENT FROM WHAT IS CONTAINED IN THIS PROXY STATEMENT. THIS PROXY STATEMENT IS DATED     ,    . YOU SHOULD NOT ASSUME THAT THE INFORMATION CONTAINED IN THIS PROXY STATEMENT IS ACCURATE AS OF ANY DATE OTHER THAN THAT DATE, AND THE MAILING OF THIS PROXY STATEMENT TO STOCKHOLDERS DOES NOT CREATE ANY IMPLICATION TO THE CONTRARY.
If you have any questions concerning the Merger, the Special Meeting or the accompanying proxy statement, would like additional copies of the accompanying proxy statement or need help voting your shares of Class A Common Stock, please contact the firm assisting us with the solicitation of proxies:

 
500 Fifth Avenue, 21st Floor
New York, NY 10110
Stockholders May Call:
(877) 456-3524 (toll-free from the U.S. and Canada), or
+1 (412) 232-3651 (from other countries)
Banks and Brokers May Call Collect: (212) 750-5833
108

TABLE OF CONTENTS

MISCELLANEOUS
Braze has supplied all of the information in this proxy statement relating to Braze. Salesforce has supplied all of the information relating to Salesforce and Banff Acquisition Sub contained in this proxy statement. You should rely only on the information contained or incorporated by reference into this proxy statement. Braze can assure the accuracy of only the information contained in this proxy statement, the annexes to this proxy statement and the documents that Braze incorporates by reference in this proxy statement. Braze has not authorized anyone to provide you with information that is different from what is contained in this proxy statement. This proxy statement is dated     ,    . You should not assume that the information contained in this proxy statement is accurate as of any date other than that date (or as of an earlier date if so indicated in this proxy statement), and the mailing of this proxy statement to stockholders does not create any implication to the contrary. This proxy statement does not constitute a solicitation of a proxy in any jurisdiction where, or to or from any person to whom, it is unlawful to make a proxy solicitation.
109

TABLE OF CONTENTS

Annex A
AGREEMENT AND PLAN OF MERGER
 
by and among
 
SALESFORCE, INC.,
 
BANFF ACQUISITION SUB INC.,
 
and
 
BRAZE, INC.
 
dated as of
 
October 19, 2026

TABLE OF CONTENTS

 
 
 
 
 
 
 
Page
ARTICLE I THE MERGER
 
 
A-1
 
 
 
 
 
 
 
 
 
 
 
 
 
Section 1.1.
 
 
The Merger
 
 
A-1
 
 
 
Section 1.2.
 
 
Effect of the Merger
 
 
A-1
 
 
 
Section 1.3.
 
 
The Closing
 
 
A-1
 
 
 
Section 1.4.
 
 
Effective Time
 
 
A-2
 
 
 
Section 1.5.
 
 
Governing Documents
 
 
A-2
 
 
 
Section 1.6.
 
 
Officers and Directors
 
 
A-2
 
 
 
 
 
 
 
 
 
 
ARTICLE II TREATMENT OF SECURITIES
 
 
A-2
 
 
 
 
 
 
 
 
 
 
 
 
 
Section 2.1.
 
 
Treatment of Capital Stock
 
 
A-2
 
 
 
Section 2.2.
 
 
Payment for Securities; Surrender of Certificates
 
 
A-3
 
 
 
Section 2.3.
 
 
Treatment of Company Equity Awards and the Company ESPP
 
 
A-5
 
 
 
Section 2.4.
 
 
Withholding
 
 
A-6
 
 
 
 
 
 
 
 
 
 
ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE COMPANY
 
 
A-7
 
 
 
 
 
 
 
 
 
 
 
 
 
Section 3.1.
 
 
Qualification, Organization, Subsidiaries, etc.
 
 
A-7
 
 
 
Section 3.2.
 
 
Capitalization
 
 
A-7
 
 
 
Section 3.3.
 
 
Corporate Authority
 
 
A-9
 
 
 
Section 3.4.
 
 
Governmental Consents; No Violation
 
 
A-9
 
 
 
Section 3.5.
 
 
SEC Reports and Financial Statements
 
 
A-10
 
 
 
Section 3.6.
 
 
Internal Controls and Procedures
 
 
A-11
 
 
 
Section 3.7.
 
 
No Undisclosed Liabilities
 
 
A-12
 
 
 
Section 3.8.
 
 
Absence of Certain Changes or Events
 
 
A-12
 
 
 
Section 3.9.
 
 
Compliance with Law; Permits
 
 
A-12
 
 
 
Section 3.10.
 
 
Employee Benefit Plans
 
 
A-13
 
 
 
Section 3.11.
 
 
Labor Matters
 
 
A-15
 
 
 
Section 3.12.
 
 
Tax Matters
 
 
A-16
 
 
 
Section 3.13.
 
 
Litigation; Orders
 
 
A-17
 
 
 
Section 3.14.
 
 
Intellectual Property
 
 
A-17
 
 
 
Section 3.15.
 
 
Privacy and Data Protection
 
 
A-20
 
 
 
Section 3.16.
 
 
Real and Personal Property
 
 
A-21
 
 
 
Section 3.17.
 
 
Material Contracts
 
 
A-22
 
 
 
Section 3.18.
 
 
Environmental Matters
 
 
A-24
 
 
 
Section 3.19.
 
 
Customers; Suppliers; Resellers; Government Entities
 
 
A-24
 
 
 
Section 3.20.
 
 
Insurance
 
 
A-24
 
 
 
Section 3.21.
 
 
Information Supplied
 
 
A-25
 
 
 
Section 3.22.
 
 
Opinion of Financial Advisor
 
 
A-25
 
 
 
Section 3.23.
 
 
State Takeover Statutes; Anti-Takeover Laws
 
 
A-25
 
 
 
Section 3.24.
 
 
Related Party Transactions
 
 
A-25
 
 
 
Section 3.25.
 
 
Finders and Brokers
 
 
A-25
 
 
 
Section 3.26.
 
 
No Other Representations
 
 
A-25
 
 
 
 
 
 
 
 
 
 
ARTICLE IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB
 
 
A-26
 
 
 
 
 
 
 
 
 
 
 
 
 
Section 4.1.
 
 
Qualification, Organization, etc.
 
 
A-26
 
 
 
Section 4.2.
 
 
Corporate Authority
 
 
A-26
 
 
 
Section 4.3.
 
 
Governmental Consents; No Violation
 
 
A-27
 
 
 
Section 4.4.
 
 
Litigation; Orders
 
 
A-27
 
 
 
Section 4.5.
 
 
Information Supplied
 
 
A-27
 
 
 
Section 4.6.
 
 
Sufficient Funds
 
 
A-27
 
 
 
Section 4.7.
 
 
Finders and Brokers
 
 
A-27
 
 
 
Section 4.8.
 
 
Stock Ownership
 
 
A-27
 
 
 
Section 4.9.
 
 
No Other Representations
 
 
A-28
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A-i

TABLE OF CONTENTS

 
 
 
 
 
 
 
Page
ARTICLE V COVENANTS RELATING TO CONDUCT OF BUSINESS PENDING THE MERGER
 
 
A-28
 
 
 
 
 
 
 
 
 
 
 
 
 
Section 5.1.
 
 
Conduct of Business by the Company Pending the Closing
 
 
A-28
 
 
 
Section 5.2.
 
 
No Solicitation by the Company
 
 
A-32
 
 
 
Section 5.3.
 
 
Preparation of Proxy Statement; Company Stockholders Meeting
 
 
A-35
 
 
 
 
 
 
 
 
 
 
ARTICLE VI ADDITIONAL AGREEMENTS
 
 
A-37
 
 
 
 
 
 
 
 
 
 
 
 
 
Section 6.1.
 
 
Access; Confidentiality; Notice of Certain Events
 
 
A-37
 
 
 
Section 6.2.
 
 
Reasonable Best Efforts
 
 
A-38
 
 
 
Section 6.3.
 
 
Publicity
 
 
A-40
 
 
 
Section 6.4.
 
 
D&O Insurance and Indemnification
 
 
A-40
 
 
 
Section 6.5.
 
 
Takeover Statutes
 
 
A-41
 
 
 
Section 6.6.
 
 
Obligations of Merger Sub
 
 
A-41
 
 
 
Section 6.7.
 
 
Employee Matters
 
 
A-41
 
 
 
Section 6.8.
 
 
Rule 16b-3
 
 
A-43
 
 
 
Section 6.9.
 
 
Stockholder Litigation
 
 
A-43
 
 
 
Section 6.10.
 
 
Delisting
 
 
A-43
 
 
 
Section 6.11.
 
 
Director Resignations
 
 
A-43
 
 
 
Section 6.12.
 
 
FIRPTA
 
 
A-43
 
 
 
Section 6.13.
 
 
Treatment of Company Indebtedness
 
 
A-44
 
 
 
 
 
 
 
 
 
 
 
 
ARTICLE VII CONDITIONS TO CONSUMMATION OF THE MERGER
 
 
A-44
 
 
 
 
 
 
 
 
 
 
 
 
 
Section 7.1.
 
 
Conditions to Each Party’s Obligations to Effect the Merger
 
 
A-44
 
 
 
Section 7.2.
 
 
Conditions to Obligations of Parent
 
 
A-45
 
 
 
Section 7.3.
 
 
Conditions to Obligations of the Company
 
 
A-46
 
 
 
 
 
 
 
 
 
 
ARTICLE VIII TERMINATION
 
 
A-46
 
 
 
 
 
 
 
 
 
 
 
 
 
Section 8.1.
 
 
Termination
 
 
A-46
 
 
 
Section 8.2.
 
 
Effect of Termination
 
 
A-47
 
 
 
 
 
 
 
 
 
 
ARTICLE IX MISCELLANEOUS
 
 
A-50
 
 
 
 
 
 
 
 
 
 
 
 
 
Section 9.1.
 
 
Amendment and Modification; Waiver
 
 
A-50
 
 
 
Section 9.2.
 
 
Non-Survival of Representations and Warranties
 
 
A-50
 
 
 
Section 9.3.
 
 
Expenses
 
 
A-50
 
 
 
Section 9.4.
 
 
Notices
 
 
A-50
 
 
 
Section 9.5.
 
 
Interpretation
 
 
A-51
 
 
 
Section 9.6.
 
 
Counterparts
 
 
A-52
 
 
 
Section 9.7.
 
 
Entire Agreement; Third-Party Beneficiaries
 
 
A-52
 
 
 
Section 9.8.
 
 
Severability
 
 
A-52
 
 
 
Section 9.9.
 
 
Governing Law; Jurisdiction
 
 
A-53
 
 
 
Section 9.10.
 
 
Waiver of Jury Trial
 
 
A-53
 
 
 
Section 9.11.
 
 
Assignment
 
 
A-53
 
 
 
Section 9.12.
 
 
Enforcement; Remedies
 
 
A-53
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Annex A
 
 
Certain Definitions
 
 
A-57
Annex B
 
 
Form of Voting and Support Agreement
 
 
A-67
 
 
 
 
 
 
 
A-ii

TABLE OF CONTENTS

AGREEMENT AND PLAN OF MERGER
This AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of October 19, 2026, is by and among Salesforce, Inc., a Delaware corporation (“Parent”), Banff Acquisition Sub Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and Braze, Inc., a Delaware corporation (the “Company”). All capitalized terms used in this Agreement shall have the meanings ascribed to such terms in Annex A or as otherwise defined elsewhere in this Agreement, unless the context clearly provides otherwise. Parent, Merger Sub and the Company are each sometimes referred to herein as a “Party” and collectively, as the “Parties.”
RECITALS
WHEREAS, it is proposed that Merger Sub shall merge with and into the Company, with the Company surviving the merger as a wholly owned Subsidiary of Parent (the “Merger”), upon the terms and subject to the conditions set forth in this Agreement and in accordance with the applicable provisions of the General Corporation Law of the State of Delaware (the “DGCL”);
WHEREAS, concurrently with the execution and delivery of this Agreement, and as a condition and material inducement to Parent to enter into this Agreement, the Persons signatory to the Voting Agreement (collectively, the “Company Support Parties”) are entering into a voting and support agreement with Parent (the “Voting Agreement”) in the form appended hereto as Annex B, pursuant to which, among other things, each Company Support Party is agreeing, subject to the terms of the Voting Agreement, to vote all shares of Class A Common Stock it owns in the manner set forth in the Voting Agreement;
WHEREAS, the board of directors of the Company (the “Company Board of Directors”) unanimously (i) determined that the terms of this Agreement and the transactions contemplated hereby (the “Transactions”), including the Merger, are fair to, and in the best interests of, the Company and its stockholders (the “Company Stockholders”), (ii) determined that it is in the best interests of the Company and the Company Stockholders and declared it advisable to enter into this Agreement, (iii) approved the execution and delivery by the Company of this Agreement and by the Company Support Parties of the Voting Agreement, the performance by the Company of its covenants and agreements contained herein and the consummation of the Merger and the other Transactions upon the terms and subject to the conditions contained herein and (iv) resolved to recommend that the Company Stockholders approve and adopt this Agreement and the Transactions, including the Merger (the “Company Board Recommendation”);
WHEREAS, the board of directors of each of Parent and Merger Sub and the sole stockholder of Merger Sub have approved this Agreement and determined that this Agreement and the Transactions, including the Merger, are (a) advisable and in the best interests of, Parent and its stockholders and (b) advisable, fair to, and in the best interest of, Merger Sub and its sole stockholder; and
WHEREAS, Parent and Merger Sub and the Company desire to make certain representations, warranties, covenants and agreements in connection with the Transactions and also to prescribe various conditions to the Transactions.
NOW, THEREFORE, in consideration of the mutual covenants and agreements contained in this Agreement and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties agree as follows:
ARTICLE I
 
THE MERGER
Section 1.1. The Merger. Upon the terms and subject to the conditions set forth in this Agreement, and in accordance with the relevant provisions of the DGCL, at the Effective Time, Merger Sub shall be merged with and into the Company, and the separate existence of Merger Sub shall cease. The Company will become a wholly owned Subsidiary of Parent and will continue as the surviving corporation in the Merger (the “Surviving Corporation”).
Section 1.2. Effect of the Merger. At the Effective Time, the effects of the Merger shall be as provided in this Agreement, the Certificate of Merger and the applicable provisions of the DGCL.
Section 1.3. The Closing. The closing of the Merger (the “Closing”) shall take place by means of a virtual closing through electronic exchange of documents and signatures at 4:00 a.m., Pacific Time, on the fifth (5th) Business
A-1

TABLE OF CONTENTS

Day after the satisfaction or, to the extent permitted by applicable Law, waiver of the last of the conditions set forth in Article VII to be satisfied or waived (other than any such conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or, to the extent permitted by applicable Law, waiver of such conditions at the Closing), unless another date or place is agreed to in writing by the Company and Parent. The date on which the Closing takes place is referred to as the “Closing Date.”
Section 1.4. Effective Time. Subject to the provisions of this Agreement, on the Closing Date, a certificate of merger satisfying the applicable requirements of the DGCL, in form and substance reasonably satisfactory to Parent and the Company (the “Certificate of Merger”), shall be duly executed by the Company and filed with the Secretary of State of the State of Delaware, and the Parties shall make any other filings, recordings or publications required to be made under the DGCL in connection with the Merger.
The Merger shall become effective upon the filing of the Certificate of Merger with the Secretary of State of the State of Delaware or, if otherwise agreed to by the Company and Parent, at such later time as may be specified in the Certificate of Merger (the effective time of the Merger being referred to as the “Effective Time”).
Section 1.5. Governing Documents. Subject to Section 6.4, at the Effective Time, (a) the Company Charter, as in effect immediately prior to the Effective Time, shall continue in full force and effect without amendment and shall be the certificate of incorporation of the Surviving Corporation until thereafter amended in accordance with the terms thereof and applicable Law, and (b) the Company Bylaws shall be amended and restated so as to read in their entirety in the form of the bylaws of Merger Sub as in effect immediately prior to the Effective Time, except that the references to Merger Sub’s name shall be replaced by references to “Braze, Inc.”, and, as so amended and restated, shall be the bylaws of the Surviving Corporation.
Section 1.6. Officers and Directors. Unless otherwise determined by Parent prior to the Effective Time, the Parties will use their respective best efforts to cause the officers of Merger Sub immediately prior to the Effective Time to be the initial officers of the Surviving Corporation from and after the Effective Time and the directors of Merger Sub immediately prior to the Effective Time to be the initial directors of the Surviving Corporation from and after the Effective Time.
ARTICLE II
 
TREATMENT OF SECURITIES
Section 2.1. Treatment of Capital Stock.
(a) The Merger. At the Effective Time by virtue of the Merger and without any action on the part of the holder thereof:
(i) Each share of Class A common stock, par value $0.0001 per share, of the Company (“Class A Common Stock”) issued and outstanding immediately prior to the Effective Time (other than any Dissenting Shares, Cancelled Shares or Converted Shares) shall be converted into the right to receive $47.50 per share of Class A Common Stock in cash, without interest (the “Per Share Merger Consideration”). From and after the Effective Time, all shares of Class A Common Stock (other than any Dissenting Shares, Cancelled Shares or Converted Shares) shall cease to be issued and outstanding and shall automatically be cancelled and retired and shall cease to exist, and each holder of a valid certificate or certificates which immediately prior to the Effective Time represented any such shares of Class A Common Stock (each, a “Certificate”) or evidenced by way of book-entry in the register of Company Stockholders immediately prior to the Effective Time (each, a “Book-Entry Share”) shall thereafter cease to have any rights with respect to such shares of Class A Common Stock, except the right to receive the Per Share Merger Consideration upon the surrender of such shares of Class A Common Stock in accordance with Section 2.2.
(ii) Each share of Class A Common Stock issued and outstanding immediately prior to the Effective Time that is owned or held in treasury by the Company or is owned by Parent shall be cancelled and shall cease to exist, and no consideration shall be delivered in exchange therefor (collectively, the “Cancelled Shares”). At the Effective Time, each share of Class A Common Stock issued and outstanding immediately prior to the Effective Time that is owned by any direct or indirect wholly owned Subsidiary of Parent or of the Company (the “Converted Shares”) shall be converted into such number of shares of common stock of the Surviving Corporation (“Surviving Corporation Stock”) equal to the product (rounded up to the nearest whole number, with 0.5 rounded up) of (i) (x) the number of shares of Class A Common Stock held by such
A-2

TABLE OF CONTENTS

Subsidiary immediately prior to the Effective Time, divided by (y) the number of shares of Class A Common Stock outstanding immediately prior to the Effective Time, and (ii) the total number of shares of Surviving Corporation Stock outstanding immediately after the consummation of the Merger.
(iii) Each share of common stock of Merger Sub issued and outstanding immediately prior to the Effective Time shall be automatically converted into and become one validly issued, fully paid and nonassessable share of Class A Common Stock of the Surviving Corporation.
(b) Dissenting Shares. Notwithstanding anything in this Agreement to the contrary, shares of Class A Common Stock that are issued and outstanding immediately prior to the Effective Time and that are owned by Company Stockholders that have properly perfected their rights of appraisal within the meaning of Section 262 of the DGCL (the “Dissenting Shares”) shall not be converted into the right to receive the Per Share Merger Consideration, unless and until such stockholders shall have failed to perfect any available right of appraisal under applicable Law, but, instead, the holders thereof shall be entitled to payment of the appraised value of such Dissenting Shares in accordance with Section 262 of the DGCL. Notwithstanding the foregoing, if any such holder shall have failed to perfect or shall have effectively withdrawn or lost such right of appraisal, such shares of Class A Common Stock held by such stockholder shall not be deemed Dissenting Shares for purposes of this Agreement and shall thereupon be deemed to have been converted into the Per Share Merger Consideration at the Effective Time in accordance with Section 2.1(a). The Company shall give Parent (A) prompt notice of any demands for appraisal filed pursuant to Section 262 of the DGCL received by the Company, withdrawals of such demands and any other instruments served or delivered in connection with such demands pursuant to the DGCL and received by the Company and (B) the opportunity and right to participate in all negotiations and proceedings with respect to demands made pursuant to Section 262 of the DGCL (it being understood that, subject to good-faith consultation with Parent, the Company will have the right to direct and control any such negotiations and proceedings). The Company shall not, except with the prior written consent of Parent, (x) make any payment with respect to any such demand, (y) offer to settle or settle any such demand or (z) waive any failure to timely deliver a written demand for appraisal or timely take any other action to perfect appraisal rights in accordance with the DGCL.
(c) Adjustment to Per Share Merger Consideration. The Per Share Merger Consideration shall be adjusted appropriately, without duplication, to reflect the effect of any stock split, reverse stock split, stock dividend (including any dividend or distribution of securities convertible into Class A Common Stock), reorganization, recapitalization, reclassification, combination, exchange of shares or other like change with respect to the number of shares of Class A Common Stock outstanding after the date hereof and prior to the Effective Time. Nothing in this Section 2.1(c) shall be construed to permit the Company to take any action with respect to its securities that is prohibited by the terms of this Agreement.
Section 2.2. Payment for Securities; Surrender of Certificates.
(a) Payment Fund. Prior to the Effective Time, Parent shall designate a bank or trust company reasonably acceptable to the Company to act as the paying agent in connection with the Merger (the “Paying Agent”). The Paying Agent shall also act as the agent for the Company Stockholders for the purpose of receiving and holding their Certificates and Book-Entry Shares and shall obtain no rights or interests in the shares represented thereby. At or immediately after the Effective Time, Parent shall deposit, or cause to be deposited, with the Paying Agent cash in immediately available funds in an amount sufficient to pay the aggregate Per Share Merger Consideration in accordance with Section 2.1(a)(i) (the “Payment Fund”), for the sole benefit of the holders of Class A Common Stock. In the event the Payment Fund shall be insufficient to pay the aggregate Per Share Merger Consideration in accordance with Section 2.1, Parent shall promptly deposit, or cause to be deposited, additional funds with the Paying Agent in an amount that is equal to the shortfall that is required to make such payment. Parent shall direct the Paying Agent to make delivery of the Per Share Merger Consideration out of the Payment Fund in accordance with this Agreement. The Payment Fund shall not be used for any purpose that is not expressly provided for in this Agreement. The Payment Fund shall be invested by the Paying Agent as reasonably directed by Parent; provided, however, that no such investment or loss thereon shall affect the amounts payable to holders of Certificates or Book-Entry Shares pursuant to this Article II. Any interest and other income resulting from such investments shall be paid to Parent. The Company shall direct its transfer agent to deliver a final record holders list to the Paying Agent at least three (3) Business Days prior to the Closing.
A-3

TABLE OF CONTENTS

(b) Procedures for Surrender.
(i) Class A Common Stock Certificates. Promptly after the Effective Time, Parent shall cause the Paying Agent to mail to each holder of record of a Certificate and whose shares of Class A Common Stock were converted pursuant to Section 2.1 into the right to receive the Per Share Merger Consideration (A) a letter of transmittal, which shall specify that delivery shall be effected, and risk of loss and title to the Certificates shall pass, only upon delivery of the Certificates (or affidavits of loss in lieu thereof and, if required by Parent, an indemnity bond) to the Paying Agent and shall be in such form and have such other provisions as Parent may reasonably specify and (B) instructions for effecting the surrender of the Certificates (or affidavits of loss in lieu thereof and, if required by Parent, an indemnity bond) in exchange for payment of the Per Share Merger Consideration into which such shares of Class A Common Stock have been converted pursuant to Section 2.1. Upon surrender of a Certificate (or an affidavit of loss in lieu thereof and, if required by Parent, an indemnity bond) for cancellation to the Paying Agent or to such other agent or agents as may be appointed by Parent, together with such letter of transmittal duly completed and validly executed in accordance with the instructions thereto, and such other documents as may be required pursuant to such instructions, the holder of such Certificate shall be entitled to receive in exchange therefor the Per Share Merger Consideration pursuant to the provisions of this Article II, and the Certificate (or affidavit of loss in lieu thereof and, if required by Parent, an indemnity bond) so surrendered shall be forthwith cancelled. The Paying Agent shall accept such Certificates (or affidavits of loss in lieu thereof and, if required by Parent, an indemnity bond) upon compliance with such reasonable terms and conditions as the Paying Agent may impose to effect an orderly exchange thereof in accordance with normal exchange practices. If payment of the Per Share Merger Consideration is to be made to a Person other than the Person in whose name the surrendered Certificate is registered, it shall be a condition precedent of payment that (x) the Certificate so surrendered shall be properly endorsed or shall be otherwise in proper form for transfer and (y) the Person requesting such payment shall have paid any transfer and other similar Taxes required by reason of the payment of the Per Share Merger Consideration to a Person other than the registered holder of the Certificate surrendered or shall have established to the satisfaction of Parent that such Tax either has been paid or is not required to be paid.
(ii) Book-Entry Shares. Any holder of any Book-Entry Shares and whose shares of Class A Common Stock were converted pursuant to Section 2.1 into the right to receive the Per Share Merger Consideration shall not be required to deliver a Certificate or an executed letter of transmittal to the Paying Agent to receive the Per Share Merger Consideration. In lieu thereof, each registered holder of one or more Book-Entry Shares shall automatically upon the Effective Time be entitled to receive, and Parent shall direct the Paying Agent to pay and deliver as promptly as reasonably practicable after the Effective Time (and in any event within five (5) Business Days following the Effective Time) the Per Share Merger Consideration pursuant to the provisions of this Article II, for each share of Class A Common Stock formerly represented by such Book-Entry Share, and the Book-Entry Share so exchanged shall be forthwith cancelled. Payment of the Per Share Merger Consideration with respect to Book-Entry Shares shall only be made to the person in whose name such Book-Entry Shares are registered.
(iii) No Interest. No interest shall be paid or accrue on any portion of the Per Share Merger Consideration payable upon surrender of any Certificate (or affidavit of loss in lieu thereof in accordance with Section 2.2(e)) or in respect of any Book-Entry Share.
(c) Transfer Books; No Further Ownership Rights in Class A Common Stock. At the Effective Time, the stock transfer books of the Company shall be closed and thereafter there shall be no further registration of transfers of Class A Common Stock on the records of the Company. The Company shall, five (5) Business Days prior to the anticipated Closing Date or such shorter period as requested by Parent, issue a stop transfer order to its transfer agent solely with respect to shares of Class A Common Stock of record. Until surrendered as contemplated by this Section 2.2, each Certificate and Book-Entry Share representing Class A Common Stock shall be deemed at any time after the Effective Time to represent only the right to receive the Per Share Merger Consideration as contemplated by this Article II. If, after the Effective Time, Certificates or Book-Entry Shares representing Class A Common Stock are presented to Parent for any reason, they shall no longer be outstanding and shall be automatically cancelled and exchanged as provided in this Agreement.
(d) Termination of Payment Fund; No Liability. At any time following the first (1st) anniversary of the Effective Time, Parent shall be entitled to require the Paying Agent to deliver to it any funds (including any interest
A-4

TABLE OF CONTENTS

received with respect thereto) remaining in the Payment Fund that have not been disbursed, or for which disbursement is pending subject only to the Paying Agent’s routine administrative procedures, to holders of Certificates or Book-Entry Shares, and thereafter such holders shall be entitled to look only to Parent (subject to abandoned property, escheat or similar Laws) as general creditors thereof with respect to the Per Share Merger Consideration, payable upon due surrender of their Certificates (or affidavit of loss in lieu thereof in accordance with Section 2.2(e)) or Book-Entry Shares and compliance with the procedures in Section 2.2(b), without any interest thereon. Notwithstanding the foregoing, none of Parent, the Company, Merger Sub, the Surviving Corporation or the Paying Agent shall be liable to any holder of a Certificate or Book-Entry Share for any Per Share Merger Consideration or other amounts delivered to a public official pursuant to any applicable abandoned property, escheat or similar Law.
(e) Lost, Stolen or Destroyed Certificates. In the event that any Certificates shall have been lost, stolen or destroyed, the Paying Agent shall issue in exchange for such lost, stolen or destroyed Certificates, upon the making of an affidavit of that fact by the holder thereof and, if required by Parent, an indemnity bond, the Per Share Merger Consideration payable in respect thereof pursuant to Section 2.1.
Section 2.3. Treatment of Company Equity Awards and the Company ESPP.
(a) At the Effective Time, each In-the-Money Company Option that is outstanding and unexercised immediately prior to the Effective Time shall, without any action on the part of Parent, the Company or the holder thereof, be cancelled, with the holder of such In-the-Money Company Option becoming entitled to receive, in full satisfaction of the rights of such holder with respect thereto, the Per Share Merger Consideration in respect of each Net Share covered by such Company Option, without interest and less applicable Tax withholdings.
(b) At the Effective Time, each Company Option that is not an In-the-Money Company Option and that is then outstanding and unexercised, whether or not vested, shall be cancelled with no consideration payable in respect thereof.
(c) At the Effective Time, each Company RSU that is outstanding immediately prior to the Effective Time and that (i) is held by a non-employee member of the Company Board of Directors or (ii) is vested shall, without any action on the part of Parent, the Company or the holder thereof, be cancelled, with the holder of such Company RSU becoming entitled to receive, in full satisfaction of the rights of such holder with respect thereto, the Per Share Merger Consideration in respect of each share of Class A Common Stock subject to such Company RSU immediately prior to the Effective Time, without interest and less applicable Tax withholdings.
(d) At the Effective Time, each Company RSU (other than any Company RSU covered by Section 2.3(c)) that is outstanding immediately prior to the Effective Time shall, without any action on the part of Parent, the Company or the holder thereof, be assumed and converted automatically into a restricted stock unit with respect to a number of shares of Parent Common Stock (each, an “Adjusted RSU”) equal to the product obtained by multiplying (i) the total number of shares of Class A Common Stock subject to the Company RSU immediately prior to the Effective Time by (ii) the Conversion Ratio, with any fractional shares rounded to the nearest whole share. Each Adjusted RSU shall otherwise be subject to the same terms and conditions applicable to the corresponding Company RSU under the applicable Company Equity Plan and the agreement evidencing the grant thereunder, including vesting terms.
(e) At the Effective Time, each Company PSU that is outstanding and unvested immediately prior to the Effective Time shall, without any action on the part of Parent, the Company or the holder thereof, be assumed and converted automatically into an Adjusted RSU equal to the product obtained by multiplying (i) the total number of shares of Class A Common Stock subject to the Company PSU immediately prior to the Effective Time (with such number of shares determined, (x) with respect to any performance period completed prior to the Closing Date (including the fiscal year beginning February 1, 2026, if the Closing Date is on or after February 1, 2027), based on the Actual Performance and (y) with respect to any performance period not completed prior to the Closing Date, the target level of performance (except that if the Closing Date occurs prior to February 1, 2027, the number of Company PSUs earned for the performance period beginning February 1, 2026 shall be determined based on the greater of (A) the target level of performance and (B) Actual Performance)) by (ii) the Conversion Ratio, with any fractional shares rounded to the nearest whole share. Each Adjusted RSU shall otherwise be subject to the same terms and conditions applicable to the corresponding Company PSU under the applicable Company Equity Plan and the agreement evidencing the grant thereunder, including vesting terms (but excluding any performance-based vesting conditions).
A-5

TABLE OF CONTENTS

(f) Notwithstanding anything to the contrary contained in this Section 2.3, if Parent determines that, for holders of Company Equity Awards (other than Company Restricted Shares) employed outside of the United States, the treatment of such Company Equity Awards prescribed by this Section 2.3 would reasonably be expected to cause a significant administrative burden to Parent, Parent may either (i) require that such awards be converted into cash-based awards, in any jurisdiction in which Parent has provided cash-based awards in lieu of equity-based awards to similarly situated employees of Parent and its Subsidiaries or in which Parent and its Subsidiaries do not have a material employee population as of immediately prior to the Effective Time, which cash-based awards shall otherwise have the same terms and conditions as the corresponding Company Equity Awards held by such individuals or (ii) cash out such awards at the Closing based on the value of the Per Share Merger Consideration.
(g) As soon as practicable following the date hereof, the Company shall take all actions with respect to the Company ESPP that are necessary to provide that: (i) with respect to any offering periods in effect as of the date hereof (the “Current ESPP Offering Periods”), no employee who is not a participant in a Current ESPP Offering Period as of the date hereof may become a participant in the Current ESPP Offering Period, and no participant may increase the percentage amount of his or her payroll deduction election from that in effect on the date hereof for such Current ESPP Offering Periods; (ii) subject to the consummation of the Merger, the Company ESPP shall terminate effective immediately prior to the Effective Time; (iii) if the Current ESPP Offering Periods terminate prior to the Effective Time, then the Company ESPP shall be suspended and no new offering period shall be commenced under the Company ESPP prior to the termination of this Agreement; and (iv) if any Current ESPP Offering Period is still in effect at the Effective Time, then the last day of such Current ESPP Offering Period shall be accelerated to a date that is no later than three (3) Business Days prior to the Closing Date.
(h) Prior to the Effective Time, the Company shall pass such resolutions and take such other actions as are necessary so as to cause the treatment of the Company Equity Awards and the Company ESPP as contemplated by this Section 2.3.
(i) Notwithstanding anything in Section 2.1(a) to the contrary, at the Effective Time, (i) each Assumed Company Restricted Share that is outstanding immediately prior to the Effective Time shall, without any action on the part of Parent, the Company or the holder thereof, be assumed and converted automatically into an award covering a number of shares of restricted Parent Common Stock (each, an “Adjusted Restricted Share”) equal to the product obtained by multiplying (x) the total number of Assumed Company Restricted Shares by (y) the Conversion Ratio, with any fractional shares rounded to the nearest whole share, and (ii) each Cashout Company Restricted Share that is outstanding immediately prior to the Effective Time shall, without any action on the part of Parent, the Company or the holder thereof, be converted, in full satisfaction of the holder’s rights in respect thereof, into the right to receive the Per Share Merger Consideration, without interest and less applicable Tax withholdings. Each Adjusted Restricted Share Award shall otherwise be subject to the same terms and conditions applicable to the corresponding Assumed Company Restricted Share under the agreement evidencing such grant, including vesting terms.
(j) Parent shall, or shall cause the Surviving Corporation to, pay to the holders of the Company Equity Awards the cash payments due pursuant to Section 2.3(a) and Section 2.3(c) (and, if applicable, Section 2.3(f) and Section 2.3(i)) as promptly as practicable following the Closing Date (but in no event later than the first payroll date that is at least ten (10) Business Days after the Closing Date); provided, however, that to the extent that any Company RSU or Company PSU constitutes nonqualified deferred compensation subject to Section 409A of the Code, such cash payment shall be paid at the earliest time permitted under the terms of such award that will not result in the application of a tax or penalty under Section 409A of the Code.
(k) Parent shall file with the SEC, at or as soon as reasonably practicable after the Effective Time, a registration statement on Form S-8 (or any successor form), to the extent such form is available, relating to the shares of Parent Common Stock issuable with respect to the Adjusted RSUs and Adjusted Restricted Shares. Parent shall use commercially reasonable efforts to maintain the effectiveness of such registration statement or statements for so long as Adjusted RSUs or Adjusted Restricted Shares remain outstanding.
Section 2.4. Withholding. Each of the Company, Parent, Merger Sub, the Surviving Corporation and the Paying Agent (without duplication) shall be entitled to deduct and withhold from amounts otherwise payable pursuant to this Agreement any amounts as are required to be withheld or deducted with respect to such payment under the Code, or any
A-6

TABLE OF CONTENTS

other applicable state, local or non-U.S. Tax Law. To the extent that amounts are so deducted or withheld and remitted to the applicable Governmental Entity, such deducted or withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction or withholding was made.
ARTICLE III
 
REPRESENTATIONS AND
WARRANTIES OF THE COMPANY
Except as disclosed in (x) any Company SEC Documents filed or furnished by the Company with or to the SEC since February 1, 2025, and publicly available prior to the date of this Agreement (including any exhibits and other information incorporated by reference therein, but excluding any predictive, cautionary or forward looking disclosures contained under the captions “risk factors,” “forward looking statements” or any similar precautionary sections and any other disclosures contained therein that are predictive, cautionary or forward looking in nature) or (y) the applicable section of the disclosure letter delivered by the Company to Parent immediately prior to the execution of this Agreement (the “Company Disclosure Letter”) (it being understood that any information set forth in one section or subsection of the Company Disclosure Letter shall be deemed to apply to and qualify (or, as applicable, a disclosure for purposes of) the representation and warranty set forth in this Agreement to which it corresponds in number and, whether or not an explicit reference or cross-reference is made, each other representation and warranty set forth in this Article III for which it is reasonably apparent on its face that such information is relevant to such other section), the Company represents and warrants to Parent and Merger Sub as set forth below.
Section 3.1. Qualification, Organization, Subsidiaries, etc.
(a) The Company is a legal entity duly organized, validly existing and in good standing under the Laws of its jurisdiction of organization. Except as would not be material to the Company and the Company Subsidiaries, taken as a whole, each Company Subsidiary is a legal entity duly organized and validly existing under the Laws of its respective jurisdiction of organization. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, each of the Company and the Company Subsidiaries has all requisite corporate or similar power and authority to own, lease and operate its properties and assets and to carry on its business as presently conducted. Each of the Company and the Company Subsidiaries is qualified to do business and is in good standing as a foreign corporation or other entity in each jurisdiction where the ownership, leasing or operation of its assets or properties or conduct of its business requires such qualification, except where the failure to be so qualified or, where relevant, in good standing, (1) has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect and (2) has not had and would not, either individually or in the aggregate, reasonably be expected to have a material adverse effect on the ability of the Company to consummate the Transactions, including the Merger, prior to the Outside Date. The Company has filed with the SEC, prior to the date hereof, a true, correct and complete copy of the Company Governing Documents as amended to the date hereof. The Company Governing Documents are in full force and effect and the Company is not in violation of the Company Governing Documents. The Company has made available to Parent prior to the date hereof true, correct and complete copies of the certificates of incorporation and bylaws, or equivalent organizational or governing documents, of each of the Company’s “significant subsidiaries” within the meaning of Rule 1-02 of Regulation S-X of the SEC, each as currently in effect.
(b) All the issued and outstanding shares of capital stock of, or other equity interests in, each Company Subsidiary have been validly issued and are fully paid and nonassessable and are wholly owned, directly or indirectly, by the Company free and clear of all Liens, other than Liens arising under any applicable securities Law or Permitted Liens. Section 3.1(b)(i) of the Company Disclosure Letter sets forth an accurate and complete list of each Company Subsidiary and each Person in which the Company or any Company Subsidiary owns an equity or other economic interest, together with (i) the jurisdiction of incorporation or organization, as the case may be, of each Company Subsidiary or such other Person, (ii) the type and percentage of interests held, directly or indirectly, by the Company in each Company Subsidiary or in each such other Person, (iii) the names and the type of and percentage of interests held by any Person other than the Company or a Company Subsidiary in each Company Subsidiary and (iv) the classification for U.S. federal income Tax purposes of each Company Subsidiary.
Section 3.2. Capitalization.
(a) The authorized capital stock of the Company consists of 2,110,000,000 shares of Class A Common Stock; and 10,000,000 shares of preferred stock, par value $0.0001 per share (“Company Preferred Stock”). As of
A-7

TABLE OF CONTENTS

October 15, 2026 (the “Company Capitalization Date”), (i) (A) 113,594,303 shares of Class A Common Stock were issued and outstanding (including 1,236,475 shares of Company Restricted Shares), (B) no shares of Class A Common Stock were held in the Company’s treasury, (C) no shares of Class A Common Stock were held by the Company Subsidiaries, (D) Company Options covering 2,859,370 shares of Class A Common Stock were outstanding (of which Company Options covering zero shares of Class A Common Stock remain unvested), with a weighted average exercise price per share of $26.49, (E) Company RSUs covering 10,691,078 shares of Class A Common Stock were outstanding, and (F) Company PSUs covering 329,336 shares of Class A Common Stock (based on achievement of the applicable performance metrics at the target level of performance) or 658,672 shares of Class A Common Stock (based on achievement of the applicable performance metrics at the maximum level of performance) were outstanding; (ii) 37,267,622 shares of Class A Common Stock were reserved for issuance pursuant to the Company Equity Plans; (iii) 5,757,391 shares of Class A Common Stock were reserved for issuance pursuant to the Company ESPP; (iv) no shares of Class B common stock, par value $0.0001 per share, of the Company were issued and outstanding and (v) no shares of Company Preferred Stock were issued or outstanding. All the outstanding shares of Class A Common Stock have been, and all shares of Class A Common Stock reserved for issuance as described above shall be, when issued in accordance with the respective terms thereof, duly authorized, validly issued, fully paid and nonassessable and free of preemptive rights and not subject to or issued in violation of any purchase option, call option, right of first refusal, or any similar right pursuant to any provision of applicable Law or any Contract to which the Company or any Company Subsidiary is a party or otherwise bound. None of the issued and outstanding shares of Class A Common Stock have been issued in violation of any applicable securities Laws.
(b) Section 3.2(b) of the Company Disclosure Letter sets forth a true, correct and complete list, as of the Company Capitalization Date, of (i) each Company Equity Award, (ii) the name, state and country of residence of the Company Equity Award holder, (iii) the number of shares of Class A Common Stock underlying each Company Equity Award (for each Company PSU, assuming achievement of each of the target and maximum levels of performance), (iv) the date on which the Company Equity Award was granted, (v) the Company Equity Plan under which the Company Equity Award was granted, (vi) the vesting commencement date and vesting schedule with respect to the Company Equity Award, including any right of acceleration of such vesting schedule, (vii) the performance metrics applicable to each Company Equity Award, if applicable, (viii) the exercise price of each Company Option, and (ix) the expiration date of each Company Option. The exercise price of each Company Option was at least equal to the fair market value (determined in accordance with Treasury Regulation Section 1.409A-1(b)(5)(iv)) of the Class A Common Stock on the date such Company Option was granted. All stock subject to the Company Options constitutes “service recipient stock” (as defined under Treasury Regulation 1.409A-1(b)(5)(iii)) with respect to the grantor thereof.
(c) Except as set forth in Section 3.2(a) and Section 3.2(b), and other than the shares of Class A Common Stock that have become outstanding after the Company Capitalization Date that were reserved for issuance as set forth in Section 3.2(a)(ii) and issued in accordance with the terms of the applicable Company Equity Plan and Company Equity Award, in each case as of the date hereof: (i) the Company does not have any shares of capital stock or other equity interests issued or outstanding and (ii) there are no outstanding subscriptions, options, warrants, puts, calls, exchangeable or convertible securities or other similar rights, agreements or commitments or any other Contract to which the Company or any Company Subsidiary is a party or is otherwise bound obligating the Company or any Company Subsidiary to (A) issue, transfer or sell, or make any payment with respect to, any shares of capital stock or other equity interests of the Company or any Company Subsidiary or securities convertible into, exchangeable for or exercisable for, or valued by reference to, or that correspond to, such shares or equity interests, (B) grant, extend or enter into any such subscription, option, warrant, put, call, exchangeable or convertible securities or other similar right, agreement or commitment, (C) redeem or otherwise acquire any such shares of capital stock or other equity interests or (D) provide any amount of funds to, or make any investment (in the form of a loan, capital contribution or otherwise) in, any Company Subsidiary that is not wholly owned or in any other Person. There are no outstanding obligations of the Company or any Company Subsidiary: (1) restricting the transfer of, (2) affecting the voting rights of, (3) requiring the repurchase, redemption or disposition of, or containing any right of first refusal, right of first offer or similar right with respect to, (4) requiring the registration for sale of or (5) granting any preemptive or anti-dilutive rights with respect to, any shares of capital stock or other equity interests of the Company or any Company Subsidiary.
A-8

TABLE OF CONTENTS

(d) Neither the Company nor any Company Subsidiary has outstanding bonds, debentures, notes or other similar obligations, the holders of which have the right to vote (or which are convertible into or exercisable for cash and/or securities having the right to vote) with the Company Stockholders on any matter.
(e) Other than the Voting Agreement with any Company Support Party, there are no voting trusts or other agreements, commitments or understandings to which the Company, any Company Subsidiary, or any Company Support Party is a party with respect to the voting of the capital stock or other equity interests of the Company or any Company Subsidiary.
(f) The Company or a Company Subsidiary owns less than fifty percent (50%) of the interest in the issued and outstanding capital stock and other equity interests of the entities set forth on Section 3.2(f) of the Company Disclosure Letter (such entities, the “Minority Investment Entities”). Section 3.2(f) of the Company Disclosure Letter sets forth a list of all Minority Investment Entities. The Company has made available to Parent prior to the date hereof true, correct and complete copies of the certificates of incorporation and bylaws, or equivalent organizational or governing documents, of the Minority Investment Entities, each as currently in effect.
Section 3.3. Corporate Authority.
(a) The Company has all requisite corporate power and authority to execute and deliver and perform its obligations under this Agreement and to consummate the Transactions, including, subject to receipt of the Company Stockholder Approval, the Merger. The execution and delivery of this Agreement, the performance of the Company’s obligations under this Agreement, and the consummation of the Transactions have been duly and validly authorized by the Company Board of Directors and no other corporate proceedings (pursuant to the Company Governing Documents or otherwise) on the part of the Company are necessary to authorize the performance of the Company’s obligations under this Agreement or the consummation of, and to consummate, the Transactions, except (i) the receipt of the Company Stockholder Approval and (ii) with respect to the Merger, the filing of the Certificate of Merger with the Secretary of State of the State of Delaware.
(b) The affirmative vote of the holders of a majority of the outstanding shares of Class A Common Stock entitled to vote thereon to approve the Merger and adopt this Agreement (the “Company Stockholder Approval”) is the only vote of the holders of any class or series of the Company’s capital stock necessary to approve and adopt this Agreement and to consummate the Transactions, including the Merger.
(c) On or prior to the date hereof, the Company Board of Directors has unanimously (i) determined that the terms of the Transactions, including the Merger, are fair to, and in the best interests of, the Company and the Company Stockholders, (ii) determined that it is fair to and in the best interests of the Company and the Company Stockholders, and declared it advisable, to enter into this Agreement, (iii) approved the execution and delivery by the Company of this Agreement and by the Company Support Parties of the Voting Agreement, the performance by the Company of its covenants and agreements contained herein and the consummation of the Merger and the other Transactions, in each case, upon the terms and subject to the conditions contained herein and (iv) unanimously resolved to recommend that the Company Stockholders approve the Merger and the Transactions and adopt this Agreement. None of the foregoing actions by the Company Board of Directors has been amended, rescinded or modified in any way (unless a Change of Recommendation has been effected after the date hereof in accordance with the terms of Section 5.2).
(d) This Agreement has been duly and validly executed and delivered by the Company and, assuming this Agreement constitutes the valid and binding agreement of Parent and Merger Sub, constitutes the valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, except that (i) such enforcement may be subject to applicable bankruptcy, insolvency, examinership, reorganization, moratorium or other similar Laws, now or hereafter in effect, relating to creditors’ rights generally and (ii) equitable remedies of specific performance and injunctive and other forms of equitable relief may be subject to equitable defenses and to the discretion of the court before which any proceeding therefor may be brought (clauses (i) and (ii), collectively, the “Enforceability Limitations”).
Section 3.4. Governmental Consents; No Violation.
(a) Other than (i) compliance with the DGCL, (ii) compliance with the Securities Act, (iii) compliance with the Exchange Act, including the filing and mailing of the Proxy Statement with the SEC and any amendments or supplements thereto, (iv) compliance with applicable state securities, takeover and “blue sky” laws, (v) compliance with the applicable requirements of the HSR Act and obtaining any requisite clearances or
A-9

TABLE OF CONTENTS

approvals under any other applicable Regulatory Laws and (vi) compliance with any applicable requirements of Nasdaq, no authorization, permit, notification to, consent or approval of, or filing with, any Governmental Entity is necessary or required, under applicable Law, for the execution, delivery and performance by the Company of this Agreement and consummation by the Company of the Transactions, except for such authorizations, permits, notifications, consents, approvals or filings that, if not obtained or made, (1) has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect or (2) a material adverse effect on the ability of the Company to consummate the Transactions, including the Merger, prior to the Outside Date.
(b) The execution and delivery by the Company of this Agreement do not, and, subject to the receipt of the Company Stockholder Approval and except as described in Section 3.4(a), the consummation of the Transactions and performance and compliance with the provisions hereof will not (i) require consent or other action by any person under or conflict with or result in any violation or breach of, or default or change of control (with or without notice or lapse of time, or both) under, or give rise to a right of, or result in, termination, modification, cancellation, first offer, first refusal or acceleration of any obligation or to the loss of a benefit under any Contract binding upon the Company or any Company Subsidiary or to which any of them are a party or by which or to which any of their respective properties, rights or assets are bound or subject, or result in the creation or imposition of any Lien upon any of the properties, rights or assets of the Company or any Company Subsidiary, other than Permitted Liens, (ii) conflict with or result in any violation of any provision of the Company Governing Documents or the organizational or governing documents of any Company Subsidiary or (iii) conflict with or violate any Laws applicable to the Company or any Company Subsidiary or any of their respective properties, rights or assets, other than in the case of clause (i) and clause (iii), any such violation, breach, conflict, default, termination, modification, cancellation, acceleration, right, loss or Lien that (1) has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect or (2) a material adverse effect on the ability of the Company to consummate the Transactions, including the Merger, prior to the Outside Date.
Section 3.5. SEC Reports and Financial Statements.
(a) Since February 1, 2023, the Company has timely filed or furnished all registration statements, forms, statements, schedules, exhibits, documents and reports required to be filed or furnished by it with the SEC (such forms, statements, schedules, documents and reports, the “Company SEC Documents”). As of their respective filing dates or, if amended prior to the date hereof, as of the date of (and giving effect to) the last such amendment, the Company SEC Documents complied in all material respects with the applicable requirements of the Sarbanes-Oxley Act of 2002, as amended (the “Sarbanes-Oxley Act”), the Securities Act and the Exchange Act, as the case may be, and the applicable rules and regulations promulgated thereunder and the listing and corporate governance rules and regulations of Nasdaq, and none of the Company SEC Documents contained (or, with respect to the Company SEC Documents filed after the date hereof, will contain) any untrue statement of a material fact or omitted (or with respect to the Company SEC Documents filed after the date hereof, will omit) to state any material fact required to be stated therein or necessary to make the statements therein, at the time and in light of the circumstances under which they were made, not misleading. Since February 1, 2025, neither the Company nor any Company Subsidiary has received from the SEC or any other Governmental Entity any written comments or questions with respect to any of the Company SEC Documents (including the financial statements included therein) that are not resolved, or, as of the date hereof, has received any written notice from the SEC or other Governmental Entity that such Company SEC Documents (including the financial statements included therein) are being reviewed or investigated, and, to the Company’s Knowledge, there is not, as of the date hereof, any investigation or review being conducted by the SEC or any other Governmental Entity of any Company SEC Documents (including the financial statements included therein). No Company Subsidiary is required to file any forms, reports or other documents with, or furnish any other material to, the SEC. As of the date of this Agreement, to the Company’s Knowledge, (i) no Company SEC Document is the subject of ongoing SEC review, and (ii) no such review is threatened with respect to any Company SEC Document.
(b) The consolidated financial statements (in each case, including all related notes and schedules) of the Company included or incorporated by reference in the Company SEC Documents when filed or, if amended prior to the date hereof, as of the date of (and giving effect to) the last such amendment, complied in all material respects with the applicable accounting requirements and the published rules and regulations of the SEC with respect thereto, in each case in effect at the time of such filing, and fairly present in all material respects the consolidated financial position of the Company and its consolidated Subsidiaries, as at the respective dates thereof, and the
A-10

TABLE OF CONTENTS

consolidated results of their operations and their consolidated cash flows for the respective periods then ended (subject, in the case of the unaudited quarterly financial statements, to normal year-end audit adjustments and any other adjustment described therein permitted by the rules and regulations of the SEC and to the absence of notes) in conformity with United States Generally Accepted Accounting Principles (“GAAP”) applied on a consistent basis during the periods involved (subject, in the case of the unaudited quarterly financial statements, to normal year-end audit adjustments and any other adjustment described therein permitted by the rules and regulations of the SEC and to the absence of notes, none of which would be reasonably expected to be, as of the date hereof, material individually or in the aggregate).
(c) The Company is in compliance in all material respects with the applicable provisions of the Sarbanes-Oxley Act and the Dodd-Frank Wall Street Reform and Consumer Protection Act, as amended. Each required form, report and document containing financial statements that has been filed with or submitted to the SEC was accompanied by any certifications required to be filed or submitted by the Company’s principal executive officer and principal financial officer pursuant to the Sarbanes-Oxley Act and, at the time of filing or submission of each such certification, such certification complied in all material respects with the applicable provisions of the Sarbanes-Oxley Act. Neither the Company nor any of its executive officers has received written notice from any Governmental Entity challenging or questioning the accuracy, completeness, form or manner of filing of such certifications.
(d) Neither the Company nor any Company Subsidiary is a party to, or has any Contract to become a party to, any joint venture, off-balance sheet partnership or any similar Contract, including any Contract relating to any transaction or relationship between or among the Company or any Company Subsidiary, on the one hand, and any unconsolidated affiliate, including any structured finance, special purpose or limited purpose entity or Person, on the other hand, or any off-balance sheet arrangements (as defined in Item 303(a) of Regulation S-K of the SEC), in any such case, where the purpose of such Contract is to avoid disclosure of any material transaction involving, or material liabilities of, the Company in the Company’s published financial statements or any Company SEC Documents.
Section 3.6. Internal Controls and Procedures. The Company has established and maintains disclosure controls and procedures and internal control over financial reporting (as such terms are defined in paragraphs (e) and (f), respectively, of Rule 13a-15 under the Exchange Act) as required by Rule 13a-15 under the Exchange Act, designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP, and which includes policies and procedures that: (a) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company and (b) are designed to provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP. The Company’s disclosure controls and procedures are reasonably designed to ensure the reliability of the Company’s financial reporting, including that all material information required to be disclosed by the Company and the Company Subsidiaries in the reports that it files or furnishes under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that all such material information is accumulated and communicated to the Company’s management by others within those entities as appropriate to allow timely decisions regarding required disclosure and to make the certifications required pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act and that such material information is disclosed to the Company’s auditors and the audit committee of the Company Board of Directors. Since February 1, 2022, the Company’s principal executive officer and its principal financial officer have disclosed to the Company’s auditors and the audit committee of the Company Board of Directors (the material circumstances of which disclosure (if any) and significant facts learned during the preparation of such disclosure have been made available to Parent prior to the date hereof) (i) any significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting, (ii) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal controls over financial reporting and (iii) any written claim or allegation regarding clause (i) or (ii). Since February 1, 2022, neither the Company nor any Company Subsidiary has received any material, unresolved complaint, allegation, assertion or claim, whether written or, to the Company’s Knowledge, oral, regarding the accounting or auditing practices, procedures, methodologies or methods of the Company or any Company Subsidiary or their respective internal accounting controls, and no attorney representing the Company or any Company Subsidiary, whether or not employed by the Company or any Company Subsidiary, has, to the Company’s Knowledge, reported in writing credible evidence of a material violation of securities
A-11

TABLE OF CONTENTS

Laws, breach of fiduciary duty or similar violation by the Company or any Company Subsidiary or their respective officers, directors, employees or agents to the Company Board of Directors or any committee thereof or to the Chief Legal Officer, Chief Executive Officer or Chief Financial Officer of the Company.
Section 3.7. No Undisclosed Liabilities. Neither the Company nor any Company Subsidiary has any liabilities of any nature, whether or not accrued, contingent, absolute, determined, determinable or otherwise, except (a) as and to the extent specifically disclosed, reflected or reserved against in the Company’s consolidated balance sheet (or the notes thereto) as of January 31, 2025, included in the Company SEC Documents filed or furnished prior to the date hereof, (b) for liabilities incurred or which have been discharged or paid in full, in each case, in the ordinary course of business consistent with past practice since January 31, 2025 (other than any liability for any material breaches of Contracts), (c) as expressly required or expressly contemplated by this Agreement and (d) for liabilities which have not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.
Section 3.8. Absence of Certain Changes or Events.
(a) From February 1, 2026, there has not occurred any Effect that has had or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.
(b) From February 1, 2026 through the date hereof, (i) except to the extent it relates to the events giving rise to and the discussion and negotiation of this Agreement and the Transactions, the businesses of the Company and the Company Subsidiaries have been conducted in all material respects in the ordinary course of business consistent with past practice and (ii) neither the Company nor any Company Subsidiary has taken any action that, if taken after the date hereof, would constitute a breach of, or require the consent of Parent under, Section 5.1(b) (other than any actions specified by clauses (i), (iv), (v), (vii), (x), (xi), (xii), (xv), (xx) or (xxvi) (to the extent clause (xxvi) relates to the foregoing clauses)).
Section 3.9. Compliance with Law; Permits.
(a) The Company and each Company Subsidiary, and, to the Company’s Knowledge, their respective directors and officers are and have been since February 1, 2023 in compliance with, and not in default under or in violation of, any Laws (including Environmental Laws and employee benefits and labor Laws) applicable to the Company or such Company Subsidiary or any of their respective properties or assets, except where such non-compliance, default or violation has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.
(b) The Company and the Company Subsidiaries are and have been since February 1, 2023 in possession of all franchises, grants, authorizations, business licenses, permits, easements, variances, exceptions, consents, certificates, approvals, registrations, clearances and orders of any Governmental Entity or pursuant to any applicable Law necessary for the Company and the Company Subsidiaries to own, lease and operate their properties and assets or to carry on their businesses as they are now being conducted (the “Company Permits”), except where the failure to have any of the Company Permits has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, all Company Permits are in full force and effect, no default (with or without notice, lapse of time or both) has occurred under any such Company Permit and none of the Company or any Company Subsidiary has received any written notice from any Governmental Entity threatening to suspend, revoke, withdraw or modify any such Company Permit.
(c) Except as would not, individually or in the aggregate, reasonably be expected to be material to the Company and the Company Subsidiaries, taken as a whole, none of the Company or any Company Subsidiary, or any of their respective directors, officers, or employees, or, to the Company’s Knowledge, agents or any other third party (including the Company’s or the Company Subsidiaries’ respective Representatives) acting on behalf of the Company or any Company Subsidiary, has, during the past five (5) years, directly or indirectly (i) taken any action in violation of any applicable Anti-Corruption Law or anti-money laundering laws, (ii) offered, authorized, provided or promised (or made attempts at doing any of the foregoing) any payment or thing of value to any Person, including a “foreign official” (as defined by the FCPA), for the purpose of influencing any acts or decision of such Person to unlawfully obtain or retain business or other advantage or (iii) taken any other action that would
A-12

TABLE OF CONTENTS

constitute an offer to pay, a promise to pay or a payment of money or anything else of value, or an authorization of such offer, promise or payment, directly or indirectly, to any Representative of another Person in the course of their business dealings with the Company or any Company Subsidiary, in order to unlawfully induce such Person to act against the interest of his or her employer or principal.
(d) Except as would not, individually or in the aggregate, reasonably be expected to be material to the Company and the Company Subsidiaries, taken as a whole, none of the Company or any Company Subsidiary or, to the Company’s Knowledge, any of their respective officers, directors, employees, agents or persons acting on it or any Company Subsidiary’s behalf, is or has in the last five (5) years been subject to any actual, pending, or, to the Company’s Knowledge, threatened civil, criminal, or administrative actions, suits, demands, claims, hearings, notices of violation, investigations, Proceedings, demand letters, settlements or enforcement actions, or made any voluntary disclosures to any Governmental Entity, involving the Company or any Company Subsidiary in any way relating to applicable Anti-Corruption Laws. The Company and each Company Subsidiary has established and maintains a compliance program and reasonable internal controls and procedures appropriate to ensure compliance with the requirements of applicable Anti-Corruption Laws.
(e) Within the last five (5) years, the Company and each Company Subsidiary and their respective officers, directors, employees, and, to the Company’s knowledge, agents have conducted their business in accordance with United States economic sanctions Laws administered by the Office of Foreign Assets Control of the U.S. Department of Treasury (“OFAC”) and all other applicable sanctions Laws in all material respects.
(f) Within the last five (5) years, the Company and each of the Company Subsidiary has conducted its export, re-export, transfer and import transactions in accordance with all applicable U.S. export, re-export, transfer, and import Laws, including the Export Administration Regulations maintained by the U.S. Department of Commerce, customs regulations maintained by the U.S. Department of Homeland Security (Customs and Border Protection), and all other applicable import and export controls in all material respects.
(g) None of the Company or any Company Subsidiary, nor any director, officer, employee, or, to the Company’s Knowledge, agent or affiliate of the Company or any Company Subsidiary: (x) is, or is 50% or more controlled or owned by one or more Persons or entities targeted by or subject to sanctions administered by OFAC, the U.S. Department of Commerce’s Bureau of Industry and Security (“BIS”), the European Union, any of the Member States of the European Union or the United Kingdom, or is included on any sanctioned party list administered by OFAC, BIS, the U.S. Department of State (including the List of Specially Designated Nationals and Blocked Persons, Foreign Sanctions Evaders List, Denied Persons List, Entity List, or Unverified List, or the Department of State Debarred Parties List, or the United Nations Security Council Consolidated List) or by the European Union, any of the Member States of the European Union, or the United Kingdom (including, without limitation, the Consolidated List of Persons, Groups, and Entities Subject to EU Financial Sanctions, and the UK’s Consolidated Sanctions List) (collectively, the “Restricted Parties”) or (y) has, at any time within the last five (5) years, conducted any business with or engaged in any transaction or arrangement with or involving, directly or indirectly, any Restricted Parties or territories subject to economic or trade sanctions in violation of applicable Law, or has otherwise been in violation of any such sanctions, restrictions, or similar Law. None of the Company or any Company Subsidiary is subject to any pending or, to the Company’s Knowledge, threatened action by any U.S. Governmental Entity or other Governmental Entity that would restrict its ability to engage in export transactions, bar it from exporting or otherwise limit its exporting activities or sales. None of the Company or any Company Subsidiary has, within the last five (5) years, received any written notice of deficiencies in connection with any Trade and Sanctions Controls from OFAC or any other Governmental Entity or made any voluntary disclosures to OFAC or any other Governmental Entity of facts that could result in any action being taken or any penalty being imposed by a Governmental Entity against the Company or any Company Subsidiary. The Company and each Company Subsidiary has, and has had at all times within the last five (5) years, in place policies and procedures designed to promote and ensure compliance with all applicable Trade and Sanctions Controls.
(h) The Company is in compliance in all material respects with the applicable listing and other rules and regulations of Nasdaq.
Section 3.10. Employee Benefit Plans.
(a) Section 3.10(a) of the Company Disclosure Letter sets forth a true, correct and complete list of each material Company Benefit Plan. For purposes of this Agreement, “Company Benefit Plan” means each
A-13

TABLE OF CONTENTS

“employee pension benefit plan” (as defined in Section 3(2) of ERISA), each “employee benefit plan” (as defined in Section 3(3) of ERISA) and each “employee welfare benefit plan” (as defined in Section 3(1) of ERISA), in each case whether or not subject to ERISA, and each other benefit or compensation plan, policy, program, agreement or arrangement, including but not limited to each bonus, stock, stock option or other equity-based compensation arrangement or plan, incentive, deferred compensation, retirement or supplemental retirement, severance, employment, change-in-control, collective bargaining, profit sharing, pension, vacation, cafeteria, dependent care, medical care, employee assistance program, education or tuition assistance programs, and each insurance and other similar fringe or employee benefit plan, policy, program, agreement or arrangement, in each case, for the benefit of current employees, directors or consultants (or any dependent or beneficiary thereof) of the Company or any Company Subsidiary or any of their ERISA Affiliates or with respect to which the Company or any Company Subsidiary has or may have any obligation or liability (whether actual or contingent), but excluding any such arrangement solely maintained by a Governmental Entity or any Multiemployer Plan. With respect to each material Company Benefit Plan, the Company has delivered or made available to Parent true, correct and complete copies of (or, to the extent no such copy exists, a description of), in each case, to the extent applicable, (i) all plan documents, summary plan descriptions, summaries of material modifications, and amendments related to such plans and any related trust agreement, (ii) the most recent Form 5500 Annual Report, (iii) the most recent audited financial statement and actuarial valuation, (iv) all material, non-routine filings and correspondence with any Governmental Entity during the past three (3) years and (v) all material related agreements, insurance contracts and other agreements which implement each such Company Benefit Plan. The Company has delivered or made available to Parent true, correct and complete copies of each Company Equity Plan and the forms of award agreements evidencing the Company Equity Awards, and with respect to the foregoing forms, other than differences with respect to the number of shares of Class A Common Stock covered thereby, the grant date, the exercise price, regular vesting schedule, and expiration date applicable thereto, no award agreement evidencing any Company Equity Award contains material terms that are not consistent with, or in addition to, such forms.
(b) Except as would not be, either, individually or in the aggregate, material to the Company and the Company Subsidiaries, taken as a whole, each of the Company Benefit Plans has been operated and administered in accordance with its terms and in compliance with applicable Law, including ERISA, the Code and, in each case, the regulations thereunder. No liability under Title IV of ERISA has been incurred by the Company, the Company Subsidiaries or any of their respective ERISA Affiliates that has not been satisfied in full, and to the Company’s Knowledge, no condition exists that is likely to cause the Company, the Company Subsidiaries or any of their ERISA Affiliates to incur any such liability. All material contributions or other material amounts payable by the Company or the Company Subsidiaries pursuant to each Company Benefit Plan in respect of current or prior plan years have been timely paid or accrued in accordance with GAAP or applicable international accounting standards. There are no pending, or, to the Company’s Knowledge, threatened or anticipated, claims, actions, investigations or audits (other than routine claims for benefits) by, on behalf of or against any of the Company Benefit Plans or any trusts related thereto that would result in a material liability.
(c) Within the last six (6) years, no Company Benefit Plan has been an employee benefit plan subject to Section 302 or Title IV of ERISA or Section 412, 430 or 4971 of the Code. None of the Company, the Company Subsidiaries or any of their respective ERISA Affiliates has incurred or is reasonably expected to incur any Controlled Group Liability that has not been satisfied in full, except, with respect to clause (iv) of the definition of Controlled Group Liability only, as would not result in a liability that is material to the Company and the Company Subsidiaries, taken as a whole. None of the Company, any of the Company Subsidiaries or any of their respective ERISA Affiliates has engaged in a non-exempt “prohibited transaction” (as such term is defined in Section 406 of ERISA and Section 4975 of the Code) or breached any fiduciary duties with respect to any Company Benefit Plan that reasonably would be expected to subject the Company, the Company Subsidiaries or the Surviving Corporation to any Tax or penalty, except as would not be, either individually or in the aggregate, material to the Company and the Company Subsidiaries, taken as a whole.
(d) Neither the Company, the Company Subsidiaries nor any of their respective ERISA Affiliates has, at any time during the preceding six (6) years, contributed to, been obligated to contribute to or had any liability (including any contingent liability) with respect to any Multiemployer Plan, a “multiple employer plan” or a “multiple employer welfare arrangement” (as such terms are defined in ERISA).
A-14

TABLE OF CONTENTS

(e) No Company Benefit Plan provides benefits, including death or medical benefits (whether or not insured), with respect to current or former employees or directors of the Company or the Company Subsidiaries beyond their retirement or other termination of service, other than coverage mandated by the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, or comparable U.S. state Law, for which the covered individual pays the full premium cost of coverage.
(f) (i) Each of the Company Benefit Plans that is intended to be “qualified” within the meaning of Section 401(a) of the Code has received a favorable determination letter or opinion letter as to its qualification and (ii) to the Company’s Knowledge, there are no existing circumstances or any events that have occurred that would reasonably be expected to adversely affect the qualified status of any such plan. Each such favorable determination letter has been provided or made available to Parent.
(g) Each Company Benefit Plan has been maintained and operated in documentary and operational compliance in all material respects with Section 409A of the Code or an available exemption therefrom.
(h) Neither the execution and delivery of this Agreement nor the consummation of the Transactions (either alone or in conjunction with any other event) could, except as provided by this Agreement or the Company Disclosure Letter, (i) result in any payment (including severance and unemployment compensation, forgiveness of Indebtedness or otherwise) becoming due to any current or former director, officer, employee or other individual service provider of the Company or any Company Subsidiary under any Company Benefit Plan or otherwise, (ii) increase any benefits otherwise payable under any Company Benefit Plan or otherwise, (iii) result in any acceleration of the time of payment or vesting of any such benefits, (iv) require a contribution or funding by the Company or any Company Subsidiary to a Company Benefit Plan or the transfer or setting aside of assets to fund any benefits under a Company Benefit Plan, (v) result in any breach or violation of, or default under or limit the right to amend, modify, terminate or transfer the assets of, any Company Benefit Plan following the Effective Time or (vi) result in any payment (whether in cash or property or the vesting of property) to any “disqualified individual” (as such term is defined in Treasury Regulations Section 1.280G-1) that could, individually or in combination with any other such payment, constitute an “excess parachute payment” (as defined in Section 280G(b)(1) of the Code).
(i) No Person is entitled to any gross-up, make-whole, or other additional payment from the Company or any Company Subsidiary with respect to any Tax or interest or penalty related thereto, including in accordance with Sections 4999 or 409A of the Code.
(j) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, each Company Benefit Plan, if any, which is maintained outside of the United States (i) has been operated in conformance and compliance with the applicable statutes or governmental regulations and rulings relating to such plans in the jurisdictions in which such Company Benefit Plan is present or operates and, to the extent relevant, the United States, (ii) that is intended to qualify for special tax treatment meet all requirements for such treatment and (iii) that is intended to be funded or book-reserved are fully funded or book reserved, as appropriate, based upon reasonable actuarial assumptions.
Section 3.11. Labor Matters.
(a) Neither the Company nor any Company Subsidiary is a party to, bound by (or otherwise subject to) or in the process of negotiating any collective bargaining agreement or other Contract with a labor union, works council, employee representative group or labor organization, and to the Company’s Knowledge, no demand has been made or petition filed or Proceedings initiated by an employee or group of employees of the Company or any Company Subsidiary with any labor relations board or other Governmental Entity seeking recognition of any labor organization. Neither the Company nor any Company Subsidiary is (or has during the past two (2) years been) subject to a material labor dispute, strike or work stoppage. There are no organizational efforts with respect to the formation of a collective bargaining unit presently being made or, to the Company’s Knowledge, threatened involving employees of the Company or any Company Subsidiary.
(b) The Company and each Company Subsidiary are and have been since February 1, 2023 in compliance with all applicable Law respecting labor and employment matters, including immigration, fair employment practices, terms and conditions of employment, workers’ compensation, occupational safety and health, plant closings, mass layoffs, worker classification, sexual harassment, discrimination, exempt and non-exempt status, compensation and benefits, wages and hours (including overtime and minimum wage requirements), disability
A-15

TABLE OF CONTENTS

rights, equal employment opportunity and the Worker Adjustment and Retraining Notification Act of 1988, as amended (the “WARN Act”), except where such non-compliance has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Neither the Company nor any Company Subsidiary has taken any action since February 1, 2023, that would (i) constitute a “Mass Layoff” or “Plant Closing” within the meaning of the WARN Act, or any similar state, local or foreign Law or (ii) otherwise trigger any material liability or obligations under the WARN Act or any similar state, local or foreign Law.
(c) There is not, and since February 1, 2023 there has not been, any (i) proceeding pending or, to the Company’s Knowledge, threatened by or before any Governmental Entity with respect to the Company or any Company Subsidiary concerning employment-related matters or (ii) proceeding pending or, to the Company’s Knowledge, threatened against or affecting the Company or any Company Subsidiary brought by any current or former applicant, employee or independent contractor of the Company or any Company Subsidiary, except as would not be, either individually or in the aggregate, material to the Company and the Company Subsidiaries, taken as a whole.
(d) To the Company’s Knowledge, in the last five (5) years, (i) no allegations of sexual harassment, sexual misconduct, sexual assault, sexual discrimination or other material harassment or discrimination allegations have been made against any member of the Company Board of Directors (in their capacity as such) or employee at the level of Vice President or above, and (ii) neither the Company nor any of the Company Subsidiaries have entered into any settlement agreements related to allegations of sexual harassment, sexual misconduct, sexual assault, sexual discrimination or other material harassment or discrimination allegations involving any member of the Company Board of Directors (in their capacity as such) or employee at the level of Vice President or above.
Section 3.12. Tax Matters. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect:
(a) The Company and the Company Subsidiaries have timely filed (taking into account any valid extension of time within which to file) all Tax Returns that are required to be filed by or with respect to any of them and all such Tax Returns are true, correct and complete;
(b) The Company and the Company Subsidiaries have timely paid in full to the appropriate Governmental Entity all Taxes required to be paid by any of them, except for Taxes for which the financial statements of the Company and the Company Subsidiaries reflect adequate reserves, in accordance with GAAP;
(c) The Company and the Company Subsidiaries have (i) timely paid, deducted, withheld and collected all amounts required to be paid, deducted, withheld or collected by any of them with respect to any payment owing to, or received from, their employees, creditors, independent contractors, customers and other third parties (and have timely paid over any amounts so withheld, deducted or collected to the appropriate Governmental Entity) and (ii) have otherwise complied in all respects with all applicable Laws relating to the payment, withholding, collection and remittance of Taxes (including information reporting requirements);
(d) There is no (i) claim, litigation, audit, examination, investigation or other proceeding pending or, to the Knowledge of the Company, threatened with respect to any Taxes or Tax Returns of the Company or any Company Subsidiary, or (ii) deficiency for Taxes that has been assessed by any Governmental Entity against the Company or any Company Subsidiary and that has not been fully satisfied by payment;
(e) Neither the Company nor any Company Subsidiary has waived any statute of limitations with respect to any Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency (other than in connection with automatic extensions of time to file Tax Returns), which waiver or extension is still in effect;
(f) Within the last two (2) years, neither the Company nor any Company Subsidiary has distributed stock of another Person, or has had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Section 355(a) of the Code;
(g) None of the Company or any Company Subsidiary (i) is a party to or bound by, or has any obligation under, any Tax allocation, sharing, indemnity, or reimbursement agreement or arrangement (other than any ordinary course commercial agreement not primarily related to Taxes, and other than any agreement or
A-16

TABLE OF CONTENTS

arrangement solely among the Company and the Company Subsidiaries) or (ii) has any liability for Taxes of any Person (other than the Company or any Company Subsidiary) under Treasury Regulations Section 1.1502-6 (or any similar provision of state, local, or non-U.S. Law) or as transferee or successor, by contract or otherwise by operation of Law;
(h) There are no Liens in respect of or on account of Taxes upon any property or assets of the Company or any Company Subsidiary, other than Permitted Liens;
(i) Within the last six (6) years, no claim has been made in writing from any Tax authority in a jurisdiction where the Company or any Company Subsidiary has not filed Tax Returns of a particular type that the Company or any Company Subsidiary is or may be subject to Tax by, or required to file Tax Returns with respect to Taxes in, such jurisdiction;
(j) Neither the Company nor any Company Subsidiary is bound with respect to the current or any future taxable period by any closing agreement (within the meaning of Section 7121(a) of the Code or any similar or analogous provision of state, local or non-U.S. Law) or other similar ruling or written agreement with a Tax authority;
(k) Neither the Company nor any Company Subsidiary has participated in any “reportable transaction” within the meaning of Treasury Regulations Section 1.6011-4(b) (or any similar provision of state, local or non-U.S. Law);
(l) Other than adjustments made in the ordinary course of business consistent with past practice for accrued income taxes, neither the Company nor any Company Subsidiary will be required to include an item of income (or exclude an item of deduction) in any taxable period (or portion thereof) beginning after the Closing Date as a result of (i) a change in or incorrect method of accounting occurring prior to the Closing Date, (ii) a prepaid amount received (or deferred revenue recognized) or paid, prior to the Closing Date, (iii) an election under Section 108(i) of the Code (or any similar provision of state, local, or non-U.S. Law), (iv) an election pursuant to Section 965(h) of the Code, (v) intercompany transaction or excess loss account described in Treasury Regulations under Section 1502 (or any corresponding or similar provision of state, local or foreign income Tax Law) occurring on or prior to the Closing Date or (vi) installment sale or open transaction disposition made on or prior to the Closing Date;
(m) Except as contemplated by this Agreement, neither the Company nor any Company Subsidiary has undergone an “ownership change” within the meaning of Section 382 of the Code and the Treasury Regulations promulgated thereunder;
(n) Neither the Company nor any Company Subsidiary (i) is or has been a resident for Tax purposes in a country outside its country of organization; (ii) has, or has ever had, a permanent establishment or other taxable presence in any country other than its country of organization; or (iii) is, or has ever been, subject to income Tax in a country outside its country of organization; and
(o) The U.S. federal income tax classifications of each Company Subsidiary is listed in Section 3.12(o) of the Company Disclosure Letter.
Section 3.13. Litigation; Orders. As of the date hereof, there are no Proceedings pending or, to the Company’s Knowledge, threatened against the Company or any Company Subsidiary or any of their respective properties, rights or assets, at law or in equity, by or before, and there are no orders, judgments, injunctions, awards or decrees of or settlement agreements with, any Governmental Entity, that are or would reasonably be expected to be, individually or in the aggregate, material to the Company and the Company Subsidiaries, taken as a whole. As of the date hereof, neither the Company nor any Company Subsidiary has any material Proceedings pending against any other Person.
Section 3.14. Intellectual Property.
(a) Section 3.14(a) of the Company Disclosure Letter sets forth a true, correct and complete list as of the date hereof of all: (i) patents and patent applications, (ii) registered trademarks, service marks, trade dress, logos, slogans, brand names, trade names and corporate names and applications therefor, (iii) domain name and social media handle registrations, (iv) copyright registrations and applications for copyright registration, and (v) any other Intellectual Property that is the subject of an application, certificate, filing, registration or other document
A-17

TABLE OF CONTENTS

issued by, filed with, or recorded by the Company or any Company Subsidiary with any state, government or other public authority, in each case, that are owned by, filed in the name of, applied for by, or subject to a valid obligation of assignment to, the Company or any Company Subsidiary, whether wholly or jointly owned (the “Company Registered Intellectual Property”).
(b) The Company solely owns each item of Company Intellectual Property free and clear of all Liens, other than Permitted Liens. Each material item of Company Registered Intellectual Property is subsisting and has not expired, been cancelled, or been abandoned, and to the Company’s Knowledge, each material item of Company Intellectual Property (other than applications for registrations) is valid and enforceable. As of the date hereof, no Proceeding (other than office actions in connection with the prosecution of applications) is pending or, to the Company’s Knowledge, threatened by or before any Governmental Entity, that challenges the legality, validity, enforceability, registration, use or ownership of any Company Intellectual Property. Neither the Company nor any Company Subsidiary receives an exclusive license under any third party Intellectual Property that is material to the conduct of the business of the Company and the Company Subsidiaries, taken as a whole.
(c) Neither the Company nor any Company Subsidiary has granted or transferred (or is obligated to grant or transfer) to any Person or has permitted (or is obligated to permit) any Person to retain any ownership interest, including any joint ownership interest, or any exclusive rights, in any Company Intellectual Property and is material to the conduct of the business of the Company and the Company Subsidiaries, taken as a whole.
(d) Except as would as would not be, either individually or in the aggregate, material to the Company and the Company Subsidiaries, taken as a whole, the Company and the Company Subsidiaries (i) own, license, sublicense or otherwise possess legally enforceable and sufficient rights to use all Intellectual Property necessary to conduct the business of the Company and the Company Subsidiaries as currently conducted, all of which rights shall survive the consummation of the Transactions (including the Merger) on substantially the same terms, without termination, cancellation, acceleration or other change of any right or obligation or the loss of any benefit with respect thereto, and (ii) may exercise, transfer, or license all Company Intellectual Property and other such rights without material restriction or material payment to any Person, except (in the case of this clause (ii)) as a result of the terms of a Contract to which Parent, but neither the Company nor a Company Subsidiary, is a party.
(e) As of the date hereof, no Proceedings are pending or, to the Company’s Knowledge, are threatened against the Company or any Company Subsidiary, alleging that the Company or any Company Subsidiary is infringing, misappropriating, diluting or otherwise violating the Intellectual Property of any Person. Except as has not been and would not reasonably be expected to be, individually or in the aggregate, material to the Company and the Company Subsidiaries, taken as a whole, (i) the conduct of the business of the Company and the Company Subsidiaries, including the commercialization and exploitation of the Company Products in connection with such business, as currently conducted or as conducted since February 1, 2023, has not infringed, violated, constituted, or misappropriated any Intellectual Property rights of any Person, violated the Digital Millennium Copyright Act (DMCA) or similar statute with respect to digital works or data, or constituted unfair competition or unfair trade practices, (ii) to the Company’s Knowledge, no Person is infringing, misappropriating, diluting, using in an unauthorized manner or otherwise violating any Company Intellectual Property, and (iii) since February 1, 2023, neither the Company nor any Company Subsidiary has instituted or threatened to institute any Proceeding against any Person alleging that such Person is infringing, misappropriating, diluting, using in an unauthorized manner or otherwise violating any Company Intellectual Property.
(f) Except as would not reasonably be expected to, either individually or in the aggregate, be material to the Company and the Company Subsidiaries, taken as a whole: (i) in each case in which the Company or any Company Subsidiary has engaged or hired an employee, consultant or contractor (whether current or former) for the purpose of developing or creating any Intellectual Property, or who has otherwise developed or created Intellectual Property material to the business of the Company and the Company Subsidiaries within the scope of their employment or engagement therefor, the Company or such Company Subsidiary has obtained, either by operation of Law or by valid assignment or transfer, exclusive ownership of all such Intellectual Property, and, to the Company’s Knowledge, no such employee, consultant or contractor retains or claims to retain any ownership or other rights in or with respect to such Intellectual Property; (ii) the Company and each Company Subsidiary have taken commercially reasonable actions to maintain and protect all Company Intellectual Property that derives independent economic value, actual or potential, from not being known to other Persons, and all such Intellectual Property has been maintained in confidence in accordance with procedures that are customarily used in the industry to protect rights of like importance; and (iii) to the Company’s Knowledge, since February 1, 2023, there
A-18

TABLE OF CONTENTS

has been no unauthorized disclosure of Company Intellectual Property, or unauthorized disclosure by the Company or any Company Subsidiary of any third party Intellectual Property. Without limiting the generality of the foregoing, the Company and the Company Subsidiaries have, and enforce, a policy requiring each employee, consultant and contractor that has access to any such Intellectual Property to execute a confidentiality agreement that obligates such Person to maintain the confidentiality thereof, except where the failure to enforce such policy has not been and would not reasonably be expected to be, individually or in the aggregate, material to the Company and the Company Subsidiaries, taken as a whole.
(g) Neither the Company nor any Company Subsidiary has used, modified, distributed, or made available any Software or other technology under an Open Source License in a manner that would require any material Company Intellectual Property to be (i) disclosed, distributed, or made available in Source Code form, (ii) licensed for the purposes of preparing derivative works, (iii) licensed under terms that allow Company Products or portions thereof or interfaces therefor to be reverse engineered, reverse assembled or disassembled, or (iv) redistributed at no charge. The Company and the Company Subsidiaries are and have been in compliance in all material respects with all Open Source Licenses to which they are subject.
(h) Section 3.14(h) of the Company Disclosure Letter contains a true, correct and complete list of, and the Company has made available to Parent prior to the date hereof true, correct and complete copies of, all Contracts in effect (or with respect to Contracts no longer in effect, to the extent of any surviving terms) pursuant to which the Company or any Company Subsidiary (i) grants any license, covenant not to assert, release, agreement not to enforce or prosecute, or other immunity to any Person under or to any patent rights or other material Company Intellectual Property, except Ordinary Course Licenses, (ii) other than Open Source Licenses, is granted a license or immunity (other than Ordinary Course Licenses) or a covenant not to assert, or release, or agreement not to enforce or prosecute to or under any Intellectual Property, or (iii) develops, acquires, or contracts with any other Person to develop or acquire Intellectual Property, including under any joint development relationship (but excluding employment, consulting, services or invention assignment agreements entered into in the ordinary course of business with employees, contractors or consultants of the Company or any Company Subsidiaries, in each case, where the applicable employee, contractor or consultant has validly assigned all rights in such Intellectual Property to the Company or the Company Subsidiaries), in each case of clauses (i) through (iii), that is material to the conduct of the business of the Company and the Company Subsidiaries, taken as a whole (the foregoing in clauses (i) through (iii), together with the Ordinary Course Licenses and Open Source Licenses, the “IP Contracts”).
(i) The Company has made available to Parent prior to the date hereof true, correct and complete list of all material Company Products.
(j) Neither the execution and delivery of this Agreement nor the consummation of the Transactions will result in or give any other Person right or option to cause or declare (i) a material breach, violation, modification, cancellation, termination, or suspension of any IP Contract that is material to the conduct of the business of the Company and the Company Subsidiaries, taken as a whole, (ii) the release of any Source Code that is Company Intellectual Property or other material proprietary or confidential Intellectual Property of the Company or any Company Subsidiary, (iii) the grant of (or requirement to grant) any license, covenant not to assert, release, agreement not to enforce or prosecute, or other immunity or similar right to or under any Company Intellectual Property that is material to the conduct of the business of the Company and the Company Subsidiaries, taken as a whole (or (except as a result of the terms of a Contract to which Parent, but neither the Company nor a Company Subsidiary, is a party) any Intellectual Property of Parent) to any Person, or (iv) the Company, any Company Subsidiary or (except as a result of the terms of a Contract to which Parent, but neither the Company nor a Company Subsidiary, is a party) Parent being subject to any non-compete or other material restriction on the operation or scope of their respective business. All IP Contracts shall remain in full force and effect following the Closing in accordance with their terms, and, as of immediately after the Closing, the Company and the Company Subsidiaries will be entitled to exercise all of their respective rights under all IP Contracts to the same extent as prior to the Closing, in each case, except has not been and would not reasonably be expected to be, individually or in the aggregate, material to the Company and the Company Subsidiaries, taken as a whole.
(k) As of the date hereof, no Proceeding by any Person is pending against the Company or any Company Subsidiary, nor has any of them received any written claim or notice since February 1, 2023, with respect to any
A-19

TABLE OF CONTENTS

material warranty or material indemnity claim relating to any Company Products or with respect to the material breach of any material agreement (including any IP Contract) under which such Company Products have been made available, in each case, which remains unresolved.
(l) To the Company’s Knowledge, no Company System, and no Software included in any Company Product, contains any undisclosed disabling codes or instructions, “time bombs,” “Trojan horses,” “back doors,” “trap doors,” “worms,” viruses, bugs, faults, security vulnerabilities (as such terms are commonly understood in the software industry) or other Software routines or hardware components that (i) enable or assist any Person to acquire or access without authorization or disable or erase any Software, Company Products or Protected Information or information, or (ii) otherwise significantly adversely affect the functionality of the Company Systems or Company Products, except as has not been and would not reasonably be expected to be, individually or in the aggregate, material to the Company and the Company Subsidiaries, taken as a whole.
(m) The Company and each Company Subsidiary maintains and adheres to policies and procedures that are compliant with applicable Law relating to the development, training, fine-tuning, evaluation, validation, testing, improvement, use and deployment of AI Systems at and by the Company or any Company Subsidiary, and there has been no actual or alleged non-compliance with any such policies and procedures. The Company and each of the Company Subsidiaries has, and at all times during the past three (3) years had, legally enforceable and sufficient rights to use or process all Training Data in the manner used or processed by or for it to develop, train, fine-tune, evaluate, validate, test or improve AI Systems, and the Company and Company Subsidiaries have provided reasonable notice of, and complied with Contract terms applicable to, such use or processing, except as would not be, either individually or in the aggregate, material to the Company and the Company Subsidiaries, taken as a whole. Neither the Company nor any Company Subsidiary is the subject of any complaint, claim, audit, investigation, proceeding, or litigation (or a request for information or testimony from regulators or legislators) regarding any AI System or Training Data. Except as has not had and would not reasonably be expected to be individually or in the aggregate, material to the Company and the Company Subsidiaries, taken as a whole, neither the Company nor any Company Subsidiary uses or makes available to third parties any High-Risk AI Systems or engages in activities that are “unacceptable” or “prohibited” under the European Union Artificial Intelligence Act (or that are subject to a similar designation under applicable Law in other jurisdictions).
Section 3.15. Privacy and Data Protection.
(a) Since February 1, 2023, the Company’s and each Company Subsidiary’s receipt, collection, monitoring, maintenance, hosting, creation, transmission, use, analysis, disclosure, storage, retention, disposal, security and other processing, as the case may be, of Protected Information, and, to the Company’s Knowledge, any such activities performed or handled by authorized third parties on the Company’s or a Company Subsidiary’s behalf, have complied in all material respects with, and neither the execution and delivery of this Agreement nor the consummation of the Transactions will result in the Company, any Company Subsidiary, Parent, Merger Sub or the Surviving Corporation being in material breach or material violation of (i) any provisions of Contracts governing Protected Information to which the Company or any Company Subsidiary is bound, (ii) applicable Information Privacy and Security Laws, (iii) PCI DSS, to the extent applicable to the Company or any Company Subsidiary, (iv) any Privacy Statements, or (v) any consents or authorizations that apply to the Protected Information that have been obtained by the Company or a Company Subsidiary. To the extent required by HIPAA, the Company and each Company Subsidiary have executed Business Associate Agreements (as such agreements are defined in HIPAA) with any Covered Entity or Business Associate (as defined in HIPAA), in compliance with HIPAA. The Company and each Company Subsidiary have all rights, authority, consents and authorizations necessary under applicable Information Privacy and Security Laws to receive, retain, access, use and disclose the Protected Information in their possession or under their control in connection with the operation of their business. Since February 1, 2023, the Company and each Company Subsidiary have posted, where required by Information Privacy and Security Laws, as applicable, privacy policies governing their use of Protected Information on their websites made available by the Company and each Company Subsidiary, and the Company and each Company Subsidiary have complied in all material respects with such current and former published privacy policies.
(b) There has been no material (i) security breach of or unauthorized access to, or malicious or unauthorized disruption to, any Company Products, or any Company System that transmits or maintains Protected Information, or (ii) incident involving the loss, damage or unauthorized access, acquisition, modification, use or disclosure of any Protected Information owned, used, hosted, maintained or controlled by or, to the Company’s Knowledge, on behalf of, the Company or the Company Subsidiaries, including any such unauthorized access, acquisition,
A-20

TABLE OF CONTENTS

modification, use or disclosure of Protected Information that would constitute a breach for which notification by the Company or any Company Subsidiary to individuals, Persons or Governmental Entities is required, or was made, under any applicable Information Privacy and Security Laws or Contracts to which the Company or a Company Subsidiary is a party. To the Company’s Knowledge, none of the Company’s or any Company Subsidiary’s vendors, suppliers and subcontractors have (A) suffered any material security breach that resulted in any unauthorized access to, modification of, use of, disclosure of or loss of or damage to any Protected Information, (B) materially breached any Contracts with the Company or any Company Subsidiary relating to Protected Information or (C) violated any applicable Information Privacy and Security Laws in relation to the processing of Protected Information on behalf of the Company or any Company Subsidiary, in each case in any material respect.
(c) Since February 1, 2023, the Company and each Company Subsidiary have implemented and maintained in a commercially reasonable manner a written information security program, covering the Company and each Company Subsidiary and their respective material Company Systems, designed to (i) identify and address internal and external risks to the security, integrity or privacy of any proprietary or confidential information in their possession, including Protected Information, (ii) implement, monitor and maintain administrative, technical and physical safeguards to control these risks, and (iii) maintain notification procedures in compliance with applicable Information Privacy and Security Laws and customer Contracts in the case of any breach of security, integrity or privacy compromising Protected Information. In each of the past three (3) fiscal years, the Company and each of the Company Subsidiaries have performed a security risk assessment covering the Company and each Company Subsidiary, and remediated all critical, high risk or material threats and deficiencies identified in such risk assessments.
(d) Since February 1, 2023 through the date hereof, no Person has (i) provided a written audit request to the Company or a Company Subsidiary, (ii) made any written claim against the Company or any Company Subsidiary, or (iii) to the Company’s Knowledge, commenced any Proceeding, in each case, with respect to (A) any alleged violation of applicable Information Privacy and Security Laws by the Company, any Company Subsidiary or (with respect to services provided to or on behalf of the Company) any third party with whom the Company or any Company Subsidiary has entered into a Contract in connection with the collection, maintenance, storage, retention, use, processing, disclosure, transfer or disposal of Protected Information or (B) any of the Company’s or a Company Subsidiary’s privacy or data security practices related to Protected Information, including any unlawful or accidental loss, damage or unauthorized access, acquisition, retention, use, disclosure, modification or other misuse of such information maintained by or on behalf of the Company or the Company Subsidiaries, and there are no facts or circumstances which could reasonably serve as the basis for any such allegations or claims. No Person has provided a complaint (written or otherwise) to the Company or a Company Subsidiary, nor, to the Company’s Knowledge, to any third party, regarding the improper disclosure of Protected Health Information (as defined in HIPAA) by the Company or a Company Subsidiary.
(e) The Company and the Company Subsidiaries have in place disaster recovery plans, procedures and facilities that satisfy applicable Law in all material respects and the Company’s and the Company Subsidiaries’ obligations under Contracts with all customers, vendors, suppliers and subcontractors of the Company and the Company Subsidiaries, and the Company and the Company Subsidiaries are in compliance therewith in all material respects.
Section 3.16. Real and Personal Property.
(a) Neither the Company nor any Company Subsidiary currently owns or has previously owned any real property.
(b) Section 3.16(b) of the Company Disclosure Letter sets forth a true, correct and complete list of all material real property leased, subleased, licensed or similarly occupied by the Company or any Company Subsidiary as of the date of this Agreement (the “Leased Real Property”) and the leases, subleases, licenses and occupancy agreements, together with all assignments thereof and amendments, supplements and modifications with respect thereto (each, a “Company Lease”). To the extent in its possession, the Company has made available to Parent true, correct and complete copies of the Company Leases. Except as has not been, and would not reasonably be expected to be, individually or in the aggregate, material to the Company and the Company
A-21

TABLE OF CONTENTS

Subsidiaries, taken as a whole, with respect to each Leased Real Property and the accompanying Company Lease, the Company or the applicable Company Subsidiary that is party thereto has good and valid leasehold interests in such Leased Real Property, free and clear of all Liens, other than Permitted Liens.
(c) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i) neither the Company nor any Company Subsidiary has leased, subleased, licensed or otherwise granted any Person a material right to use or occupy the Leased Real Property, or any portion thereof and (ii) to the Company’s Knowledge, there is no existing material condemnation or other proceeding in eminent domain, or any proceeding pending or threatened in writing, affecting any portion of the Leased Real Property.
(d) The Company and the Company Subsidiaries have good and valid title to, or a valid right to use, all of its tangible assets sufficient for the conduct of its business as presently conducted, except for defects in title, easements, restrictive covenants and similar encumbrances that have not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Except as has not been, and would not reasonably be expected to be, individually or in the aggregate, material to the Company and the Company Subsidiaries, taken as a whole, all such assets are free and clear of all Liens, except for Permitted Liens.
Section 3.17. Material Contracts.
(a) Except for this Agreement, Section 3.17(a) of the Company Disclosure Letter contains a true, correct and complete list, as of the date hereof, of each Contract described below in this Section 3.17(a) under which the Company or any Company Subsidiary has any current or future rights, responsibilities, obligations or liabilities (in each case, whether contingent or otherwise) or to which the Company or any Company Subsidiary is a party or to which any of their respective properties or assets is subject, in each case as of the date hereof other than Company Benefit Plans listed on Section 3.10(a) of the Company Disclosure Letter (all Contracts of the type described in this Section 3.17(a), whether or not set forth on Section 3.17(a) of the Company Disclosure Letter, being referred to herein as the “Material Contract”):
(i) each Contract that limits in any material respect the freedom of the Company, any Company Subsidiary or any of their respective affiliates (including Parent and its affiliates after the Effective Time) to compete or engage in any line of business or geographic region or with any Person or sell, supply or distribute any product or service or that otherwise has the effect of restricting the Company, the Company Subsidiaries or any of their respective affiliates (including Parent and its affiliates after the Effective Time) from the development, marketing or distribution of products and services, in each case, in any geographic area;
(ii) each Contract that limits the freedom of the Company, any Company Subsidiary or any of their respective affiliates to negotiate or, except for provisions requiring notice or consent to assignment by the counterparty thereto, consummate any of the Transactions;
(iii) any material partnership, joint venture, strategic alliance, limited liability company agreement (other than any such agreement solely between or among the Company and its wholly owned Subsidiaries), development, co-development, co-promotion or similar material Contract;
(iv) each acquisition or divestiture Contract that contains representations, covenants, indemnities or other obligations (including “earnout” or other contingent payment obligations) that would reasonably be expected to result in the receipt or making by the Company or any Company Subsidiary of future payments in excess of $2,000,000;
(v) each Contract that gives any Person the right to acquire any assets of the Company or any Company Subsidiary (excluding ordinary course commitments to purchase Company Products) after the date hereof with consideration of more than $2,000,000;
(vi) each Contract set forth, or required to be set forth, in Section 3.14(h) of the Company Disclosure Letter;
(vii) any Contract to put Source Code for any Company Product in escrow with a third Person, and any other Contract to provide Source Code for any Company Product to any third Person other than an employee, contractor, agent or representative of the Company or a Company Subsidiary in the ordinary course of business consistent with past practice;
A-22

TABLE OF CONTENTS

(viii) any order, settlement agreement or similar Contract involving any resolution or settlement of any actual or threatened Proceeding (A) with any Governmental Entity, (B) restricting in any material respect the operations or conduct of the Company, any Company Subsidiary or any of their respective affiliates (including Parent and its affiliates after the Effective Time), (C) imposing any material non-monetary obligations or requirements, or (D) involving any admissions of criminal liability;
(ix) each Contract not otherwise described in any other subsection of this Section 3.17(a) pursuant to which the Company or any Company Subsidiary is obligated to pay, or entitled to receive, payments in excess of $5,000,000 in the twelve (12)-month period following the date hereof;
(x) any Contract that obligates the Company or any Company Subsidiary to make any capital investment or capital expenditure outside the ordinary course of business consistent with past practice and in excess of $1,000,000;
(xi) each Contract that is a Material Customer Agreement, a Material Supplier Agreement or a Material Reseller Agreement;
(xii) each Contract that grants any right of first refusal or right of first offer or that limits the ability of the Company, any Company Subsidiary or any of their respective affiliates (including Parent and its affiliates after the Effective Time) to own, operate, sell, transfer, pledge or otherwise dispose of any businesses or material assets;
(xiii) each Contract that contains any exclusivity rights or “most favored nations” provisions or minimum use, supply or display requirements that are binding on the Company or its affiliates (including Parent and its affiliates after the Effective Time);
(xiv) each Contract entered into with a Government Entity;
(xv) each Company Lease with rent payments (assuming projected renewals as provided by the Company to Parent) over the remaining life of such Company Lease in excess of $1,000,000;
(xvi) each Contract (A) relating to outstanding or potential Indebtedness (or commitments in respect thereof) of the Company or any Company Subsidiary (whether incurred, assumed, guaranteed or secured by any asset) in an individual amount in excess of $1,000,000, other than Indebtedness solely between the Company and any wholly owned Company Subsidiary or solely between wholly owned Company Subsidiaries, or (B) relating to any Liens on any assets of the Company or any Company Subsidiary (other than Permitted Liens);
(xvii) each Contract involving other derivative financial instruments or arrangements (including swaps, caps, floors, futures, forward contracts and option agreements) for which the aggregate exposure of (or aggregate value to) the Company and the Company Subsidiaries under any such Contract is reasonably expected to be in excess of $500,000 for such Contract or with a notional amount in excess of $500,000 for such Contract;
(xviii) each Contract between the Company or any Company Subsidiary, on the one hand, and any officer, director or affiliate (other than a wholly owned Company Subsidiary) of the Company or any Company Subsidiary, any beneficial owner, directly or indirectly, of more than five percent (5%) of the number or voting power of the shares of Class A Common Stock or any of their respective “associates” or “immediate family” members (as such terms are defined in Rule 12b-2 and Rule 16a-1 of the Exchange Act), on the other hand, including any Contract pursuant to which the Company or any Company Subsidiary has an obligation to indemnify such officer, director, affiliate, beneficial owner, associate or immediate family member; and
(xix) any Contract not otherwise described in any other subsection of this Section 3.17(a) that would constitute a “material contract” (as such term is defined in Item 601(b)(10) of Regulation S-K of the SEC) with respect to the Company.
(b) True, correct and complete copies of each Material Contract (and any material amendments, supplements, modifications or supplements thereto) in effect as of the date hereof have been made available to Parent or publicly filed with the SEC prior to the date hereof. None of the Company or any Company Subsidiary is in breach of or default under the terms of any Material Contract, including any terms related to the use of
A-23

TABLE OF CONTENTS

Material Customer data, except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. To the Company’s Knowledge, as of the date hereof, no other party to any Material Contract is in breach of or default under the terms of any Material Contract, where such breach or default has had or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, each Material Contract is a valid, binding and enforceable obligation of the Company or the Company Subsidiary which is party thereto and, to the Company’s Knowledge, of each other party thereto, and is in full force and effect, subject to the Enforceability Limitations.
Section 3.18. Environmental Matters. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (a) the Company and the Company Subsidiaries have complied in all material respects with all Environmental Laws since February 1, 2023, and neither the Company nor any Company Subsidiary is in violation of any Environmental Law, (b) the Company and the Company Subsidiaries have all permits, licenses and other authorizations required under any Environmental Law to operate their business in the ordinary course and the Company and the Company Subsidiaries are in compliance with such permits, licenses and other authorizations, (c) as of the date hereof, no Proceeding is pending, or, to the Company’s Knowledge, threatened, and no notice, demand, letter, claim or request for information has been received by the Company or any Company Subsidiary, concerning or relating to the operations of the Company or any Company Subsidiary that seeks to impose, or that is reasonably likely to result in the imposition of, any liability arising under any Environmental Law upon the Company or any Company Subsidiary, and (d) neither the Company nor any Company Subsidiary is subject to any order or other agreement with any Governmental Entity or any indemnity or other agreement with any third party relating to any obligations or liabilities under any Environmental Law.
Section 3.19. Customers; Suppliers; Resellers; Government Entities.
(a) Section 3.19(a) of the Company Disclosure Letter sets forth a list of the top twenty-five (25) customers of the Company and the Company Subsidiaries based on revenue received by the Company or any Company Subsidiary during the last twelve (12) months ended July 31, 2026 (each, a “Material Customer” and each such Contract with a Material Customer, a “Material Customer Agreement”). As of the date hereof, neither the Company nor any Company Subsidiary has received any written notice from any Material Customer that such Material Customer shall not continue as a customer of the Company or that such Material Customer intends to terminate or materially and adversely modify existing Contracts with the Company or the Company Subsidiaries.
(b) Section 3.19(b) of the Company Disclosure Letter sets forth a list of the top twenty-five (25) suppliers and vendors of the Company and the Company Subsidiaries, based on amounts paid by the Company and the Company Subsidiaries, during the last twelve (12) months ended July 31, 2026 (each, a “Material Supplier” and each Contract pursuant to which the Company or a Company Subsidiary paid those amounts to the applicable Material Supplier, a “Material Supplier Agreement”). As of the date hereof, neither the Company nor any Company Subsidiary has received any written notice from any Material Supplier that such supplier shall not continue as a supplier to the Company or that such supplier intends to terminate or materially and adversely modify existing Contracts with the Company or the Company Subsidiaries.
(c) Section 3.19(c) of the Company Disclosure Letter sets forth a list of each of the top twenty-five (25) technology partner, reseller, OEM, independent software vendor and distributor of Company Products pursuant to which the Company or any Company Subsidiary has had billings or received revenue during the last twelve (12) months ended July 31, 2026 (each, a “Material Reseller” and each Contract with each Material Reseller, a “Material Reseller Agreement”). As of the date hereof, neither the Company nor any Company Subsidiary has received any written notice from any Material Reseller that such Material Reseller shall not continue as a technology vendor, partner, reseller, OEM, independent software vendor and distributor of Company Products, as applicable, to the Company or that such Material Reseller intends to terminate or adversely modify existing Contracts with the Company or the Company Subsidiaries.
Section 3.20. Insurance. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (a) all current insurance policies and insurance Contracts of the Company and the Company Subsidiaries are in full force and effect and are valid and enforceable and cover against the risks as are customary for companies of similar size in the same or similar lines of business and neither the Company nor any Company Subsidiary is in breach or default under any material insurance policy, and (b) all premiums due thereunder have been paid. Neither the Company nor any Company Subsidiary has received notice of cancellation or
A-24

TABLE OF CONTENTS

termination with respect to any current third-party insurance policies or insurance Contracts (other than in connection with normal renewals of any such insurance policies or Contracts) where such cancellation or termination has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.
Section 3.21. Information Supplied. The information relating to the Company and the Company Subsidiaries to the extent supplied by or on behalf of the Company and the Company Subsidiaries to be contained in, or incorporated by reference in the Proxy Statement to be sent to the Company Stockholders in connection with the Merger and the Transactions, will not, at the time it and any amendments or supplements thereto are filed with the SEC, at the date the Proxy Statement is first mailed to the Company Stockholders or at the time of the Company Stockholders Meeting, (a) contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, at the time and in light of the circumstances under which they were made, not false or misleading or (b) fail to comply in all material respects with the requirements of the DGCL, the Exchange Act and the rules and regulations promulgated thereunder. Notwithstanding the foregoing provisions of this Section 3.21, no representation or warranty is made by the Company with respect to information or statements made or incorporated by reference in the Proxy Statement, which information or statements were not supplied by or on behalf of the Company.
Section 3.22. Opinion of Financial Advisor. The Company Board of Directors has received the opinion of Qatalyst Partners LP (“Qatalyst Partners”) to the effect that, as of the date of such opinion and based upon and subject to the various qualifications, assumptions, limitations and other matters set forth therein, the Per Share Merger Consideration to be paid to the holders of shares of Class A Common Stock (other than Parent or any affiliate of Parent) pursuant to, and in accordance with, the terms of this Agreement is fair, from a financial point of view, to such holders. The Company shall, following the execution of this Agreement by all Parties, furnish an accurate, complete and confidential copy of the aforementioned opinion letter to Parent solely for informational purposes.
Section 3.23. State Takeover Statutes; Anti-Takeover Laws. Assuming the accuracy of Parent’s and Merger Sub’s representations and warranties set forth in Section 4.8, the Company Board of Directors has taken all action necessary to render inapplicable to this Agreement and the Transactions Section 203 of the DGCL and any similar provisions in the Company Governing Documents or any other Takeover Statute. The Company has no rights plan, “poison-pill” or other comparable agreement designed to have the effect of delaying, deferring or discouraging any Person from acquiring control of the Company.
Section 3.24. Related Party Transactions. Except as set forth in the Company SEC Documents, there are no transactions, agreements, arrangements or understandings between the Company or any Company Subsidiary, on the one hand, and any affiliate (including any officer or director) thereof, but not including any wholly owned Subsidiary of the Company, on the other hand, that are required to be disclosed under Item 404 of Regulation S-K of the SEC that are not so disclosed.
Section 3.25. Finders and Brokers. Other than Qatalyst Partners, neither the Company nor any Company Subsidiary has employed or engaged any investment banker, broker or finder in connection with the Transactions who is entitled to any fee or any commission in connection with this Agreement or upon or as a result of the consummation of the Merger; provided that any amounts due to Qatalyst Partners upon or as a result of the consummation of the Merger shall be paid immediately prior to the Closing. A true and complete copy of the engagement letter with Qatalyst Partners has been made available to Parent prior to the execution of this Agreement.
Section 3.26. No Other Representations. Except for the representations and warranties contained in Article IV and the certificate delivered pursuant to Section 7.3(c), the Company acknowledges that none of Parent or Merger Sub or any of their respective Representatives makes, and the Company acknowledges that it has not relied upon or otherwise been induced by, any other express or implied representation or warranty with respect to Parent or Merger Sub or any of their respective Subsidiaries or with respect to any other information provided or made available to the Company or its Representatives in connection with the Transactions, including any information, documents, projections, forecasts or other material made available to the Company or to the Company’s Representatives in certain “data rooms” or management presentations in expectation of the Transactions or the accuracy or completeness of any of the foregoing, except, in each case for the representations and warranties contained in Article IV and the certificate delivered pursuant to Section 7.3(c). Without limiting the generality of the foregoing, the Company acknowledges that, except as may be expressly provided in Article IV and the certificate delivered pursuant to Section 7.3(c), no representations or warranties are made with respect to any projections, forecasts, estimates, budgets or prospective
A-25

TABLE OF CONTENTS

information that may have been made available, directly or indirectly, to the Company, any of its Representatives or any other Person. Notwithstanding the foregoing, nothing in this Agreement shall limit the ability of the Company to bring a claim or cause of action against any Person in the case of Fraud by such Person.
ARTICLE IV
 
REPRESENTATIONS AND WARRANTIES
OF PARENT AND MERGER SUB
Except as disclosed in (x) any registration statements, forms, statements, schedules, exhibits, documents and reports filed or furnished by Parent with or to the SEC since February 1, 2025 and publicly available prior to the date of this Agreement (but excluding any predictive, cautionary or forward looking disclosures contained under the captions “risk factors,” “forward looking statements” or any similar precautionary sections and any other disclosures contained therein that are predictive, cautionary or forward looking in nature) or (y) the applicable section of the disclosure letter delivered by Parent to the Company immediately prior to the execution of this Agreement (the “Parent Disclosure Letter”) (it being understood that any information set forth in one section or subsection of the Parent Disclosure Letter shall be deemed to apply to and qualify (or, as applicable, a disclosure for purposes of) the representation and warranty set forth in this Agreement to which it corresponds in number and, whether or not an explicit reference or cross-reference is made, each other representation and warranty set forth in this Article IV for which it is reasonably apparent on its face that such information is relevant to such other section), Parent and Merger Sub represent and warrant to the Company as set forth below.
Section 4.1. Qualification, Organization, etc. Each of Parent and Merger Sub is a legal entity duly organized, validly existing and in good standing under the Laws of its respective jurisdiction of organization, and Merger Sub is a direct, wholly owned Subsidiary of Parent. Except as would not be material to Parent and Parent Subsidiaries, taken as a whole, each Parent Subsidiary is a legal entity duly organized and validly existing under the Laws of its respective jurisdiction of organization. Except as would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, each of Parent and the Parent Subsidiaries has all requisite corporate or similar power and authority to own, lease and operate its properties and assets and to carry on its business as presently conducted. Each of Parent, Merger Sub and the other Parent Subsidiaries is qualified to do business and is in good standing as a foreign corporation or other entity in each jurisdiction where the ownership, leasing or operation of its assets or properties or conduct of its business requires such qualification, except where the failure to be so qualified or, where relevant, in good standing, has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.
Section 4.2. Corporate Authority.
(a) Parent and Merger Sub have all requisite corporate power and authority to execute and deliver this Agreement and to consummate the Transactions, including the Merger. The execution and delivery of this Agreement, the performance of Parent’s and Merger Sub’s obligations under this Agreement and the consummation of the Transactions have been duly and validly authorized by all necessary corporate action of Parent and Merger Sub and no other corporate proceedings on the part of Parent or Merger Sub are necessary to authorize the performance of Parent’s or Merger Sub’s obligations under this Agreement or the consummation of, and to consummate, the Transactions, except, with respect to the Merger, for the filing of the Certificate of Merger with the Secretary of State of the State of Delaware.
(b) No vote or consent of the holders of any class or series of capital stock of Parent or the holders of any other securities of Parent (equity or otherwise) is necessary to adopt this Agreement, or to approve the Merger or the other Transactions. The vote or consent of Parent, as the sole stockholder of Merger Sub, is the only vote or consent of the holders of any class or series of capital stock of Merger Sub necessary to approve the Merger and adopt this Agreement. Prior to the execution of this Agreement, Parent, as sole stockholder of Merger Sub, duly executed and delivered a stockholder consent, such consent to be effective immediately following the execution of this Agreement, adopting this Agreement pursuant to Sections 228 and 251 of the DGCL and Parent has delivered or promptly following execution of this Agreement will deliver to the Company a copy of such consent, which is currently in effect and has not been rescinded.
A-26

TABLE OF CONTENTS

(c) This Agreement has been duly and validly executed and delivered by Parent and Merger Sub and, assuming this Agreement constitutes the valid and binding agreement of the Company, constitutes the valid and binding agreement of Parent and Merger Sub, is enforceable against Parent and Merger Sub in accordance with its terms, subject to the Enforceability Limitations.
Section 4.3. Governmental Consents; No Violation.
(a) Other than in connection with or in compliance with (i) the DGCL, (ii) the Securities Act, (iii) the Exchange Act, including the filing and mailing of the Proxy Statement with the SEC and any amendments or supplements thereto (iv) applicable state securities, takeover and “blue sky” laws, (v) the HSR Act and obtaining any requisite clearances or approvals under any other applicable Regulatory Laws and (vi) any applicable requirements of the Nasdaq, no authorization, permit, notification to, consent or approval of, or filing with, any Governmental Entity is necessary or required, under applicable Law, for the consummation by Parent and Merger Sub of the Transactions, except for such authorizations, permits, notifications, consents, approvals or filings that, if not obtained or made, would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.
(b) The execution and delivery by Parent and Merger Sub of this Agreement do not, and, except as described in Section 4.3(a), the performance and the consummation of the Transactions and compliance with the provisions hereof will not, (i) conflict with or result in any violation or breach of, or default or change of control (with or without notice or lapse of time, or both) under, or give rise to a right of, or result in, termination, modification, cancellation, first offer, first refusal or acceleration of any obligation or to the loss of a benefit under any Contract binding upon Parent or any Parent Subsidiary or to which any of them are a party or by which or to which any of their respective properties, rights or assets are bound or subject, or result in the creation of any Lien upon any of the properties, rights or assets of Parent or any Parent Subsidiary, other than Permitted Liens, (ii) conflict with or result in any violation of any provision of the certificate of incorporation and bylaws of Parent as amended to the date hereof or the organizational or governing documents of Merger Sub or (iii) conflict with or violate any Laws applicable to Parent or any Parent Subsidiary or any of their respective properties, rights or assets, other than in the case of clauses (i) and (iii), any such violation, breach, conflict, default, termination, modification, cancellation, acceleration, right, loss or Lien that would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.
Section 4.4. Litigation; Orders. As of the date hereof, there are no Proceedings pending or, to Parent’s Knowledge, threatened against Parent or any Parent Subsidiary or any of their respective properties, rights or assets by or before, and there are no orders, judgments or decrees of or settlement agreements with, any Governmental Entity, that are or would reasonably be expected to, individually or in the aggregate, cause a Parent Material Adverse Effect.
Section 4.5. Information Supplied. The information relating to Parent and the Parent Subsidiaries to the extent supplied by or on behalf of Parent and the Parent Subsidiaries to be contained in, or incorporated by reference in, the Proxy Statement will not, at the time it and any amendments or supplements thereto are filed with the SEC, at the date the Proxy Statement is first mailed to the Company Stockholders or at the time of the Company Stockholders Meeting, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, at the time and in light of the circumstances under which they were made, not false or misleading. Notwithstanding the foregoing provisions of this Section 4.5, no representation or warranty is made by Parent or Merger Sub with respect to information or statements made or incorporated by reference in the Proxy Statement, which information or statements were not supplied by or on behalf of Parent or Merger Sub.
Section 4.6. Sufficient Funds. Assuming the accuracy of the Company’s representations and warranties set forth in Section 3.2(a), Section 3.2(b), Section 3.2(c) and Section 3.2(d), Parent will have at the Closing access to all of the funds that are necessary for it to pay the aggregate Per Share Merger Consideration and consummate the Transactions, and to perform its obligations under this Agreement.
Section 4.7. Finders and Brokers. Other than J.P. Morgan Securities LLC, neither Parent nor any Parent Subsidiary has employed or engaged any investment banker, broker or finder in connection with the Transactions who is entitled to any fee or any commission in connection with this Agreement or upon or as a result of the consummation of the Merger.
Section 4.8. Stock Ownership. Parent is not, nor at any time for the past three (3) years has been, an “interested stockholder” of the Company as defined in Section 203 of the DGCL.
A-27

TABLE OF CONTENTS

Section 4.9. No Other Representations. Except for the representations and warranties contained in Article III, the certificate delivered pursuant to Section 7.2(d) and the Voting Agreement (which representations in the Voting Agreement are limited to those made by the Company Support Parties and are not made by or on behalf of the Company), each of Parent and Merger Sub acknowledges that none of the Company, any of its Representatives or any other Person makes, and each of Parent and Merger Sub acknowledges that it has not relied upon or otherwise been induced by, any express or implied representation or warranty with respect to the Company or any Company Subsidiary or with respect to any other information provided or made available to Parent, Merger Sub or their respective Representatives in connection with the Transactions, including any information, documents, projections, forecasts or other material made available to Parent, Merger Sub or their respective Representatives in certain “data rooms” or management presentations in expectation of the Transactions or the accuracy or completeness of any of the foregoing, except, in each case for the representations and warranties contained in Article III, the certificate delivered pursuant to Section 7.2(d) and the Voting Agreement (which representations in the Voting Agreement are limited to those made by the Company Support Parties and are not made by or on behalf of the Company). Without limiting the generality of the foregoing, each of Parent and Merger Sub acknowledges that, except as may be expressly provided in Article III, the certificate delivered pursuant to Section 7.2(d) and the Voting Agreement (which representations in the Voting Agreement are limited to those made by the Company Support Parties and are not made by or on behalf of the Company), no representations or warranties are made with respect to any projections, forecasts, estimates, budgets or prospective information that may have been made available, directly or indirectly, to Parent, Merger Sub, any of their respective Representatives or any other Person. Notwithstanding the foregoing, nothing in this Agreement shall limit the ability of Parent or Merger Sub to bring a claim or cause of action against any Person in the case of Fraud by such Person.
ARTICLE V
 
COVENANTS RELATING TO CONDUCT OF BUSINESS
PENDING THE MERGER
Section 5.1. Conduct of Business by the Company Pending the Closing. The Company agrees that between the date hereof and the earlier of the Effective Time or the date, if any, on which this Agreement is validly terminated pursuant to Section 8.1, except as set forth in Section 5.1 of the Company Disclosure Letter, as specifically permitted or required by this Agreement, as required by applicable Law or as consented to in writing by Parent (with respect to actions otherwise prohibited by clauses (i) (with respect to the organizational documents of any Company Subsidiary only), (ix), (x), (xi), (xii), (xiii), (xv), (xvi), (xvii), (xx) and (xxii) (or (xxvi) with respect to any of the foregoing) of Section 5.1(b) only, such consent not to be unreasonably withheld, conditioned or delayed), the Company (a) shall, and shall cause each Company Subsidiary to, use reasonable best efforts to (i) conduct its business in all material respects in the ordinary course of business consistent with past practice, (ii) preserve intact its and their present business organizations, goodwill and ongoing businesses, (iii) keep available the services of its and their present officers and other key employees (other than where termination of such services is for cause or due to resignation) and (iv) preserve its and their relationships with customers, suppliers, vendors, resellers, licensors, licensees, Governmental Entities, employees and other Persons with whom it and they have material business relations (it being agreed by the Parties that with respect to the matters specifically addressed by any provision of Section 5.1(b), such specific provisions shall govern over the more general provisions of this Section 5.1(a)); and (b) shall not, and shall cause each Company Subsidiary not to, directly or indirectly:
(i) amend, modify, waive, rescind, change or otherwise restate the Company’s or any Company Subsidiary’s certificate of incorporation, bylaws or organizational documents;
(ii) authorize, declare, set aside, make or pay any dividends on or make any distribution with respect to its outstanding shares of capital stock or other equity interests (whether in cash, assets, shares or other securities of the Company or any Company Subsidiary) (other than dividends or distributions made by any wholly owned Company Subsidiary to the Company or any wholly owned Company Subsidiary), or enter into any agreement and arrangement with respect to voting or registration, or file any registration statement with the SEC with respect to, any of its capital stock or other equity interests or securities;
(iii) split, combine, subdivide, reduce or reclassify any of its capital stock or other equity interests, or redeem, purchase or otherwise acquire any of its capital stock or other equity interests, or issue or authorize the issuance of any of its capital stock or other equity interests or any other securities in respect of, in lieu of or in substitution for, shares of its capital stock or other equity interests, except for (A) the acceptance of shares of Class A Common Stock as payment of the exercise price of Company Options or for withholding Taxes in respect of Company Equity Awards, in each case in accordance with past practice and the terms of such Company Equity
A-28

TABLE OF CONTENTS

Awards, or (B) any such transaction by a wholly owned Company Subsidiary which remains a wholly owned Company Subsidiary after consummation of such transaction;
(iv) issue, deliver, grant, sell, pledge, modify, transfer, dispose of or encumber or grant, or authorize the issuance, delivery, grant, sale, pledge, modification, transfer, disposition or encumbrance or grant of, directly or indirectly, any shares in the capital stock, voting securities or other equity interest in the Company or any Company Subsidiary or any securities convertible into or exchangeable or exercisable for any such shares, voting securities or equity interest, or any rights, warrants or options to acquire any such shares, voting securities or equity interest or any “phantom” stock, “phantom” stock rights, stock appreciation rights or stock based performance units or take any action to cause to be exercisable or vested any otherwise unexercisable or unvested Company Equity Award under any existing Company Equity Plan (except pursuant to the express terms of any Company Equity Award), other than (A) issuances of Class A Common Stock in respect of any exercise of Company Options outstanding on the date hereof or the vesting and settlement of Company Equity Awards outstanding on the date hereof, in all cases in accordance with their respective terms as of the date hereof, (B) issuance of shares of Class A Common Stock pursuant to the exercise of Company Options if necessary to effectuate an optionee direction upon exercise or pursuant to the settlement of Company Equity Awards in order to satisfy Tax withholding obligations, (C) issuances of Class A Common Stock in respect of any options outstanding under the Company ESPP in respect of any Current ESPP Offering Periods or granted under any future Company ESPP offering periods or (D) transactions solely between the Company and a wholly owned Company Subsidiary or solely between wholly owned Company Subsidiaries;
(v) except as required by any Company Benefit Plan in existence as of the date hereof, (A) increase or commit to increase the compensation, bonus, incentive compensation, severance, termination pay or other benefits payable or to become payable to any of its directors, officers, employees or individual independent contractors, (B) pay, grant or award, or commit to pay, grant or award, any bonuses, retention or incentive compensation, including any Company Equity Awards, to any of its directors, officers, employees or individual independent contractors, (C) establish, adopt, enter into, amend or terminate any collective bargaining agreement or Company Benefit Plan (or any arrangement that would be a Company Benefit Plan if in effect on the date of this Agreement), except for (x) any amendments to health and welfare plans in the ordinary course of business consistent with past practice that do not contravene the other covenants set forth in this clause (v) and do not materially increase the cost to the Company of maintaining such Company Benefit Plan or the benefits provided thereunder and (y) entry into at-will offer letters that do not provide for severance or change-in-control (or term of similar import) entitlements, (D) take any action to amend or waive any performance or vesting criteria or accelerate vesting, exercisability or funding under any Company Benefit Plan, (E) make any contributions or payments to any rabbi trust or other funding vehicle with respect to any Company Benefit Plan, (F) change any actuarial or other assumptions used to calculate funding obligations with respect to any Company Benefit Plan or change the manner in which such contributions are determined, except as may be required by GAAP, (G) loan or advance money or other property to any directors, officers, employees or individual independent contractors (other than advances for reimbursable employee expenses in the ordinary course of business consistent with past practice and in accordance with the Company’s expense reimbursement policies), (H) terminate the employment of any employee at the level of Vice President or above, other than for cause, (I) (x) promote any employee to the level of Vice President or above or (y) hire any new employees or engage any individual independent contractor, (J) enter into, materially amend, renegotiate, renew or extend a Contract or relationship with a professional employer organization, employer-of-record or similar arrangement, (K) form or otherwise establish any employing entity in any country that does not currently have an employing entity or (L) waive, release or limit the scope of any restrictive covenant or any similar post-termination obligation by which any current or former director, officer, employee or individual independent contractor is bound;
(vi) acquire (including by merger, consolidation or acquisition of stock or assets or any other means) or authorize or announce an intention to so acquire, or enter into any agreements providing for any acquisitions of, any equity interests in or assets of any Person or any business or division thereof, or otherwise engage in any mergers, consolidations or business combinations, except for (A) transactions solely between the Company and a wholly owned Company Subsidiary or solely between wholly owned Company Subsidiaries, (B) acquisitions of supplies or equipment in the ordinary course of business consistent with past practice, or (C) transactions involving an amount up to $15,000,000 of cash consideration in the aggregate that would not reasonably be expected to materially delay, impede or prevent the consummation of the Transactions on or before the Outside Date;
A-29

TABLE OF CONTENTS

(vii) merge or consolidate the Company or any Company Subsidiary with any Person or liquidate (completely or partially), dissolve, restructure, recapitalize or effect any other reorganization (including any restructuring, recapitalization or reorganization between or among any of the Company and/or the Company Subsidiaries), or adopt any plan or resolution providing for any of the foregoing;
(viii) make any loans, advances or capital contributions to, or investments in, any other Person, except for (A) loans solely among the Company and its wholly owned Company Subsidiaries or solely among the Company’s wholly owned Company Subsidiaries, (B) advances for reimbursable employee expenses in the ordinary course of business consistent with past practice or pursuant to any advancement obligations under the Company Governing Documents or indemnification agreements with directors or officers of the Company or its Subsidiaries in existence on the date of this Agreement and set forth on Section 6.4(a) of the Company Disclosure Letter, or (C) capital contributions to or investments in wholly owned Company Subsidiaries;
(ix) sell, lease, license, assign, abandon, permit to lapse, transfer, exchange, swap or otherwise dispose of any of its material properties, rights or assets (including shares in the capital of the Company or the Company Subsidiaries), subject to any Lien (other than Permitted Liens), any of its material properties, rights or assets (including shares in the capital of the Company or the Company Subsidiaries), or enter into any Contract requiring any of the foregoing, except (A) dispositions of obsolete or worthless equipment, in the ordinary course of business consistent with past practice, (B) non-exclusive licenses of Company Intellectual Property entered into in the ordinary course of business consistent with past practice with customers or resellers of the Company or the Company Subsidiaries in connection with Company Products and (C) pursuant to transactions solely among the Company and its wholly owned Company Subsidiaries or solely among wholly owned Company Subsidiaries;
(x) terminate or materially amend or modify any written policies or procedures with respect to (A) the use or distribution by the Company or any Company Subsidiary of any open source Software or (B) the use by or for the Company or any Company Subsidiary of AI Systems, except to comply with applicable Law;
(xi) (A) enter into any Contract that would, if entered into prior to the date hereof, be a Material Contract of the types referred to in clause (i), (ii), (iii), (v), (viii), (xii), (xiii), (xvi) or (xviii) of Section 3.17, or (B) (1) materially (x) modify, (y) amend, (z) extend or terminate any Material Contract (other than renewals and non-renewals occurring in the ordinary course of business consistent with past practice), or (2) waive, release or assign any material (x) rights or (y) claims thereunder, in the case of this clause (2) other than in the ordinary course of business consistent with past practice;
(xii) except in accordance with the Company’s capital budget set forth on Section 5.1(b)(xii) of the Company Disclosure Letter, make any capital expenditure or expenditures, enter into agreements or arrangements providing for capital expenditure or expenditures or otherwise commit to do so;
(xiii) commence (other than any collection action in the ordinary course of business consistent with past practice), waive, release, assign, compromise or settle any threatened or pending claim, litigation, investigation or Proceeding (for the avoidance of doubt, including with respect to matters in which the Company or any Company Subsidiary is a plaintiff, or in which any of their officers or directors in their capacities as such are parties), other than the compromise or settlement of any claim, litigation or proceeding that is not brought by Governmental Entities and that: (A) is for an amount not to exceed, for any such compromise or settlement individually, $1,000,000, or in the aggregate, $2,000,000, (B) does not impose any injunctive relief on the Company and the Company Subsidiaries and does not involve the admission of wrongdoing by the Company, any Company Subsidiary or any of their respective officers or directors or otherwise establish a materially adverse precedent for similar settlements by Parent or any Parent Subsidiaries (including, following the Effective Time, the Company and the Company Subsidiaries) and (C) does not provide for the license of any Intellectual Property or the termination, modification or amendment of any license of Intellectual Property;
(xiv) change the Company’s fiscal year or make any change in financial accounting policies, practices, principles or procedures or any of its methods of reporting income, deductions or other material items for financial accounting purposes, except as required by GAAP or Regulation S-X of the Exchange Act;
(xv) amend or modify in any material respect any Privacy Statement of the Company or any Company Subsidiary;
(xvi) except as expressly provided in or required by Section 6.13, (A) make, change or revoke any material Tax election, other than in the ordinary course of business consistent with past practice, (B) adopt or change any
A-30

TABLE OF CONTENTS

annual Tax accounting period or material method of Tax accounting, (C) amend any material Tax Return, (D) except as required by Law, file any material Tax Return that is inconsistent in any material respect with a previously filed material Tax Return of the same type for a prior taxable period (taking into account any amendments prior to the date hereof), (E) settle or compromise any material Tax audit, claim or other proceeding relating to Taxes for an amount in excess of any amount accrued or reserved therefor in the Company SEC Documents (plus any interest that has been incurred since the filing of such Company SEC Documents), (F) enter into any material “closing agreement” within the meaning of Section 7121 of the Code (or any similar provision of state, local or non-U.S. Law) or any material advance pricing arrangements or agreements with a Tax authority under any U.S. federal, state, local or non-U.S. Law, (G) surrender any right to claim a material refund of Taxes, (H) request a private letter ruling from the IRS or a comparable ruling from any other Tax authority, in each case, with respect to any material amount of Taxes, or (I) agree to an extension or waiver of the statute of limitations with respect to a material amount of Taxes (other than in connection with automatic extensions of time to file Tax Returns);
(xvii) redeem, repurchase, repay, prepay, defease, incur, assume, endorse, guarantee or otherwise become liable for or modify in any material respect the terms of any Indebtedness or any derivative financial instruments or arrangements (including swaps, caps, floors, futures, forward contracts and option agreements), or issue or sell any debt securities or calls, options, warrants or other rights to acquire any debt securities (directly, contingently or otherwise), in each case except for the incurrence and repayment of any Indebtedness solely among the Company and its wholly owned Company Subsidiaries or solely among wholly owned Company Subsidiaries, in each case in the ordinary course of business;
(xviii) enter into any transactions or Contracts with any affiliate or other Person that would be required to be disclosed by the Company under Item 404 of Regulation S-K of the SEC;
(xix) fail to use commercially reasonable efforts to maintain the Company’s insurance policies or comparable replacement policies with respect to the material assets, operations and activities of the Company and the Company Subsidiaries;
(xx) (A) (i) acquire any real property or (ii) enter into any lease or sublease of real property (whether as a lessor, sublessor, lessee or sublessee) that if in existence as of the date hereof would constitute a Material Contract, (B) materially modify or amend or exercise any right to renew any Company Lease (other than entering into an amendment or extension agreement to extend the term of a Company Lease in accordance with its terms), or waive any material term or condition thereof or grant any material consents thereunder, or (C) grant or otherwise knowingly create or consent to the creation of any material easement, covenant, restriction, assessment or charge affecting any real property leased by the Company, or any interest therein or part thereof, other than Permitted Liens, in the case of each of clauses (B) and (C), other than in the ordinary course of business consistent with past practice;
(xxi) other than the Company Stockholders Meeting, convene any special meeting (or any adjournment or postponement thereof) of the Company Stockholders;
(xxii) other than in the ordinary course of business consistent with past practice, abandon, withdraw, suspend, abrogate, terminate or modify, amend or waive in any material respect any right under any material Company Permit;
(xxiii) adopt or otherwise implement any stockholder rights plan, “poison-pill” or other comparable agreement;
(xxiv) forgive any material loans or advances to any officers, employees, directors or other individual service providers of the Company or any Company Subsidiary, or any of their respective affiliates, or change their respective existing borrowing or lending arrangements for or on behalf of any of such Persons in accordance with an employee benefit plan or otherwise, except in the ordinary course of business consistent with past practice in connection with relocation activities to any employees of the Company or any Company Subsidiary or (B) expense or indemnification reimbursement pursuant to any advancement obligations under the Company Governing Documents or indemnification agreements with directors or officers of the Company or its Subsidiaries in existence on the date of this Agreement set forth on Section 6.4(a) of the Company Disclosure Letter;
A-31

TABLE OF CONTENTS

(xxv) use or make available any High-Risk AI Systems or engage in activities that are “unacceptable” or “prohibited” under the European Union Artificial Intelligence Act (or that are subject to a similar designation under applicable Law in other jurisdictions); or
(xxvi) agree, commit or authorize, in writing or otherwise, or announce an intention, to take any of the foregoing actions.
Any covenant of the Company to cause the Company Subsidiaries to take or refrain from taking any actions under this Section 5.1 shall, with respect to each Minority Investment Entity, be deemed to be a covenant of the Company to use reasonable best efforts, in each case, solely to the extent consistent with applicable fiduciary and legal duties, to cause such Minority Investment Entity, as applicable, to take or refrain from taking such action, which efforts shall be limited to the exercise of management, voting, consent or similar rights available to the Company or any Company Subsidiary under any existing organizational document or other Contract with respect to such Minority Investment Entity, as applicable.
Nothing contained in this Agreement shall give Parent or Merger Sub, directly or indirectly, the right to control or direct the operations of the Company or any of its Subsidiaries prior to the Effective Time. Prior to the Effective Time, the Company shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision over its and its Subsidiaries’ respective operations.
Section 5.2. No Solicitation by the Company.
(a) Except as expressly permitted by this Section 5.2, from and after the date hereof until the earlier of the Effective Time or the date, if any, on which this Agreement is validly terminated pursuant to Section 8.1, the Company agrees that it shall not, and shall cause the Company Subsidiaries and its and their respective officers and directors not to, and shall use its reasonable best efforts to cause its and the Company Subsidiaries’ other Representatives to not, directly or indirectly: (i) solicit, initiate or knowingly encourage or facilitate (including by way of providing information or taking any other action) any inquiry, proposal or offer, or the making, submission or announcement of any inquiry, proposal or offer which constitutes or would reasonably be expected to lead to an Acquisition Proposal; (ii) participate in any negotiations regarding, or furnish to any person any information relating to the Company or any Company Subsidiary in connection with an actual or potential Acquisition Proposal; (iii) adopt, approve, endorse or recommend, or propose to adopt, approve, endorse or recommend, any Acquisition Proposal; (iv) withdraw, change, amend, modify or qualify, or otherwise propose to withdraw, change, amend, modify or qualify, in a manner adverse to Parent, the Company Board Recommendation, or resolve or agree to take any such action; (v) if an Acquisition Proposal has been publicly disclosed, fail to publicly recommend against any such Acquisition Proposal and reaffirm the Company Board Recommendation (provided, that the Company shall not be required to reaffirm more than once per Acquisition Proposal unless the terms of such Acquisition Proposal change in any material respects and such change is publicly announced or disclosed) within ten (10) Business Days (or, if earlier, by the second (2nd) Business Day prior to the Company Stockholders Meeting) after the public disclosure of such Acquisition Proposal (or subsequently withdraw, change, amend, modify or qualify, in a manner adverse to Parent, such rejection of such Acquisition Proposal); (vi) include any adverse amendment, withdrawal, alteration, modification or qualification of the Company Board Recommendation in the Proxy Statement or any other legally required disclosure to the Company Stockholders with regard to an Acquisition Proposal; (vii) approve, or authorize, or cause or permit the Company or any Company Subsidiary to enter into, any merger agreement, acquisition agreement, reorganization agreement, letter of intent, memorandum of understanding, agreement in principle, option agreement, joint venture agreement, partnership agreement or similar agreement or document with respect to, or any other agreement or commitment providing for, any Acquisition Proposal (other than an Acceptable Confidentiality Agreement entered into in accordance with this Section 5.2) (a “Company Acquisition Agreement”); (viii) call or convene a meeting of the Company Stockholders to consider a proposal that would reasonably be expected to materially impair, prevent or delay the consummation of the Transactions or (ix) resolve or agree to do any of the foregoing (any act described in clauses (iii), (iv), (v), (vi), (vii), (viii) and/or (ix) (to the extent related to the foregoing clauses (iii), (iv), (v), (vi), (vii) or (viii)), a “Change of Recommendation”). The Company shall, and shall cause the Company Subsidiaries and its and their respective officers and directors to, and shall use its reasonable best efforts to cause its and the Company Subsidiaries’ other Representatives to, immediately cease any and all solicitation, encouragement, discussions or negotiations with any persons (or provision of any information to any persons) with respect to any inquiry, proposal or offer that constitutes, or would reasonably be expected to lead to, an Acquisition Proposal. Promptly after the date hereof (and in any event within two (2) Business Days following the date hereof), the
A-32

TABLE OF CONTENTS

Company shall (A) request in writing that each person that has heretofore executed a confidentiality agreement in connection with its consideration of an Acquisition Proposal or potential Acquisition Proposal promptly destroy or return to the Company all nonpublic information heretofore furnished by the Company or any of its Representatives to such person or any of its Representatives in accordance with the terms of such confidentiality agreement and (B) terminate access to any physical or electronic data rooms relating to a possible Acquisition Proposal by such person and its Representatives. The Company shall enforce, and not waive, terminate or modify without Parent’s prior written consent, any confidentiality, standstill or similar provision in any confidentiality, standstill or other agreement; provided that, if the Company Board of Directors determines in good faith after consultation with the Company’s outside legal counsel that the failure to waive a particular standstill provision would be reasonably likely to violate the directors’ fiduciary duties under applicable Law, the Company may, with prior written notice to Parent, waive such standstill solely to the extent necessary to permit the applicable person (if it has not been solicited in violation of this Section 5.2) to make, on a confidential basis to the Company Board of Directors, an Acquisition Proposal, conditioned upon such person agreeing to disclosure of such Acquisition Proposal to Parent, in each case as contemplated by this Section 5.2. For purposes of this Section 5.2, the term “person” means any Person or “group,” as defined in Section 13(d) of the Exchange Act, other than, with respect to the Company, Parent or any Parent Subsidiary or any of their Representatives. Notwithstanding the limitations set forth in Section 5.2(a), if the Company receives, prior to the Company Stockholder Approval being obtained, an unsolicited bona fide written Acquisition Proposal that did not result from a breach of this Section 5.2, the Company and the Company Subsidiaries and the Company’s Representatives may contact the Person or any of its Representatives who has made such Acquisition Proposal solely to clarify (and not to negotiate or engage in any discussions regarding or relating to) the material terms and conditions of such Acquisition Proposal so that the Company may determine whether such Acquisition Proposal constitutes a Superior Proposal or would reasonably be expected to result in a Superior Proposal. For the avoidance of doubt, any violation of the restrictions set forth in this Section 5.2 by (x) a Company Subsidiary, (y) a director or officer of the Company or any Company Subsidiary or (z) any other Representatives acting on behalf or at the direction of the Company or any Company Subsidiary shall be a breach of this Section 5.2 by the Company.
(b) Notwithstanding the limitations set forth in Section 5.2(a), if the Company receives, prior to the Company Stockholder Approval being obtained, an unsolicited bona fide, written Acquisition Proposal that did not result from a breach of this Section 5.2, which the Company Board of Directors determines in good faith after consultation with the Company’s outside legal counsel and financial advisors (i) constitutes a Superior Proposal or (ii) would reasonably be expected to result in a Superior Proposal and, in each case, that the failure to take such action would be reasonably likely to violate the directors’ fiduciary duties under applicable Law, then in either event the Company may take the following actions: (x) furnish nonpublic information with respect to the Company to the person making such Acquisition Proposal and its Representatives, if, and only if, prior to so furnishing such information, the Company receives from such person an executed Acceptable Confidentiality Agreement and the Company also provides Parent, prior to or substantially concurrently with the time such information is provided or made available to such person, any nonpublic information furnished to such other person that was not previously furnished to Parent, and (y) engage in discussions or negotiations with such person with respect to such Acquisition Proposal.
(c) The Company shall promptly (and in any event within twenty-four (24) hours) notify Parent of the Company’s or any of its controlled affiliates’ or its or their respective Representatives’ receipt of any Acquisition Proposal, any proposals or inquiries that would reasonably be expected to lead to an Acquisition Proposal, or any inquiry or request for nonpublic information relating to the Company or any Company Subsidiary by any person who has made or would reasonably be expected to make any Acquisition Proposal. Such notice shall indicate the identity of the person making the Acquisition Proposal, inquiry or request, and the material terms and conditions of any such proposal or offer or the nature of the information requested pursuant to such inquiry or request, including unredacted copies of all written requests, proposals, correspondence or offers, including proposed agreements received by the Company or its Representatives relating to such Acquisition Proposal or, if such Acquisition Proposal is not in writing, a reasonably detailed written description of the material terms and conditions thereof. Without limiting the Company’s other obligations under this Section 5.2, the Company shall keep Parent reasonably informed on a prompt and timely basis of the status and material terms (including any amendments or proposed amendments to such material terms) of any such Acquisition Proposal or potential Acquisition Proposal and keep Parent reasonably informed on a prompt and timely basis as to the nature of any information requested of the Company with respect thereto and promptly (and in any event within twenty-four (24) hours) provide to Parent copies of all proposals, offers and proposed agreements relating to an
A-33

TABLE OF CONTENTS

Acquisition Proposal received by the Company or its Representatives or, if such information or communication is not in writing, a reasonably detailed written description of the material contents thereof. Without limiting the Company’s other obligations under this Section 5.2, the Company shall promptly provide (and in any event within twenty-four (24) hours) to Parent any material nonpublic information concerning the Company provided to any other person in connection with any Acquisition Proposal that was not previously provided to Parent. Without limiting the foregoing, the Company shall promptly (and in any event within twenty-four (24) hours after such determination) inform Parent in writing if the Company determines to begin providing information or to engage in discussions or negotiations concerning an Acquisition Proposal pursuant to Section 5.2(b). Unless this Agreement has been validly terminated pursuant to Section 8.1, the Company shall not take any action to exempt any person other than Parent or Merger Sub from the restrictions on “business combinations” contained in any applicable Takeover Statute or in the Company Governing Documents, or otherwise cause such restrictions not to apply. The Company agrees that it will not, directly or indirectly, enter into any agreement with any person which directly or indirectly prohibits the Company from providing any information to Parent in accordance with, or otherwise complying with, this Section 5.2.
(d) Notwithstanding anything in this Section 5.2 to the contrary, but subject to Section 5.2(e), at any time prior to the Company Stockholder Approval being obtained, the Company Board of Directors may (i) make a Change of Recommendation in response to an Intervening Event if the Company Board of Directors has determined, in good faith after consultation with the Company’s outside legal counsel and financial advisors, that the failure to take such action would be reasonably likely to violate the directors’ fiduciary duties under applicable Law or (ii) make a Change of Recommendation, and cause the Company to terminate this Agreement pursuant to and in accordance with Section 8.1(h) in order to enter into a definitive agreement providing for an unsolicited Acquisition Proposal received after the date of this Agreement (which, for the avoidance of doubt, did not result from a breach of this Section 5.2 and such Acquisition Proposal is not withdrawn) if the Company Board of Directors determines in good faith after consultation with the Company’s outside legal counsel and financial advisors that such Acquisition Proposal constitutes a Superior Proposal, but only if the Company Board of Directors has determined in good faith after consultation with the Company’s outside legal counsel and financial advisors, that failure to take such action would be reasonably likely to violate the directors’ fiduciary duties under applicable Law; provided that notwithstanding anything to the contrary herein, neither the Company nor any Company Subsidiary shall enter into any Company Acquisition Agreement unless this Agreement has been validly terminated in accordance with Section 8.1. “Intervening Event” means any Effect that is material to the Company and the Company Subsidiaries (taken as a whole) and was not known by or reasonably foreseeable to the Company Board of Directors as of or prior to the date hereof; provided, however, that in no event shall the following events, changes or developments constitute an Intervening Event: (A) the receipt, existence or terms of an Acquisition Proposal or any inquiry or communications relating thereto or any matter relating thereto or consequence thereof, (B) changes in the market price or trading volume of the Class A Common Stock or any other securities of the Company or Company Subsidiaries, or any change in credit rating or the fact that the Company meets or exceeds internal or published estimates, projections, forecasts or predictions for any period, (C) changes in general economic, political or financial conditions or markets (including changes in interest rates, exchange rates, stock, bond and/or debt prices), (D) changes in GAAP, other applicable accounting rules or applicable Law or, in any such case, changes in the interpretation thereof or (E) natural disasters, epidemics or pandemics.
(e) Prior to the Company taking any action permitted (i) under Section 5.2(d)(i), the Company shall provide Parent with four (4) Business Days’ prior written notice advising Parent that the Company Board of Directors intends to effect a Change of Recommendation and specifying, in reasonable detail, the reasons therefor, and during such four (4) Business Day period (which period shall expire at 11:59 p.m., Pacific Time, on the fourth (4th) Business Day), the Company shall cause its Representatives (including its executive officers) to negotiate in good faith (to the extent Parent desires to negotiate) any proposal by Parent to amend the terms and conditions of this Agreement in a manner that would obviate the need to effect a Change of Recommendation and at the end of such four (4) Business Day period (which period shall expire at 11:59 p.m., Pacific Time, on the fourth (4th) Business Day) the Company Board of Directors again makes the determination under Section 5.2(d)(i) (after in good faith taking into account any amendments proposed by Parent) or (ii) under Section 5.2(d)(ii), the Company shall provide Parent with four (4) Business Days’ prior written notice advising Parent that the Company Board of Directors intends to take such action and specifying the material terms and conditions of the Acquisition Proposal, including a copy of any proposed definitive documentation, and during such four (4) Business Day period (which period shall expire at 11:59 p.m., Pacific Time, on the fourth (4th) Business Day), the Company shall cause its Representatives (including its executive officers) to negotiate in good faith (to the extent Parent desires
A-34

TABLE OF CONTENTS

to negotiate) any proposal by Parent to amend the terms and conditions of this Agreement such that such Acquisition Proposal would no longer constitute a Superior Proposal and at the end of such four (4) Business Day period (which period shall expire at 11:59 p.m., Pacific Time, on the fourth (4th) Business Day) the Company Board of Directors again makes the determination under Section 5.2(d)(ii) (after in good faith taking into account the amendments proposed by Parent). With respect to this Section 5.2(e), if there are any material amendments, revisions or changes to the terms of any such Superior Proposal (including any revision to the amount, form or mix of consideration the Company Stockholders would receive as a result of the Superior Proposal), the Company shall notify Parent of each such amendment, revision or change in compliance with Section 5.2(c) and the applicable four (4) Business Day period shall be extended until at least three (3) Business Days after the time that Parent receives notification from the Company of each such revision, and the Company Board of Directors shall not take any such action permitted under Section 5.2(d)(ii) prior to the end of any such period (which period shall expire at 11:59 p.m., Pacific Time, on the applicable day) as so extended in accordance with the terms of this Section 5.2(e).
(f) Nothing in this Agreement shall prohibit the Company or the Company Board of Directors from (i) disclosing to the Company Stockholders a position contemplated by Rules 14d-9 and 14e-2(a) promulgated under the Exchange Act, (ii) making any “stop, look and listen” communication to the Company Stockholders pursuant to Rule 14d-9(f) promulgated under the Exchange Act or (iii) making any legally required disclosure to the Company Stockholders with regard to an Acquisition Proposal, which actions, in the case of clauses (i)–(iii), shall not constitute or be deemed to constitute a Change of Recommendation so long as any such disclosure (x) includes an express reaffirmation, and does not include any adverse amendment, withdrawal, alteration, modification or qualification, of the Company Board Recommendation and (y) does not include any statement that constitutes, and does not otherwise constitute, a Change of Recommendation. For the avoidance of doubt, (1) this Section 5.2(f) shall not permit the Company Board of Directors to make (or otherwise modify the definition of) a Change of Recommendation except to the extent expressly permitted by Section 5.2(d) and Section 5.2(e) and (2) factually accurate statement by the Company or the Company Board of Directors (or a committee thereof) that confirms the receipt of an Acquisition Proposal and that no position has been taken by the Company or the Company Board of Directors (or a committee thereof) as to the advisability or desirability of such Acquisition Proposal, shall not constitute a Change of Recommendation; provided that if such statement has the substantive effect of withdrawing, qualifying or modifying the Company Board Recommendation, such statement shall constitute a Change of Recommendation unless the Company expressly reaffirms the Company Board Recommendation in such statement.
Section 5.3. Preparation of Proxy Statement; Company Stockholders Meeting.
(a) As promptly as reasonably practicable after the date hereof, the Company (with Parent’s reasonable cooperation) shall prepare and file with the SEC a mutually acceptable proxy statement in preliminary form relating to the Company Stockholders Meeting (such proxy statement, including, for the avoidance of doubt, any amendments or supplements thereto, and the definitive proxy statement related thereto, and any amendments or supplements to such definitive proxy statement, the “Proxy Statement”) and the Company will use its reasonable best efforts to cause such filing to occur no later than thirty-five (35) days following the execution of this Agreement. Each of the Company and Parent shall furnish all information concerning itself and its affiliates that is required to be included in the Proxy Statement or that is customarily included in proxy statements prepared in connection with transactions of the type contemplated by this Agreement. The Company shall use reasonable best efforts to cause the Proxy Statement to comply with the applicable rules and regulations promulgated by the SEC. Parent shall provide the Company such assistance and cooperation as may be reasonably requested by the Company in the preparation of the information related to Parent or Merger Sub to be included in the Proxy Statement. The Company agrees that all information relating to Parent, its affiliates and its and their respective Representatives included in the Proxy Statement shall be in form and content reasonably satisfactory to Parent. Each of the Company and Parent shall use its respective reasonable best efforts to respond as promptly as practicable to any comments of the SEC with respect to the Proxy Statement, and the Company shall use its reasonable best efforts to cause the definitive Proxy Statement to be filed with the SEC and mailed to the Company Stockholders as promptly as practicable after the date on which the Company learns that the Proxy Statement will not be reviewed or that the SEC staff has no further comments thereon. Each of the Company and Parent, as applicable, shall notify the other promptly (and in any case no later than twenty-four (24) hours) upon the receipt of any comments from the SEC or its staff or any request from the SEC or its staff for amendments or supplements to the Proxy Statement or for additional information. The Company shall give Parent and its counsel reasonable opportunity to review and comment on the Proxy Statement, including all amendments and supplements thereto,
A-35

TABLE OF CONTENTS

prior to filing such documents with the SEC or disseminating them to holders of shares of Class A Common Stock and a reasonable opportunity to review and comment on all responses to requests for additional information, and shall consider any comments proposed by Parent and its counsel in good faith; provided that, without limiting the generality of this Section 5.3, with respect to documents filed by the Company or Parent, as applicable, which are incorporated by reference in the Proxy Statement, this right to review and comment shall apply only with respect to information relating to the other Party or such other Party’s business, financial condition or results of operations or the Transactions. If, at any time prior to the Company Stockholders Meeting, any information relating to the Company, Parent or any of their respective affiliates, officers or directors should be discovered by the Company or Parent that should be set forth in an amendment or supplement to the Proxy Statement, so that the Proxy Statement shall not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading, the party that discovers such information shall promptly notify the other parties and correct such information, and the Company shall file with the SEC an appropriate amendment or supplement describing such information.
(b) Subject to the earlier termination of this Agreement in accordance with Section 8.1, the Company shall (i) as promptly as reasonably practicable after the date hereof and in consultation with Parent, conduct a “broker search” in accordance with Rule 14a-13 of the Exchange Act for a record date for the Company Stockholders Meeting assuming that, for such purposes only, the record date of the Company Stockholders Meeting will be not less than twenty (20) Business Days after the date the broker search is conducted and (ii) duly call, give notice of, convene and hold a meeting of the Company Stockholders for the purpose of seeking the Company Stockholder Approval (as it may be adjourned or postponed as provided below, the “Company Stockholders Meeting”) as soon as reasonably practicable after the date hereof (and the Company shall use reasonable best efforts to cause the Company Stockholders Meeting to be held no later than forty-five (45) days following the date on which the Company learns that the Proxy Statement will not be reviewed or that the SEC staff has no further comments thereon), and the Company shall submit such proposal to the Company Stockholders at the Company Stockholders Meeting and shall not submit any other proposal to the Company Stockholders in connection with the Company Stockholders Meeting (other than an advisory vote regarding merger-related compensation and a customary proposal regarding adjournment of the Company Stockholders Meeting) without the prior written consent of Parent. The Company agrees (i) to provide Parent with reasonably detailed periodic updates concerning proxy solicitation results on a timely basis (including, if requested, promptly providing daily voting reports in the last seven (7) days prior to the Company Stockholders Meeting) and to give written notice (which, for the avoidance of doubt, may be given via email) to Parent one (1) day prior to, and on the date of, the Company Stockholders Meeting, indicating whether, as of such date, sufficient proxies representing the Company Stockholder Approval have been obtained.
(c) Notwithstanding anything to the contrary contained in this Agreement, the Company shall not adjourn or postpone the Company Stockholders Meeting without Parent’s prior written consent; provided that without Parent’s prior written consent, the Company may adjourn or postpone the Company Stockholders Meeting (i) after consultation with Parent, to the extent necessary to ensure that any supplement or amendment to the Proxy Statement required by Law is provided to the stockholders of the Company within a reasonable amount of time in advance of the Company Stockholders Meeting or (ii) if there are not sufficient affirmative votes in person or by proxy at such meeting to constitute a quorum at the Company Stockholders Meeting or to obtain the Company Stockholder Approval, to allow reasonable additional time for solicitation of proxies for purposes of obtaining a quorum or the Company Stockholder Approval; provided that unless agreed to in writing by Parent, (x) any such adjournment or postponement shall be for a period of no more than ten (10) Business Days, and (y) the Company shall only be permitted to effect no more than one (1) such adjournment or postponement pursuant to this clause (ii); provided that (A) no postponement contemplated by this clause (ii) shall be permitted if it would require a change to the record date for the Company Stockholders Meeting, and (B) if requested by Parent, the Company shall effect an adjournment or postponement of the Company Stockholders Meeting under the circumstances contemplated by this clause (ii) for a period of up to ten (10) Business Days (provided that Parent shall make no more than one (1) such request, and no such request for a postponement shall be permitted if it would require a change in the record date for the Company Stockholders Meeting). The Company shall use its reasonable best efforts to (A) solicit from the Company Stockholders proxies in favor of the adoption of this Agreement and approval of the Transactions, including the Merger and (B) take all other action necessary or advisable to secure the Company Stockholder Approval, including, unless the Company Board of Directors has validly made a Change of Recommendation in accordance with Section 5.2, by communicating to the Company’s stockholders the Company Board Recommendation and including such Company Board Recommendation in the Proxy Statement.
A-36

TABLE OF CONTENTS

Notwithstanding any Change of Recommendation, unless this Agreement is terminated in accordance with its terms, (x) the Company Stockholders Meeting shall be convened and this Agreement shall be submitted to the Company Stockholders for approval at the Company Stockholders Meeting, and nothing contained herein shall be deemed to relieve the Company of such obligation and (y) all other obligations of the Parties hereunder shall continue in full force and effect and such obligations shall not be affected by the commencement, public proposal, public disclosure or communication to the Company of any Acquisition Proposal (whether or not a Superior Proposal).
ARTICLE VI
 
ADDITIONAL AGREEMENTS
Section 6.1. Access; Confidentiality; Notice of Certain Events.
(a) From the date hereof until the earlier of the Effective Time or the date, if any, on which this Agreement is validly terminated pursuant to Section 8.1, to the extent permitted by applicable Law, the Company shall, and shall cause each Company Subsidiary to, afford to Parent and Parent’s Representatives reasonable access during normal business hours and upon reasonable advance notice to the Company’s and the Company Subsidiaries’ offices, properties, Contracts, personnel, books and records (so long as any such access does not unreasonably interfere with the Company’s business), and during such period, the Company shall, and shall cause each Company Subsidiary to, furnish as promptly as practicable to Parent all information and materials (financial or otherwise) concerning its business, properties, offices, Contracts and personnel as Parent may reasonably request (solely for purposes of consummating the Transactions and for reasonable transition and integration planning). Notwithstanding the foregoing, the Company shall not be required by this Section 6.1 to provide Parent or Parent’s Representatives with access to or to disclose information (i) that is prohibited from being disclosed pursuant to the terms of a confidentiality agreement with (or a Contract’s confidentiality obligations to) a third party entered into prior to the date hereof or after the date hereof in the ordinary course of business consistent with past practice (provided, however, that, at Parent’s written request, the Company shall use its commercially reasonable efforts (x) to obtain the required consent of such third party to such access or disclosure or (y) to make appropriate substitute arrangements to permit reasonable access or disclosure not in violation of such consent requirement), (ii) the disclosure of which, in the reasonable good-faith judgment of the Company after consultation with legal counsel, would violate applicable Law (provided, however, that the Company shall use its commercially reasonable efforts to make appropriate substitute arrangements to permit reasonable disclosure not in violation of such Law) or (iii) the disclosure of which, in the reasonable good-faith judgment of the Company after consultation with legal counsel, would cause the loss of any attorney-client, attorney work product or other legal privilege (provided, however, that the Company shall use its commercially reasonable efforts to allow for such access or disclosure to the maximum extent that such access or disclosure would not jeopardize attorney-client, attorney work product or other legal privilege). Notwithstanding the foregoing, the Company may, as it deems advisable and necessary, reasonably designate any competitively sensitive information provided to the Parent and Parent’s Representatives as “outside counsel only,” and any such materials designated as “outside counsel only” and the information contained therein shall be given only to outside counsel of Parent and will not be disclosed by such outside counsel to employees, officers or directors of Parent and its affiliates unless advance, express permission is given by the Company.
(b) Each of the Company and Parent will hold, and will cause their respective Representatives and affiliates to hold, any nonpublic information exchanged pursuant to this Section 6.1, in confidence to the extent required by and in accordance with, and will otherwise comply with, the terms of the Confidentiality Agreement, the Clean Room Agreement or the Joint Defense Agreement, as applicable; provided that notwithstanding anything to the contrary herein or in the Confidentiality Agreement, such information and any other nonpublic information obtained by Parent, Merger Sub or their respective Representatives from or on behalf of the Company may be disclosed (i) to prospective lenders, underwriters, initial purchasers, dealer managers, agents and other actual and potential financing sources during syndication and marketing of any financing of Parent, Merger Sub or their respective Subsidiaries, subject (in the case of non-public information) to customary confidentiality undertakings (including customary “click-through” confidentiality undertakings) and (ii) on a confidential basis to rating agencies.
(c) The Company shall give prompt notice to Parent and Parent shall give prompt written notice to the Company (subject to Section 6.2(b)) (i) of any notice or other communication received by such Party from any Governmental Entity in connection with this Agreement, the Voting Agreement, or the Transactions, including the Merger, or from any Person alleging that the consent of such Person is or may be required in connection with the
A-37

TABLE OF CONTENTS

Merger and (ii) of any legal proceeding commenced or, to such Party’s Knowledge, threatened against such Party or any of its Subsidiaries, affiliates, directors or officers or otherwise relating to, involving or affecting such Party or any of its Subsidiaries, affiliates, directors or officers, in each case in connection with, arising from or otherwise relating to the Merger or any other transaction contemplated by this Agreement or the Voting Agreement; provided, however, that the delivery of any notice pursuant to this Section 6.1(c) shall not cure any breach of any representation or warranty requiring disclosure of such matter prior to the date hereof or otherwise limit or affect the remedies available hereunder; provided, further, that either Party’s obligations, actions or inactions pursuant to this Section 6.1(c), in each case in and of themselves, shall be deemed excluded for purposes of determining whether the condition set forth in Section 7.2(b) or Section 7.3(b), as applicable, has been satisfied.
Section 6.2. Reasonable Best Efforts.
(a) Subject to the terms and conditions of this Agreement, each Party will use its reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable Law to consummate the Transactions, including the Merger, as soon as practicable after the date hereof, including (i) preparing and filing or otherwise providing, in consultation with the other Party and as promptly as practicable and advisable after the date hereof, all documentation to effect all necessary applications, notices, petitions, filings and other documents and to obtain as promptly as reasonably practicable all waiting period expirations or terminations, consents, clearances, waivers, licenses, orders, registrations, approvals, permits and authorizations necessary or advisable to be obtained from any Governmental Entity and/or any third party in order to consummate the Transactions, including the Merger, and (ii) taking all actions and steps as may be necessary, subject to the limitations in this Section 6.2, to obtain (and cooperating with each other in obtaining) all such waiting period expirations or terminations, consents, clearances, waivers, licenses, registrations, permits, authorizations, orders and approvals, including defending through litigation on the merits any claim asserted in court by any Governmental Entity of the federal government of the United States under the HSR Act, the Sherman Act, the Clayton Act and the Federal Trade Commission Act, in each case, as amended, to avoid entry of, or to have vacated or terminated, any decree, order or judgment (whether temporary, preliminary or permanent) that would prevent the Closing from occurring prior to the Outside Date. In furtherance and not in limitation of the foregoing, each Party agrees to (x) make an appropriate filing of a Notification and Report Form pursuant to the HSR Act with respect to the Transactions as promptly as practicable, and in any event within twenty (20) Business Days after the execution of this Agreement (unless a later date is mutually agreed between the Parties), and to supply as promptly as reasonably practicable and advisable any additional information and documentary materials that may be requested pursuant to the HSR Act and to take all other actions necessary to cause the expiration or termination of the applicable waiting periods under the HSR Act as soon as reasonably practicable and (y) make all other necessary or advisable filings as promptly as reasonably practicable after the date hereof, and to supply as promptly as reasonably practicable and advisable any additional information and documentary materials that may be requested under any Regulatory Laws. In furtherance and not in limitation of the foregoing, if and to the extent necessary to obtain clearance of the Merger pursuant to the HSR Act and any other Regulatory Laws of the jurisdictions contemplated by Section 7.1(b) of the Company Disclosure Letter, (1) Parent, Merger Sub and their respective Subsidiaries will (and will direct the Company and its Subsidiaries to) and (2) the Company and its Subsidiaries will, solely to the extent directed by Parent, offer, negotiate, commit to and effect, by consent decree, hold separate order or otherwise, any requirement, condition, limitation, understanding, agreement or order to (A) sell, license, assign, transfer, divest, hold separate or otherwise dispose of any assets, business or portion of business of the Company or any Company Subsidiary, (B) conduct, restrict, operate, invest or otherwise change the assets, the business or portion of the business of the Company or any Company Subsidiary in any manner, or (C) impose any restriction, requirement or limitation on the operation of the business or portion of the business of the Company or any Company Subsidiary. Notwithstanding anything in this Agreement to the contrary, Parent, the Company and their respective Subsidiaries will not be required, either pursuant to this Section 6.2(a) or otherwise, to offer, negotiate, commit to, effect or otherwise take any action that would reasonably be expected to, individually or in the aggregate, (x) impact Parent, the Company or their respective Subsidiaries in an adverse manner or amount that is material relative to the value of the Company and the Company Subsidiaries, taken as a whole or (y) have any impact on any asset, business (or portions thereof), product lines or product of Parent or any Parent Subsidiary (excluding any asset, business (or portions thereof), product lines or product of the Company and its Subsidiaries) or (z) materially reduce the reasonably anticipated benefits to Parent and its Subsidiaries, taken as a whole (including anticipated synergies) of the transactions contemplated by this Agreement (each of clauses (x), (y) and (z), a “Burdensome Condition”); provided that if requested by Parent, the Company and its
A-38

TABLE OF CONTENTS

Subsidiaries will become subject to, consent to or offer or agree to, and otherwise take any action with respect to, any requirement, condition, limitation, understanding, agreement or order so long as such requirement, condition, limitation, understanding, agreement or order is only binding on the Company or its Subsidiaries in the event the Closing occurs; provided, further, that in no event shall Parent, the Company or their respective Subsidiaries be required to propose, negotiate, commit to or effect any action with respect to, any such requirement, condition, limitation, understanding, agreement or order unless such action is conditioned upon the consummation of the Merger and does not take effect until the Effective Time.
(b) Each of Parent and the Company shall, in connection with and without limiting the efforts referenced in Section 6.2(a) to obtain all waiting period expirations or terminations, consents, clearances, waivers, licenses, orders, registrations, approvals, permits and authorizations for the Transactions under the HSR Act or any other Regulatory Law(s), to the extent not prohibited by applicable Law, (i) cooperate in all respects and consult with each other in connection with any filing or submission and in connection with any investigation or other inquiry, including any proceeding initiated by a private party, including by allowing the other Party to have a reasonable opportunity to review in advance and comment on drafts of filings and submissions and reasonably considering in good faith comments of the other Party and furnish the other Party with such necessary information and reasonable assistance as the other Party may reasonably request in connection with its preparation of necessary filings or submissions of information to any such Governmental Entity, (ii) promptly inform the other Party of any communication received by such Party from, or given by such Party to, the Antitrust Division of the Department of Justice (the “DOJ”), the Federal Trade Commission (the “FTC”) or any other Governmental Entity, by promptly providing copies to the other Party of any such written communications (or, in the case of oral communications, advise the other Party of such communications), and of any communication received or given in connection with any proceeding by a private party, in each case regarding any of the Transactions and (iii) permit the other Party to review in advance any communication that it gives to, and consult with each other in advance of any meeting, substantive telephone call or conference with, the DOJ, the FTC or any other Governmental Entity or, in connection with any proceeding by a private party, with any other Person, and to the extent permitted by the DOJ, the FTC or other applicable Governmental Entity or other Person, give the other Party the opportunity to attend and participate in any in-person meetings, substantive telephone calls or conferences with the DOJ, the FTC or other Governmental Entity or other Person; provided, however, that materials required to be provided pursuant to the foregoing clauses (i)–(iii) may be redacted (A) to remove references concerning the valuation of Parent, Company or any of their respective Subsidiaries, (B) as necessary to comply with contractual arrangements and (C) as necessary to address reasonable privilege or confidentiality concerns; provided, further, that each of Parent and the Company may, as each deems advisable and necessary, reasonably designate any competitively sensitive material provided to the other under this Section 6.2(b) as “Antitrust Counsel Only Material,” which such material and the information contained therein shall be given only to the outside antitrust counsel of the recipient and will not be disclosed by such outside counsel to employees, officers or directors of the recipient unless express permission is obtained in advance from the source of the materials (Parent on the one hand or the Company on the other) or its legal counsel. Notwithstanding anything in this Agreement to the contrary, but without limiting Parent’s and Merger Sub’s obligations set forth in this Section 6.2, Parent shall, on behalf of the Parties, control and direct all communications and strategy in dealing with any Governmental Entity under the HSR Act or other Regulatory Laws; provided that Parent shall consider in good faith the views and comments of the Company and its outside counsel with respect to such communications and strategies. In furtherance and not in limitation of the foregoing, after consultation with the Company and its outside counsel, Parent shall have the right to, without the consent of the Company, voluntarily withdraw its notification under the HSR Act on one occasion during the initial waiting period so long as Parent refiles its HSR Act notification within two (2) Business Days after such withdrawal (unless otherwise agreed by the Parties hereto).
(c) In connection with and without limiting the foregoing, in the event that Parent requests the Company to do so, the Company shall give any notices to third parties required under Contracts, and the Company shall use, and cause each of the Company Subsidiaries to use, its reasonable best efforts to obtain any third party consents to any Contracts that are necessary, proper or advisable to consummate the Transactions, including the Merger. Notwithstanding anything to the contrary herein, none of Parent, the Company or any of their respective Subsidiaries shall be required to pay any consent or other similar fee, payment or consideration, make any other concession or provide any additional security (including a guaranty), to obtain such third party consents (which for
A-39

TABLE OF CONTENTS

the avoidance of doubt does not apply to any consents under Regulatory Laws governed by the remainder of this Section 6.2) (except, in the case of the Company, if requested by Parent and either (i) reimbursed or indemnified by Parent or (ii) subject to the occurrence of the Closing).
Section 6.3. Publicity. From and after the date hereof until the earlier of the Closing or the date, if any, on which this Agreement is validly terminated pursuant to Section 8.1, neither the Company nor Parent, nor any of their respective Subsidiaries, shall issue or cause the publication of any press release or other public announcement or disclosure with respect to the Merger, the other Transactions or this Agreement or the Voting Agreement without the prior written consent of the other Party, unless such Party determines, after consultation with outside counsel, that it is required by applicable Law or by any listing agreement with or the listing rules of a national securities exchange or trading market to issue or cause the publication of such press release or other public announcement or disclosure with respect to the Merger, the other Transactions or this Agreement or the Voting Agreement, in which event such Party shall endeavor, on a basis reasonable under the circumstances, to provide a meaningful opportunity to the other Party to review and comment upon such press release or other announcement or disclosure in advance and shall give due consideration to all reasonable additions, deletions or changes suggested thereto; provided, however, that (i) the Parties shall not be required by this Section 6.3 to provide any such review or opportunity to comment to, or obtain the consent of, the other Party relating to any dispute between the Parties relating to this Agreement; (ii) each Party may make statements that are consistent with previous press releases, public disclosures or public statements made by Parent or the Company in compliance with this Section 6.3 or make statements regarding the actual or expected financial impact (including earnings guidance) of the Transactions on such Party; and (iii) the obligations set forth in this Section 6.3 shall not apply to any communication regarding an Acquisition Proposal in accordance with Section 5.2(f) or a Change of Recommendation in accordance with Section 5.2(a).
Section 6.4. D&O Insurance and Indemnification.
(a) For six (6) years from and after the Effective Time, Parent shall, or shall cause the Surviving Corporation to, indemnify and hold harmless all past and present directors and officers of the Company and the Company Subsidiaries (collectively, the “Indemnified Parties”) against any costs or expenses (including advancing attorneys’ fees and expenses prior to the final disposition of any actual or threatened claim, suit, proceeding or investigation to each Indemnified Party to the fullest extent permitted by applicable Law and the Company Governing Documents; provided that such Indemnified Party agrees in advance to return any such funds to which a court of competent jurisdiction determines in a final, non-appealable judgment that such Indemnified Party is not ultimately entitled), judgments, fines, losses, claims, damages, liabilities and amounts paid in settlement in connection with any actual or threatened claim, action, investigation, suit or proceeding in respect of acts or omissions occurring or alleged to have occurred at or prior to the Effective Time (including acts or omissions occurring in connection with the approval of this Agreement and the consummation of the Merger or any of the other Transactions), whether asserted or claimed prior to, at or after the Effective Time, in connection with such Indemnified Party serving as an officer, director or other fiduciary of the Company or any Company Subsidiary or of any other Person if such service was at the request or for the benefit of the Company or any Company Subsidiary, to the fullest extent permitted by applicable Law and the Company Governing Documents or the organizational documents of the applicable Company Subsidiary (as applicable) or any indemnification agreements with such Indemnified Party in existence on the date of this Agreement and provided to Parent prior to the date of this Agreement. The Parties agree that all rights to elimination of liability, indemnification and advancement of expenses for acts or omissions occurring or alleged to have occurred at or prior to the Effective Time, whether asserted or claimed prior to, at or after the Effective Time, now existing in favor of the Indemnified Parties as provided in the Company’s or the Company Subsidiaries’ respective certificate of incorporation or bylaws (or comparable organizational documents) or in any indemnification agreement of the Company or a Company Subsidiary with any Indemnified Party in existence on the date of this Agreement as set forth on Section 6.4(a) of the Company Disclosure Letter and provided to Parent prior to the date of this Agreement shall survive the Transactions, including the Merger, and shall continue in full force and effect in accordance with the terms thereof; provided that, for the avoidance of doubt, such indemnification agreements shall survive the Closing only with respect to acts or omissions occurring or alleged to have occurred at or prior to the Effective Time (whether asserted or claimed prior to, at or after the Effective Time) and shall not apply to any acts or omissions occurring or alleged to have occurred after the Effective Time. Notwithstanding anything herein to the contrary, if any Indemnified Party notifies the Surviving Corporation on or prior to the sixth (6th) anniversary of the Effective
A-40

TABLE OF CONTENTS

Time of a matter in respect of which such Person intends in good faith to seek advancement or indemnification pursuant to this Section 6.4, the provisions of this Section 6.4 shall continue in effect with respect to such matter until the final disposition of all claims, actions, investigations, suits and proceedings relating thereto.
(b) For six (6) years after the Effective Time, Parent shall cause to be maintained in effect the provisions in (i) the Company Governing Documents and (ii) subject to Section 6.4(a), any indemnification agreement of the Company or a Company Subsidiary with any Indemnified Party in existence on the date of this Agreement and provided to Parent prior to the date of this Agreement, except to the extent that such agreement provides for an earlier termination, in each case, regarding elimination of liability, indemnification of officers and directors and advancement of expenses that are in existence on the date hereof, and no such provision shall be amended, modified or repealed in any manner that would adversely affect the rights or protections thereunder of any such Indemnified Party in respect of acts or omissions occurring or alleged to have occurred at or prior to the Effective Time (including acts or omissions occurring in connection with the approval of this Agreement and the consummation of the Merger or any of the other Transactions).
(c) At or prior to the Effective Time, the Company shall purchase a six (6)-year prepaid “tail” policy on terms and conditions providing coverage retentions, limits and other material terms substantially equivalent to the current policies of directors’ and officers’ liability insurance and fiduciary liability insurance maintained by the Company and the Company Subsidiaries with respect to matters arising at or prior to the Effective Time; provided, however, that the Company shall not commit or spend on such “tail” policy, in the aggregate, more than three hundred percent (300%) of the last aggregate annual premium paid by the Company prior to the date hereof for the Company’s current policies of directors’ and officers’ liability insurance and fiduciary liability insurance (the “Base Amount”), and if the cost of such “tail” policy would otherwise exceed the Base Amount, the Company shall be permitted to purchase only as much coverage as reasonably practicable for the Base Amount. The Company and Parent shall in good faith cooperate with each other prior to the Closing with respect to the procurement of such “tail” policy, including with respect to the selection of the broker, available policy price and coverage options.
(d) In the event Parent or the Surviving Corporation or any of their respective successors or assigns (i) consolidates with or merges into any other Person and shall not be the continuing or surviving corporation or entity of such consolidation or merger or (ii) transfers all or substantially all of its properties and assets to any Person, then, and in each such case, proper provision shall be made so that the successors and assigns of Parent or the Surviving Corporation, as the case may be, shall assume the obligations set forth in this Section 6.4. The rights and obligations under this Section 6.4 shall survive consummation of the Merger and shall not be terminated or amended in a manner that is adverse to any Indemnified Party without the written consent of such Indemnified Party. The Parties acknowledge and agree that the Indemnified Parties shall be third party beneficiaries of this Section 6.4, each of whom may enforce the provisions thereof.
Section 6.5. Takeover Statutes. The Parties shall use their respective reasonable best efforts (a) to take all action necessary so that no Takeover Statute is or becomes applicable to the Merger or any of the other Transactions (including, for the avoidance of doubt, the Voting Agreement) and (b) if any such Takeover Statute is or becomes applicable to any of the foregoing, to take all action necessary so that the Merger and the other Transactions (including, for the avoidance of doubt, the Voting Agreement) may be consummated as promptly as practicable on the terms contemplated by this Agreement and otherwise to eliminate or minimize the effect of such Takeover Statute on the Merger and the other Transactions. No Change of Recommendation shall change, or be deemed to change, or permit the Company or the Company Board of Directors to change, in any manner or respect, the approval of the Company Board of Directors for purposes of causing any Takeover Statute to be inapplicable to the Merger or any of the other Transactions (including, for the avoidance of doubt, the Voting Agreement).
Section 6.6. Obligations of Merger Sub. Parent shall take all action necessary to cause Merger Sub to perform its obligations under this Agreement and to consummate the Transactions, including the Merger, upon the terms and subject to the conditions set forth in this Agreement. For the avoidance of doubt, any violation of the obligations of Merger Sub under this Agreement shall also be deemed to be a breach of this Agreement by Parent.
Section 6.7. Employee Matters.
(a) Parent shall assume, honor and fulfill all of the Company Benefit Plans in accordance with their terms as in effect immediately prior to the Closing if either (x) in effect as of the date hereof or (y) amended, adopted, entered into or terminated prior to the Closing as permitted pursuant to the terms of such Company Benefit Plans
A-41

TABLE OF CONTENTS

and this Agreement. Parent hereby acknowledges and agrees that a “change in control” (or similar phrase) within the meaning of each Company Benefit Plan containing change in control provisions will occur as of the Effective Time. Effective as of the Effective Time and for a period of twelve (12) months thereafter, Parent shall provide to each employee of the Company and Company Subsidiary who continues to be employed by Parent or any Subsidiary thereof (the “Continuing Employees”), (i) on target earnings, consisting of base pay or wage rate, as applicable, and target incentive cash compensation opportunities, that are, in the aggregate, no less favorable than those in effect for such Continuing Employee immediately prior to the Closing (provided that such Continuing Employee’s base pay or wage rate during such twelve (12) month period shall be no less than that in effect immediately prior to the Closing), (ii) other employee benefits (including retirement, health and welfare benefits, but excluding cash and equity incentive opportunities) that are, in the aggregate, no less favorable than those in effect for similarly situated employees of Parent and its Subsidiaries and (iii) severance entitlements that are no less favorable than those as set forth on Section 6.7(a)(iii) of the Company Disclosure Letter.
(b) For all purposes (including purposes of vesting, eligibility to participate and level of benefits) under the employee benefit plans of Parent and its Subsidiaries providing benefits to any Continuing Employees after the Effective Time (the “New Plans”), each Continuing Employee shall, subject to applicable law and applicable tax qualification requirements, be credited with his or her years of service with the Company and its Subsidiaries and their respective predecessors before the Effective Time, to the same extent as such Continuing Employee was entitled, before the Effective Time, to credit for such service under any similar Company Benefit Plan in which such Continuing Employee participated or was eligible to participate immediately prior to the Effective Time; provided that the foregoing shall not apply to the extent that its application would result in a duplication of benefits, for purposes of any pension plan or for purposes of any benefit plan that is a frozen plan or provides grandfathered benefits. In addition, and without limiting the generality of the foregoing, (i) each Continuing Employee shall be immediately eligible to participate, without any waiting time (other than any administrative delays in connection with any transition to Parent’s tax qualified defined contribution plan), in any and all New Plans to the extent coverage under such New Plan is of the same type as the Company Benefit Plan in which such Continuing Employee participated immediately before the Effective Time (such plans, collectively, the “Old Plans”), and (ii) (A) for purposes of each New Plan providing medical, dental, pharmaceutical or vision benefits to any Continuing Employee, Parent or its applicable Subsidiary shall cause all preexisting condition exclusions and actively-at-work requirements of such New Plan to be waived for such Continuing Employee and his or her covered dependents, unless such conditions would not have been waived under the Old Plan in which such Continuing Employee participated immediately prior to the Effective Time and (B) Parent and its applicable Subsidiary shall use commercially reasonable efforts to cause any eligible expenses incurred by such Continuing Employee and his or her covered dependents during the portion of the plan year of the Old Plan ending on the date such employee’s participation in the corresponding New Plan begins to be taken into account under such New Plan for purposes of satisfying all deductible and maximum out-of-pocket requirements applicable to such employee and his or her covered dependents for the applicable plan year as if such amounts had been paid in accordance with such New Plan.
(c) The Company shall take (or cause to be taken) all actions necessary or appropriate to terminate any and all 401(k) plans effective as of the day immediately preceding the Closing Date (the “401(k) Termination Date”), unless Parent provides the Company with written notice at least ten (10) Business Days prior to the Closing Date instructing that the Company not terminate such 401(k) plan(s). The Company shall provide Parent with evidence that such 401(k) plan(s) have been terminated pursuant to resolution of the Company’s Board of Directors at least two (2) Business Days prior to the Closing Date; provided that, prior to amending or terminating the Company’s 401(k) plan and at least ten (10) Business Days prior to the Closing Date, the Company shall provide Parent with the form and substance of any applicable resolutions or amendments for review, and the Company shall reflect any reasonable comments promptly received from Parent. If the Company 401(k) plan is terminated pursuant to this Section 6.7(c), then as soon as practicable following the 401(k) Termination Date, Parent shall permit all Continuing Employees who were eligible to participate in the Company 401(k) plan immediately prior to the 401(k) Termination Date to participate in Parent’s 401(k) plan and shall permit each such Continuing Employee to elect to transfer his or her account balance when distributed from the terminated Company 401(k) plan, including any outstanding participant loans, to Parent’s 401(k) plan, except to the extent accepting such transfers would adversely affect the tax-qualified status of Parent’s 401(k) plan or as may be prohibited by Parent’s 401(k) plan.
(d) Following the date hereof, the Parties shall, and shall cause their respective affiliates to, cooperate and use good faith efforts in all matters reasonably necessary for employee, compensation and benefits integration
A-42

TABLE OF CONTENTS

planning, including exchanging information and data relating to employees, organizational structure, compensation and employee benefits, and distributing communications to the employees of the Company and the Company Subsidiaries. Prior to the Closing, Parent shall be provided the opportunity and a reasonable period of time to review and comment on any broad-based or otherwise material employee notices or communication materials (including website postings) regarding the transactions contemplated by this Agreement from the Company or the Company Subsidiaries to the employees of the Company or the Company Subsidiaries, including broad-based or otherwise material notices or communication materials with respect to employment, compensation or benefits matters addressed in this Agreement or related, directly or indirectly, to the transactions contemplated by this Agreement or employment after the Closing prepared by the Company or the Company Subsidiaries prior to their distribution, and the Company and the Company Subsidiaries shall reflect any reasonable comments promptly received from Parent.
(e) Except as otherwise agreed in writing by Parent, the Company shall use commercially reasonable efforts to terminate all Contracts, arrangements or relationships between the Company or any Company Subsidiary, on the one hand, and any professional employer organization, on the other hand, effective as of the Closing Date.
(f) Nothing in this Agreement shall confer upon any employee (including any Continuing Employee), officer, director or other individual service provider any right to continue in the employ or service of Parent or any affiliate of Parent, or shall interfere with or restrict in any way the rights of Parent or any affiliate of Parent, which rights are hereby expressly reserved, to discharge or terminate the services of any employee, officer, director or other individual service provider at any time for any reason whatsoever, with or without cause. Notwithstanding any provision in this Agreement to the contrary, nothing in this Section 6.7 shall (i) be deemed or construed to be an amendment or other modification of any Company Benefit Plan or employee benefit plan of Parent or Merger Sub, (ii) create any third party rights in any Continuing Employee or other current or former service provider of the Company or its affiliates (or any beneficiaries or dependents thereof) or (iii) alter or limit the right of Parent, the Company, the Surviving Corporation or any of their Subsidiaries or affiliates to amend, modify or terminate any Company Benefit Plan, Old Plan, New Plan or any other compensation or benefit plan, program, policy, agreement or arrangement on or after the Effective Time.
Section 6.8. Rule 16b-3. Prior to the Effective Time, the Company and Parent shall, as applicable, take all such steps as may be reasonably necessary or advisable hereto to cause any dispositions of Company equity securities (including derivative securities) and acquisitions of Parent equity securities pursuant to the Transactions by each individual who is a director or officer of the Company subject to the reporting requirements of Section 16(a) of the Exchange Act with respect to the Company to be exempt under Rule 16b-3 promulgated under the Exchange Act.
Section 6.9. Stockholder Litigation. The Company shall provide Parent prompt notice (and in any event within forty-eight (48) hours) of any litigation brought by any stockholder of the Company or purported stockholder of the Company against the Company, any of its Subsidiaries and/or any of their respective directors or officers relating to the Merger or any of the other Transactions or this Agreement or the Voting Agreement, and shall keep Parent informed on a prompt and timely basis with respect to the status thereof. The Company shall give Parent the opportunity to participate (at Parent’s expense) in the defense or settlement of any such litigation and reasonably cooperate with Parent in conducting the defense or settlement of such litigation, and no such settlement shall be agreed without Parent’s prior written consent, which consent shall not be unreasonably withheld or delayed, except that Parent may, in its sole discretion, withhold such consent to any settlement which does not include a full release of Parent and its affiliates (including the Surviving Corporation and its Subsidiaries) or which imposes an injunction or other equitable relief on the Company, Parent or any of their affiliates (including, after the Effective Time, the Surviving Corporation and its Subsidiaries). In the event of, and to the extent of, any conflict or overlap between the provisions of this Section 6.9 and Section 5.1 or Section 6.2, the provisions of this Section 6.9 shall control.
Section 6.10. Delisting. Each of the Parties agrees to cooperate with the other Parties in taking, or causing to be taken, all actions necessary to delist the Class A Common Stock from Nasdaq and terminate its registration under the Exchange Act; provided that such delisting and termination shall not be effective until at or after the Effective Time.
Section 6.11. Director Resignations. The Company shall use its reasonable best efforts to cause to be delivered to Parent resignations in a form reasonably acceptable to Parent executed by each director of the Company in office as of immediately prior to the Effective Time and effective upon the Effective Time.
Section 6.12. FIRPTA. At or prior to Closing, the Company shall deliver to Parent (with a copy to the Paying Agent) (A) a duly executed certificate in accordance with Treasury Regulations Sections 1.897-2(h) and 1.1445-2(c)(3),
A-43

TABLE OF CONTENTS

certifying that the Company was not a “United States real property holding corporation” within the meaning of Section 897(c)(2) of the Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code, and (B) a notice to the IRS in accordance with Treasury Regulations Section 1.897-2(h)(2), together with written authorization for Parent to deliver such notice to the IRS on behalf of the Company after the Closing.The Company’s obligation to deliver the certificate, notice and authorization contemplated by this Section 6.12 shall be disregarded for purposes of determining whether the conditions to Closing set forth in Article VII have been satisfied, and the sole remedy in the absence of such certificate, notice to the IRS and authorization being delivered at or prior to Closing shall be the entitlement of the Paying Agent, Parent, the Company, Merger Sub and the Surviving Corporation to deduct and withhold from any cash amount payable pursuant to this Agreement amounts that are required to be deducted or withheld in accordance with Section 2.4.
Section 6.13. Certain Tax Matters. The Parties shall, and shall cause their respective Subsidiaries to, take the actions listed in Section 6.13 of the Company Disclosure Letter.
Section 6.14. Treatment of Company Indebtedness. The Company shall (and shall, if applicable, cause the Company Subsidiaries to) deliver all notices and take all other actions within its or their sole control (as applicable) required to facilitate, at or prior to the Effective Time, the termination of all commitments under the New Revolving Credit Agreement (as defined on Section 5.1 of the Company Disclosure Letter), if any, that is entered into after the date hereof and that will be outstanding as of immediately prior to the Closing Date, the repayment in full of all obligations outstanding thereunder (the “Specified Indebtedness”) and the release of any guarantees in connection therewith (collectively, the “Specified Indebtedness Termination”). In furtherance and not in limitation of the foregoing, and if and only if such Specified Indebtedness exists, the Company shall, and shall, if applicable, cause the Company Subsidiaries to, use reasonable best efforts to (A) deliver to Parent at least three (3) Business Days prior to the Closing Date, a draft payoff letter and, if applicable, draft related guarantee release documentation and (B) deliver to Parent at least one (1) Business Day prior to the Closing Date, an executed payoff letter (the “Payoff Letter”) and, if applicable, executed related guarantee release documentation (any such guarantee release documentation, for the avoidance of doubt, shall not be required to be effective until the Effective Time), in each case, with respect to such Specified Indebtedness in form and substance customary for a transaction of this type, from the agent on behalf of the Persons to whom such Specified Indebtedness is owed, which Payoff Letter together with any related guarantee release documentation shall, among other things, include the payoff amount and provide that any guarantees granted in connection with such Specified Indebtedness shall, upon the payment of the amount set forth in the Payoff Letter at or prior to the Effective Time, be released and terminated. Notwithstanding anything herein to the contrary, in no event shall this Section 6.14 require the Company or any of the Company Subsidiaries to cause the Specified Indebtedness Termination to be effective unless and until the Effective Time has occurred and Parent has provided or caused to be provided to the Company or the Company Subsidiaries funds (or Parent has directed the Company or any of the Company Subsidiaries to use funds on their respective balance sheets) to pay in full the then outstanding principal amount of and accrued and unpaid interest and fees with respect to the Specified Indebtedness. At Parent’s request, the Company shall, and shall cause the Company Subsidiaries to, make its and their available cash available to be used on the Closing Date to fund any payments with respect to the Specified Indebtedness designated by Parent to be made on or after such date.
ARTICLE VII
 
CONDITIONS TO CONSUMMATION OF THE MERGER
Section 7.1. Conditions to Each Party’s Obligations to Effect the Merger. The respective obligations of each Party to consummate the Merger shall be subject to the satisfaction on or prior to the Closing Date of each of the following conditions, any and all of which may be waived in whole or in part by Parent, Merger Sub and the Company, as the case may be, to the extent permitted by applicable Law:
(a) Company Stockholder Approval. The Company shall have obtained the Company Stockholder Approval.
(b) Government Consents. (i) The waiting period (or extensions thereof), and any commitments not to close before a certain date under a timing agreement entered into with Governmental Entities, applicable to the consummation of the Merger under the HSR Act relating to the Transactions shall have expired, been terminated or otherwise waived and (ii) all applicable filings, registrations, waiting periods (or extensions thereof) and
A-44

TABLE OF CONTENTS

approvals and clearances under each other applicable Regulatory Law of the jurisdictions contemplated by Section 7.1(b) of the Company Disclosure Letter shall have been made, expired, terminated or obtained, as the case may be, and remain in effect, without the imposition, individually or in the aggregate, of a Burdensome Condition.
(c) No Legal Prohibition. No Governmental Entity of competent jurisdiction shall have (i) enacted, issued or promulgated any Law that is in effect as of immediately prior to the Effective Time or (ii) issued or granted any order, injunction, decree or ruling (whether temporary, preliminary or permanent) that is in effect as of immediately prior to the Effective Time, in each case, which has the effect of (x) restraining, enjoining, making illegal or otherwise prohibiting the consummation of the Merger or (y) imposing a Burdensome Condition, unless agreed to in writing by Parent.
Section 7.2. Conditions to Obligations of Parent. The obligations of Parent and Merger Sub to consummate the Merger shall be subject to the satisfaction on or prior to the Closing Date of each of the following conditions, any and all of which may be waived in whole or in part by Parent and Merger Sub, as the case may be, to the extent permitted by applicable Law:
(a) Representations and Warranties. (A) The representations and warranties of the Company set forth in Section 3.1(a) (other than the last sentence thereof) (Qualification, Organization, Subsidiaries, etc.), the first sentence of Section 3.1(b) (Qualification, Organization, Subsidiaries, etc.), Section 3.3 (Corporate Authority), Section 3.22 (Opinion of Financial Advisor), Section 3.23 (State Takeover Statutes; Anti-Takeover Laws) and Section 3.25 (Finders and Brokers) (x) that are qualified by materiality or Company Material Adverse Effect shall be true and correct in all respects as of the date hereof and shall be true and correct in all respects as of the Closing as though made as of the Closing (except representations and warranties that by their terms speak specifically as of another date, in which case as of such date) and (y) that are not qualified by materiality or Company Material Adverse Effect shall be true and correct in all material respects as of the date hereof and shall be true and correct in all material respects as of the Closing as though made as of the Closing (except representations and warranties that by their terms speak specifically as of another date, in which case as of such date); (B) the representations and warranties of the Company set forth in Section 3.2(a) (Capitalization), Section 3.2(c) (Capitalization), Section 3.2(d) (Capitalization) and Section 3.2(e) (Capitalization) shall be true and correct other than for de minimis inaccuracies as of the date hereof and shall be true and correct other than for de minimis inaccuracies as of the Closing as though made as of the Closing (except representations and warranties that by their terms speak specifically as of another date, in which case as of such date); (C) the representations and warranties of the Company set forth in Section 3.8(a) (Absence of Certain Changes or Events) shall be true and correct in all respects as of the date hereof and shall be true and correct in all respects as of the Closing as though made as of the Closing; and (D) the other representations and warranties of the Company set forth in this Agreement (without giving effect to any qualification as to materiality or Company Material Adverse Effect contained therein) shall be true and correct as of the date hereof and shall be true and correct as of the Closing as though made as of the Closing (except representations and warranties that by their terms speak specifically as of another date, in which case as of such date), except, with respect to this clause (D), where any failures of any such representations and warranties to be true and correct (without giving effect to any qualification as to materiality or Company Material Adverse Effect contained therein) have not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.
(b) Performance of Obligations of the Company. The Company shall have performed or complied in all material respects with the obligations, covenants and agreements required to be performed or complied with by it under the Agreement at or prior to the Closing.
(c) No Company Material Adverse Effect. A Company Material Adverse Effect shall not have, individually or in the aggregate, occurred on or after the date of the Agreement and be continuing as of immediately prior to the Closing.
(d) Company Officer’s Certificate. Parent shall have received a certificate, dated as of the Closing Date, signed by the chief executive officer, chief financial officer or another executive officer of the Company certifying that each of the conditions set forth in Section 7.2(a), Section 7.2(b) and Section 7.2(c) has been satisfied.
A-45

TABLE OF CONTENTS

Section 7.3. Conditions to Obligations of the Company. The obligations of the Company to consummate the Merger shall be subject to the satisfaction on or prior to the Closing Date of each of the following conditions, any and all of which may be waived in whole or in part by the Company to the extent permitted by applicable Law:
(a) Representations and Warranties. (A) The representations and warranties of Parent and Merger Sub set forth in Section 4.1 (Qualification, Organization, etc.) (with respect to the first sentence only) and Section 4.2 (Corporate Authority) (x) that are qualified by materiality or Parent Material Adverse Effect shall be true and correct in all respects as of the date hereof and shall be true and correct in all respects as of the Closing as though made as of the Closing (except representations and warranties that by their terms speak specifically as of another date, in which case as of such date) and (y) that are not qualified by materiality or Parent Material Adverse Effect shall be true and correct in all material respects as of the date hereof and shall be true and correct in all material respects as of the Closing as though made as of the Closing (except representations and warranties that by their terms speak specifically as of another date, in which case as of such date); and (B) the other representations and warranties of Parent and Merger Sub set forth in this Agreement shall be true and correct (without giving effect to any qualification as to materiality or Parent Material Adverse Effect contained therein) as of the date hereof and as of the Closing as if made on and as of the Closing (except representations and warranties that by their terms speak specifically as of another date, in which case as of such date), except where the failure of any such representations and warranties to be so true and correct (without giving effect to any qualification as to materiality or Parent Material Adverse Effect contained therein) have not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.
(b) Performance of Obligations of Parent. Each of Parent and Merger Sub shall have performed or complied in all material respects with the obligations, covenants and agreements required to be performed or complied with by it under the Agreement at or prior to the Closing.
(c) Parent Officer’s Certificate. The Company shall have received a certificate, dated as of the Closing Date, signed by the chief executive officer, chief financial officer or another executive officer of Parent certifying that each of the conditions set forth in Section 7.3(a) and Section 7.3(b) has been satisfied.
ARTICLE VIII
 
TERMINATION
Section 8.1. Termination. This Agreement may be terminated and the Merger and the other Transactions may be abandoned at any time before the Closing, as follows (with any termination by Parent also being an effective termination by Merger Sub):
(a) by mutual written consent of Parent and the Company;
(b) by the Company, in the event that (i) Parent and/or Merger Sub shall have breached, failed to perform or violated their respective covenants or agreements under this Agreement or (ii) any of the representations and warranties of Parent or Merger Sub set forth in this Agreement shall have become inaccurate, in either case of clause (i) or (ii) in a manner that would give rise to the failure of a condition set forth in Section 7.3(a) or Section 7.3(b) and such breach, failure to perform, violation or inaccuracy is not capable of being cured by the Outside Date or, if capable of being cured by the Outside Date, is not cured by Parent or Merger Sub, as applicable, before the earlier of (x) the Business Day immediately prior to the Outside Date and (y) the thirtieth (30th) calendar day following receipt of written notice from the Company of such breach, failure to perform, violation or inaccuracy; provided that the Company shall not have the right to terminate this Agreement pursuant to this Section 8.1(b) if the Company is then in breach of any of its representations, warranties, covenants or agreements contained in this Agreement, which breach would give rise to the failure of a condition set forth in Section 7.2(a), Section 7.2(b) or Section 7.2(c);
(c) by Parent, in the event that (i) the Company shall have breached, failed to perform or violated its covenants or agreements under this Agreement or (ii) any of the representations and warranties of the Company set forth in this Agreement shall have become inaccurate, in either case of clause (i) or (ii) in a manner that would give rise to the failure of a condition set forth in Section 7.2(a), Section 7.2(b) or Section 7.2(c) and such breach, failure to perform, violation or inaccuracy is not capable of being cured by the Outside Date or, if capable of being cured by the Outside Date, is not cured by the Company before the earlier of (x) the Business Day immediately prior to the Outside Date and (y) the thirtieth (30th) calendar day following receipt of written notice from Parent of such breach, failure to perform, violation or inaccuracy; provided that Parent shall not have the right to terminate this
A-46

TABLE OF CONTENTS

Agreement pursuant to this Section 8.1(c) if Parent or Merger Sub is then in breach of any of its representations, warranties, covenants or agreements contained in this Agreement, which breach would give rise to the failure of a condition set forth in Section 7.3(a) or Section 7.3(b);
(d) by either Parent or the Company if the Closing has not occurred on or before the first anniversary of the date hereof (as such date may be extended or amended pursuant to this Section 8.1(d), the “Outside Date”); provided that (i) if, on the Outside Date, all of the conditions to Closing, other than the conditions set forth in Section 7.1(b) and Section 7.1(c) (to the extent any such injunction or order is in respect of, or any such Law is, the HSR Act or any other Regulatory Law) and those conditions that by their nature are to be satisfied at Closing (but provided that such conditions shall then be capable of being satisfied if the Closing were to take place on such date), shall have been satisfied or waived, then the Outside Date shall automatically be extended one (1) time for all purposes hereunder for an additional ninety (90) days, which date shall thereafter be deemed to be the Outside Date and (ii) if on the Outside Date as so extended pursuant to clause (i) of this Section 8.1(d), all of the conditions to Closing, other than the conditions set forth in Section 7.1(b) and Section 7.1(c) (to the extent any such injunction or order is in respect of, or any such Law is, the HSR Act or any other Regulatory Law) and those conditions that by their nature are to be satisfied at Closing (but provided that such conditions shall then be capable of being satisfied if the Closing were to take place on such date), shall have been satisfied or waived, then the Outside Date shall automatically be extended one (1) additional time for all purposes hereunder for an additional ninety (90) days, which date shall thereafter be deemed to be the Outside Date; provided, further, notwithstanding the foregoing provisions of this Section 8.1(d), Parent and the Company may mutually agree in writing to amend the Outside Date to any other date as agreed; provided, further, that the right to terminate this Agreement pursuant to this Section 8.1(d) shall not be available to any Party whose action or failure to fulfill any obligation under this Agreement has been a proximate cause of the failure of the Transactions to be consummated by the Outside Date and such action or failure to act constitutes a material breach of this Agreement;
(e) by Parent, prior to the time the Company Stockholder Approval is obtained, if (i) the Company Board of Directors shall have effected a Change of Recommendation (whether or not in compliance with this Agreement) or (ii) the Company has materially breached Section 5.2;
(f) by either the Company or Parent if a Governmental Entity of competent jurisdiction shall have issued a final, non-appealable order, injunction, decree or ruling in each case permanently restraining, enjoining or otherwise prohibiting the consummation of the Transactions or any Law that permanently makes consummation of the Transactions illegal or otherwise prohibited shall be in effect;
(g) by either the Company or Parent, if the Company Stockholder Approval shall not have been obtained upon a vote taken thereon at the Company Stockholders Meeting duly convened therefor or at any adjournment or postponement thereof; or
(h) by the Company, prior to the time the Company Stockholder Approval is obtained, in order to effect a Change of Recommendation and substantially concurrently enter into a definitive agreement providing for a Superior Proposal; provided that (i) the Company has complied in all material respects with the terms of Section 5.2, and (ii) substantially concurrently with or prior to (and as a condition to) the termination of this Agreement, the Company pays or causes to be paid to Parent the Termination Fee.
Section 8.2. Effect of Termination.
(a) In the event of the valid termination of this Agreement as provided in Section 8.1, written notice thereof shall forthwith be given to the other Party or Parties specifying the provision hereof pursuant to which such termination is made, and this Agreement shall forthwith become null and void and there shall be no liability on the part of Parent, Merger Sub or the Company, except that the Confidentiality Agreement, the Clean Room Agreement, the Joint Defense Agreement, this Section 8.2, Section 6.2(c) (clause (i) of the second sentence only) and Section 9.3 through Section 9.12 shall survive such termination; provided that nothing herein shall relieve any Party from liability for Fraud or willful breach of this Agreement prior to such termination. For purposes of this Agreement, (i) “willful breach” shall mean an action or omission taken or omitted to be taken that the breaching party intentionally takes (or fails to take) and actually knows would, or would reasonably be expected to, be or cause a material breach of this Agreement and (ii) “Fraud” shall mean common law fraud that is committed with actual knowledge of falsity and with the intent to deceive or mislead another.
A-47

TABLE OF CONTENTS

(b) Termination Fees.
(i) If (x) this Agreement is terminated (I) by Parent or the Company pursuant to Section 8.1(d) or (II) by Parent or the Company pursuant to Section 8.1(f) (with respect to Section 8.1(f), solely to the extent that any such injunction, order, decree or ruling is in respect of, or any such Law relates to, the HSR Act or any other applicable Regulatory Law) (provided, that, in order for a termination by the Company to trigger the Regulatory Termination Fee under this clause (II), the Company must deliver a signed written notice (the “Company Notice”) to Parent stating that (A) such termination shall not be effective until five (5) Business Days following receipt of such notice by Parent (the “Notice Period”) and (B) if Parent and Merger Sub deliver a signed written notice (the “Parent Notice”) to the Company stating that they irrevocably waive the condition in Section 7.1(c) with respect to such injunction, order, decree, ruling or Law within the Notice Period then such termination by the Company under this clause (II) shall be null and void and deemed withdrawn; provided, further, for the avoidance of doubt that, if Parent and Merger Sub deliver the Parent Notice within the Notice Period, then such termination by the Company under this clause (II) shall be null and void and deemed withdrawn and the Company, Parent and Merger Sub shall be deemed to have irrevocably waived the condition in Section 7.1(c) with respect to such injunction, order, decree, ruling or Law), (y) on the date of such termination all of the conditions to the Closing set forth in Section 7.1, Section 7.2(a), Section 7.2(b), Section 7.2(c) and Section 7.2(d) are satisfied or duly waived (other than those conditions that by their nature are to be satisfied at Closing, each of which is capable of being satisfied at the Closing if the Closing were to take place on such date), other than the conditions set forth in Section 7.1(b) or Section 7.1(c) (with respect to Section 7.1(c), solely to the extent that any such injunction, order, decree or ruling is in respect of, or any such Law relates to, the HSR Act or any other applicable Regulatory Law) and (z) in the case of a termination by the Company pursuant to Section 8.1(d) or Section 8.1(f), (1) the Company has delivered a signed written notice (which may, if applicable, be included in the Company Notice) to Parent stating that the Company irrevocably waives in writing the conditions set forth in Section 7.1(c) with respect to such injunction, order, decree, ruling or Law, if any, and irrevocably confirms in writing to Parent that it is ready, willing and able to consummate the Closing (and, in the case of a termination by the Company pursuant to Section 8.1(d), upon delivery of such notice the Outside Date shall be extended by five (5) Business Days) and (2) Parent and Merger Sub, in the case of a termination by the Company pursuant to Section 8.1(d), fail to effect the Closing, or in the case of a termination by the Company pursuant to Section 8.1(f), fail to effect the Closing or deliver the Parent Notice, in each case within five (5) Business Days following receipt of such notice by Parent (which period may, if applicable, coincide with the Notice Period), then Parent shall pay to the Company a fee of $300,000,000 in cash (the “Regulatory Termination Fee”) within two (2) Business Days after such termination. In the event any amount is payable to the Company pursuant to this clause (i), such amount shall be paid by wire transfer of immediately available funds to an account designated in writing by the Company. For the avoidance of doubt, in no event shall Parent be obligated to pay the Regulatory Termination Fee on more than one occasion.
(ii) If (A) Parent or the Company terminates this Agreement pursuant to Section 8.1(d) or Section 8.1(g), or Parent terminates this Agreement pursuant to Section 8.1(c) as a result of a breach, failure to perform or violation described in such Section that (except with respect to a breach of Section 5.2(a)) first occurred following the making of an Acquisition Proposal of the type referenced in the following clause (B), (B) after the date hereof and prior to the date of such termination (or prior to the Company Stockholder Approval in the case of termination pursuant to Section 8.1(g)), a bona fide Acquisition Proposal is publicly disclosed (whether by the Company or a third party), or otherwise made known to the Company Board of Directors or the Company’s management, and in each case, is not withdrawn (publicly, if publicly disclosed) at least three (3) Business Days prior to the earlier of the date of the Company Stockholders Meeting and the date of such termination and (C) within twelve (12) months of such termination, an Acquisition Proposal is consummated or a definitive agreement with respect to an Acquisition Proposal is entered into, then on or prior to the date that is the earlier of (x) the date any such Acquisition Proposal is consummated and (y) the date of entry in any such definitive agreement, the Company shall pay or caused to be paid to Parent a fee of $191,390,000 in cash (the “Termination Fee”). Solely for purposes of this Section 8.2(b)(ii), the term “Acquisition Proposal” shall have the meaning assigned to such term in Annex A, except that all references to “fifteen percent (15%)” and “eighty five percent (85%)” therein shall be deemed to be references to “fifty percent (50%).”
A-48

TABLE OF CONTENTS

(iii) If (x) Parent terminates this Agreement pursuant to Section 8.1(e) or (y) the Company terminates this Agreement pursuant to Section 8.1(d) at a time when Parent would be permitted to terminate this Agreement pursuant to Section 8.1(e), within two (2) Business Days after such termination, the Company shall pay or caused to be paid to Parent the Termination Fee.
(iv) If the Company terminates this Agreement pursuant to Section 8.1(h), substantially concurrently with or prior to (and as a condition to) such termination, the Company shall pay or caused to be paid to Parent the Termination Fee.
(v) In the event any amount is payable by the Company pursuant to the preceding clauses (ii), (iii) or (iv), such amount shall be paid by wire transfer of immediately available funds to an account designated in writing by Parent. For the avoidance of doubt, in no event shall the Company be obligated to pay the Termination Fee on more than one occasion.
(c) Each Party acknowledges that the agreements contained in this Section 8.2 are an integral part of the Transactions and that, without these agreements, the Parties hereto would not enter into this Agreement. Each Party further acknowledges that each of the Termination Fee and the Regulatory Termination Fee is not a penalty, but rather is liquidated damages in a reasonable amount that will compensate Parent and Merger Sub or the Company, as applicable, in the circumstances in which the Termination Fee or the Regulatory Termination Fee, as applicable, is payable for the efforts and resources expended and opportunities foregone while negotiating this Agreement and in reliance on this Agreement and on the expectation of the consummation of the Transactions. In addition, if the Company or Parent, as applicable, fails to pay in a timely manner any amount due pursuant to Section 8.2(b), then (i) the Company or Parent, as applicable, shall reimburse the other Party for all reasonable out-of-pocket costs and expenses (including disbursements and fees of counsel) incurred in the collection of such overdue amounts, including in connection with any related claims, actions or proceedings commenced and (ii) the Company or Parent, as applicable, shall pay to the other Party interest on the amounts payable pursuant to Section 8.2(b) from and including the date payment of such amounts were due to but excluding the date of actual payment at the prime rate set forth in the Wall Street Journal in effect on the date such payment was required to be made. Notwithstanding anything to the contrary in this Agreement, (1) except for the right to seek monetary damages for Fraud (in each case, solely as it relates to (x) the representations and warranties expressly made in Article III, (y) certificates delivered pursuant hereto, or (z) filings submitted to Governmental Entities pursuant hereto (or documents submitted to such Governmental Entities in connection with such filings)) or willful breach occurring prior to the valid termination of this Agreement, and without limiting Parent’s or Merger Sub’s, right to specific performance in accordance with Section 9.12, (A) the Termination Fee (and any other amounts expressly required by this Section 8.2, if any) shall be the sole and exclusive monetary remedy available to Parent and Merger Sub in connection with this Agreement and the Transactions in any circumstance in which the Termination Fee becomes due and payable and is paid by the Company in accordance with this Agreement, and (B) upon Parent’s receipt of the full Termination Fee (and any other amounts required by this Section 8.2(c)) pursuant to this Section 8.2 in circumstances in which the Termination Fee is payable, none of the Company, any Company Subsidiary or any of their respective former, current or future officers, directors, partners, stockholders, managers, members, affiliates or agents shall have any further liability or obligation relating to or arising out of this Agreement or the Transactions, except for Fraud (in each case, solely as it relates to (x) the representations and warranties expressly made in Article III, (y) certificates delivered pursuant hereto, or (z) filings submitted to Governmental Entities pursuant hereto (or documents submitted to such Governmental Entities in connection with such filings)) or willful breach (each as defined in Section 8.2(a)), and (2) except for the right to seek monetary damages for Fraud (in each case, solely as it relates to (x) the representations and warranties expressly made in Article IV, (y) certificates delivered pursuant hereto, or (z) filings submitted to Governmental Entities pursuant hereto (or documents submitted to such Governmental Entities in connection with such filings)) or willful breach occurring prior to the valid termination of this Agreement, and without limiting the Company’s right to specific performance in accordance with Section 9.12, (A) the Regulatory Termination Fee (and any other amounts expressly required by this Section 8.2, if any) shall be the sole and exclusive monetary remedy available to the Company in connection with this Agreement and the Transactions in any circumstance in which the Regulatory Termination Fee becomes due and payable and is paid by Parent in accordance with this Agreement and (B) upon the Company’s receipt of the full Regulatory Termination Fee (and any other amounts required by this Section 8.2(c)) pursuant to this Section 8.2 in circumstances in which the Regulatory Termination Fee is payable, none of Parent, any Parent Subsidiary or any of their respective former, current or future officers, directors, partners, stockholders, managers, members, affiliates or agents shall have any further liability or obligation relating to or arising out of this
A-49

TABLE OF CONTENTS

Agreement or the Transactions, except for Fraud (in each case, solely as it relates to (x) the representations and warranties expressly made in Article IV, (y) certificates delivered pursuant hereto, or (z) filings submitted to Governmental Entities pursuant hereto (or documents submitted to such Governmental Entities in connection with such filings)) or willful breach (each as defined in Section 8.2(a)). For the avoidance of doubt, Parent or the Company, as applicable, may seek specific performance to cause the other Party to consummate the Transactions in accordance with Section 9.12 and the payment of the Termination Fee or Regulatory Termination Fee, as applicable, pursuant to this Section 8.2(c), but in no event shall Parent or the Company, as applicable, be entitled to both (i) specific performance to cause the Company to consummate the Transactions in accordance with Section 9.12 and (ii) the payment of the Termination Fee or Regulatory Termination Fee, as applicable, pursuant to this Section 8.2(c).
ARTICLE IX
 
MISCELLANEOUS
Section 9.1. Amendment and Modification; Waiver.
(a) Subject to applicable Law and except as otherwise provided in this Agreement, this Agreement may be amended, modified and supplemented by written agreement of each of the Parties.
(b) At any time and from time to time prior to the Effective Time, either the Company, on the one hand, or Parent and Merger Sub, on the other hand, may, to the extent legally allowed and except as otherwise set forth herein, (i) extend the time for the performance of any of the obligations or other acts of the other Parties, as applicable, (ii) waive any inaccuracies in the representations and warranties made by the other Parties contained herein or in any document delivered pursuant hereto and (iii) waive compliance with any of the agreements or conditions for their respective benefit contained herein. Any agreement on the part of Parent, Merger Sub or the Company to any such extension or waiver shall be valid only if set forth in an instrument in writing signed on behalf of Parent or the Company, as applicable. No failure or delay by the Company, Parent or Merger Sub in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise of any other right hereunder.
Section 9.2. Non-Survival of Representations and Warranties. None of the representations and warranties in this Agreement or in any schedule, instrument or other document delivered pursuant to this Agreement shall survive the Effective Time.
Section 9.3. Expenses. Except as otherwise expressly provided in this Agreement, all costs and expenses incurred in connection with this Agreement and the Transactions shall be paid by the Party incurring such costs and expenses; provided, however, that Parent shall pay all filing fees under the HSR Act and any other applicable Regulatory Law relating to the Transactions.
Section 9.4. Notices. All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally (notice deemed given upon receipt), by electronic mail (notice deemed given upon transmission so long as there is no return error message or other notification of non-delivery received by the sender; provided that, electronic mail received after 6:00 p.m., Pacific Time, shall be deemed received on the next day) or sent by a nationally recognized overnight courier service or express delivery service (notice deemed given upon receipt of proof of delivery), to the Parties at the following addresses (or at such other address for a Party as shall be specified by like notice):
 
 
 
 
 
 
 
if to Parent or Merger Sub, to:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Salesforce, Inc.
 
 
 
 
 
 
Salesforce Tower
 
 
 
 
 
 
415 Mission Street, 3rd Fl
 
 
 
 
 
 
San Francisco, California 94105
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
Chief Legal Officer
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A-50

TABLE OF CONTENTS

 
 
 
 
 
 
 
with a copy to:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Wachtell, Lipton, Rosen & Katz
 
 
 
 
 
 
51 West 52nd Street
 
 
 
 
 
 
New York, New York 10019
 
 
 
 
 
 
Email:
 
 
ajnussbaum@wlrk.com
mlu@wlrk.com
 
 
 
 
 
 
Attention:
 
 
Andrew J. Nussbaum
Meng Lu
 
 
 
 
 
 
 
 
 
 
 
 
 
if to the Company, to:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Braze, Inc.
 
 
 
 
 
 
63 Madison Building
 
 
 
 
 
 
28 East 28th Street, Floor 12
 
 
 
 
 
 
New York, New York 10016
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
General Counsel
 
 
 
 
 
 
 
 
 
 
 
 
 
with copies to:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Davis Polk & Wardwell LLP
 
 
 
 
 
 
900 Middlefield Road
 
 
 
 
 
 
Redwood City, CA 94063
 
 
 
 
 
 
Email:
 
 
paul.scrivano@davispolk.com
cheryl.chan@davispolk.com
 
 
 
 
 
 
Attention:
 
 
Paul S. Scrivano
Cheryl Chan
 
 
 
 
 
 
 
 
 
 
Section 9.5. Interpretation. When a reference is made in this Agreement to sections, such reference shall be to a section of this Agreement, unless otherwise indicated. Whenever the words “include,” “includes” or “including” are used in this Agreement they shall be deemed to be followed by the words “without limitation.” As used in this Agreement, the term “affiliates” shall have the meaning set forth in Rule 12b-2 of the Exchange Act. The word “extent” and the phrase “to the extent” when used in this Agreement shall mean the degree to which a subject or other things extends, and such word or phrase shall not merely mean “if.” The term “or” is not exclusive, and shall be interpreted as “and/or.” The phrases “the date of this Agreement,” “the date hereof,” “of even date herewith” and terms of similar import, shall be deemed to refer to the date set forth in the preamble to this Agreement. The phrase “made available,” when used in reference to anything made available to Parent or its Representatives shall be deemed to mean uploaded to and/or made available to Parent and its Representatives no less than one (1) Business Day prior to the date hereof in the online data room hosted on behalf of the Company under the name “Project Banff” (which, for the avoidance of doubt, includes the materials provided in any folder of such data room, including the “clean room” and other folders to which a limited subset of Parent employees and Parent’s Representatives have access). The table of contents and headings set forth in this Agreement or any schedule delivered pursuant to this Agreement are for convenience of reference purposes only and shall not affect or be deemed to affect in any way the meaning or interpretation of this Agreement or such schedule or any term or provision hereof or thereof. All references herein to the Subsidiaries of a Person shall be deemed to include all direct and indirect Subsidiaries of such Person, unless otherwise indicated or the context otherwise requires. A reference to any specific Law or to any provision of any Law, whether or not followed by the phrase “as amended,” includes any amendment to, and any modification, re-enactment or successor thereof, any legislative provision substituted therefor and all rules, regulations and statutory instruments issued thereunder or pursuant thereto, except that, for purposes of any representations and warranties in this Agreement that are made as a specific date, references to any specific Law will be deemed to refer to such legislation or provision (and all rules, regulations and statutory instruments issued thereunder or pursuant thereto) as of such date. If any period expires on a day that is not a Business Day or event or condition is required by the terms of this Agreement to occur or be fulfilled on a day that is not a Business Day, such period shall expire or such event or condition shall occur or be fulfilled,
A-51

TABLE OF CONTENTS

as the case may be, on the next succeeding Business Day. Any action required to be taken “within” a specified time period following the occurrence of an event shall be required to be taken no later than 5:00 P.M. U.S. Pacific Time on the last day of such time period, which shall be calculated starting with the day immediately following the date of the event. The Parties agree that they have been represented by counsel during the negotiation and execution of this Agreement and, therefore, waive the application of any Law, regulation, holding or rule of construction providing that ambiguities in an agreement or other document will be construed against the party drafting such agreement or document.
Section 9.6. Counterparts. This Agreement may be executed manually or by other electronic transmission by the Parties, in any number of counterparts, each of which shall be considered one and the same agreement and shall become effective when a counterpart hereof shall have been signed by each of the Parties and delivered to the other Parties. The exchange of a fully executed Agreement (in counterparts or otherwise) by electronic transmission in .pdf or DocuSign format shall be sufficient to bind the Parties to the terms and conditions of this Agreement.
Section 9.7. Entire Agreement; Third-Party Beneficiaries.
(a) This Agreement, the Voting Agreement, the Clean Room Agreement, the Joint Defense Agreement and the Confidentiality Agreement constitute the entire agreement among the Parties with respect to the subject matter hereof and thereof and supersede all other prior agreements (except that the Confidentiality Agreement shall be deemed amended hereby so that until the termination of this Agreement in accordance with Section 8.1, Parent and Merger Sub shall be permitted to take the actions contemplated by this Agreement) and understandings, both written and oral, among the Parties or any of them with respect to the subject matter hereof and thereof. The Company Disclosure Letter and the Parent Disclosure Letter referred to herein shall not be deemed part of this Agreement for purposes of any provision of the DGCL but shall have the effects provided in this Agreement and in the last sentence of the second paragraph of each of the Company Disclosure Letter and the Parent Disclosure Letter.
(b) Nothing in this Agreement (including the Company Disclosure Letter and the Parent Disclosure Letter) or in the Confidentiality Agreement, express or implied, is intended to confer upon any Person other than the Parties any rights or remedies hereunder or thereunder, except (i) as provided in Section 6.4, and (ii) if the Effective Time occurs, the right of the Company Stockholders under Section 2.1(a) and holders of Company Equity Awards under Section 2.3 to receive the Per Share Merger Consideration (if applicable) pursuant to the terms thereof. The Company shall be entitled, on behalf of the Company Stockholders and holders of Company Equity Awards (each of which are third party beneficiaries of this Agreement to the extent required for this provision to be enforceable), to pursue specific performance as set forth in Section 9.12 or, if specific performance is not sought or granted as a remedy, claims for damages in accordance with this Agreement (which, to the extent proven and awarded by a court of competent jurisdiction, and pursuant to Section 261 of the DGCL, may include the benefit of the bargain lost by the Company Stockholders and holders of Company Equity Awards, it being understood and agreed that any such damages award shall take account of the Regulatory Termination Fee if paid in accordance with this Agreement) in the event of a breach hereof by Parent or Merger Sub of this Agreement that gives rise to any such claim, in each case, pursuant to and in accordance with Section 8.2, it being agreed that the rights granted pursuant to this sentence shall be enforceable only by the Company, on behalf of and as representative of and agent for the Company Stockholders and holders of Company Equity Awards, and in no event shall any Company Stockholder or holder of Company Equity Awards be entitled to enforce any of such rights, or any of Parent’s or Merger Sub’s obligations, under this Agreement in the event of any such breach, but rather the Company shall have the sole and exclusive right to do so as agent for such holders.
Section 9.8. Severability. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by rule of Law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the Merger is not affected in any manner adverse to any Party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible in an acceptable manner to the end that the Merger is fulfilled to the extent possible.
A-52

TABLE OF CONTENTS

Section 9.9. Governing Law; Jurisdiction.
(a) This Agreement and any disputes relating to or arising out of this Agreement and the transactions contemplated hereby (whether based in contract, tort or otherwise) shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to conflicts of laws principles that would result in the application of the Law of any other state.
(b) Each of the Parties hereto hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of the Court of Chancery of the State of Delaware, or, if (and only if) such court finds it lacks jurisdiction, the Federal court of the United States of America sitting in Delaware, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Agreement and the rights and obligations hereunder or the agreements delivered in connection herewith or the transactions contemplated hereby or thereby or for recognition or enforcement of any judgment relating thereto, and each of the Parties hereby irrevocably and unconditionally (i) agrees not to commence any such action or proceeding, except in the Court of Chancery of the State of Delaware, or, if (and only if) such court finds it lacks jurisdiction, the Federal court of the United States of America sitting in Delaware, and any appellate court from any thereof; (ii) agrees that any claim in respect of any such action or proceeding may be heard and determined in the Court of Chancery of the State of Delaware, or, if (and only if) such court finds it lacks jurisdiction, the Federal court of the United States of America sitting in Delaware, and any appellate court from any thereof; (iii) waives, to the fullest extent it may legally and effectively do so, any objection that it may now or hereafter have to the laying of venue of any such action or proceeding in such courts; and (iv) waives, to the fullest extent permitted by Law, the defense of an inconvenient forum to the maintenance of such action or proceeding in such courts. Each of the Parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Law. Each Party to this Agreement irrevocably consents to service of process inside or outside the territorial jurisdiction of the courts referred to in this Section 9.9(b) in the manner provided for notices in Section 9.4. Nothing in this Agreement will affect the right of any Party to this Agreement to serve process in any other manner permitted by applicable Law.
Section 9.10. Waiver of Jury Trial. EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE MERGER OR THE OTHER TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE SUCH WAIVERS, (B) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVERS, (C) IT MAKES SUCH WAIVERS VOLUNTARILY AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 9.10.
Section 9.11. Assignment. This Agreement shall not be assigned by any of the Parties (whether by operation of Law or otherwise) without the prior written consent of the other Parties. Subject to the preceding sentence, but without relieving any Party of any obligation hereunder, this Agreement will be binding upon, inure to the benefit of and be enforceable by the Parties and their respective successors and assigns.
Section 9.12. Enforcement; Remedies.
(a) Except as otherwise expressly provided herein, any and all remedies herein expressly conferred upon a Party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by Law or equity upon such Party, and the exercise by a Party of any one remedy will not preclude the exercise of any other remedy.
(b) The Parties agree that irreparable injury, for which monetary damages (even if available) would not be an adequate remedy, will occur in the event that any of the provisions of this Agreement (including failing to take such actions as are required of it hereunder to consummate the Merger or the other Transactions) is not performed in accordance with its specific terms or is otherwise breached. Accordingly, it is agreed that each Party shall be entitled to an injunction or injunctions to prevent or remedy any breaches or threatened breaches of this Agreement by any other Party, a decree or order of specific performance specifically enforcing the terms and provisions of this Agreement and any further equitable relief, in each case in accordance with Section 9.9, this being in addition to any other remedy to which such Party is entitled under the terms of this Agreement at law or in equity.
A-53

TABLE OF CONTENTS

(c) The Parties’ rights in this Section 9.12 are an integral part of the Transactions and each Party hereby waives any objections to any remedy referred to in this Section 9.12 (including any objection on the basis that there is an adequate remedy at Law or that an award of such remedy is not an appropriate remedy for any reason at Law or equity). For the avoidance of doubt, each Party agrees that there is not an adequate remedy at Law for a breach of this Agreement by any Party. In the event any Party seeks any remedy referred to in this Section 9.12, such Party shall not be required to obtain, furnish, post or provide any bond or other security in connection with or as a condition to obtaining any such remedy.
[Remainder of Page Intentionally Left Blank]
A-54

TABLE OF CONTENTS

IN WITNESS WHEREOF, Parent, Merger Sub and the Company have caused this Agreement to be signed by their respective officers thereunto duly authorized as of the date first written above.
 
 
 
 
 
 
 
SALESFORCE, INC.
 
 
 
 
 
 
 
 
 
 
By:
 
 
/s/ John Somorjai
 
 
 
Name:
 
 
John Somorjai
 
 
 
Title:
 
 
President, Corporate Development and Investments
 
 
 
 
 
 
 
 
 
 
BANFF ACQUISITION SUB INC.
 
 
 
 
 
 
 
 
 
 
By:
 
 
/s/ John Somorjai
 
 
 
Name:
 
 
John Somorjai
 
 
 
Title:
 
 
Vice President
 
 
 
 
 
 
 
[Signature Page to Agreement and Plan of Merger]
A-55

TABLE OF CONTENTS

IN WITNESS WHEREOF, Parent, Merger Sub and the Company have caused this Agreement to be signed by their respective officers thereunto duly authorized as of the date first written above.
 
 
 
 
 
 
 
BRAZE, INC.
 
 
 
 
 
 
 
 
 
 
By:
 
 
/s/ William Magnuson
 
 
 
Name:
 
 
William Magnuson
 
 
 
Title:
 
 
Chief Executive Officer
 
 
 
 
 
 
 
[Signature Page to Agreement and Plan of Merger]
A-56

TABLE OF CONTENTS

Annex A
 
Certain Definitions
For the purposes of this Agreement, the term:
“Acceptable Confidentiality Agreement” means a confidentiality agreement entered into after the date hereof that contains terms that (i) are no less favorable in the aggregate to the Company than those contained in the Confidentiality Agreement (it being understood that such confidentiality agreement need not contain a “standstill” or similar provision) and (ii) do not in any way restrict the Company or its Representatives from complying with its disclosure obligations under this Agreement.
“Acquisition Proposal” means any offer, proposal or indication of interest from a Person (other than a proposal or offer by Parent or any Parent Subsidiary) at any time relating to any transaction or series of related transactions (other than the Transactions) involving: (a) any acquisition or purchase by any person, directly or indirectly, of more than fifteen percent (15%) of any class of outstanding voting or equity securities of the Company (whether by voting power or number of shares), or any tender offer (including a self-tender offer) or exchange offer that, if consummated, would result in any person beneficially owning more than fifteen percent (15%) of any class of outstanding voting or equity securities of the Company (whether by voting power or number of shares); (b) any merger, consolidation, share exchange, business combination, joint venture, recapitalization, reorganization or other similar transaction involving the Company and a person pursuant to which the Company Stockholders immediately preceding such transaction hold less than eighty five percent (85%) of the equity interests in the surviving, resulting or ultimate parent entity of such transaction (whether by voting power or number of shares); or (c) any sale, lease, exchange, transfer or other disposition to a person of more than fifteen percent (15%) of the consolidated assets of the Company and the Company Subsidiaries (measured by the fair market value thereof).
“Actual Performance” means the actual level of performance, as determined by the Compensation and Leadership Development Committee of the Company Board of Directors, as of the latest practicable date prior to the Effective Time, which shall be done in the ordinary course of business.
“AI System” means any system or Software that: (a) consists of, incorporates, is based on, or uses artificial intelligence (including as implemented through any neural network, large language model, machine learning, natural language processing or supervised, semi-supervised, unsupervised or reinforcement learning algorithms or other technologies now existing or that may exist in the future) or (b) is otherwise designed to or can operate with varying levels of autonomy and that may exhibit adaptiveness after deployment and that, for explicit or implicit objectives, infers, from the input it receives, how to generate outputs such as predictions, content, recommendations, or decisions that can influence physical or virtual environments.
“Anti-Corruption Law” means any Law related to combating bribery and corruption, including legislation implementing the OECD Convention on Combating Bribery of Foreign Officials in International Business Transactions or the U.N. Convention Against Corruption including, the U.S. Foreign Corrupt Practices Act of 1977, as amended (the “FCPA”), and the U.K. Bribery Act 2010.
“Assumed Company Restricted Shares” means the shares of Class A Common Stock held by the individuals listed on Section 2.3(i)(A) of the Company Disclosure Letter that are subject to a substantial risk of forfeiture (within the meaning of Section 83 of the Code) as of immediately prior to the Effective Time.
“Business Days” means any day, other than a Saturday, Sunday and any day which is a legal holiday under the Laws of the State of California or the State of New York or is a day on which banking institutions located in such states are authorized or required by applicable Law or other governmental action to close.
“Cashout Company Restricted Shares” means the shares of Class A Common Stock held by the individuals listed on Section 2.3(i)(B) of the Company Disclosure Letter that are subject to a substantial risk of forfeiture (within the meaning of Section 83 of the Code) as of immediately prior to the Effective Time.
“Clean Room Agreement” means the Clean Room Agreement, dated as of August 28, 2026, between Parent and the Company.
“Code” means the Internal Revenue Code of 1986, as amended.
“Company Bylaws” means the Amended and Restated Bylaws of the Company as in effect on the date hereof.
A-57

TABLE OF CONTENTS

“Company Charter” means the Amended and Restated Certificate of Incorporation of the Company as in effect on the date hereof.
“Company Equity Awards” means the Company Options, the Company RSUs, the Company PSUs and the Company Restricted Shares.
“Company Equity Plans” means (i) the Company’s 2021 Equity Incentive Plan and (ii) the Company’s Amended and Restated 2011 Equity Incentive Plan.
“Company ESPP” means the Company’s 2021 Employee Stock Purchase Plan.
“Company Governing Documents” means the Company Bylaws and the Company Charter.
“Company Intellectual Property” means all Intellectual Property owned by (or claimed to be owned by), or filed in the name of the Company or any Company Subsidiary.
“Company Material Adverse Effect” means any Effect that, individually or in the aggregate, has had or would reasonably be expected to have, individually or in the aggregate, a material adverse effect on the business, financial condition, or operations of the Company and the Company Subsidiaries, taken as a whole; provided, however, that no Effects to the extent resulting or arising from the following shall be deemed to constitute a Company Material Adverse Effect or shall be taken into account when determining whether a Company Material Adverse Effect exists or has occurred: (a) any changes in United States, regional, global or international economic conditions, including any changes affecting financial, credit, foreign exchange or capital market conditions; (b) any changes in conditions generally affecting the cross-channel customer messaging software industry; (c) any changes in political, geopolitical regulatory or legislative conditions in the United States or any other country or region of the world; (d) any changes after the date hereof in GAAP or the authoritative interpretation thereof; (e) any changes after the date hereof in applicable Law or the authoritative interpretation thereof; (f) any failure by the Company to meet any internal or published projections, estimates or expectations of the Company’s revenue, earnings or other financial performance or results of operations for any period, in and of itself, or any failure by the Company to meet its internal budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operations, in and of itself (it being understood that the facts or occurrences giving rise or contributing to such failure that are not otherwise excluded from this definition of a “Company Material Adverse Effect” may be taken into account in determining whether there has been a Company Material Adverse Effect); (g) any acts of terrorism or sabotage, war (whether or not declared), the commencement, continuation or escalation of a war, acts of armed hostility, weather conditions, natural disasters epidemics, pandemics, or similar force majeure events, including any material worsening of such conditions threatened or existing as of the date hereof, or any action taken by any Governmental Entity in response to any of the foregoing; (h) the execution and delivery of this Agreement, the identity of Parent or any Parent Subsidiary, the pendency or consummation of this Agreement, the Merger and the other Transactions, including the effect thereof on the relationships with current or prospective customers, suppliers, distributors, partners, financing sources, employees or sales representatives, or the public announcement of this Agreement or the Transactions, including the initiation or settlement of any litigation arising out of or relating to this Agreement or the Transactions commenced by or involving (1) any Governmental Entity in connection with this Agreement or the Transactions or (2) any current or former stockholder of the Company (on their own or on behalf of the Company), to the extent relating to this Agreement or the Transactions, the identity of Parent or any Parent Subsidiary, the pendency or consummation of this Agreement, the Merger and the other Transactions, or the public announcement of this Agreement and the Transactions, as applicable (provided that this clause (h) shall not apply to any representation or warranty to the extent the purpose of such representation or warranty is to address, as applicable, the consequences resulting from the execution and delivery or public announcement of this Agreement, the pendency or consummation of this Agreement, the Merger and the other Transactions); and (i) any action or failure to take any action which action or failure to act is requested in writing by Parent or otherwise expressly required to be taken by this Agreement (other than pursuant to Section 5.1(a)); provided that with respect to the exceptions set forth in clauses (a), (b), (c), (d), (e) and (g), if such Effect has had, or would reasonably be expected to have, a disproportionate adverse effect on the Company or any Company Subsidiary relative to other companies operating in the cross-channel customer messaging software industry, then only the incremental disproportionate adverse effect of such Effect that would reasonably be expected to occur shall be taken into account for the purpose of determining whether a Company Material Adverse Effect exists or has occurred.
“Company Option” means each option to purchase Class A Common Stock granted under any Company Equity Plan that is outstanding and unexercised immediately prior to the Effective Time.
A-58

TABLE OF CONTENTS

“Company Products” means any and all products and services, including Software as a service (SaaS) and any professional or consulting services, that are or have been in the three (3) years prior to the date of this Agreement marketed, offered, sold, licensed, made available or distributed by the Company or any Company Subsidiary.
“Company PSU” means each restricted stock unit award relating to shares of Class A Common Stock granted under any Company Equity Plan that is outstanding immediately prior to the Effective Time and subject to performance-based and service-based vesting requirements.
“Company Restricted Shares” means the Assumed Company Restricted Shares and the Cashout Company Restricted Shares.
“Company RSU” means each restricted stock unit award relating to shares of Class A Common Stock granted under any Company Equity Plan that is outstanding immediately prior to the Effective Time and subject solely to service-based vesting requirements.
“Company Subsidiaries” means the Subsidiaries of the Company.
“Company Systems” means the computer systems and other information technology, including any Software, servers, networks, workstations, hubs, circuits, switches, cloud storage and computing platforms and mobile devices, in each case, that are used or held for use, by the Company or any of its Subsidiaries for use in the conduct of its business.
“Confidentiality Agreement” means the Confidentiality Agreement, dated June 8, 2026, between Parent and the Company, as may be amended.
“Contract” means any legally binding written or oral agreement, contract, subcontract, settlement agreement, lease, sublease, instrument, permit, concession, franchise, binding understanding, note, option, bond, mortgage, indenture, trust document, loan or credit agreement, license, sublicense, insurance policy or other commitment or undertaking of any nature.
“Controlled Group Liability” means any and all liabilities (i) under Title IV of ERISA; (ii) under Section 302 of ERISA; (iii) under Sections 412 and 4971 of the Code; (iv) as a result of a failure to comply with the continuation coverage requirements of Section 601 et seq. of ERISA and Section 4980B of the Code; and (v) under corresponding or similar provisions of foreign laws or regulations, other than such liabilities that arise solely out of, or relate solely to, plans directly sponsored by the Company and the Company Subsidiaries.
“Conversion Ratio” means the quotient (rounded to the 4th decimal place) obtained by dividing (i) the Per Share Merger Consideration by (ii) the Parent Trading Price.
“Effect” means any change, effect, development, circumstance, condition, state of facts, event or occurrence.
“Environmental Law” means any and all applicable Law which (a) regulate or relate to the protection or clean-up of the environment; the use, treatment, storage, transportation, handling, disposal or release of Hazardous Substances, the preservation or protection of waterways, groundwater, drinking water, air, wildlife, plants or other natural resources, or, solely to the extent pertaining to exposure to Hazardous Substances, the health and safety of persons or property, including protection of the health and safety of employees or (b) impose liability or responsibility with respect to any of the foregoing, including the Comprehensive Environmental Response, Compensation and Liability Act (42 U.S.C. § 9601 et seq.), or any other Law of similar effect.
“ERISA” means the Employee Retirement Income Security Act of 1974, as amended, and the regulations promulgated and rulings issued thereunder.
“ERISA Affiliate” means, with respect to any entity, trade or business, any other entity, trade or business that is a member of a group described in Section 414(b), (c), (m) or (o) of the Code or Section 4001(b)(1) of ERISA that includes the first entity, trade or business, or that is a member of the same “controlled group” as the first entity, trade or business pursuant to Section 4001(a)(14) of ERISA.
“Exchange Act” means the United States Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
“GDPR” means Regulation (EU) 2016/679 (General Data Protection Regulation) of the European Parliament and of the Council on the protection of natural persons with regard to the processing of personal data and on the free movement of such data as currently in effect and as may be amended from time to time.
A-59

TABLE OF CONTENTS

“Governmental Entity” means (a) any supranational, national, federal, state, county, municipal, local, or foreign government or any entity exercising executive, legislative, judicial, regulatory, taxing, or administrative functions of or pertaining to government, (b) any public international governmental organization or (c) any agency, division, bureau, department, or other political subdivision of any government, entity or organization described in the foregoing clause (a) or (b) of this definition (including patent and trademark offices and self-regulatory organizations).
“Hazardous Substances” means any toxic, infectious, carcinogenic, reactive, corrosive, ignitable or flammable chemical, chemical compound, pollutant, hazardous substance, material or waste, whether solid, liquid or gas, that is subject to regulation, control or remediation under any Environmental Laws, due to its deleterious or toxic characteristics, including any quantity of petroleum product or byproduct, solvent, flammable or explosive material, radioactive material, asbestos, lead paint, polychlorinated biphenyls (or PCBs), dioxins, dibenzofurans, heavy metals, radon gas, mold, mold spores, and mycotoxins.
“High-Risk AI Systems” means AI Systems that are “high risk” (or are similarly categorized) under applicable Law (including the European Union Artificial Intelligence Act).
“HSR Act” means the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder.
“Import Restrictions” means all applicable U.S. and foreign import Laws, except to the extent inconsistent with U.S. Law, including Title 19 Chapter 1 of the Code of Federal Regulations.
“Indebtedness” means, with respect to any Person, (a) all obligations of such Person for borrowed money; (b) all obligations of such Person evidenced by bonds, debentures, notes or similar instruments; (c) all Indebtedness of others secured by any Lien on owned or acquired property of such Person, whether or not the Indebtedness secured thereby has been assumed; (d) all guarantees (or any other arrangement having the economic effect of a guarantee) by such Person of Indebtedness of others; (e) all finance and capital lease obligations and all synthetic lease obligations of such Person; (f) all obligations, contingent or otherwise, of such Person as an account party in respect of financial guaranties, bankers’ acceptances, letters of credit, letters of guaranty, surety bonds and other similar instruments, in each case, to the extent drawn; (g) all securitization transactions; (h) all obligations representing the deferred and unpaid purchase price of property (other than trade payables, accounts payable and other current liabilities, in each case that are not overdue and are incurred in the ordinary course of business consistent with past practice); or (i) net cash payment obligations of such Person under swaps, options, hedging agreements or arrangements and other derivative agreements or arrangements that will be payable upon termination thereof (assuming they were terminated on the date of determination).
“Information Privacy and Security Laws” means (a) any Law, rule, regulation or directive and all binding guidance issued by any Governmental Entity thereunder applicable to the Company or to any Company Subsidiary and (b) to the extent the Company has agreed to comply with the same, any binding applicable self-regulatory guidelines, in each case, relating to: (i) the privacy, protection, or security of Protected Information, including as relevant to the collection, storage, retention, processing, transfer, disclosure, sharing, disposal and destruction of Protected Information or (ii) requirements for websites and mobile applications, online behavioral advertising, tracking technologies, call or electronic monitoring or recording, or any outbound calling and text messaging, telemarketing, or email marketing. Without limiting the foregoing, “Information Privacy and Security Laws” includes, to the extent applicable to Company and Company Subsidiary, the Federal Trade Commission Act, the Telephone Consumer Protection Act, the Telemarketing and Consumer Fraud and Abuse Prevention Act, the Controlling the Assault of Non-Solicited Pornography and Marketing Act of 2003, the Children’s Online Privacy Protection Act, the Computer Fraud and Abuse Act, the Electronic Communications Privacy Act, the Fair Credit Reporting Act, the Fair and Accurate Credit Reporting Act, the Health Insurance Portability and Accountability Act of 1996, as amended and supplemented by the Health Information Technology for Economic and Clinical Health Act of the American Recovery and Reinvestment Act of 2009 (together, “HIPAA”), the Gramm-Leach-Bliley Act, state privacy and data security laws, state social security number protection laws, state data breach notification laws, state consumer protection laws, the GDPR (and any European Union member states’ laws and regulations implementing the GDPR), the Canadian Personal Information Protection and Electronic Documents Act, India’s Information Technology Act, Japan’s Act on the Protection of Personal Information, Hong Kong’s Personal Data (Privacy) Ordinance, and Australia’s Privacy Amendment (Private Sector) Act 2000, as amended by the Privacy Amendment (Enhancing Privacy Protection) Act 2012, the Saudi Arabia Personal Data Protection Law, and other applicable data protection laws of the jurisdictions in which the Company or the Company Subsidiaries operate or which are applicable to their respective businesses.
A-60

TABLE OF CONTENTS

“Intellectual Property” means all technology and intellectual property or other proprietary rights, whether statutory, common law or otherwise, in any jurisdiction throughout the world, including all: (a) inventions, invention disclosures, discoveries, improvements, patents and patent applications; (b) trademarks, service marks, trade dress, logos, slogans, brand names, trade names, Internet domain names and corporate names (whether or not registered), social media handles and other identifiers and indicia of origin, and all applications and registrations in connection therewith; (c) all works of authorship and copyrights (whether or not published), and all applications and registrations in connection therewith, including audiovisual works, collective works, computer programs, compilations, databases, derivative works, literary works, mask works, and sound recordings; (d) Software and intellectual property rights in Software; (e) mask works and industrial designs, and all applications and registrations in connection therewith; (f) trade secrets and other intellectual property rights in confidential and proprietary information (including inventions, ideas, research and development information, know-how, formulas, compositions, manufacturing and production processes and techniques, technical data, designs, drawings, schematics, specifications, research records, test information, financial, marketing and business data, customer and supplier lists, algorithms and information, pricing and cost information, business and marketing plans and proposals, and databases and compilations, including any and all data and collections of data); (g) renewals, extensions, combinations, statutory invention registrations, provisionals, continuations, continuations-in-part, reexaminations, divisions or reissues of any of the foregoing; and (h) rights of attribution and integrity and other moral rights of an author.
“In-the-Money Company Option” means each Company Option with a per share exercise price that is less than the amount of the Per Share Merger Consideration.
“IRS” means the U.S. Internal Revenue Service.
“Joint Defense Agreement” means the Joint Defense Agreement, dated as of September 19, 2026, between Davis Polk & Wardwell LLP and Wachtell, Lipton, Rosen & Katz, on behalf of the Company and Parent, respectively.
“Knowledge” will be deemed to be, as the case may be, the actual knowledge of (a) the individuals set forth on Section 1.1(a) of the Parent Disclosure Letter with respect to Parent or Merger Sub or (b) the individuals set forth on Section 1.1(a) of the Company Disclosure Letter with respect to the Company, in each case after reasonable inquiry of those employees of such Party and its Subsidiaries who would reasonably be expected to have actual knowledge of the matter in question.
“Law” means any law (including common law), statute, requirement, code, rule, regulation, order, ordinance, judgment or decree or other pronouncement of any Governmental Entity.
“Lien” means any lien, pledge, hypothecation, mortgage, deed of trust, security interest, conditional or installment sale agreement, encumbrance, covenant, charge, claim, option, right of first refusal, easement, right of way, encroachment, occupancy right, preemptive right, community property interest or restriction of any nature (including any restriction on the voting of any security, any restriction on the transfer of any security or other asset, or any restriction on the possession, exercise or transfer of any other attribute of ownership of any asset), whether voluntarily incurred or arising by operation of Law.
“Multiemployer Plan” means any “multiemployer plan” within the meaning of Section 3(37) of ERISA or any plan that has two (2) or more contributing sponsors at least two (2) of whom are not under common control within the meaning of Section 4063 of ERISA.
“Nasdaq” means The Nasdaq Stock Market LLC.
“National Security Laws” means the National Industrial Security Program Operating Manual (“NISPOM”), 32 C.F.R. Part 117, and any supplements, amendments, or revised editions thereof.
“Net Share” means, with respect to a Company Option, the quotient obtained by dividing (a) the product of (i) the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such Company Option, multiplied by (ii) the number of shares of Class A Common Stock subject to such Company Option immediately prior to the Effective Time, by (b) the Per Share Merger Consideration.
“NYSE” means the New York Stock Exchange.
“Open Source License” means any license that is approved by the Open Source Initiative and listed at http://www.opensource.org/licenses or the Free Software Foundation and listed at https://www.gnu.org/licenses/license-list.en.html, and any similar license for “free,” “publicly available” or “open
A-61

TABLE OF CONTENTS

source” software, including the Affero General Public License, Server Side Public License (SSPL), GNU General Public License, the Lesser GNU General Public License, the Apache License, the BSD License, Mozilla Public License (MPL), the MIT License or any other license that otherwise requires, as a condition of use, modification, distribution, or making available of the Software or other technology licensed thereunder, that other Software or other technology incorporated into, derived from, distributed, or made available with, such Software or other technology (a) be, in the case of Software, disclosed or distributed in Source Code form, (b) be licensed for purposes of preparing derivative works, (c) be licensed under terms that allow Company Products or portions thereof or interfaces therefor to be reverse engineered, reverse assembled or disassembled, or (d) be redistributed at no or de minimis charge.
“Ordinary Course License” means standard non-exclusive licenses contained in: (a) customer subscription, terms of use or terms of service, license or other service or similar agreements, in each case, with respect to Company Products; (b) confidentiality and invention assignment agreements entered into in the ordinary course of business consistent with past practice; (c) end-user license agreements granted to the Company or Company Subsidiaries for their use of Software or information technology services on standard terms that are generally commercially available; or (d) agreements based on a form used by the Company or Company Subsidiary that has been made available to Parent (other than stand-alone licenses, covenants not to assert, releases, agreements not to enforce or prosecute, or other immunities or similar rights with respect to patents or trademarks), including each form of (i) distributor, reseller, or sales representatives agreement, (ii) agreement with employees and independent contractors, and (iii) vendor, professional services, outsourced development, consulting, support or maintenance agreement, in each case of the foregoing clauses (a) through (d), that are granted in the ordinary course of business consistent with past practice.
“Parent Common Stock” means shares of common stock, par value $0.001 per share, of Parent.
“Parent Material Adverse Effect” means any Effect that prevents, materially impairs or materially delays, or has a material adverse effect on, the ability of Parent or Merger Sub to consummate the Transactions by the Outside Date.
“Parent Subsidiaries” means the Subsidiaries of Parent.
“Parent Trading Price” means the volume weighted average closing sale price of one (1) share of Parent Common Stock as reported on NYSE for the twenty (20) consecutive trading days ending on the trading day immediately preceding the Closing Date (as adjusted as appropriate to reflect any stock splits, stock dividends, combinations, reorganizations, reclassifications or similar events).
“PCI DSS” means the Payment Card Industry Data Security Standard, issued by the Payment Card Industry Security Standards Council, as may be revised from time to time.
“Permitted Liens” means any Lien (i) for Taxes or governmental assessments, charges or claims of payment not yet due or that is being contested in good faith by appropriate proceedings and for which adequate reserves have been established in accordance with GAAP; (ii) which is a carriers’, warehousemen’s, mechanics’, materialmen’s, repairmen’s or other similar Lien arising by operation of Law in the ordinary course of business for amounts not yet delinquent or that are being contested in good faith by appropriate proceedings; (iii) is specifically disclosed on the most recent consolidated balance sheet of the Company or the notes thereto included in the Company SEC Documents as of the date hereof as securing indebtedness or liabilities reflected in the most recent consolidated balance sheet of the Company or the notes thereto included in the Company SEC Documents as of the date hereof; (iv) which is a statutory, contractual or common law Lien to secure landlords, lessors or renters under leases or rental agreements; (v) which encumbers or is imposed on the underlying fee interest in real property subject to a real property lease; (vi) that arises as a result of a non-exclusive license or other non-exclusive grant of rights under Intellectual Property in the ordinary course of business consistent with past practice; (vii) that arises from pledges or deposits to secure obligations pursuant to workers’ compensation Laws, unemployment insurance, social security, retirement and similar Laws or similar legislation or to secure public or statutory obligations, in each case in the ordinary course of business consistent with past practice; (viii) for a matter (1) of record, defect, imperfection, irregularity in title, charge, encumbrance, easement, covenant, condition, restriction, easement, right of way, zoning, building, entitlement or other similar restriction or other Lien, (2) that would be shown by a current, accurate survey or a physical inspection of real property, in each case, that do not adversely affect in any material respect the current use or value of the applicable property owned, leased, used or held for use by the Company or any Company Subsidiary; and (ix) is a pledge or deposit to secure performance of bids, trade contracts, leases, surety and appeal bonds, performance bonds and other obligations of a similar nature that, in each case, is not material and is incurred in the ordinary course of business consistent with past practice.
A-62

TABLE OF CONTENTS

“Person” means a natural person, partnership, corporation, limited liability company, business trust, joint stock company, trust, unincorporated association, joint venture, Governmental Entity or other entity or organization.
“Personal Data” means any and all information that can reasonably be associated with an individual natural person or household, including information that identifies or could be used to identify, alone or in combination with other information, an individual natural person or household, including name, physical address, telephone number, email address, financial account number, passwords or PINs, device identifier or unique identification number, government-issued identifier (including Social Security number and driver’s license number), medical, health or insurance information, gender, date of birth, educational or employment information, religious or political views or affiliations and marital or other status (to the extent any of these data elements can reasonably be associated with an individual natural person or household or is linked to any such data element that can reasonably be associated with an individual natural person or household). Personal Data also includes any information not listed above if such information is defined as “personal data,” “personally identifiable information,” “individually identifiable health information,” “protected health information” or “personal information” under any applicable Law and is regulated by such Law.
“Privacy Statements” means, collectively, all of the Company’s and the Company Subsidiaries’ (a) internal privacy policies and notices, and (b) publicly posted privacy policies and notices (including if posted on the Company’s or the Company Subsidiaries’ products and services), in each case regarding the collection, use, disclosure, transfer, storage, maintenance, retention, deletion, disposal, modification or processing of Protected Information.
“Proceedings” means all legal, civil, criminal, administrative, regulatory, arbitral, mediatory, enforcement, civil penalty, alternative dispute resolution, examination, debarment, seizure or other actions, suits, charges, complaints, subpoenas, prosecutions, assessments, claims, hearings, arbitrations, litigations, mediations, audits, inquiries, investigations, examinations or other similar proceedings, in each case, by or before any Governmental Entity.
“Protected Information” means (a) Personal Data, (b) any information that is governed, regulated or protected by one or more Information Privacy and Security Laws, (c) any information that is covered by the PCI DSS, (d) any proprietary or confidential information and (e) any information, the use or other processing of which is covered by Contract.
“Regulatory Laws” means any applicable supranational, national, federal, state, county, local or foreign antitrust, competition, trade regulation, or foreign investment Laws that are designed or intended to prohibit, restrict or regulate (a) actions having the purpose or effect of monopolization or restraint of trade or lessening competition through merger or acquisition, including the HSR Act, the Sherman Act, the Clayton Act and the Federal Trade Commission Act, in each case, as amended, and other similar antitrust, competition or trade regulation laws of any jurisdiction other than the United States (collectively, “Antitrust Laws”) or (b) investments by entities that are deemed a foreign entity for purposes of any applicable law or regulation.
“Representatives” means, when used with respect to any Person, the directors, officers, employees, consultants, financial advisors, accountants, legal counsel, investment bankers and other agents, advisors and representatives of such Person and its Subsidiaries.
“SEC” means the United States Securities and Exchange Commission.
“Securities Act” means the United States Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
“Software” means any and all (a) computer programs, including any and all software, firmware, and middleware, including all software implementations of algorithms, application programming interfaces (APIs), software development kits (SDKs), connectors, models, embeddings, vector databases and methodologies, whether in Source Code, object code or other form; (b) data, databases, datasets and other compilations or collections of data or information, whether machine readable or otherwise; (c) descriptions, flow-charts and other work product used to design, plan, organize and develop any of the foregoing; and (d) all user documentation, including user manuals and training materials, relating to any of the foregoing.
“Source Code” means Software code, in form other than object code or machine readable form, including related programmer comments and annotations, help text, data and data structures, instructions and procedural, object-oriented and other code, which may be printed out or displayed in human readable form.
“Subsidiary” means, with respect to any Person, any corporation, limited liability company, partnership or other organization, whether incorporated or unincorporated, of which (a) at least a majority of the outstanding shares of
A-63

TABLE OF CONTENTS

capital stock, or other equity interests, having by their terms ordinary voting power to elect a majority of the board of directors or others performing similar functions with respect to such corporation, limited liability company, partnership or other organization is directly or indirectly owned or controlled by such Person or by any one or more of its Subsidiaries, or by such Person and one or more of its Subsidiaries, or (b) with respect to a partnership, such Person or any other Subsidiary of such Person is a general partner or managing member of such partnership.
“Superior Proposal” means a bona fide, unsolicited written Acquisition Proposal (with references in the definition thereof to fifteen percent (15%) and eighty-five percent (85%) being deemed to be replaced with references to eighty percent (80%) and twenty percent (20%), respectively) that was made by a third party, which the Company Board of Directors determines in good faith after consultation with the Company’s outside legal counsel and financial advisors to be more favorable to the Company Stockholders from a financial point of view than the Merger, taking into account all relevant factors (including all the terms and conditions of such proposal or offer (including the transaction consideration, conditionality, timing, certainty of financing and/or regulatory approvals and likelihood of consummation) and this Agreement (and, if applicable, any changes to the terms of this Agreement proposed by Parent pursuant to Section 5.2)).
“Takeover Statute” means any “business combination,” “control share acquisition,” “fair price,” “moratorium” or other takeover or anti-takeover statute or similar Law.
“Tax” or “Taxes” means any and all U.S. federal, state, local and non-U.S. taxes of any kind imposed by any Governmental Entity, including income, franchise, windfall or other profits, gross receipts, property, sales, use, net worth, capital stock, payroll, employment, social security, workers’ compensation, unemployment compensation, excise, withholding, ad valorem, stamp, transfer, value-added, occupation, environmental, customs duty, disability, real property, personal property, registration, alternative or add-on minimum, or estimated tax, including any interest, penalty, additions to tax and any additional amounts imposed with respect thereto, whether disputed or not.
“Tax Return” means any report, return, claim for refund, estimated Tax filing, information return or similar filing filed or required to be filed with any Governmental Entity with respect to Taxes, including any schedule or attachment thereto, and including any amendments or supplements thereof.
“Training Data” means any data, datasets or databases processed or otherwise used to develop, train, fine-tune, evaluate, validate, test or improve an AI System.
“Treasury Regulations” means the U.S. Treasury regulations promulgated under the Code.
Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below:
 
 
 
 
401(k) Termination Date
 
 
Section 6.7(c)
Acquisition Proposal
 
 
Section 8.2(b)(ii)
Adjusted RSU
 
 
Section 2.3(d)
Agreement
 
 
Preamble
Antitrust Laws
 
 
Definition of Regulatory Laws
Base Amount
 
 
Section 6.4(c)
BIS
 
 
Section 3.9(g)
Book-Entry Share
 
 
Section 2.1(a)(i)
Burdensome Condition
 
 
Section 6.2(a)
Cancelled Shares
 
 
Section 2.1(a)(ii)
Certificate
 
 
Section 2.1(a)(i)
Certificate of Merger
 
 
Section 1.4
Change of Recommendation
 
 
Section 5.2(a)
Class A Common Stock
 
 
Section 2.1(a)(i)
Closing
 
 
Section 1.3
Closing Date
 
 
Section 1.3
Company
 
 
Preamble
Company Acquisition Agreement
 
 
Section 5.2(a)
Company Benefit Plan
 
 
Section 3.10(a)
Company Board of Directors
 
 
Recitals
 
 
 
 
A-64

TABLE OF CONTENTS

 
 
 
 
Company Board Recommendation
 
 
Recitals
Company Capitalization Date
 
 
Section 3.2(a)
Company Disclosure Letter
 
 
Article III
Company Lease
 
 
Section 3.16(b)
Company Permits
 
 
Section 3.9(b)
Company Preferred Stock
 
 
Section 3.2(a)
Company Registered Intellectual Property
 
 
Section 3.14(a)
Company SEC Documents
 
 
Section 3.5(a)
Company Stockholder Approval
 
 
Section 3.3(b)
Company Stockholders
 
 
Recitals
Company Stockholders Meeting
 
 
Section 5.3(b)
Company Support Parties
 
 
Recitals
Continuing Employees
 
 
Section 6.7(a)
Converted Shares
 
 
Section 2.1(a)(ii)
Current ESPP Offering Periods
 
 
Section 2.3(g)
DGCL
 
 
Recitals
Dissenting Shares
 
 
Section 2.1(b)
DOJ
 
 
Section 6.2(b)
Effective Time
 
 
Section 1.4
Enforceability Limitations
 
 
Section 3.3(d)
FCPA
 
 
Definition of Anti-Corruption Law
Fraud
 
 
Section 8.2(a)
FTC
 
 
Section 6.2(b)
GAAP
 
 
Section 3.5(b)
HIPAA
 
 
Definition of Information Privacy and Security Laws
Indemnified Parties
 
 
Section 6.4(a)
Intervening Event
 
 
Section 5.2(d)
IP Contracts
 
 
Section 3.14(h)
Leased Real Property
 
 
Section 3.16(b)
Material Contract
 
 
Section 3.17(a)
Material Customer
 
 
Section 3.19(a)
Material Customer Agreement
 
 
Section 3.19(a)
Material Reseller
 
 
Section 3.19(c)
Material Reseller Agreement
 
 
Section 3.19(c)
Material Supplier
 
 
Section 3.19(b)
Material Supplier Agreement
 
 
Section 3.19(b)
Merger
 
 
Recitals
Merger Sub
 
 
Preamble
Minority Investment Entities
 
 
Section 3.2(f)
New Plans
 
 
Section 6.7(b)
NISPOM
 
 
Definition of National Security Laws
Notice Period
 
 
Section 8.2(b)(i)
OFAC
 
 
Section 3.9(e)
Old Plans
 
 
Section 6.7(b)
Outside Date
 
 
Section 8.1(d)
Parent
 
 
Preamble
Parent Disclosure Letter
 
 
Article IV
Parent Notice
 
 
Section 8.2(b)(i)
Parties
 
 
Preamble
Party
 
 
Preamble
Paying Agent
 
 
Section 2.2(a)
 
 
 
 
A-65

TABLE OF CONTENTS

 
 
 
 
Payment Fund
 
 
Section 2.2(a)
Payoff Letter
 
 
Section 6.14
Per Share Merger Consideration
 
 
Section 2.1(a)(i)
person
 
 
Section 5.2(a)
Proxy Statement
 
 
Section 5.3(a)
Qatalyst Partners
 
 
Section 3.22
Regulatory Termination Fee
 
 
Section 8.2(b)(i)
Restricted Parties
 
 
Section 3.9(f)
Sarbanes-Oxley Act
 
 
Section 3.5(a)
Specified Indebtedness
 
 
Section 6.14
Specified Indebtedness Termination
 
 
Section 6.14
Surviving Corporation
 
 
Section 1.1
Surviving Corporation Stock
 
 
Section 2.1(a)(ii)
Termination Fee
 
 
Section 8.2(b)(ii)
Transactions
 
 
Recitals
Voting Agreement
 
 
Recitals
WARN Act
 
 
Section 3.11(b)
willful breach
 
 
Section 8.2(a)
 
 
 
 
A-66

TABLE OF CONTENTS

Form of Voting and Support Agreement
VOTING AND SUPPORT AGREEMENT
This VOTING AND SUPPORT AGREEMENT is entered into as of October 19, 2026 (this “Agreement”), by and among Salesforce, Inc., a Delaware corporation (“Parent”), and each of the persons set forth on Schedule A hereto (each, a “Stockholder” and collectively, the “Stockholders”). Parent and the Stockholders are each sometimes referred to herein as a “Party” and collectively as the “Parties.”
W I T N E S S E T H:
WHEREAS, Parent, Braze, Inc., a Delaware corporation (the “Company”), and Banff Acquisition Sub Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), are entering into an Agreement and Plan of Merger dated as of the date hereof (as it may be amended or supplemented from time to time, the “Merger Agreement”), pursuant to which, among other things, at the Effective Time under the Merger Agreement, Merger Sub will merge with and into the Company (the “Merger”), with the Company being the surviving corporation in the Merger (the “Surviving Corporation”) upon the terms and subject to the conditions set forth in the Merger Agreement and in accordance with the applicable provisions of the General Corporation Law of the State of Delaware (the “DGCL”);
WHEREAS, as of the date hereof, each Stockholder is the record and beneficial owner of such number of shares of each class of capital stock of the Company as set forth opposite such Stockholder’s name on Schedule A hereto (the “Existing Shares”);
WHEREAS, the board of directors of the Company (the “Board”) has (i) unanimously adopted the Merger Agreement and approved the transactions contemplated thereby, including the Merger, and (ii) the Board has taken all action necessary to render inapplicable to the Merger Agreement and transactions contemplated thereby (including, for the avoidance of doubt, this Agreement) Section 203 of the DGCL and any similar provisions in the Company Governing Documents or any other Takeover Statute; and WHEREAS, as a condition to the willingness of Parent and Merger Sub to enter into the Merger Agreement and incur the obligations set forth therein, and as an inducement and in consideration for Parent and Merger Sub to enter into the Merger Agreement, the Stockholders have agreed to enter into this Agreement concurrently with the execution and delivery of the Merger Agreement, pursuant to which, among other things, each Stockholder is agreeing, subject to the terms of this Agreement, to vote all of such Stockholder’s Shares in accordance with the terms of this Agreement.
NOW, THEREFORE, in consideration of the foregoing and the mutual covenants, representations, warranties and agreements contained herein, and intending to be legally bound hereby, the Parties agree as follows:
ARTICLE I
GENERAL
1.1 Definitions. For the purposes of and under this Agreement, the following capitalized terms shall have the respective meanings below. Capitalized terms used but not defined herein shall have the meanings set forth in the Merger Agreement.
(a) “beneficial ownership” by a Person of any securities includes ownership by any Person who, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares (i) voting power, which includes the power to vote, or to direct the voting of, such security, and/or (ii) investment power, which includes the power to dispose, or to direct the disposition, of such security, and shall otherwise be interpreted in accordance with the term “beneficial ownership” as defined in Rule 13d-3 under the Exchange Act and the rules and regulations of the SEC thereunder; provided that for purposes of determining beneficial ownership, a Person shall be deemed to be the beneficial owner of any securities that may be acquired by such Person pursuant to any agreement, arrangement or understanding or upon the exercise of conversion rights, exchange rights, warrants or options, or otherwise (irrespective of whether the right to acquire such securities is exercisable immediately or only after the passage of time, including the passage of time in excess of sixty (60) days, the satisfaction of any conditions, the occurrence of any event or any combination of the foregoing). For purposes of this Agreement, a Person shall be deemed to beneficially own any securities beneficially owned by its Affiliates or any Group of which such Person or any such Affiliate is or becomes a member or is otherwise acting in concert. For the avoidance of doubt, beneficially own and beneficial ownership shall also include record ownership of securities. The terms “beneficially own,” “beneficially owned” and “beneficial owner” shall each have a correlative meaning.
A-67

TABLE OF CONTENTS

(b) “Shares” means, with respect to each Stockholder, (1) such Stockholder’s Existing Shares and (2) any shares of Class A common stock, par value $0.0001 per share, of the Company (the “Class A Common Stock”) or other voting capital stock of the Company and any securities convertible into or exercisable or exchangeable for shares of Class A Common Stock or other voting capital stock of the Company, in each case that such Stockholder, directly or indirectly, has or acquires beneficial ownership of on or after the date hereof.
ARTICLE II
AGREEMENT TO VOTE
2.1 Agreement to Vote.
(a) Each Stockholder hereby irrevocably and unconditionally agrees that during the period beginning on the date hereof and ending on the Termination Date, it shall, at any meeting of the stockholders of the Company (whether annual or special and whether or not an adjourned or postponed meeting, including the Company Stockholders Meeting), however called (the date of the taking of any such action being an applicable “Determination Date”), in each case to the fullest extent that such Stockholder’s Shares are entitled to vote thereon, appear at such meeting or otherwise cause such Stockholder’s Shares to be counted as present thereat for purposes of establishing a quorum; and
(i)
vote, or cause to be voted at such meeting, in person or by proxy, all of such Stockholder’s Shares:
(A)
in favor of the approval and adoption of (1) the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger, and (2) any related proposal in furtherance thereof, including in favor of any proposal to adjourn or postpone to a later date any meeting of the stockholders of the Company at which any of the foregoing matters are submitted for consideration and vote of the stockholders of the Company if there are not sufficient votes for approval of such matters on the date on which the meeting is held; and
(B)
against (1) any Acquisition Proposal or any related action or proposal in furtherance thereof; (2) any action or agreement that is in opposition to the Merger or that would reasonably be expected to result in a breach of any covenant, representation or warranty of the Company or any of its Subsidiaries contained in the Merger Agreement, or of the Stockholder contained in this Agreement; and (3) any other action that would reasonably be expected to impede, interfere with, delay, postpone, frustrate the purposes of, or adversely affect the transactions contemplated by the Merger Agreement, including the Merger, or this Agreement or the performance by the Company of its obligations under the Merger Agreement.
(b) The obligations of each Stockholder in this Section 2.1 shall apply whether or not the Merger or any action above is recommended by the Board (or any committee thereof).
(c) Any vote required to be cast pursuant to this Section 2.1 shall be cast or executed in accordance with the applicable procedures relating thereto so as to ensure that it is duly counted for purposes of recording the results of that vote. Any attempt by a Stockholder to vote, consent or express dissent with respect to (or otherwise to utilize the voting power of) such Stockholder’s Shares in contravention of this Section 2.1 shall be null and void ab initio. If a Stockholder is the beneficial owner, but not the holder of record, of any Shares, such Stockholder agrees to take all actions necessary to cause the holder of record and any nominees to vote all of such Shares in accordance with this Section 2.1. To the extent a Stockholder does not fully control the determinations of such stockholder entity, such Stockholder agrees to exercise all voting or other rights it has in such entity to carry out the intent and purposes of the support and voting obligations in this Section 2.1 or otherwise set forth in this Agreement. For the avoidance of doubt, the foregoing commitments apply to any Shares held by any trust, limited partnership or other entity holding Shares over which the applicable Stockholder exercises direct or indirect voting control.
(d) Nothing in this Agreement shall obligate any Stockholder to exercise any option or any other right to acquire any shares of Class A Common Stock.
ARTICLE III
ADDITIONAL AGREEMENTS
3.1 Waiver of Appraisal Rights and Certain Other Actions; Litigation. To the fullest extent permitted by Law, each Stockholder hereby irrevocably and unconditionally waives, and agrees not to exercise, any rights of appraisal (including under Section 262 of the DGCL), any dissenters’ rights and any similar rights relating to the Merger that such
A-68

TABLE OF CONTENTS

Stockholder may have, directly or indirectly, by virtue of the ownership of any Shares, or may acquire in connection with the Merger. Each Stockholder further agrees not to commence, join in, facilitate, assist or knowingly encourage, and agrees to take all actions necessary to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against Parent, Merger Sub or the Company or any of their respective affiliates and each of their successors, directors, managers or officers relating to the negotiation, execution or delivery of this Agreement or the Merger Agreement or the consummation of the transactions contemplated hereby or thereby, including any claim (a) challenging the validity of, or seeking to enjoin or delay the operation of, any provision of this Agreement or the Merger Agreement (including any claim seeking to enjoy or delay the closing of the Merger) or (b) alleging a breach of any duty of the Board or any Stockholder in connection with this Agreement, the Merger Agreement or the transactions contemplated hereby or thereby, and hereby irrevocably waives any claim or rights whatsoever with respect to any of the foregoing.
3.2 No Inconsistent Arrangements; No Transfer.
(a) Each Stockholder represents, covenants and agrees that, except for this Agreement, such Stockholder (i) has not entered into, and shall not enter into at any time prior to the Termination Date, any voting agreement, voting trust or similar arrangement or understanding with respect to such Stockholder’s Shares, (ii) has not granted, and shall not grant at any time prior to the Termination Date, a proxy, consent or power of attorney with respect to such Stockholder’s Shares, (iii) has not taken, and shall not take at any time while this Agreement remains in effect, any action that would, or would reasonably be expected to, (A) make any representation or warranty of such Stockholder contained herein untrue or incorrect, (B) violate or conflict with such Stockholder’s covenants and obligations under this Agreement, (C) otherwise have the effect of preventing, impairing or materially delaying such Stockholder from performing any of its obligations under this Agreement or (D) have the effect of preventing, impairing or materially delaying the Merger or the other transactions contemplated by the Merger Agreement or the performance by the Company of its obligations under the Merger Agreement.
(b) Except as provided hereunder, from and after the date hereof and until the Termination Date, each Stockholder shall not, directly or indirectly: (i) create or permit to exist any Encumbrances, other than Permitted Encumbrances, on such Stockholder’s Shares; (ii) transfer, sell, short sell, assign, tender, exchange, encumber, gift, hedge, distribute, pledge or otherwise dispose of (by merger, by testamentary disposition, by operation of Law or otherwise), or grant a proxy with respect to, such Stockholder’s Shares, beneficial ownership thereof or any other interest therein, or enter into any derivative arrangement (collectively, “Transfer”) with respect to such Stockholder’s Shares, or any right or interest therein (or offer to do or consent to any of the foregoing); (iii) enter into or acquire any Contract with respect to such Stockholder’s Shares or any legal or beneficial interest therein, including any derivative contract, any futures or forward contract to deliver such Stockholder’s Shares or any other hedging or other derivative, swap, “put-call,” margin, securities lending or other transaction that has or reasonably would be expected to have the effect of changing, limiting, arbitraging or reallocating the economic benefits and risks of ownership of such Stockholder’s Shares; (iv) grant or permit the grant of any proxy, power-of-attorney or other authorization or consent in or with respect to such Stockholder’s Shares; or (v) deposit or permit the deposit of such Stockholder’s Shares into a voting trust or enter into a voting agreement or arrangement with respect to such Stockholder’s Shares. Any action taken in violation of the immediately preceding sentence shall be null and void ab initio. Notwithstanding the foregoing, each Stockholder may Transfer such Stockholder’s Shares (A) in connection with the payment of the exercise price and/or the satisfaction of any tax withholding obligations arising from the exercise, vesting and/or settlement of any Company Option, Company RSU or Company PSU, (B) pursuant to a Rule 10b5-1 trading plan in effect as of the date hereof, or (C) if such Stockholder is the Chief Executive Officer of the Company as of the date hereof, (1) in sales or transfers of up to 210,530 Shares in the aggregate and (2) in transfers of up to 210,530 Shares in the aggregate to a charitable remainder trust (any such Transfer or any Transfer with Parent’s prior written consent, a “Permitted Transfer”), provided that any Transfer of Shares pursuant to clauses (A), (B) and (C), in the aggregate (taking into account all Transfers of Shares pursuant to this clause by any Stockholder from and after the date of this Agreement), will not, and would not reasonably be expected to, exceed one and one-half percent (1.5%) of the total voting power of the outstanding shares of Class A Common Stock as of immediately prior to the applicable Determination Date. If any involuntary Transfer of such Stockholder’s Shares in the Company shall occur (including, but not limited to, a sale by any Stockholder’s trustee in any bankruptcy, or a sale to a purchaser at any creditor’s or court sale), the transferee (including any transferees and subsequent transferees of the initial transferee) shall take and hold such Shares subject to all of the terms of this Agreement applicable to the initial Stockholder of such Shares.
A-69

TABLE OF CONTENTS

3.3 Adjustments. In the event of any stock split (including a reverse stock split), stock dividend, merger, reorganization, recapitalization, reclassification, combination, exchange of shares or the like of the capital stock of the Company affecting such Stockholder’s Shares, the terms of this Agreement shall apply to the resulting securities.
3.4 No Shop Obligations of the Stockholders.
(a) Subject to Section 5.14 and from the date hereof until the Termination Date, each Stockholder shall not, and shall cause its affiliates and its and their respective Representatives not to, directly or indirectly, (i) solicit, initiate or knowingly encourage or facilitate (including by way of providing information or taking any other action) any inquiry, proposal or offer, or the making, submission or announcement of any inquiry, proposal or offer which constitutes or would reasonably be expected to lead to an Acquisition Proposal, (ii) participate in any negotiations regarding, or furnish to any person any information relating to, the Company or any Company Subsidiary in connection with an actual or potential Acquisition Proposal, (iii) otherwise cooperate with or assist or participate in, or facilitate, any such inquiries, proposals, offers, discussions or negotiations, (iv) encourage or recommend any other holder of Class A Common Stock to not adopt the Merger Agreement or approve the transactions contemplated by the Merger Agreement, including the Merger, (v) support, recommend, endorse, authorize or approve, or propose to support, recommend, endorse, authorize or approve, any Acquisition Proposal or enter into any Company Acquisition Agreement or (vi) resolve or agree to do any of the foregoing. Each Stockholder shall, and shall cause its affiliates and its and their respective Representatives to, immediately cease any and all solicitation, encouragement, discussion or negotiation with any Person or groups or provision of any information to any persons (other than Parent, its Subsidiaries, and their respective Representatives acting on their behalf) with respect to any inquiry, proposal or offer that constitutes, or would reasonably be expected to lead to, an Acquisition Proposal. Notwithstanding the foregoing, each Stockholder, its affiliates and its and their respective Representatives may engage in such activities to the extent that the Company is permitted to engage in such activities pursuant to the terms of the Merger Agreement, but only if such Stockholder and its affiliates and its and their respective Representatives each comply with the terms of the Merger Agreement as if it were the Company.
(b) From and after the date hereof until the Effective Time, each Stockholder shall promptly (and in any event within twenty-four (24) hours) (i) notify Parent of (A) any Acquisition Proposal it receives in its capacity as a stockholder of the Company, (B) any proposals or inquiries it receives in its capacity as a stockholder of the Company that would reasonably be expected to lead to an Acquisition Proposal and (C) any inquiry or request it receives in its capacity as a stockholder of the Company for information relating to the Company or any Company Subsidiary by any person who has made or would reasonably be expected to make any Acquisition Proposal, (ii) if such Acquisition Proposal, request or inquiry is in writing, deliver to Parent a copy of such Acquisition Proposal, request or inquiry and any related draft agreements and other written materials setting forth the terms and conditions of such Acquisition Proposal, request or inquiry, and (iii) if such Acquisition Proposal, request or inquiry is oral, provide to Parent a reasonably detailed summary thereof. Such notice shall indicate the identity of the Person making such Acquisition Proposal, inquiry, proposal or request. Without limiting any Stockholder’s other obligations hereunder, each Stockholder shall keep Parent reasonably informed on a prompt and timely basis of the status and material details of any such Acquisition Proposal and with respect to any material change to the terms of any such Acquisition Proposal within twenty-four (24) hours of any such material change.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES
4.1 Representations and Warranties of Each Stockholder. Each Stockholder hereby represents and warrants to Parent, as to such Stockholder with respect to his, her or its own account and with respect to its Shares, on a several basis, that:
(a) Authorization; Binding Agreement If such Stockholder is not an individual, such Stockholder is duly organized and validly existing in good standing (where such concept is recognized) under the Laws of the jurisdiction in which it is incorporated or constituted and the consummation of the transactions contemplated hereby are within such Stockholder’s entity powers and have been duly authorized by all necessary entity actions on the part of such Stockholder, and such Stockholder has all requisite entity power and authority to execute, deliver and perform this Agreement and to consummate the transactions contemplated hereby. If such Stockholder is an individual, such Stockholder has all requisite legal capacity, right and authority to execute and deliver this Agreement and to perform such Stockholder’s obligations hereunder. This Agreement has been duly and validly executed and delivered by such Stockholder and, assuming the due authorization, execution and delivery by Parent constitutes a legal, valid and binding obligation of such Stockholder, enforceable against such Stockholder in accordance with its terms, subject to the Enforceability Limitations. If such Stockholder is an individual and is
A-70

TABLE OF CONTENTS

married, and such Stockholder’s Shares constitute community property or otherwise need spousal or other approval for this Agreement to be legal, valid and binding, this Agreement has been duly and validly executed and delivered by such Stockholder’s spouse and, assuming the due authorization, execution and delivery by Parent, constitutes a legal, valid and binding obligation of such Stockholder’s spouse, enforceable against such Stockholder’s spouse in accordance with its terms, subject to the Enforceability Limitations.
(b) Non-Contravention. Neither the execution and delivery of this Agreement by such Stockholder (and if applicable, such Stockholder’s spouse) nor the consummation of the transactions contemplated hereby nor compliance by such Stockholder (and if applicable, such Stockholder’s spouse) with any provisions herein will (a) violate, contravene or conflict with or result in any breach of any provision of the certificate of incorporation or bylaws (or other similar governing documents) of such Stockholder, (b) require any consent, approval, authorization or permit of, or filing with or notification to, any Governmental Entity on the part of such Stockholder (and if applicable, such Stockholder’s spouse), except for compliance with the applicable requirements of the Securities Act, the Exchange Act or any other United States or federal securities laws and the rules and regulations promulgated thereunder, (c) violate, conflict with, or result in a breach of any provisions of, or require any consent, waiver or approval or result in a default or loss of a benefit (or give rise to any right of termination, cancellation, modification or acceleration or any event that, with the giving of notice, the passage of time or otherwise, would constitute a default or give rise to any such right) under any of the terms, conditions or provisions of any Contract to which such Stockholder (and if applicable, such Stockholder’s spouse) is a party or by which such Stockholder (and if applicable, such Stockholder’s spouse) or such Stockholder’s Shares may be bound, (d) result (or, with the giving of notice, the passage of time or otherwise, would result) in the creation or imposition of any Lien (other than Permitted Liens) on any asset of such Stockholder (and if applicable, such Stockholder’s spouse) (other than one created by Parent or Merger Sub) or (e) violate any Law applicable to such Stockholder (and if applicable, such Stockholder’s spouse) or by which such Stockholder’s Shares are bound, except, in the case of each of clauses (c), (d) and (e), as would not reasonably be expected to prevent or materially delay or impair the consummation by such Stockholder of the transactions contemplated by this Agreement or otherwise materially impair such Stockholder’s ability to perform its obligations hereunder.
(c) Ownership of Shares; Total Shares. Such Stockholder is the record and beneficial owner of all of the Existing Shares and has good and marketable title to all of the Existing Shares free and clear of any Liens, claims, proxies, voting trusts or agreements, options, rights, understandings or arrangements or any other encumbrances or restrictions whatsoever on title, transfer or exercise of any rights of a stockholder in respect of such Existing Shares (collectively, “Encumbrances”), except for any such Encumbrance that may be imposed pursuant to (i) this Agreement, (ii) any applicable restrictions on transfer under the Securities Act or any state securities law, (iii) the Company Governing Documents, and (iv) any applicable Company Equity Plan or agreements evidencing grants thereunder ((i) through (iv), collectively, “Permitted Encumbrances”).
(d) The Existing Shares listed on Schedule A opposite such Stockholder’s name constitute all of the shares of Class A Common Stock, Company Options, Company RSUs and Company PSUs, and any other securities of the Company beneficially owned by such Stockholder as of the date hereof.
(e) Voting Power. Such Stockholder has full voting power with respect to all of such Stockholder’s Shares (to the extent such Shares have voting rights), and full power of disposition with respect to such Shares to the extent they consist of vested shares of Class A Common Stock, full power to issue instructions with respect to the matters set forth herein and full power to agree to all of the matters set forth in this Agreement, in each case with respect to all of such Stockholder’s Shares.
(f) Absence of Other Voting Agreements. (i) None of such Stockholder’s Shares is or will be subject to any voting trust, proxy or other agreement, arrangement or restriction with respect to the voting of such Shares, in each case, that is inconsistent with this Agreement and (ii) none of such Stockholder’s Shares is subject to any pledge agreement pursuant to which such Stockholder does not retain sole and exclusive voting rights with respect to such Shares subject to such pledge agreement at least until the occurrence of an event of default under the related debt instrument.
(g) Absence of Litigation. With respect to such Stockholder, as of the date hereof, there is no Proceeding pending against (i) such Stockholder, or, to the knowledge of such Stockholder, threatened against such
A-71

TABLE OF CONTENTS

Stockholder or its affiliates or (ii) any of such Stockholder’s properties or assets (including any of such Stockholder’s Shares), in each case, that would reasonably be expected to restrict, prevent, materially delay or impair the performance by such Stockholder of its obligations under this Agreement.
(h) Reliance by Parent and Merger Sub. Such Stockholder understands and acknowledges that Parent and Merger Sub are entering into the Merger Agreement in reliance upon such Stockholder’s execution and delivery of this Agreement and the representations and warranties of such Stockholder contained herein. Such Stockholder understands and acknowledges that the Merger Agreement governs the terms of the Merger and the other transactions contemplated thereby.
4.2 Representations and Warranties of Parent. Parent hereby represents and warrants to each Stockholder as follows:
(a) Organization and Qualification. Parent is a duly organized and validly existing corporation in good standing under the Laws of the jurisdiction of its organization. All of the issued and outstanding capital stock of Merger Sub is owned directly or indirectly by Parent.
(b) Authority for this Agreement. Parent has all requisite entity power and authority to execute, deliver and perform its obligations under this Agreement and to consummate the transactions contemplated hereby. The execution and delivery of this Agreement by Parent have been duly and validly authorized by all necessary entity action on the part of Parent, and no other entity proceedings on the part of Parent are necessary to authorize this Agreement. This Agreement has been duly and validly executed and delivered by Parent and, assuming the due authorization, execution and delivery by each Stockholder, constitutes a legal, valid and binding obligation of Parent, enforceable against Parent in accordance with its terms, subject to the Enforceability Limitations.
ARTICLE V
MISCELLANEOUS
5.1 Notices. All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally (notice deemed given upon receipt), by electronic mail (notice deemed given upon transmission so long as there is no return error message or other notification of non-delivery received by the sender; provided that electronic mail received after 6:00 p.m., Pacific Time, shall be deemed received on the next day) or sent by a nationally recognized overnight courier service or express delivery service (notice deemed given upon receipt of proof of delivery), to the Parties at the following addresses (or at such other address for a Party as shall be specified by like notice):
 
 
 
 
 
 
 
if to Parent or Merger Sub, to:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Salesforce, Inc.
 
 
 
 
 
 
415 Mission Street, 3rd Fl
 
 
 
 
 
 
San Francisco, California 94105
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
Chief Legal Officer
 
 
 
 
 
 
 
 
 
 
 
 
 
with a copy to:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Wachtell, Lipton, Rosen & Katz
 
 
 
 
 
 
51 West 52nd Street
 
 
 
 
 
 
New York, New York 10019
 
 
 
 
 
 
Email:
 
 
ajnussbaum@wlrk.com
 
 
 
 
 
 
 
 
 
mlu@wlrk.com
 
 
 
 
 
 
Attention:
 
 
Andrew J. Nussbaum
 
 
 
 
 
 
 
 
 
Meng Lu
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A-72

TABLE OF CONTENTS

 
 
 
 
 
 
 
if to a Stockholder, to such Stockholder’s address or email address set forth below:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
William Magnuson
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
William Magnuson
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scintillating Holdings LLC
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
William Magnuson
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Jonathan Hyman
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
Jonathan Hyman
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hyman 2026 Charitable Remainder Trust
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
Jonathan Hyman
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hyman 2021 GST Descendants Trust
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
Kate Hyman
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hyman 2021 GST Family Trust
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
Lauren Meyer
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Neeraj Agrawal
 
 
 
 
 
 
c/o Battery Ventures One
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
Neeraj Agrawal
 
 
 
 
 
 
 
 
 
 
 
 
 
with a copy to:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Davis Polk & Wardwell LLP
 
 
 
 
 
 
900 Middlefield Road
 
 
 
 
 
 
Redwood City, California 94063
 
 
 
 
 
 
Email:
 
 
paul.scrivano@davispolk.com
 
 
 
 
 
 
 
 
 
cheryl.chan@davispolk.com
 
 
 
 
 
 
Attention:
 
 
Paul S. Scrivano
 
 
 
 
 
 
 
 
 
Cheryl Chan
 
 
 
 
 
 
 
 
 
 
A-73

TABLE OF CONTENTS

5.2 Termination. This Agreement shall terminate automatically with respect to a Stockholder and Parent, without any notice or other action by any Person, upon the earliest to occur of (a) the valid termination of the Merger Agreement in accordance with its terms, (b) the Effective Time, (c) the entry without the prior written consent of such Stockholder into any amendment, waiver or modification to the Merger Agreement that results in a decrease in the Merger Consideration or changes the mix of Merger Consideration or (d) the delivery of written notice by Parent to such Stockholder of termination of this Agreement, and upon the occurrence of the earliest of such events this Agreement shall terminate and be of no further force (the date of termination, the “Termination Date”). Upon termination of this Agreement with respect to a Stockholder and Parent, neither such Stockholder nor Parent shall have any further obligations or liabilities under this Agreement; provided, however, that (i) nothing set forth in this Section 5.2 shall relieve any Party from liability for any breach of this Agreement prior to termination hereof or relieve or otherwise limit the liability of any Party for Fraud or any willful breach (as defined in the Merger Agreement) of this Agreement prior to termination hereof, and (ii) the provisions of this Article V shall survive any termination of this Agreement.
5.3 Amendments and Waivers.
(a) Subject to applicable Law and except as otherwise provided in this Agreement, this Agreement may be amended, modified and supplemented by written agreement of each of the Parties.
(b) At any time and from time to time prior to the Effective Time, each Party may, to the extent legally allowed and except as otherwise set forth herein, (i) extend the time for the performance of any of the obligations or other acts of the other Party, as applicable, (ii) waive any inaccuracies in the representations and warranties made by the other Party contained herein or in any document delivered pursuant hereto and (iii) waive compliance with any of the agreements or conditions for their respective benefit contained herein. Any agreement on the part of Parent or any Stockholder to any such extension or waiver shall be valid only if set forth in an instrument in writing signed on behalf of Parent or such Stockholder, as applicable. No failure or delay by Parent or a Stockholder in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise of any other right hereunder.
5.4 Entire Agreement; Third-Party Beneficiaries. This Agreement and the other documents and certificates delivered pursuant hereto constitute the entire agreement, and supersede all prior agreements and understandings, both written and oral, among the Parties with respect to the subject matter of this Agreement. Nothing in this Agreement, express or implied, is intended to confer upon any Person other than the Parties any rights or remedies hereunder or thereunder.
5.5 Enforcement; Remedies. The Parties agree that irreparable damage would occur and that the Parent and Merger Sub would not have any adequate remedy at law in the event that any Stockholder did not perform any of the provisions of this Agreement in accordance with their specific terms or otherwise breached any such provisions. It is accordingly agreed that Parent and Merger Sub shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in addition to any other remedy to which they are entitled at law or in equity. Any and all remedies herein expressly conferred upon Parent and Merger Sub will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by Law or equity upon Parent or Merger Sub, and the exercise by Parent or Merger Sub of any one remedy will not preclude the exercise of any other remedy.
5.6 Governing Law; Jurisdiction.
(a) This Agreement and any disputes relating to or arising out of this Agreement and the transactions contemplated hereby (whether based in contract, tort or otherwise) shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to conflicts of laws principles that would result in the application of the Law of any other state.
(b) Each of the Parties hereto hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of the Court of Chancery of the State of Delaware, or, if (and only if) such court finds it lacks jurisdiction, the Federal court of the United States of America sitting in Delaware, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Agreement and the rights and obligations hereunder or the agreements delivered in connection herewith or the transactions contemplated hereby or thereby or for recognition or enforcement of any judgment relating thereto, and each of the Parties hereby irrevocably and unconditionally (i) agrees not to commence any such action or proceeding, except in the Court of Chancery of the State of Delaware, or, if (and only if) such court finds it lacks jurisdiction, the Federal court of the
A-74

TABLE OF CONTENTS

United States of America sitting in Delaware, and any appellate court from any thereof; (ii) agrees that any claim in respect of any such action or proceeding may be heard and determined in the Court of Chancery of the State of Delaware, or, if (and only if) such court finds it lacks jurisdiction, the Federal court of the United States of America sitting in Delaware, and any appellate court from any thereof; (iii) waives, to the fullest extent it may legally and effectively do so, any objection that it may now or hereafter have to the laying of venue of any such action or proceeding in such courts; and (iv) waives, to the fullest extent permitted by Law, the defense of an inconvenient forum to the maintenance of such action or proceeding in such courts. Each of the Parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Law. Each Party to this Agreement irrevocably consents to service of process inside or outside the territorial jurisdiction of the courts referred to in this Section 5.6(b) in the manner provided for notices in Section 5.1. Nothing in this Agreement will affect the right of any Party to this Agreement to serve process in any other manner permitted by applicable Law.
5.7 Waiver of Jury Trial.
(a) EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR MERGER OR THE OTHER TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH PARTY HERETO CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE SUCH WAIVERS, (B) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVERS, (C) IT MAKES SUCH WAIVERS VOLUNTARILY AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 5.7.
5.8 Assignment This Agreement shall not be assigned by any Party (including by operation of law, by merger or otherwise) without the prior written consent of (a) Parent, in the case of an assignment by a Stockholder and (b) each Stockholder, in the case of an assignment by Parent; provided that Parent may assign any of its respective rights and obligations to any direct or indirect Subsidiary of Parent, but no such assignment shall relieve Parent of its obligations hereunder. Subject to the preceding sentence, but without relieving any Party of any obligation hereunder, this Agreement will be binding upon, inure to the benefit of and be enforceable by the Parties and their respective successors and assigns.
5.9 Descriptive Headings. The table of contents and headings set forth in this Agreement or any schedule delivered pursuant to this Agreement are for convenience of reference purposes only and shall not affect or be deemed to affect in any way the meaning or interpretation of this Agreement or such schedule or any term or provision hereof or thereof.
5.10 Severability. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by rule of Law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible in an acceptable manner.
5.11 Counterparts. This Agreement may be executed manually or by other electronic transmission by the Parties, in any number of counterparts, each of which shall be considered one and the same agreement and shall become effective when a counterpart hereof shall have been signed by each of the Parties and delivered to the other Parties. The exchange of a fully executed Agreement (in counterparts or otherwise) by electronic transmission in .pdf or DocuSign format shall be sufficient to bind the Parties to the terms and conditions of this Agreement.
5.12 Interpretation. When a reference is made in this Agreement to sections, such reference shall be to a section of this Agreement, unless otherwise indicated. Whenever the words “include,” “includes” or “including” are used in this Agreement they shall be deemed to be followed by the words “without limitation.” As used in this Agreement, the term “affiliates” shall have the meaning set forth in Rule 12b-2 of the Exchange Act. The word “extent” and the phrase “to the extent” when used in this Agreement shall mean the degree to which a subject or other things extends, and such word or phrase shall not merely mean “if.” The term “or” is not exclusive, and shall be interpreted as “and/or.” The phrases “the date of this Agreement,” “the date hereof,” “of even date herewith” and terms of similar import, shall be
A-75

TABLE OF CONTENTS

deemed to refer to the date set forth in the preamble to this Agreement. All references herein to a Subsidiary of a Party shall be deemed to include all direct and indirect Subsidiaries of such Party, unless otherwise indicated or the context otherwise requires. A reference to any specific Law or to any provision of any Law, whether or not followed by the phrase “as amended,” includes any amendment to, and any modification, re-enactment or successor thereof, any legislative provision substituted therefor and all rules, regulations and statutory instruments issued thereunder or pursuant thereto, except that, for purposes of any representations and warranties in this Agreement that are made as a specific date, references to any specific Law will be deemed to refer to such legislation or provision (and all rules, regulations and statutory instruments issued thereunder or pursuant thereto) as of such date. The Parties agree that they have been represented by counsel during the negotiation and execution of this Agreement and, therefore, waive the application of any Law, regulation, holding or rule of construction providing that ambiguities in an agreement or other document will be construed against the Party drafting such agreement or document.
5.13 Publicity; Documentation and Information. Each Stockholder agrees that it shall not make any public announcement regarding this Agreement or the transactions contemplated hereby without the prior written consent of Parent, except as may be required by applicable Law (provided that reasonable notice of any such disclosure will be provided to Parent, and such Stockholder will consider in good faith the reasonable comments of Parent with respect to such disclosure and otherwise cooperate with Parent in obtaining confidential treatment with respect to such disclosure). Each Stockholder consents to and hereby authorizes Parent, Merger Sub and the Company to publish and disclose in all documents and schedules filed with the SEC or any other Governmental Entity or applicable securities exchange, and any press release or other disclosure document that Parent or Merger Sub reasonably determines to be necessary or advisable in connection with the Merger or any other transactions contemplated by the Merger Agreement or this Agreement, including, without limitation, any definitive proxy statement (and any amendments or supplements thereto), such Stockholder’s identity and ownership of such Stockholder’s Shares, the existence of this Agreement and the nature of such Stockholder’s commitments and obligations under this Agreement, and each Stockholder acknowledges that Parent, Merger Sub or the Company may, in Parent’s or the Company’s sole discretion, as applicable, file this Agreement or a form hereof with the SEC or any other Governmental Entity or securities exchange.
5.14 Capacity as Stockholder. Each Stockholder signs this Agreement in such Stockholder’s capacity as a stockholder of the Company, and not, if applicable, in such Stockholder’s capacity as a director, officer or employee of the Company. Notwithstanding anything herein to the contrary, nothing in this Agreement shall in any way restrict a director or officer of the Company in the taking of any actions (or the failure to take any actions) in his or her capacity as a director or officer of the Company, or in the exercise of his or her fiduciary duties in his or her capacity as a director or officer of the Company, or prevent, or be construed to create any obligation on the part of, any director or officer of the Company from taking any action in his or her capacity as such director or officer.
5.15 Expenses. All costs and expenses incurred in connection with this Agreement shall be paid by the Party incurring such costs or expenses.
5.16 Further Assurances. Each Stockholder will execute and deliver, or cause to be executed and delivered, all further documents and instruments and use its reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable Law, to perform its obligations under this Agreement.
5.17 Stockholder Obligation Several and Not Joint. The obligations of each Stockholder hereunder shall be several and not joint, and no Stockholder shall be liable for any breach of the terms of this Agreement by any other Stockholder.
[Signature Page Follows]
A-76

TABLE OF CONTENTS

IN WITNESS WHEREOF, the Parties, intending to be legally bound hereby, have executed or caused this Agreement to be executed in counterparts, all as of the day and year first above written.
 
 
 
 
 
 
 
SALESFORCE, INC.
 
 
 
 
 
 
 
 
 
 
By:
 
 
 
 
 
 
Name:
 
 
 
 
 
 
Title:
 
 
 
 
 
 
 
 
 
 
[Signature Page to Voting and Support Agreement]
A-77

TABLE OF CONTENTS

 
 
 
 
 
 
 
STOCKHOLDERS:
 
 
 
 
 
 
 
 
 
 
By:
 
 
 
 
 
 
Name:
 
 
 
 
 
 
 
 
 
 
 
 
 
By:
 
 
 
 
 
 
Spouse (if applicable):
 
 
 
 
[Signature Page to Voting and Support Agreement]
A-78

TABLE OF CONTENTS

SCHEDULE A
 
EXISTING SHARES
 
 
 
 
 
 
 
 
 
 
 
 
 
Name of Stockholder
 
 
Number of
Shares of
Class A
Common
Stock
 
 
Company
Options
 
 
Company
RSUs
 
 
Company
PSUs
William Magnuson
 
 
4,258,551
 
 
1,251,658
 
 
585,809
 
 
125,944
Scintillating Holdings LLC
 
 
470
 
 
 
 
 
 
 
 
 
Jonathan Hyman
 
 
946,035
 
 
325,213
 
 
187,184
 
 
38,412
Hyman 2026 Charitable Remainder Trust
 
 
350,000
 
 
 
 
 
 
 
 
 
Hyman 2021 GST Descendants Trust
 
 
221,436
 
 
 
 
 
 
 
 
 
Hyman 2021 GST Family Trust
 
 
28,564
 
 
 
 
 
 
 
 
 
Neeraj Agrawal
 
 
194,769
 
 
 
 
 
7,753
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A-79

TABLE OF CONTENTS

Annex B
EXECUTION VERSION
VOTING AND SUPPORT AGREEMENT
This VOTING AND SUPPORT AGREEMENT is entered into as of October 19, 2026 (this “Agreement”), by and among Salesforce, Inc., a Delaware corporation (“Parent”), and each of the persons set forth on Schedule A hereto (each, a “Stockholder” and collectively, the “Stockholders”). Parent and the Stockholders are each sometimes referred to herein as a “Party” and collectively as the “Parties.”
W I T N E S S E T H:
WHEREAS, Parent, Braze, Inc., a Delaware corporation (the “Company”), and Banff Acquisition Sub Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), are entering into an Agreement and Plan of Merger dated as of the date hereof (as it may be amended or supplemented from time to time, the “Merger Agreement”), pursuant to which, among other things, at the Effective Time under the Merger Agreement, Merger Sub will merge with and into the Company (the “Merger”), with the Company being the surviving corporation in the Merger (the “Surviving Corporation”) upon the terms and subject to the conditions set forth in the Merger Agreement and in accordance with the applicable provisions of the General Corporation Law of the State of Delaware (the “DGCL”);
WHEREAS, as of the date hereof, each Stockholder is the record and beneficial owner of such number of shares of each class of capital stock of the Company as set forth opposite such Stockholder’s name on Schedule A hereto (the “Existing Shares”);
WHEREAS, the board of directors of the Company (the “Board”) has (i) unanimously adopted the Merger Agreement and approved the transactions contemplated thereby, including the Merger, and (ii) the Board has taken all action necessary to render inapplicable to the Merger Agreement and transactions contemplated thereby (including, for the avoidance of doubt, this Agreement) Section 203 of the DGCL and any similar provisions in the Company Governing Documents or any other Takeover Statute; and
WHEREAS, as a condition to the willingness of Parent and Merger Sub to enter into the Merger Agreement and incur the obligations set forth therein, and as an inducement and in consideration for Parent and Merger Sub to enter into the Merger Agreement, the Stockholders have agreed to enter into this Agreement concurrently with the execution and delivery of the Merger Agreement, pursuant to which, among other things, each Stockholder is agreeing, subject to the terms of this Agreement, to vote all of such Stockholder’s Shares in accordance with the terms of this Agreement.
NOW, THEREFORE, in consideration of the foregoing and the mutual covenants, representations, warranties and agreements contained herein, and intending to be legally bound hereby, the Parties agree as follows:
ARTICLE I
GENERAL
1.1 Definitions. For the purposes of and under this Agreement, the following capitalized terms shall have the respective meanings below. Capitalized terms used but not defined herein shall have the meanings set forth in the Merger Agreement.
(a) “beneficial ownership” by a Person of any securities includes ownership by any Person who, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares (i) voting power, which includes the power to vote, or to direct the voting of, such security, and/or (ii) investment power, which includes the power to dispose, or to direct the disposition, of such security, and shall otherwise be interpreted in accordance with the term “beneficial ownership” as defined in Rule 13d-3 under the Exchange Act and the rules and regulations of the SEC thereunder; provided that for purposes of determining beneficial ownership, a Person shall be deemed to be the beneficial owner of any securities that may be acquired by such Person pursuant to any agreement, arrangement or understanding or upon the exercise of conversion rights, exchange rights, warrants or options, or otherwise (irrespective of whether the right to acquire such securities is exercisable immediately or only after the passage of time, including the passage of time in excess of sixty (60) days, the satisfaction of any conditions, the occurrence of any event or any combination of the foregoing). For purposes of this Agreement, a Person shall be deemed to beneficially own any securities beneficially owned by its Affiliates or any Group of
B-1

TABLE OF CONTENTS

which such Person or any such Affiliate is or becomes a member or is otherwise acting in concert. For the avoidance of doubt, beneficially own and beneficial ownership shall also include record ownership of securities. The terms “beneficially own,” “beneficially owned” and “beneficial owner” shall each have a correlative meaning.
(b) “Shares” means, with respect to each Stockholder, (1) such Stockholder’s Existing Shares and (2) any shares of Class A common stock, par value $0.0001 per share, of the Company (the “Class A Common Stock”) or other voting capital stock of the Company and any securities convertible into or exercisable or exchangeable for shares of Class A Common Stock or other voting capital stock of the Company, in each case that such Stockholder, directly or indirectly, has or acquires beneficial ownership of on or after the date hereof.
ARTICLE II
AGREEMENT TO VOTE
2.1 Agreement to Vote.
(a) Each Stockholder hereby irrevocably and unconditionally agrees that during the period beginning on the date hereof and ending on the Termination Date, it shall, at any meeting of the stockholders of the Company (whether annual or special and whether or not an adjourned or postponed meeting, including the Company Stockholders Meeting), however called (the date of the taking of any such action being an applicable “Determination Date”), in each case to the fullest extent that such Stockholder’s Shares are entitled to vote thereon, appear at such meeting or otherwise cause such Stockholder’s Shares to be counted as present thereat for purposes of establishing a quorum; and
(i)
vote, or cause to be voted at such meeting, in person or by proxy, all of such Stockholder’s Shares:
(A)
in favor of the approval and adoption of (1) the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger, and (2) any related proposal in furtherance thereof, including in favor of any proposal to adjourn or postpone to a later date any meeting of the stockholders of the Company at which any of the foregoing matters are submitted for consideration and vote of the stockholders of the Company if there are not sufficient votes for approval of such matters on the date on which the meeting is held; and
(B)
against (1) any Acquisition Proposal or any related action or proposal in furtherance thereof; (2) any action or agreement that is in opposition to the Merger or that would reasonably be expected to result in a breach of any covenant, representation or warranty of the Company or any of its Subsidiaries contained in the Merger Agreement, or of the Stockholder contained in this Agreement; and (3) any other action that would reasonably be expected to impede, interfere with, delay, postpone, frustrate the purposes of, or adversely affect the transactions contemplated by the Merger Agreement, including the Merger, or this Agreement or the performance by the Company of its obligations under the Merger Agreement.
(b) The obligations of each Stockholder in this Section 2.1 shall apply whether or not the Merger or any action above is recommended by the Board (or any committee thereof).
(c) Any vote required to be cast pursuant to this Section 2.1 shall be cast or executed in accordance with the applicable procedures relating thereto so as to ensure that it is duly counted for purposes of recording the results of that vote. Any attempt by a Stockholder to vote, consent or express dissent with respect to (or otherwise to utilize the voting power of) such Stockholder’s Shares in contravention of this Section 2.1 shall be null and void ab initio. If a Stockholder is the beneficial owner, but not the holder of record, of any Shares, such Stockholder agrees to take all actions necessary to cause the holder of record and any nominees to vote all of such Shares in accordance with this Section 2.1. To the extent a Stockholder does not fully control the determinations of such stockholder entity, such Stockholder agrees to exercise all voting or other rights it has in such entity to carry out the intent and purposes of the support and voting obligations in this Section 2.1 or otherwise set forth in this Agreement. For the avoidance of doubt, the foregoing commitments apply to any Shares held by any trust, limited partnership or other entity holding Shares over which the applicable Stockholder exercises direct or indirect voting control.
(d) Nothing in this Agreement shall obligate any Stockholder to exercise any option or any other right to acquire any shares of Class A Common Stock.
B-2

TABLE OF CONTENTS

ARTICLE III
ADDITIONAL AGREEMENTS
3.1 Waiver of Appraisal Rights and Certain Other Actions; Litigation. To the fullest extent permitted by Law, each Stockholder hereby irrevocably and unconditionally waives, and agrees not to exercise, any rights of appraisal (including under Section 262 of the DGCL), any dissenters’ rights and any similar rights relating to the Merger that such Stockholder may have, directly or indirectly, by virtue of the ownership of any Shares, or may acquire in connection with the Merger. Each Stockholder further agrees not to commence, join in, facilitate, assist or knowingly encourage, and agrees to take all actions necessary to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against Parent, Merger Sub or the Company or any of their respective affiliates and each of their successors, directors, managers or officers relating to the negotiation, execution or delivery of this Agreement or the Merger Agreement or the consummation of the transactions contemplated hereby or thereby, including any claim (a) challenging the validity of, or seeking to enjoin or delay the operation of, any provision of this Agreement or the Merger Agreement (including any claim seeking to enjoy or delay the closing of the Merger) or (b) alleging a breach of any duty of the Board or any Stockholder in connection with this Agreement, the Merger Agreement or the transactions contemplated hereby or thereby, and hereby irrevocably waives any claim or rights whatsoever with respect to any of the foregoing.
3.2 No Inconsistent Arrangements; No Transfer.
(a) Each Stockholder represents, covenants and agrees that, except for this Agreement, such Stockholder (i) has not entered into, and shall not enter into at any time prior to the Termination Date, any voting agreement, voting trust or similar arrangement or understanding with respect to such Stockholder’s Shares, (ii) has not granted, and shall not grant at any time prior to the Termination Date, a proxy, consent or power of attorney with respect to such Stockholder’s Shares, (iii) has not taken, and shall not take at any time while this Agreement remains in effect, any action that would, or would reasonably be expected to, (A) make any representation or warranty of such Stockholder contained herein untrue or incorrect, (B) violate or conflict with such Stockholder’s covenants and obligations under this Agreement, (C) otherwise have the effect of preventing, impairing or materially delaying such Stockholder from performing any of its obligations under this Agreement or (D) have the effect of preventing, impairing or materially delaying the Merger or the other transactions contemplated by the Merger Agreement or the performance by the Company of its obligations under the Merger Agreement.
(b) Except as provided hereunder, from and after the date hereof and until the Termination Date, each Stockholder shall not, directly or indirectly: (i) create or permit to exist any Encumbrances, other than Permitted Encumbrances, on such Stockholder’s Shares; (ii) transfer, sell, short sell, assign, tender, exchange, encumber, gift, hedge, distribute, pledge or otherwise dispose of (by merger, by testamentary disposition, by operation of Law or otherwise), or grant a proxy with respect to, such Stockholder’s Shares, beneficial ownership thereof or any other interest therein, or enter into any derivative arrangement (collectively, “Transfer”) with respect to such Stockholder’s Shares, or any right or interest therein (or offer to do or consent to any of the foregoing); (iii) enter into or acquire any Contract with respect to such Stockholder’s Shares or any legal or beneficial interest therein, including any derivative contract, any futures or forward contract to deliver such Stockholder’s Shares or any other hedging or other derivative, swap, “put-call,” margin, securities lending or other transaction that has or reasonably would be expected to have the effect of changing, limiting, arbitraging or reallocating the economic benefits and risks of ownership of such Stockholder’s Shares; (iv) grant or permit the grant of any proxy, power-of-attorney or other authorization or consent in or with respect to such Stockholder’s Shares; or (v) deposit or permit the deposit of such Stockholder’s Shares into a voting trust or enter into a voting agreement or arrangement with respect to such Stockholder’s Shares. Any action taken in violation of the immediately preceding sentence shall be null and void ab initio. Notwithstanding the foregoing, each Stockholder may Transfer such Stockholder’s Shares (A) in connection with the payment of the exercise price and/or the satisfaction of any tax withholding obligations arising from the exercise, vesting and/or settlement of any Company Option, Company RSU or Company PSU, (B) pursuant to a Rule 10b5-1 trading plan in effect as of the date hereof, or (C) if such Stockholder is the Chief Executive Officer of the Company as of the date hereof, (1) in sales or transfers of up to 210,530 Shares in the aggregate and (2) in transfers of up to 210,530 Shares in the aggregate to a charitable remainder trust (any such Transfer or any Transfer with Parent’s prior written consent, a “Permitted Transfer”), provided that any Transfer of Shares pursuant to clauses (A), (B) and (C), in the aggregate (taking into account all Transfers of Shares pursuant to this clause by any Stockholder from and after the date of this Agreement), will not, and would not reasonably be expected to, exceed one and one-half percent (1.5%) of the total voting power of the outstanding shares of Class A Common Stock as of immediately prior to the applicable Determination Date. If any involuntary Transfer of such
B-3

TABLE OF CONTENTS

Stockholder’s Shares in the Company shall occur (including, but not limited to, a sale by any Stockholder’s trustee in any bankruptcy, or a sale to a purchaser at any creditor’s or court sale), the transferee (including any transferees and subsequent transferees of the initial transferee) shall take and hold such Shares subject to all of the terms of this Agreement applicable to the initial Stockholder of such Shares.
3.3 Adjustments. In the event of any stock split (including a reverse stock split), stock dividend, merger, reorganization, recapitalization, reclassification, combination, exchange of shares or the like of the capital stock of the Company affecting such Stockholder’s Shares, the terms of this Agreement shall apply to the resulting securities.
3.4 No Shop Obligations of the Stockholders.
(a) Subject to Section 5.14 and from the date hereof until the Termination Date, each Stockholder shall not, and shall cause its affiliates and its and their respective Representatives not to, directly or indirectly, (i) solicit, initiate or knowingly encourage or facilitate (including by way of providing information or taking any other action) any inquiry, proposal or offer, or the making, submission or announcement of any inquiry, proposal or offer which constitutes or would reasonably be expected to lead to an Acquisition Proposal, (ii) participate in any negotiations regarding, or furnish to any person any information relating to, the Company or any Company Subsidiary in connection with an actual or potential Acquisition Proposal, (iii) otherwise cooperate with or assist or participate in, or facilitate, any such inquiries, proposals, offers, discussions or negotiations, (iv) encourage or recommend any other holder of Class A Common Stock to not adopt the Merger Agreement or approve the transactions contemplated by the Merger Agreement, including the Merger, (v) support, recommend, endorse, authorize or approve, or propose to support, recommend, endorse, authorize or approve, any Acquisition Proposal or enter into any Company Acquisition Agreement or (vi) resolve or agree to do any of the foregoing. Each Stockholder shall, and shall cause its affiliates and its and their respective Representatives to, immediately cease any and all solicitation, encouragement, discussion or negotiation with any Person or groups or provision of any information to any persons (other than Parent, its Subsidiaries, and their respective Representatives acting on their behalf) with respect to any inquiry, proposal or offer that constitutes, or would reasonably be expected to lead to, an Acquisition Proposal. Notwithstanding the foregoing, each Stockholder, its affiliates and its and their respective Representatives may engage in such activities to the extent that the Company is permitted to engage in such activities pursuant to the terms of the Merger Agreement, but only if such Stockholder and its affiliates and its and their respective Representatives each comply with the terms of the Merger Agreement as if it were the Company.
(b) From and after the date hereof until the Effective Time, each Stockholder shall promptly (and in any event within twenty-four (24) hours) (i) notify Parent of (A) any Acquisition Proposal it receives in its capacity as a stockholder of the Company, (B) any proposals or inquiries it receives in its capacity as a stockholder of the Company that would reasonably be expected to lead to an Acquisition Proposal and (C) any inquiry or request it receives in its capacity as a stockholder of the Company for information relating to the Company or any Company Subsidiary by any person who has made or would reasonably be expected to make any Acquisition Proposal, (ii) if such Acquisition Proposal, request or inquiry is in writing, deliver to Parent a copy of such Acquisition Proposal, request or inquiry and any related draft agreements and other written materials setting forth the terms and conditions of such Acquisition Proposal, request or inquiry, and (iii) if such Acquisition Proposal, request or inquiry is oral, provide to Parent a reasonably detailed summary thereof. Such notice shall indicate the identity of the Person making such Acquisition Proposal, inquiry, proposal or request. Without limiting any Stockholder’s other obligations hereunder, each Stockholder shall keep Parent reasonably informed on a prompt and timely basis of the status and material details of any such Acquisition Proposal and with respect to any material change to the terms of any such Acquisition Proposal within twenty-four (24) hours of any such material change.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES
4.1 Representations and Warranties of Each Stockholder. Each Stockholder hereby represents and warrants to Parent, as to such Stockholder with respect to his, her or its own account and with respect to its Shares, on a several basis, that:
(a) Authorization; Binding Agreement. If such Stockholder is not an individual, such Stockholder is duly organized and validly existing in good standing (where such concept is recognized) under the Laws of the jurisdiction in which it is incorporated or constituted and the consummation of the transactions contemplated hereby are within such Stockholder’s entity powers and have been duly authorized by all necessary entity actions on the part of such Stockholder, and such Stockholder has all requisite entity power and authority to execute, deliver and perform this Agreement and to consummate the transactions contemplated hereby. If such Stockholder
B-4

TABLE OF CONTENTS

is an individual, such Stockholder has all requisite legal capacity, right and authority to execute and deliver this Agreement and to perform such Stockholder’s obligations hereunder. This Agreement has been duly and validly executed and delivered by such Stockholder and, assuming the due authorization, execution and delivery by Parent constitutes a legal, valid and binding obligation of such Stockholder, enforceable against such Stockholder in accordance with its terms, subject to the Enforceability Limitations. If such Stockholder is an individual and is married, and such Stockholder’s Shares constitute community property or otherwise need spousal or other approval for this Agreement to be legal, valid and binding, this Agreement has been duly and validly executed and delivered by such Stockholder’s spouse and, assuming the due authorization, execution and delivery by Parent, constitutes a legal, valid and binding obligation of such Stockholder’s spouse, enforceable against such Stockholder’s spouse in accordance with its terms, subject to the Enforceability Limitations.
(b) Non-Contravention. Neither the execution and delivery of this Agreement by such Stockholder (and if applicable, such Stockholder’s spouse) nor the consummation of the transactions contemplated hereby nor compliance by such Stockholder (and if applicable, such Stockholder’s spouse) with any provisions herein will (a) violate, contravene or conflict with or result in any breach of any provision of the certificate of incorporation or bylaws (or other similar governing documents) of such Stockholder, (b) require any consent, approval, authorization or permit of, or filing with or notification to, any Governmental Entity on the part of such Stockholder (and if applicable, such Stockholder’s spouse), except for compliance with the applicable requirements of the Securities Act, the Exchange Act or any other United States or federal securities laws and the rules and regulations promulgated thereunder, (c) violate, conflict with, or result in a breach of any provisions of, or require any consent, waiver or approval or result in a default or loss of a benefit (or give rise to any right of termination, cancellation, modification or acceleration or any event that, with the giving of notice, the passage of time or otherwise, would constitute a default or give rise to any such right) under any of the terms, conditions or provisions of any Contract to which such Stockholder (and if applicable, such Stockholder’s spouse) is a party or by which such Stockholder (and if applicable, such Stockholder’s spouse) or such Stockholder’s Shares may be bound, (d) result (or, with the giving of notice, the passage of time or otherwise, would result) in the creation or imposition of any Lien (other than Permitted Liens) on any asset of such Stockholder (and if applicable, such Stockholder’s spouse) (other than one created by Parent or Merger Sub) or (e) violate any Law applicable to such Stockholder (and if applicable, such Stockholder’s spouse) or by which such Stockholder’s Shares are bound, except, in the case of each of clauses (c), (d) and (e), as would not reasonably be expected to prevent or materially delay or impair the consummation by such Stockholder of the transactions contemplated by this Agreement or otherwise materially impair such Stockholder’s ability to perform its obligations hereunder.
(c) Ownership of Shares; Total Shares. Such Stockholder is the record and beneficial owner of all of the Existing Shares and has good and marketable title to all of the Existing Shares free and clear of any Liens, claims, proxies, voting trusts or agreements, options, rights, understandings or arrangements or any other encumbrances or restrictions whatsoever on title, transfer or exercise of any rights of a stockholder in respect of such Existing Shares (collectively, “Encumbrances”), except for any such Encumbrance that may be imposed pursuant to (i) this Agreement, (ii) any applicable restrictions on transfer under the Securities Act or any state securities law, (iii) the Company Governing Documents, and (iv) any applicable Company Equity Plan or agreements evidencing grants thereunder ((i) through (iv), collectively, “Permitted Encumbrances”).
(d) The Existing Shares listed on Schedule A opposite such Stockholder’s name constitute all of the shares of Class A Common Stock, Company Options, Company RSUs and Company PSUs, and any other securities of the Company beneficially owned by such Stockholder as of the date hereof.
(e) Voting Power. Such Stockholder has full voting power with respect to all of such Stockholder’s Shares (to the extent such Shares have voting rights), and full power of disposition with respect to such Shares to the extent they consist of vested shares of Class A Common Stock, full power to issue instructions with respect to the matters set forth herein and full power to agree to all of the matters set forth in this Agreement, in each case with respect to all of such Stockholder’s Shares.
(f) Absence of Other Voting Agreements. (i) None of such Stockholder’s Shares is or will be subject to any voting trust, proxy or other agreement, arrangement or restriction with respect to the voting of such Shares, in each case, that is inconsistent with this Agreement and (ii) none of such Stockholder’s Shares is subject to any pledge agreement pursuant to which such Stockholder does not retain sole and exclusive voting rights with respect to such Shares subject to such pledge agreement at least until the occurrence of an event of default under the related debt instrument.
B-5

TABLE OF CONTENTS

(g) Absence of Litigation. With respect to such Stockholder, as of the date hereof, there is no Proceeding pending against (i) such Stockholder, or, to the knowledge of such Stockholder, threatened against such Stockholder or its affiliates or (ii) any of such Stockholder’s properties or assets (including any of such Stockholder’s Shares), in each case, that would reasonably be expected to restrict, prevent, materially delay or impair the performance by such Stockholder of its obligations under this Agreement.
(h) Reliance by Parent and Merger Sub. Such Stockholder understands and acknowledges that Parent and Merger Sub are entering into the Merger Agreement in reliance upon such Stockholder’s execution and delivery of this Agreement and the representations and warranties of such Stockholder contained herein. Such Stockholder understands and acknowledges that the Merger Agreement governs the terms of the Merger and the other transactions contemplated thereby.
4.2 Representations and Warranties of Parent. Parent hereby represents and warrants to each Stockholder as follows:
(a) Organization and Qualification. Parent is a duly organized and validly existing corporation in good standing under the Laws of the jurisdiction of its organization. All of the issued and outstanding capital stock of Merger Sub is owned directly or indirectly by Parent.
(b) Authority for this Agreement. Parent has all requisite entity power and authority to execute, deliver and perform its obligations under this Agreement and to consummate the transactions contemplated hereby. The execution and delivery of this Agreement by Parent have been duly and validly authorized by all necessary entity action on the part of Parent, and no other entity proceedings on the part of Parent are necessary to authorize this Agreement. This Agreement has been duly and validly executed and delivered by Parent and, assuming the due authorization, execution and delivery by each Stockholder, constitutes a legal, valid and binding obligation of Parent, enforceable against Parent in accordance with its terms, subject to the Enforceability Limitations.
ARTICLE V
MISCELLANEOUS
5.1 Notices. All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally (notice deemed given upon receipt), by electronic mail (notice deemed given upon transmission so long as there is no return error message or other notification of non-delivery received by the sender; provided that electronic mail received after 6:00 p.m., Pacific Time, shall be deemed received on the next day) or sent by a nationally recognized overnight courier service or express delivery service (notice deemed given upon receipt of proof of delivery), to the Parties at the following addresses (or at such other address for a Party as shall be specified by like notice):
 
 
 
 
 
 
 
if to Parent or Merger Sub, to:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Salesforce, Inc.
 
 
 
 
 
 
415 Mission Street, 3rd Fl
 
 
 
 
 
 
San Francisco, California 94105
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
Chief Legal Officer
 
 
 
 
 
 
 
 
 
 
 
 
 
with a copy to:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Wachtell, Lipton, Rosen & Katz
 
 
 
 
 
 
51 West 52nd Street
 
 
 
 
 
 
New York, New York 10019
 
 
 
 
 
 
Email:
 
 
ajnussbaum@wlrk.com
 
 
 
 
 
 
 
 
 
mlu@wlrk.com
 
 
 
 
 
 
Attention:
 
 
Andrew J. Nussbaum
 
 
 
 
 
 
 
 
 
Meng Lu
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B-6

TABLE OF CONTENTS

 
 
 
 
 
 
 
if to a Stockholder, to such Stockholder’s address or email address set forth below:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
William Magnuson
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
William Magnuson
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scintillating Holdings LLC
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
William Magnuson
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Jonathan Hyman
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
Jonathan Hyman
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hyman 2026 Charitable Remainder Trust
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
Jonathan Hyman
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hyman 2021 GST Descendants Trust
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
Kate Hyman
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hyman 2021 GST Family Trust
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
Lauren Meyer
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Neeraj Agrawal
 
 
 
 
 
 
c/o Battery Ventures One
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
[***]
 
 
 
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
Attention:
 
 
Neeraj Agrawal
 
 
 
 
 
with a copy to:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Davis Polk & Wardwell LLP
 
 
 
 
 
 
900 Middlefield Road
 
 
 
 
 
 
Redwood City, California 94063
 
 
 
 
 
 
Email:
 
 
paul.scrivano@davispolk.com
 
 
 
 
 
 
 
 
 
cheryl.chan@davispolk.com
 
 
 
 
 
 
Attention:
 
 
Paul S. Scrivano
 
 
 
 
 
 
 
 
 
Cheryl Chan
 
 
 
 
 
 
 
 
 
 
B-7

TABLE OF CONTENTS

5.2 Termination. This Agreement shall terminate automatically with respect to a Stockholder and Parent, without any notice or other action by any Person, upon the earliest to occur of (a) the valid termination of the Merger Agreement in accordance with its terms, (b) the Effective Time, (c) the entry without the prior written consent of such Stockholder into any amendment, waiver or modification to the Merger Agreement that results in a decrease in the Merger Consideration or changes the mix of Merger Consideration or (d) the delivery of written notice by Parent to such Stockholder of termination of this Agreement, and upon the occurrence of the earliest of such events this Agreement shall terminate and be of no further force (the date of termination, the “Termination Date”). Upon termination of this Agreement with respect to a Stockholder and Parent, neither such Stockholder nor Parent shall have any further obligations or liabilities under this Agreement; provided, however, that (i) nothing set forth in this Section 5.2 shall relieve any Party from liability for any breach of this Agreement prior to termination hereof or relieve or otherwise limit the liability of any Party for Fraud or any willful breach (as defined in the Merger Agreement) of this Agreement prior to termination hereof, and (ii) the provisions of this Article V shall survive any termination of this Agreement.
5.3 Amendments and Waivers.
(a) Subject to applicable Law and except as otherwise provided in this Agreement, this Agreement may be amended, modified and supplemented by written agreement of each of the Parties.
(b) At any time and from time to time prior to the Effective Time, each Party may, to the extent legally allowed and except as otherwise set forth herein, (i) extend the time for the performance of any of the obligations or other acts of the other Party, as applicable, (ii) waive any inaccuracies in the representations and warranties made by the other Party contained herein or in any document delivered pursuant hereto and (iii) waive compliance with any of the agreements or conditions for their respective benefit contained herein. Any agreement on the part of Parent or any Stockholder to any such extension or waiver shall be valid only if set forth in an instrument in writing signed on behalf of Parent or such Stockholder, as applicable. No failure or delay by Parent or a Stockholder in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise of any other right hereunder.
5.4 Entire Agreement; Third-Party Beneficiaries. This Agreement and the other documents and certificates delivered pursuant hereto constitute the entire agreement, and supersede all prior agreements and understandings, both written and oral, among the Parties with respect to the subject matter of this Agreement. Nothing in this Agreement, express or implied, is intended to confer upon any Person other than the Parties any rights or remedies hereunder or thereunder.
5.5 Enforcement; Remedies. The Parties agree that irreparable damage would occur and that the Parent and Merger Sub would not have any adequate remedy at law in the event that any Stockholder did not perform any of the provisions of this Agreement in accordance with their specific terms or otherwise breached any such provisions. It is accordingly agreed that Parent and Merger Sub shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in addition to any other remedy to which they are entitled at law or in equity. Any and all remedies herein expressly conferred upon Parent and Merger Sub will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by Law or equity upon Parent or Merger Sub, and the exercise by Parent or Merger Sub of any one remedy will not preclude the exercise of any other remedy.
5.6 Governing Law; Jurisdiction.
(a) This Agreement and any disputes relating to or arising out of this Agreement and the transactions contemplated hereby (whether based in contract, tort or otherwise) shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to conflicts of laws principles that would result in the application of the Law of any other state.
(b) Each of the Parties hereto hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of the Court of Chancery of the State of Delaware, or, if (and only if) such court finds it lacks jurisdiction, the Federal court of the United States of America sitting in Delaware, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Agreement and the rights and obligations hereunder or the agreements delivered in connection herewith or the transactions contemplated hereby or thereby or for recognition or enforcement of any judgment relating thereto, and each of the Parties hereby irrevocably and unconditionally (i) agrees not to commence any such action or proceeding, except in the Court of Chancery of the State of Delaware, or, if (and only if) such court finds it lacks jurisdiction, the Federal court of the
B-8

TABLE OF CONTENTS

United States of America sitting in Delaware, and any appellate court from any thereof; (ii) agrees that any claim in respect of any such action or proceeding may be heard and determined in the Court of Chancery of the State of Delaware, or, if (and only if) such court finds it lacks jurisdiction, the Federal court of the United States of America sitting in Delaware, and any appellate court from any thereof; (iii) waives, to the fullest extent it may legally and effectively do so, any objection that it may now or hereafter have to the laying of venue of any such action or proceeding in such courts; and (iv) waives, to the fullest extent permitted by Law, the defense of an inconvenient forum to the maintenance of such action or proceeding in such courts. Each of the Parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Law. Each Party to this Agreement irrevocably consents to service of process inside or outside the territorial jurisdiction of the courts referred to in this Section 5.6(b) in the manner provided for notices in Section 5.1. Nothing in this Agreement will affect the right of any Party to this Agreement to serve process in any other manner permitted by applicable Law.
5.7 Waiver of Jury Trial.
(a) EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR MERGER OR THE OTHER TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH PARTY HERETO CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE SUCH WAIVERS, (B) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVERS, (C) IT MAKES SUCH WAIVERS VOLUNTARILY AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 5.7.
5.8 Assignment. This Agreement shall not be assigned by any Party (including by operation of law, by merger or otherwise) without the prior written consent of (a) Parent, in the case of an assignment by a Stockholder and (b) each Stockholder, in the case of an assignment by Parent; provided that Parent may assign any of its respective rights and obligations to any direct or indirect Subsidiary of Parent, but no such assignment shall relieve Parent of its obligations hereunder. Subject to the preceding sentence, but without relieving any Party of any obligation hereunder, this Agreement will be binding upon, inure to the benefit of and be enforceable by the Parties and their respective successors and assigns.
5.9 Descriptive Headings. The table of contents and headings set forth in this Agreement or any schedule delivered pursuant to this Agreement are for convenience of reference purposes only and shall not affect or be deemed to affect in any way the meaning or interpretation of this Agreement or such schedule or any term or provision hereof or thereof.
5.10 Severability. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by rule of Law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible in an acceptable manner.
5.11 Counterparts. This Agreement may be executed manually or by other electronic transmission by the Parties, in any number of counterparts, each of which shall be considered one and the same agreement and shall become effective when a counterpart hereof shall have been signed by each of the Parties and delivered to the other Parties. The exchange of a fully executed Agreement (in counterparts or otherwise) by electronic transmission in .pdf or DocuSign format shall be sufficient to bind the Parties to the terms and conditions of this Agreement.
5.12 Interpretation. When a reference is made in this Agreement to sections, such reference shall be to a section of this Agreement, unless otherwise indicated. Whenever the words “include,” “includes” or “including” are used in this Agreement they shall be deemed to be followed by the words “without limitation.” As used in this Agreement, the term “affiliates” shall have the meaning set forth in Rule 12b-2 of the Exchange Act. The word “extent” and the phrase “to the extent” when used in this Agreement shall mean the degree to which a subject or other things extends, and such word or phrase shall not merely mean “if.” The term “or” is not exclusive, and shall be interpreted as “and/or.” The phrases “the date of this Agreement,” “the date hereof,” “of even date herewith” and terms of similar import, shall be
B-9

TABLE OF CONTENTS

deemed to refer to the date set forth in the preamble to this Agreement. All references herein to a Subsidiary of a Party shall be deemed to include all direct and indirect Subsidiaries of such Party, unless otherwise indicated or the context otherwise requires. A reference to any specific Law or to any provision of any Law, whether or not followed by the phrase “as amended,” includes any amendment to, and any modification, re-enactment or successor thereof, any legislative provision substituted therefor and all rules, regulations and statutory instruments issued thereunder or pursuant thereto, except that, for purposes of any representations and warranties in this Agreement that are made as a specific date, references to any specific Law will be deemed to refer to such legislation or provision (and all rules, regulations and statutory instruments issued thereunder or pursuant thereto) as of such date. The Parties agree that they have been represented by counsel during the negotiation and execution of this Agreement and, therefore, waive the application of any Law, regulation, holding or rule of construction providing that ambiguities in an agreement or other document will be construed against the Party drafting such agreement or document.
5.13 Publicity; Documentation and Information. Each Stockholder agrees that it shall not make any public announcement regarding this Agreement or the transactions contemplated hereby without the prior written consent of Parent, except as may be required by applicable Law (provided that reasonable notice of any such disclosure will be provided to Parent, and such Stockholder will consider in good faith the reasonable comments of Parent with respect to such disclosure and otherwise cooperate with Parent in obtaining confidential treatment with respect to such disclosure). Each Stockholder consents to and hereby authorizes Parent, Merger Sub and the Company to publish and disclose in all documents and schedules filed with the SEC or any other Governmental Entity or applicable securities exchange, and any press release or other disclosure document that Parent or Merger Sub reasonably determines to be necessary or advisable in connection with the Merger or any other transactions contemplated by the Merger Agreement or this Agreement, including, without limitation, any definitive proxy statement (and any amendments or supplements thereto), such Stockholder’s identity and ownership of such Stockholder’s Shares, the existence of this Agreement and the nature of such Stockholder’s commitments and obligations under this Agreement, and each Stockholder acknowledges that Parent, Merger Sub or the Company may, in Parent’s or the Company’s sole discretion, as applicable, file this Agreement or a form hereof with the SEC or any other Governmental Entity or securities exchange.
5.14 Capacity as Stockholder. Each Stockholder signs this Agreement in such Stockholder’s capacity as a stockholder of the Company, and not, if applicable, in such Stockholder’s capacity as a director, officer or employee of the Company. Notwithstanding anything herein to the contrary, nothing in this Agreement shall in any way restrict a director or officer of the Company in the taking of any actions (or the failure to take any actions) in his or her capacity as a director or officer of the Company, or in the exercise of his or her fiduciary duties in his or her capacity as a director or officer of the Company, or prevent, or be construed to create any obligation on the part of, any director or officer of the Company from taking any action in his or her capacity as such director or officer.
5.15 Expenses. All costs and expenses incurred in connection with this Agreement shall be paid by the Party incurring such costs or expenses.
5.16 Further Assurances. Each Stockholder will execute and deliver, or cause to be executed and delivered, all further documents and instruments and use its reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable Law, to perform its obligations under this Agreement.
5.17 Stockholder Obligation Several and Not Joint. The obligations of each Stockholder hereunder shall be several and not joint, and no Stockholder shall be liable for any breach of the terms of this Agreement by any other Stockholder.
[Signature Page Follows]
B-10

TABLE OF CONTENTS

IN WITNESS WHEREOF, the Parties, intending to be legally bound hereby, have executed or caused this Agreement to be executed in counterparts, all as of the day and year first above written.
 
 
 
 
 
 
 
SALESFORCE, INC.
 
 
 
 
 
 
 
 
 
 
By:
 
 
/s/ John Somorjai
 
 
 
Name:
 
 
John Somorjai
 
 
 
Title:
 
 
President, Corporate Development and Investments
 
 
 
 
 
 
 
[Signature Page to Voting and Support Agreement]
B-11

TABLE OF CONTENTS

 
 
 
 
 
 
 
STOCKHOLDER:
 
 
 
 
 
 
 
 
 
 
By:
 
 
/s/ William Magnuson
 
 
 
Name:
 
 
William Magnuson
 
 
 
 
 
 
 
[Signature Page to Voting and Support Agreement]
B-12

TABLE OF CONTENTS

 
 
 
 
 
 
 
SCINTILLATING HOLDINGS LLC:
 
 
 
 
 
 
 
 
 
 
 
By:
 
 
/s/ William Magnuson
 
 
 
 
Name:
 
 
William Magnuson
 
 
 
 
Title:
 
 
Member
 
 
 
 
 
 
 
 
 
[Signature Page to Voting and Support Agreement]
B-13

TABLE OF CONTENTS

 
 
 
 
 
 
 
STOCKHOLDER:
 
 
 
 
 
 
 
 
 
 
 
By:
 
 
/s/ Jonathan Hyman
 
 
 
 
Name:
 
 
Jonathan Hyman
 
 
 
 
 
 
 
 
 
[Signature Page to Voting and Support Agreement]
B-14

TABLE OF CONTENTS

 
 
 
 
 
 
 
HYMAN 2026 CHARITABLE REMAINDER TRUST:
 
 
 
 
 
 
 
 
 
 
 
By:
 
 
/s/ Jonathan Hyman
 
 
 
 
Name:
 
 
Jonathan Hyman
 
 
 
 
Title:
 
 
Trustee
 
 
 
 
 
 
 
 
 
[Signature Page to Voting and Support Agreement]
B-15

TABLE OF CONTENTS

 
 
 
 
 
 
 
HYMAN 2021 GST DESCENDANTS TRUST:
 
 
 
 
 
 
 
 
 
 
 
By:
 
 
/s/ Kate Hyman
 
 
 
 
Name:
 
 
Kate Hyman
 
 
 
 
Title:
 
 
Trustee
 
 
 
 
 
 
 
 
 
[Signature Page to Voting and Support Agreement]
B-16

TABLE OF CONTENTS

 
 
 
 
 
 
 
JONATHAN HYMAN 2021 GST FAMILY TRUST:
 
 
 
 
 
 
 
 
 
 
By:
 
 
/s/ Lauren Meyer
 
 
 
Name:
 
 
Lauren Meyer
 
 
 
Title:
 
 
Trustee
 
 
 
 
 
 
 
[Signature Page to Voting and Support Agreement]
B-17

TABLE OF CONTENTS

 
 
 
 
 
 
 
STOCKHOLDER:
 
 
 
 
 
 
 
 
 
 
 
By:
 
 
/s/ Neeraj Agrawal
 
 
 
 
Name:
 
 
Neeraj Agrawal
 
 
 
 
 
 
 
 
 
[Signature Page to Voting and Support Agreement]
B-18

TABLE OF CONTENTS

SCHEDULE A
 
EXISTING SHARES
 
 
 
 
 
 
 
 
 
 
 
 
 
Name of Stockholder
 
 
Number of
Shares of
Class A
Common
Stock
 
 
Company
Options
 
 
Company
RSUs
 
 
Company
PSUs
William Magnuson
 
 
4,258,551
 
 
1,251,658
 
 
585,809
 
 
125,944
Scintillating Holdings LLC
 
 
470
 
 
 
 
 
 
 
 
 
Jonathan Hyman
 
 
946,035
 
 
325,213
 
 
187,184
 
 
38,412
Hyman 2026 Charitable Remainder Trust
 
 
350,000
 
 
 
 
 
 
 
 
 
Hyman 2021 GST Descendants Trust
 
 
221,436
 
 
 
 
 
 
 
 
 
Hyman 2021 GST Family Trust
 
 
28,564
 
 
 
 
 
 
 
 
 
Neeraj Agrawal
 
 
194,769
 
 
 
 
 
7,753
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B-19

TABLE OF CONTENTS

Annex C
Opinion of Qatalyst Partners LP

 
October 19, 2026
Board of Directors
Braze, Inc.
28 East 28th Street, Floor 12
New York, NY 10016
Members of the Board:
We understand that Braze, Inc., a Delaware corporation (the “Company”), Salesforce, Inc., a Delaware corporation (“Parent”), and Banff Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), propose to enter into an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which, among other things, Merger Sub will merge with and into the Company (the “Merger”). The Company will be the surviving entity in the Merger, and from and after the effective time of the Merger, will be a wholly owned subsidiary of Parent. Pursuant to the Merger, each share of Class A common stock, par value $0.0001 per share, of the Company (“Class A Common Stock”) that is issued and outstanding immediately prior to the effective time of the Merger, other than (a) shares of Class A Common Stock owned or held in treasury by the Company or owned by Parent, (b) shares of Class A Common Stock owned by any direct or indirect wholly owned subsidiary of Parent or of the Company, and (c) Dissenting Shares (as such term is defined in the Merger Agreement), will be cancelled and converted into the right to receive an amount equal to $47.50 per share in cash, without interest thereon (the “Merger Consideration”). The terms and conditions of the Merger are more fully set forth in the Merger Agreement.
You have asked for our opinion as to whether the Merger Consideration to be received pursuant to, and in accordance with, the terms of the Merger Agreement by the holders of shares of Class A Common Stock (other than Parent or any affiliate of Parent) (the “Holders”), is fair, from a financial point of view, to such Holders.
For purposes of the opinion set forth herein, we have reviewed a draft of the Merger Agreement, dated October 18, 2026 (the “Draft Merger Agreement”), certain related documents and certain publicly available financial statements and other business and financial information of the Company. We have also reviewed certain forward-looking information relating to the Company prepared by the management of the Company, including financial projections and operating data of the Company (the “Company Projections”). Additionally, we discussed the past and current operations and financial condition and the prospects of the Company with senior management of the Company, and participated in and advised the Company on, certain of the negotiations relating to the Merger. We also reviewed the historical market prices and trading activity for Class A Common Stock and compared the financial performance of the Company and the prices and trading activity of Class A Common Stock with that of certain other selected publicly-traded companies and their securities. In addition, we reviewed the financial terms, to the extent publicly available, of selected acquisition transactions and performed such other analyses, reviewed such other information and considered such other factors as we have deemed appropriate.
In arriving at our opinion, we have assumed and relied upon, without independent verification, the accuracy and completeness of the information that was publicly available or supplied or otherwise made available to, or discussed with, us by the Company. With respect to the Company Projections, we have been advised by the management of the Company, and have assumed based on discussions with the management and the Board of Directors of the Company, that they have been reasonably prepared on bases reflecting the best currently available estimates and judgments of the management of the Company of the future financial performance of the Company and other matters covered thereby. We express no view as to such Company Projections or the assumptions on which they were based. We have assumed that the terms of the Draft Merger Agreement will not differ materially from the final executed Merger Agreement, and that the Merger will be consummated in accordance with the terms set forth in the Merger Agreement, without any modification, waiver or delay of any terms or conditions. In addition, we have assumed that in connection with the
Three Embarcadero Center | 15th Floor | San Francisco, CA 94111
Tel: 415.844.7700 | www.qatalyst.com
C-1

TABLE OF CONTENTS

receipt of all the necessary approvals of the proposed Merger, no delays, limitations, conditions or restrictions will be imposed that could have an adverse effect on the Company or the contemplated benefits expected to be derived in the proposed Merger. We have relied upon, without independent verification, the assessment of the Company and its legal, tax or regulatory advisors with respect to legal, tax or regulatory matters. We have not made any independent evaluation or appraisal of the assets or liabilities (contingent or otherwise) of the Company or its affiliates nor have we been furnished with any such evaluation or appraisal. In addition, we have relied, without independent verification, upon the assessment of the management of the Company as to the existing and future technology and products of the Company and the risks associated with such technology and products. In arriving at our opinion, we were not authorized to solicit, and did not solicit, interest from any party with respect to an acquisition, business combination or other extraordinary transaction involving the Company.
We have acted as financial advisor to the Company in connection with the Merger and will receive a fee for our services a portion of which has been earned, and a further portion of which will become payable upon delivery of this opinion. We will receive an additional, larger fee if the Merger is consummated. In addition, the Company has agreed to reimburse our expenses and indemnify us for certain liabilities arising out of our engagement. During the two-year period prior to the date hereof, no material relationship existed between Qatalyst Partners or any of its affiliates, on the one hand, and the Company or Parent, on the other hand, pursuant to which compensation was received by Qatalyst Partners or its affiliates. Qatalyst Partners and/or its affiliates may in the future provide investment banking and other financial services to the Company or Parent and their respective affiliates for which we would expect to receive compensation.
Qatalyst Partners provides investment banking and other services to a wide range of entities and individuals, domestically and offshore, from which conflicting interests or duties may arise. In the ordinary course of these activities, affiliates of Qatalyst Partners may at any time hold long or short positions, and may trade or otherwise effect transactions in debt or equity securities or loans of the Company, Parent or certain of their respective affiliates.
This opinion has been approved by our opinion committee in accordance with our customary practice. This opinion is for the information of the Board of Directors of the Company and may not be used for any other purpose without our prior written consent. This opinion does not constitute a recommendation as to how stockholders of the Company should vote with respect to the Merger or any other matter and does not in any manner address the price at which Class A Common Stock will trade at any time.
Our opinion is necessarily based on financial, economic, market and other conditions as in effect on, and the information made available to us as of, the date hereof. Events occurring after the date hereof may affect this opinion and the assumptions used in preparing it, and we do not assume any obligation to update, revise or reaffirm this opinion. Our opinion does not address the underlying business decision of the Company to engage in the Merger, or the relative merits of the Merger as compared to any strategic alternatives that may be available to the Company. We have not been asked to, nor do we express any view on, and our opinion does not address, any other term or aspect of the Merger Agreement, the Merger or any of the other transactions contemplated by the Merger Agreement, including, without limitation, the structure or form of the Merger, or any other agreements or arrangements contemplated by the Merger Agreement or entered into in connection with or otherwise contemplated by the Merger or any of the other transactions contemplated by the Merger Agreement, including, without limitation, the fairness of the Merger or any other term or aspect of the Merger or any of the other transactions contemplated by the Merger Agreement to, or any consideration to be received in connection therewith by, or the impact of the Merger or any of the other transactions contemplated by the Merger Agreement on, the holders (other than the Holders) of any class of securities, creditors or other constituencies of the Company or any other party. Our opinion is limited to the fairness, from a financial point of view, of the Merger Consideration to be received by the Holders pursuant to, and in accordance with, the terms of the Merger Agreement, and we express no opinion with respect to the fairness of the amount or nature of the compensation to any of the officers, directors or employees of the Company or any of its affiliates, or any class of such persons, relative to such consideration.
Based on and subject to the foregoing, we are of the opinion on the date hereof that the Merger Consideration to be received by the Holders pursuant to, and in accordance with, the terms of the Merger Agreement, is fair, from a financial point of view, to such Holders.
Yours faithfully,
/s/ Qatalyst Partners
QATALYST PARTNERS LP
Three Embarcadero Center | 15th Floor | San Francisco, CA 94111
Tel: 415.844.7700 | www.qatalyst.com
C-2

TABLE OF CONTENTS


 

TABLE OF CONTENTS


 

Keep reading